Skip to main content
Erschienen in: Journal of Neural Transmission 8/2019

18.06.2019 | High Impact Review in Neuroscience, Neurology or Psychiatry - Review Article

Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update—I. Hypokinetic-rigid movement disorders

verfasst von: Kurt A. Jellinger

Erschienen in: Journal of Neural Transmission | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

Extrapyramidal movement disorders include hypokinetic rigid and hyperkinetic or mixed forms, most of them originating from dysfunction of the basal ganglia (BG) and their information circuits. The functional anatomy of the BG, the cortico-BG–thalamocortical, and BG–cerebellar circuit connections are briefly reviewed. Pathophysiologic classification of extrapyramidal movement disorder mechanisms distinguish (1) parkinsonian syndromes, (2) chorea and related syndromes, (3) dystonias, (4) myoclonic syndromes, (5) ballism, (6) tics, and (7) tremor syndromes. Recent genetic and molecular–biologic classifications distinguish (1) synucleinopathies (Parkinson’s disease, dementia with Lewy bodies, Parkinson’s disease–dementia, and multiple system atrophy); (2) tauopathies (progressive supranuclear palsy, corticobasal degeneration, FTLD-17; Guamian Parkinson–dementia; Pick’s disease, and others); (3) polyglutamine disorders (Huntington’s disease and related disorders); (4) pantothenate kinase-associated neurodegeneration; (5) Wilson’s disease; and (6) other hereditary neurodegenerations without hitherto detected genetic or specific markers. The diversity of phenotypes is related to the deposition of pathologic proteins in distinct cell populations, causing neurodegeneration due to genetic and environmental factors, but there is frequent overlap between various disorders. Their etiopathogenesis is still poorly understood, but is suggested to result from an interaction between genetic and environmental factors. Multiple etiologies and noxious factors (protein mishandling, mitochondrial dysfunction, oxidative stress, excitotoxicity, energy failure, and chronic neuroinflammation) are more likely than a single factor. Current clinical consensus criteria have increased the diagnostic accuracy of most neurodegenerative movement disorders, but for their definite diagnosis, histopathological confirmation is required. We present a timely overview of the neuropathology and pathogenesis of the major extrapyramidal movement disorders in two parts, the first one dedicated to hypokinetic-rigid forms and the second to hyperkinetic disorders.
Literatur
Zurück zum Zitat Abbott RD, Nelson JS, Ross GW, Uyehara-Lock JH, Tanner CM, Masaki KH, Launer LJ, White LR, Petrovitch H (2017) Marinesco bodies and substantia nigra neuron density in Parkinson’s disease. Neuropathol Appl Neurobiol 43:621–630CrossRefPubMedPubMedCentral Abbott RD, Nelson JS, Ross GW, Uyehara-Lock JH, Tanner CM, Masaki KH, Launer LJ, White LR, Petrovitch H (2017) Marinesco bodies and substantia nigra neuron density in Parkinson’s disease. Neuropathol Appl Neurobiol 43:621–630CrossRefPubMedPubMedCentral
Zurück zum Zitat Abeliovich A, Gitler AD (2016) Defects in trafficking bridge Parkinson’s disease pathology and genetics. Nature 539:207–216CrossRefPubMed Abeliovich A, Gitler AD (2016) Defects in trafficking bridge Parkinson’s disease pathology and genetics. Nature 539:207–216CrossRefPubMed
Zurück zum Zitat Adamowicz DH, Roy S, Salmon DP, Galasko DR, Hansen LA, Masliah E, Gage FH (2017) Hippocampal alpha-synuclein in dementia with Lewy bodies contributes to memory impairment and is consistent with spread of pathology. J Neurosci 37:1675–1684CrossRefPubMedPubMedCentral Adamowicz DH, Roy S, Salmon DP, Galasko DR, Hansen LA, Masliah E, Gage FH (2017) Hippocampal alpha-synuclein in dementia with Lewy bodies contributes to memory impairment and is consistent with spread of pathology. J Neurosci 37:1675–1684CrossRefPubMedPubMedCentral
Zurück zum Zitat Adler CH, Caviness JN, Sabbagh MN, Shill HA, Connor DJ, Sue L, Evidente VG, Driver-Dunckley E, Beach TG (2010a) Heterogeneous neuropathological findings in Parkinson’s disease with mild cognitive impairment. Acta Neuropathol 120:827–828CrossRefPubMedPubMedCentral Adler CH, Caviness JN, Sabbagh MN, Shill HA, Connor DJ, Sue L, Evidente VG, Driver-Dunckley E, Beach TG (2010a) Heterogeneous neuropathological findings in Parkinson’s disease with mild cognitive impairment. Acta Neuropathol 120:827–828CrossRefPubMedPubMedCentral
Zurück zum Zitat Adler CH, Connor DJ, Hentz JG, Sabbagh MN, Caviness JN, Shill HA, Noble B, Beach TG (2010b) Incidental Lewy body disease: clinical comparison to a control cohort. Mov Disord 25:642–646CrossRefPubMedPubMedCentral Adler CH, Connor DJ, Hentz JG, Sabbagh MN, Caviness JN, Shill HA, Noble B, Beach TG (2010b) Incidental Lewy body disease: clinical comparison to a control cohort. Mov Disord 25:642–646CrossRefPubMedPubMedCentral
Zurück zum Zitat Adler CH, Dugger BN, Hentz JG, Hinni ML, Lott DG, Driver-Dunckley E, Mehta S, Serrano G, Sue LI, Duffy A, Intorcia A, Filon J, Pullen J, Walker DG, Beach TG (2016) Peripheral synucleinopathy in early Parkinson’s disease: submandibular gland needle biopsy findings. Mov Disord 31:250–256CrossRefPubMedPubMedCentral Adler CH, Dugger BN, Hentz JG, Hinni ML, Lott DG, Driver-Dunckley E, Mehta S, Serrano G, Sue LI, Duffy A, Intorcia A, Filon J, Pullen J, Walker DG, Beach TG (2016) Peripheral synucleinopathy in early Parkinson’s disease: submandibular gland needle biopsy findings. Mov Disord 31:250–256CrossRefPubMedPubMedCentral
Zurück zum Zitat Agarwal S, Gilbert R (2019) Progressive supranuclear palsy, 2018/09/26 edn. StatPearls Publishing, Treasure Island Agarwal S, Gilbert R (2019) Progressive supranuclear palsy, 2018/09/26 edn. StatPearls Publishing, Treasure Island
Zurück zum Zitat Ahmed Z, Josephs KA, Gonzalez J, DelleDonne A, Dickson DW (2008) Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy. Brain 131:460–472CrossRefPubMed Ahmed Z, Josephs KA, Gonzalez J, DelleDonne A, Dickson DW (2008) Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy. Brain 131:460–472CrossRefPubMed
Zurück zum Zitat Ahmed Z, Asi YT, Sailer A, Lees AJ, Houlden H, Revesz T, Holton JL (2012) The neuropathology, pathophysiology and genetics of multiple system atrophy. Neuropathol Appl Neurobiol 38:4–24CrossRefPubMed Ahmed Z, Asi YT, Sailer A, Lees AJ, Houlden H, Revesz T, Holton JL (2012) The neuropathology, pathophysiology and genetics of multiple system atrophy. Neuropathol Appl Neurobiol 38:4–24CrossRefPubMed
Zurück zum Zitat Alafuzoff I, Hartikainen P (2017) Alpha-synucleinopathies. In: Kovacs GG, Alafuzoff I (eds) Handbook of clinical neurology. Neuropathology, vol 145. Elsevier B.V., New York, pp 339–353 Alafuzoff I, Hartikainen P (2017) Alpha-synucleinopathies. In: Kovacs GG, Alafuzoff I (eds) Handbook of clinical neurology. Neuropathology, vol 145. Elsevier B.V., New York, pp 339–353
Zurück zum Zitat Alafuzoff I, Ince PG, Arzberger T, Al-Sarraj S, Bell J, Bodi I, Bogdanovic N, Bugiani O, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Ironside JW, Kavantzas N, King A, Korkolopoulou P, Kovacs GG, Meyronet D, Monoranu C, Parchi P, Parkkinen L, Patsouris E, Roggendorf W, Rozemuller A, Stadelmann-Nessler C, Streichenberger N, Thal DR, Kretzschmar H (2009) Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium. Acta Neuropathol 117:635–652CrossRefPubMed Alafuzoff I, Ince PG, Arzberger T, Al-Sarraj S, Bell J, Bodi I, Bogdanovic N, Bugiani O, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Ironside JW, Kavantzas N, King A, Korkolopoulou P, Kovacs GG, Meyronet D, Monoranu C, Parchi P, Parkkinen L, Patsouris E, Roggendorf W, Rozemuller A, Stadelmann-Nessler C, Streichenberger N, Thal DR, Kretzschmar H (2009) Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium. Acta Neuropathol 117:635–652CrossRefPubMed
Zurück zum Zitat Albrecht F, Bisenius S, Morales Schaack R, Neumann J, Schroeter ML (2017) Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses. NPJ Parkinsons Dis 3:12CrossRefPubMedPubMedCentral Albrecht F, Bisenius S, Morales Schaack R, Neumann J, Schroeter ML (2017) Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses. NPJ Parkinsons Dis 3:12CrossRefPubMedPubMedCentral
Zurück zum Zitat Alexander SK, Rittman T, Xuereb JH, Bak TH, Hodges JR, Rowe JB (2014) Validation of the new consensus criteria for the diagnosis of corticobasal degeneration. J Neurol Neurosurg Psychiatry 85:925–929CrossRefPubMed Alexander SK, Rittman T, Xuereb JH, Bak TH, Hodges JR, Rowe JB (2014) Validation of the new consensus criteria for the diagnosis of corticobasal degeneration. J Neurol Neurosurg Psychiatry 85:925–929CrossRefPubMed
Zurück zum Zitat Alexandris A, Walker L, Liu AKL, McAleese KE, Johnson M, Pearce RK, Gentleman SM, Attems J (2019) Cholinergic deficits and galaninergic hyperinnervation of the nucleus basalis of Meynert in Alzheimer’s disease and Lewy body disorders. Neuropathol Appl Neurobiol (accepted article) Alexandris A, Walker L, Liu AKL, McAleese KE, Johnson M, Pearce RK, Gentleman SM, Attems J (2019) Cholinergic deficits and galaninergic hyperinnervation of the nucleus basalis of Meynert in Alzheimer’s disease and Lewy body disorders. Neuropathol Appl Neurobiol (accepted article)
Zurück zum Zitat Ali F, Josephs K (2018a) The diagnosis of progressive supranuclear palsy: current opinions and challenges. Expert Rev Neurother 18:603–616CrossRefPubMed Ali F, Josephs K (2018a) The diagnosis of progressive supranuclear palsy: current opinions and challenges. Expert Rev Neurother 18:603–616CrossRefPubMed
Zurück zum Zitat Ali F, Josephs KA (2018b) Corticobasal degeneration: key emerging issues. J Neurol 265:439–445CrossRefPubMed Ali F, Josephs KA (2018b) Corticobasal degeneration: key emerging issues. J Neurol 265:439–445CrossRefPubMed
Zurück zum Zitat Ali F, Martin PR, Botha H, Ahlskog JE, Bower JH, Masumoto JY, Maraganore D, Hassan A, Eggers S, Boeve BF, Knopman DS, Drubach D, Petersen RC, Dunkley ED, van Gerpen J, Uitti R, Whitwell JL, Dickson DW, Josephs KA (2019) Sensitivity and specificity of diagnostic criteria for progressive supranuclear palsy. Mov Disord. https://doi.org/10.1002/mds.27619 CrossRefPubMedPubMedCentral Ali F, Martin PR, Botha H, Ahlskog JE, Bower JH, Masumoto JY, Maraganore D, Hassan A, Eggers S, Boeve BF, Knopman DS, Drubach D, Petersen RC, Dunkley ED, van Gerpen J, Uitti R, Whitwell JL, Dickson DW, Josephs KA (2019) Sensitivity and specificity of diagnostic criteria for progressive supranuclear palsy. Mov Disord. https://​doi.​org/​10.​1002/​mds.​27619 CrossRefPubMedPubMedCentral
Zurück zum Zitat Allen M, Burgess JD, Ballard T, Serie D, Wang X, Younkin CS, Sun Z, Kouri N, Baheti S, Wang C, Carrasquillo MM, Nguyen T, Lincoln S, Malphrus K, Murray M, Golde TE, Price ND, Younkin SG, Schellenberg GD, Asmann Y, Ordog T, Crook J, Dickson D, Ertekin-Taner N (2016) Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci. Acta Neuropathol 132:197–211CrossRefPubMedPubMedCentral Allen M, Burgess JD, Ballard T, Serie D, Wang X, Younkin CS, Sun Z, Kouri N, Baheti S, Wang C, Carrasquillo MM, Nguyen T, Lincoln S, Malphrus K, Murray M, Golde TE, Price ND, Younkin SG, Schellenberg GD, Asmann Y, Ordog T, Crook J, Dickson D, Ertekin-Taner N (2016) Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci. Acta Neuropathol 132:197–211CrossRefPubMedPubMedCentral
Zurück zum Zitat Allen M, Wang X, Serie DJ, Strickland SL, Burgess JD, Koga S, Younkin CS, Nguyen TT, Malphrus KG, Lincoln SJ, Alamprese M, Zhu K, Chang R, Carrasquillo MM, Kouri N, Murray ME, Reddy JS, Funk C, Price ND, Golde TE, Younkin SG, Asmann YW, Crook JE, Dickson DW, Ertekin-Taner N (2018) Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsy. Acta Neuropathol 136:709–727CrossRefPubMedPubMedCentral Allen M, Wang X, Serie DJ, Strickland SL, Burgess JD, Koga S, Younkin CS, Nguyen TT, Malphrus KG, Lincoln SJ, Alamprese M, Zhu K, Chang R, Carrasquillo MM, Kouri N, Murray ME, Reddy JS, Funk C, Price ND, Golde TE, Younkin SG, Asmann YW, Crook JE, Dickson DW, Ertekin-Taner N (2018) Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsy. Acta Neuropathol 136:709–727CrossRefPubMedPubMedCentral
Zurück zum Zitat American P, Association, Force D-T (2013) Diagnostic and statistical manual of mental disorders: DSM–5, 5th edn. American Psychiatric Publishing Inc., ArlingtonCrossRef American P, Association, Force D-T (2013) Diagnostic and statistical manual of mental disorders: DSM–5, 5th edn. American Psychiatric Publishing Inc., ArlingtonCrossRef
Zurück zum Zitat Ammal Kaidery N, Thomas B (2018) Current perspective of mitochondrial biology in Parkinson’s disease. Neurochem Int 117:91–113CrossRefPubMed Ammal Kaidery N, Thomas B (2018) Current perspective of mitochondrial biology in Parkinson’s disease. Neurochem Int 117:91–113CrossRefPubMed
Zurück zum Zitat Angot E, Steiner JA, Lema Tome CM, Ekstrom P, Mattsson B, Bjorklund A, Brundin P (2012) Alpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons In vivo. PLoS One 7:e39465CrossRefPubMedPubMedCentral Angot E, Steiner JA, Lema Tome CM, Ekstrom P, Mattsson B, Bjorklund A, Brundin P (2012) Alpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons In vivo. PLoS One 7:e39465CrossRefPubMedPubMedCentral
Zurück zum Zitat Ansari M, Adib Moradi S, Ghazi Sherbaf F, Hedayatnia A, Aarabi MH (2019) Comparison of structural connectivity in Parkinson’s disease with depressive symptoms versus non-depressed: a diffusion MRI connectometry study. Int Psychogeriatr 31:5–12CrossRefPubMed Ansari M, Adib Moradi S, Ghazi Sherbaf F, Hedayatnia A, Aarabi MH (2019) Comparison of structural connectivity in Parkinson’s disease with depressive symptoms versus non-depressed: a diffusion MRI connectometry study. Int Psychogeriatr 31:5–12CrossRefPubMed
Zurück zum Zitat Aoki N, Boyer PJ, Lund C, Lin WL, Koga S, Ross OA, Weiner M, Lipton A, Powers JM, White CL 3rd, Dickson DW (2015) Atypical multiple system atrophy is a new subtype of frontotemporal lobar degeneration: frontotemporal lobar degeneration associated with alpha-synuclein. Acta Neuropathol 130:93–105CrossRefPubMedPubMedCentral Aoki N, Boyer PJ, Lund C, Lin WL, Koga S, Ross OA, Weiner M, Lipton A, Powers JM, White CL 3rd, Dickson DW (2015) Atypical multiple system atrophy is a new subtype of frontotemporal lobar degeneration: frontotemporal lobar degeneration associated with alpha-synuclein. Acta Neuropathol 130:93–105CrossRefPubMedPubMedCentral
Zurück zum Zitat Arawaka S, Sato H, Sasaki A, Koyama S, Kato T (2017) Mechanisms underlying extensive Ser129-phosphorylation in alpha-synuclein aggregates. Acta Neuropathol Commun 5:48CrossRefPubMedPubMedCentral Arawaka S, Sato H, Sasaki A, Koyama S, Kato T (2017) Mechanisms underlying extensive Ser129-phosphorylation in alpha-synuclein aggregates. Acta Neuropathol Commun 5:48CrossRefPubMedPubMedCentral
Zurück zum Zitat Arima K (2006) Ultrastructural characteristics of tau filaments in tauopathies: immuno-electron microscopic demonstration of tau filaments in tauopathies. Neuropathology 26:475–483CrossRefPubMed Arima K (2006) Ultrastructural characteristics of tau filaments in tauopathies: immuno-electron microscopic demonstration of tau filaments in tauopathies. Neuropathology 26:475–483CrossRefPubMed
Zurück zum Zitat Armstrong RA (2013) White matter pathology in progressive supranuclear palsy (PSP): a quantitative study of 8 cases. Clin Neuropathol 32:399–405CrossRefPubMed Armstrong RA (2013) White matter pathology in progressive supranuclear palsy (PSP): a quantitative study of 8 cases. Clin Neuropathol 32:399–405CrossRefPubMed
Zurück zum Zitat Armstrong MJ (2018) Progressive supranuclear palsy: an update. Curr Neurol Neurosci Rep 18:12CrossRefPubMed Armstrong MJ (2018) Progressive supranuclear palsy: an update. Curr Neurol Neurosci Rep 18:12CrossRefPubMed
Zurück zum Zitat Armstrong MJ (2019) Lewy body dementias. Continuum (Minneap Minn) 25:128–146 Armstrong MJ (2019) Lewy body dementias. Continuum (Minneap Minn) 25:128–146
Zurück zum Zitat Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, Boxer AL, Dickson DW, Grossman M, Hallett M, Josephs KA, Kertesz A, Lee SE, Miller BL, Reich SG, Riley DE, Tolosa E, Troster AI, Vidailhet M, Weiner WJ (2013) Criteria for the diagnosis of corticobasal degeneration. Neurology 80:496–503CrossRefPubMedPubMedCentral Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, Boxer AL, Dickson DW, Grossman M, Hallett M, Josephs KA, Kertesz A, Lee SE, Miller BL, Reich SG, Riley DE, Tolosa E, Troster AI, Vidailhet M, Weiner WJ (2013) Criteria for the diagnosis of corticobasal degeneration. Neurology 80:496–503CrossRefPubMedPubMedCentral
Zurück zum Zitat Armstrong RA, Kotzbauer PT, Perlmutter JS, Campbell MC, Hurth KM, Schmidt RE, Cairns NJ (2014) A quantitative study of alpha-synuclein pathology in fifteen cases of dementia associated with Parkinson disease. J Neural Transm 121:171–181CrossRefPubMed Armstrong RA, Kotzbauer PT, Perlmutter JS, Campbell MC, Hurth KM, Schmidt RE, Cairns NJ (2014) A quantitative study of alpha-synuclein pathology in fifteen cases of dementia associated with Parkinson disease. J Neural Transm 121:171–181CrossRefPubMed
Zurück zum Zitat Arnaoutoglou NA, O’Brien JT, Underwood BR (2019) Dementia with Lewy bodies—from scientific knowledge to clinical insights. Nat Rev Neurol 15:103–112CrossRefPubMed Arnaoutoglou NA, O’Brien JT, Underwood BR (2019) Dementia with Lewy bodies—from scientific knowledge to clinical insights. Nat Rev Neurol 15:103–112CrossRefPubMed
Zurück zum Zitat Aroso M, Ferreira R, Freitas A, Vitorino R, Gomez-Lazaro M (2016) New insights on the mitochondrial proteome plasticity in Parkinson’s disease. Proteom Clin Appl 10:416–429CrossRef Aroso M, Ferreira R, Freitas A, Vitorino R, Gomez-Lazaro M (2016) New insights on the mitochondrial proteome plasticity in Parkinson’s disease. Proteom Clin Appl 10:416–429CrossRef
Zurück zum Zitat Asi YT, Ling H, Ahmed Z, Lees AJ, Revesz T, Holton JL (2014) Neuropathological features of multiple system atrophy with cognitive impairment. Mov Disord 29:884–888CrossRefPubMed Asi YT, Ling H, Ahmed Z, Lees AJ, Revesz T, Holton JL (2014) Neuropathological features of multiple system atrophy with cognitive impairment. Mov Disord 29:884–888CrossRefPubMed
Zurück zum Zitat Attems J, Jellinger KA (2008) The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson’s disease. Neuropathol Appl Neurobiol 34:466–467CrossRefPubMed Attems J, Jellinger KA (2008) The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson’s disease. Neuropathol Appl Neurobiol 34:466–467CrossRefPubMed
Zurück zum Zitat Attems J, Walker L, Jellinger KA (2014) Olfactory bulb involvement in neurodegenerative diseases. Acta Neuropathol 127:459–475CrossRefPubMed Attems J, Walker L, Jellinger KA (2014) Olfactory bulb involvement in neurodegenerative diseases. Acta Neuropathol 127:459–475CrossRefPubMed
Zurück zum Zitat Ayers JI, Giasson BI, Borchelt DR (2018) Prion-like spreading in tauopathies. Biol Psychiatry 83:337–346CrossRefPubMed Ayers JI, Giasson BI, Borchelt DR (2018) Prion-like spreading in tauopathies. Biol Psychiatry 83:337–346CrossRefPubMed
Zurück zum Zitat Bachhuber T, Katzmarski N, McCarter JF, Loreth D, Tahirovic S, Kamp F, Abou-Ajram C, Nuscher B, Serrano-Pozo A, Muller A, Prinz M, Steiner H, Hyman BT, Haass C, Meyer-Luehmann M (2015) Inhibition of amyloid-beta plaque formation by alpha-synuclein. Nat Med 21:802–807CrossRefPubMed Bachhuber T, Katzmarski N, McCarter JF, Loreth D, Tahirovic S, Kamp F, Abou-Ajram C, Nuscher B, Serrano-Pozo A, Muller A, Prinz M, Steiner H, Hyman BT, Haass C, Meyer-Luehmann M (2015) Inhibition of amyloid-beta plaque formation by alpha-synuclein. Nat Med 21:802–807CrossRefPubMed
Zurück zum Zitat Bae EJ, Yang NY, Song M, Lee CS, Lee JS, Jung BC, Lee HJ, Kim S, Masliah E, Sardi SP, Lee SJ (2014) Glucocerebrosidase depletion enhances cell-to-cell transmission of alpha-synuclein. Nat Commun 5:4755CrossRefPubMed Bae EJ, Yang NY, Song M, Lee CS, Lee JS, Jung BC, Lee HJ, Kim S, Masliah E, Sardi SP, Lee SJ (2014) Glucocerebrosidase depletion enhances cell-to-cell transmission of alpha-synuclein. Nat Commun 5:4755CrossRefPubMed
Zurück zum Zitat Bagetta V, Ghiglieri V, Sgobio C, Calabresi P, Picconi B (2010) Synaptic dysfunction in Parkinson’s disease. Biochem Soc Trans 38:493–497CrossRefPubMed Bagetta V, Ghiglieri V, Sgobio C, Calabresi P, Picconi B (2010) Synaptic dysfunction in Parkinson’s disease. Biochem Soc Trans 38:493–497CrossRefPubMed
Zurück zum Zitat Bailey RM, Covy JP, Melrose HL, Rousseau L, Watkinson R, Knight J, Miles S, Farrer MJ, Dickson DW, Giasson BI, Lewis J (2013) LRRK2 phosphorylates novel tau epitopes and promotes tauopathy. Acta Neuropathol 126:809–827CrossRefPubMedPubMedCentral Bailey RM, Covy JP, Melrose HL, Rousseau L, Watkinson R, Knight J, Miles S, Farrer MJ, Dickson DW, Giasson BI, Lewis J (2013) LRRK2 phosphorylates novel tau epitopes and promotes tauopathy. Acta Neuropathol 126:809–827CrossRefPubMedPubMedCentral
Zurück zum Zitat Balestrino R, Schapira AHV (2018) Glucocerebrosidase and Parkinson disease: molecular, clinical, and therapeutic implications. Neuroscientist 24:540–559CrossRefPubMed Balestrino R, Schapira AHV (2018) Glucocerebrosidase and Parkinson disease: molecular, clinical, and therapeutic implications. Neuroscientist 24:540–559CrossRefPubMed
Zurück zum Zitat Ballanger B, Klinger H, Eche J, Lerond J, Vallet AE, Le Bars D, Tremblay L, Sgambato-Faure V, Broussolle E, Thobois S (2012) Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson’s disease. Mov Disord 27:84–89CrossRefPubMed Ballanger B, Klinger H, Eche J, Lerond J, Vallet AE, Le Bars D, Tremblay L, Sgambato-Faure V, Broussolle E, Thobois S (2012) Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson’s disease. Mov Disord 27:84–89CrossRefPubMed
Zurück zum Zitat Bandres-Ciga S, Saez-Atienzar S, Bonet-Ponce L, Billingsley K, Vitale D, Blauwendraat C, Gibbs JR, Pihlstrom L, Gan-Or Z, Cookson MR, Nalls MA, Singleton AB (2019) The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson’s disease. Mov Disord 34:460–468CrossRefPubMedPubMedCentral Bandres-Ciga S, Saez-Atienzar S, Bonet-Ponce L, Billingsley K, Vitale D, Blauwendraat C, Gibbs JR, Pihlstrom L, Gan-Or Z, Cookson MR, Nalls MA, Singleton AB (2019) The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson’s disease. Mov Disord 34:460–468CrossRefPubMedPubMedCentral
Zurück zum Zitat Barca E, Kleiner G, Tang G, Ziosi M, Tadesse S, Masliah E, Louis ED, Faust P, Kang UJ, Torres J, Cortes EP, Vonsattel JP, Kuo SH, Quinzii CM (2016) Decreased coenzyme q10 levels in multiple system atrophy cerebellum. J Neuropathol Exp Neurol 75:663–672CrossRefPubMedPubMedCentral Barca E, Kleiner G, Tang G, Ziosi M, Tadesse S, Masliah E, Louis ED, Faust P, Kang UJ, Torres J, Cortes EP, Vonsattel JP, Kuo SH, Quinzii CM (2016) Decreased coenzyme q10 levels in multiple system atrophy cerebellum. J Neuropathol Exp Neurol 75:663–672CrossRefPubMedPubMedCentral
Zurück zum Zitat Bassil F, Guerin PA, Dutheil N, Li Q, Klugmann M, Meissner WG, Bezard E, Fernagut PO (2017) Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy. Mov Disord 32:1230–1239CrossRefPubMed Bassil F, Guerin PA, Dutheil N, Li Q, Klugmann M, Meissner WG, Bezard E, Fernagut PO (2017) Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy. Mov Disord 32:1230–1239CrossRefPubMed
Zurück zum Zitat Batla A, De Pablo-Fernandez E, Erro R, Reich M, Calandra-Buonaura G, Barbosa P, Balint B, Ling H, Islam S, Cortelli P, Volkmann J, Quinn N, Holton JL, Warner TT, Bhatia KP (2018) Young-onset multiple system atrophy: clinical and pathological features. Mov Disord 33:1099–1107CrossRefPubMed Batla A, De Pablo-Fernandez E, Erro R, Reich M, Calandra-Buonaura G, Barbosa P, Balint B, Ling H, Islam S, Cortelli P, Volkmann J, Quinn N, Holton JL, Warner TT, Bhatia KP (2018) Young-onset multiple system atrophy: clinical and pathological features. Mov Disord 33:1099–1107CrossRefPubMed
Zurück zum Zitat Beach TG, Adler CH, Sue LI, Peirce JB, Bachalakuri J, Dalsing-Hernandez JE, Lue LF, Caviness JN, Connor DJ, Sabbagh MN, Walker DG (2008) Reduced striatal tyrosine hydroxylase in incidental Lewy body disease. Acta Neuropathol 115:445–451CrossRefPubMed Beach TG, Adler CH, Sue LI, Peirce JB, Bachalakuri J, Dalsing-Hernandez JE, Lue LF, Caviness JN, Connor DJ, Sabbagh MN, Walker DG (2008) Reduced striatal tyrosine hydroxylase in incidental Lewy body disease. Acta Neuropathol 115:445–451CrossRefPubMed
Zurück zum Zitat Beach TG, Adler CH, Lue L, Sue LI, Bachalakuri J, Henry-Watson J, Sasse J, Boyer S, Shirohi S, Brooks R, Eschbacher J, White CL 3rd, Akiyama H, Caviness J, Shill HA, Connor DJ, Sabbagh MN, Walker DG (2009) Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol 117:613–634CrossRefPubMedPubMedCentral Beach TG, Adler CH, Lue L, Sue LI, Bachalakuri J, Henry-Watson J, Sasse J, Boyer S, Shirohi S, Brooks R, Eschbacher J, White CL 3rd, Akiyama H, Caviness J, Shill HA, Connor DJ, Sabbagh MN, Walker DG (2009) Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol 117:613–634CrossRefPubMedPubMedCentral
Zurück zum Zitat Beach TG, Adler CH, Sue LI, Vedders L, Lue L, White Iii CL, Akiyama H, Caviness JN, Shill HA, Sabbagh MN, Walker DG (2010) Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 119:689–702CrossRefPubMedPubMedCentral Beach TG, Adler CH, Sue LI, Vedders L, Lue L, White Iii CL, Akiyama H, Caviness JN, Shill HA, Sabbagh MN, Walker DG (2010) Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 119:689–702CrossRefPubMedPubMedCentral
Zurück zum Zitat Beck G, Singh A, Papa SM (2018) Dysregulation of striatal projection neurons in Parkinson’s disease. J Neural Transm (Vienna) 125:449–460CrossRef Beck G, Singh A, Papa SM (2018) Dysregulation of striatal projection neurons in Parkinson’s disease. J Neural Transm (Vienna) 125:449–460CrossRef
Zurück zum Zitat Bengoa-Vergniory N, Roberts RF, Wade-Martins R, Alegre-Abarrategui J (2017) Alpha-Synuclein oligomers: a new hope. Acta Neuropathol 134:819–838CrossRefPubMedPubMedCentral Bengoa-Vergniory N, Roberts RF, Wade-Martins R, Alegre-Abarrategui J (2017) Alpha-Synuclein oligomers: a new hope. Acta Neuropathol 134:819–838CrossRefPubMedPubMedCentral
Zurück zum Zitat Benskey MJ, Perez RG, Manfredsson FP (2016) The contribution of alpha synuclein to neuronal survival and function—implications for Parkinson’s disease. J Neurochem 137:331–359CrossRefPubMedPubMedCentral Benskey MJ, Perez RG, Manfredsson FP (2016) The contribution of alpha synuclein to neuronal survival and function—implications for Parkinson’s disease. J Neurochem 137:331–359CrossRefPubMedPubMedCentral
Zurück zum Zitat Berciano J, Valldeoriola F, Ferrer I, Rumia J, Pascual J, Marin C, Rey MJ, Tolosa E (2002) Presynaptic parkinsonism in multiple system atrophy mimicking Parkinson’s disease: a clinicopathological case study. Mov Disord 17:812–816CrossRefPubMed Berciano J, Valldeoriola F, Ferrer I, Rumia J, Pascual J, Marin C, Rey MJ, Tolosa E (2002) Presynaptic parkinsonism in multiple system atrophy mimicking Parkinson’s disease: a clinicopathological case study. Mov Disord 17:812–816CrossRefPubMed
Zurück zum Zitat Bereczki E, Francis PT, Howlett D, Pereira JB, Hoglund K, Bogstedt A, Cedazo-Minguez A, Baek JH, Hortobagyi T, Attems J, Ballard C, Aarsland D (2016) Synaptic proteins predict cognitive decline in Alzheimer’s disease and Lewy body dementia. Alzheimers Dement 12:1149–1158CrossRefPubMed Bereczki E, Francis PT, Howlett D, Pereira JB, Hoglund K, Bogstedt A, Cedazo-Minguez A, Baek JH, Hortobagyi T, Attems J, Ballard C, Aarsland D (2016) Synaptic proteins predict cognitive decline in Alzheimer’s disease and Lewy body dementia. Alzheimers Dement 12:1149–1158CrossRefPubMed
Zurück zum Zitat Berg D, Postuma RB, Bloem B, Chan P, Dubois B, Gasser T, Goetz CG, Halliday GM, Hardy J, Lang AE, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschl G (2014) Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson’s disease. Mov Disord 29:454–462CrossRefPubMedPubMedCentral Berg D, Postuma RB, Bloem B, Chan P, Dubois B, Gasser T, Goetz CG, Halliday GM, Hardy J, Lang AE, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschl G (2014) Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson’s disease. Mov Disord 29:454–462CrossRefPubMedPubMedCentral
Zurück zum Zitat Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20:415–455CrossRefPubMed Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20:415–455CrossRefPubMed
Zurück zum Zitat Bhatia KP, Bain P, Bajaj N, Elble RJ, Hallett M, Louis ED, Raethjen J, Stamelou M, Testa CM, Deuschl G (2018) Consensus Statement on the classification of tremors from the task force on tremor of the International Parkinson and Movement Disorder Society. Mov Disord 33:75–87CrossRefPubMed Bhatia KP, Bain P, Bajaj N, Elble RJ, Hallett M, Louis ED, Raethjen J, Stamelou M, Testa CM, Deuschl G (2018) Consensus Statement on the classification of tremors from the task force on tremor of the International Parkinson and Movement Disorder Society. Mov Disord 33:75–87CrossRefPubMed
Zurück zum Zitat Bhattacharjee P, Ohrfelt A, Lashley T, Blennow K, Brinkmalm A, Zetterberg H (2019) Mass spectrometric analysis of Lewy body-enriched alpha-synuclein in Prkinson’s disease. J Proteome Res 18:2109–2120CrossRefPubMed Bhattacharjee P, Ohrfelt A, Lashley T, Blennow K, Brinkmalm A, Zetterberg H (2019) Mass spectrometric analysis of Lewy body-enriched alpha-synuclein in Prkinson’s disease. J Proteome Res 18:2109–2120CrossRefPubMed
Zurück zum Zitat Bieri G, Brahic M, Bousset L, Couthouis J, Kramer NJ, Ma R, Nakayama L, Monbureau M, Defensor E, Schule B, Shamloo M, Melki R, Gitler AD (2019) LRRK2 modifies alpha-syn pathology and spread in mouse models and human neurons. Acta Neuropathol 137:961–980CrossRefPubMedPubMedCentral Bieri G, Brahic M, Bousset L, Couthouis J, Kramer NJ, Ma R, Nakayama L, Monbureau M, Defensor E, Schule B, Shamloo M, Melki R, Gitler AD (2019) LRRK2 modifies alpha-syn pathology and spread in mouse models and human neurons. Acta Neuropathol 137:961–980CrossRefPubMedPubMedCentral
Zurück zum Zitat Birdi S, Rajput AH, Fenton M, Donat JR, Rozdilsky B, Robinson C, Macaulay R, George D (2002) Progressive supranuclear palsy diagnosis and confounding features: report on 16 autopsied cases. Mov Disord 17:1255–1264CrossRefPubMed Birdi S, Rajput AH, Fenton M, Donat JR, Rozdilsky B, Robinson C, Macaulay R, George D (2002) Progressive supranuclear palsy diagnosis and confounding features: report on 16 autopsied cases. Mov Disord 17:1255–1264CrossRefPubMed
Zurück zum Zitat Bizzarri JV, Giupponi G, Maniscalco I, Schroffenegger P, Conca A, Kapfhammer HP (2015) Parkinson’s disease and psychoses. Neuropsychiatry 29:1–13CrossRef Bizzarri JV, Giupponi G, Maniscalco I, Schroffenegger P, Conca A, Kapfhammer HP (2015) Parkinson’s disease and psychoses. Neuropsychiatry 29:1–13CrossRef
Zurück zum Zitat Blandini F, Cilia R, Cerri S, Pezzoli G, Schapira AHV, Mullin S, Lanciego JL (2018) Glucocerebrosidase mutations and synucleinopathies: toward a model of precision medicine. Mov Disord 34:9–21CrossRefPubMed Blandini F, Cilia R, Cerri S, Pezzoli G, Schapira AHV, Mullin S, Lanciego JL (2018) Glucocerebrosidase mutations and synucleinopathies: toward a model of precision medicine. Mov Disord 34:9–21CrossRefPubMed
Zurück zum Zitat Blauwendraat C, Heilbron K, Vallerga CL, Bandres-Ciga S, von Coelln R, Pihlstrom L, Simon-Sanchez J, Schulte C, Sharma M, Krohn L, Siitonen A, Iwaki H, Leonard H, Noyce AJ, Tan M, Gibbs JR, Hernandez DG, Scholz SW, Jankovic J, Shulman LM, Lesage S, Corvol JC, Brice A, van Hilten JJ, Marinus J, Eerola-Rautio J, Tienari P, Majamaa K, Toft M, Grosset DG, Gasser T, Heutink P, Shulman JM, Wood N, Hardy J, Morris HR, Hinds DA, Gratten J, Visscher PM, Gan-Or Z, Nalls MA, Singleton AB (2019) Parkinson’s disease age at onset genome-wide association study: defining heritability, genetic loci, and alpha-synuclein mechanisms. Mov Disord. https://doi.org/10.1002/mds.27659 CrossRefPubMedPubMedCentral Blauwendraat C, Heilbron K, Vallerga CL, Bandres-Ciga S, von Coelln R, Pihlstrom L, Simon-Sanchez J, Schulte C, Sharma M, Krohn L, Siitonen A, Iwaki H, Leonard H, Noyce AJ, Tan M, Gibbs JR, Hernandez DG, Scholz SW, Jankovic J, Shulman LM, Lesage S, Corvol JC, Brice A, van Hilten JJ, Marinus J, Eerola-Rautio J, Tienari P, Majamaa K, Toft M, Grosset DG, Gasser T, Heutink P, Shulman JM, Wood N, Hardy J, Morris HR, Hinds DA, Gratten J, Visscher PM, Gan-Or Z, Nalls MA, Singleton AB (2019) Parkinson’s disease age at onset genome-wide association study: defining heritability, genetic loci, and alpha-synuclein mechanisms. Mov Disord. https://​doi.​org/​10.​1002/​mds.​27659 CrossRefPubMedPubMedCentral
Zurück zum Zitat Bodea LG, Eckert A, Ittner LM, Piguet O, Gotz J (2016) Tau physiology and pathomechanisms in frontotemporal lobar degeneration. J Neurochem 138(Suppl 1):71–94CrossRefPubMedPubMedCentral Bodea LG, Eckert A, Ittner LM, Piguet O, Gotz J (2016) Tau physiology and pathomechanisms in frontotemporal lobar degeneration. J Neurochem 138(Suppl 1):71–94CrossRefPubMedPubMedCentral
Zurück zum Zitat Bohnen NI, Albin RL, Muller ML, Petrou M, Kotagal V, Koeppe RA, Scott PJ, Frey KA (2015) Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects. JAMA Neurol 72:194–200CrossRefPubMedPubMedCentral Bohnen NI, Albin RL, Muller ML, Petrou M, Kotagal V, Koeppe RA, Scott PJ, Frey KA (2015) Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects. JAMA Neurol 72:194–200CrossRefPubMedPubMedCentral
Zurück zum Zitat Bohnen NI, Kanel P, Zhou Z, Koeppe RA, Frey KA, Dauer WT, Albin RL, Müller MLTM (2019) Cholinergic system changes of falls and freezing of gait in Parkinson disease. Ann Neurol 85:538–549CrossRefPubMedPubMedCentral Bohnen NI, Kanel P, Zhou Z, Koeppe RA, Frey KA, Dauer WT, Albin RL, Müller MLTM (2019) Cholinergic system changes of falls and freezing of gait in Parkinson disease. Ann Neurol 85:538–549CrossRefPubMedPubMedCentral
Zurück zum Zitat Book A, Guella I, Candido T, Brice A, Hattori N, Jeon B, Farrer MJ (2018) A meta-analysis of alpha-synuclein multiplication in familial parkinsonism. Front Neurol 9:1021CrossRefPubMedPubMedCentral Book A, Guella I, Candido T, Brice A, Hattori N, Jeon B, Farrer MJ (2018) A meta-analysis of alpha-synuclein multiplication in familial parkinsonism. Front Neurol 9:1021CrossRefPubMedPubMedCentral
Zurück zum Zitat Bordia T, Perez XA (2019) Cholinergic control of striatal neurons to modulate l-dopa-induced dyskinesias. Eur J Neurosci 49:859–868CrossRefPubMed Bordia T, Perez XA (2019) Cholinergic control of striatal neurons to modulate l-dopa-induced dyskinesias. Eur J Neurosci 49:859–868CrossRefPubMed
Zurück zum Zitat Borroto-Escuela DO, Perez De La Mora M, Manger P, Narvaez M, Beggiato S, Crespo-Ramirez M, Navarro G, Wydra K, Diaz-Cabiale Z, Rivera A, Ferraro L, Tanganelli S, Filip M, Franco R, Fuxe K (2018) Brain dopamine transmission in health and Parkinson’s disease: modulation of synaptic transmission and plasticity through volume transmission and dopamine heteroreceptors. Front Synaptic Neurosci 10:20CrossRefPubMedPubMedCentral Borroto-Escuela DO, Perez De La Mora M, Manger P, Narvaez M, Beggiato S, Crespo-Ramirez M, Navarro G, Wydra K, Diaz-Cabiale Z, Rivera A, Ferraro L, Tanganelli S, Filip M, Franco R, Fuxe K (2018) Brain dopamine transmission in health and Parkinson’s disease: modulation of synaptic transmission and plasticity through volume transmission and dopamine heteroreceptors. Front Synaptic Neurosci 10:20CrossRefPubMedPubMedCentral
Zurück zum Zitat Bourdenx M, Koulakiotis NS, Sanoudou D, Bezard E, Dehay B, Tsarbopoulos A (2017) Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: examples of amyloidopathies, tauopathies and synucleinopathies. Prog Neurobiol 155:171–193CrossRefPubMed Bourdenx M, Koulakiotis NS, Sanoudou D, Bezard E, Dehay B, Tsarbopoulos A (2017) Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: examples of amyloidopathies, tauopathies and synucleinopathies. Prog Neurobiol 155:171–193CrossRefPubMed
Zurück zum Zitat Braak H, Del Tredici K (2008) Nervous system pathology in sporadic Parkinson disease. Neurology 70:1916–1925CrossRefPubMed Braak H, Del Tredici K (2008) Nervous system pathology in sporadic Parkinson disease. Neurology 70:1916–1925CrossRefPubMed
Zurück zum Zitat Braak H, Del Tredici K (2009) Neuroanatomy and pathology of sporadic Parkinson’s disease. Adv Anat Embryol Cell Biol 201:1–119PubMed Braak H, Del Tredici K (2009) Neuroanatomy and pathology of sporadic Parkinson’s disease. Adv Anat Embryol Cell Biol 201:1–119PubMed
Zurück zum Zitat Braak H, Del Tredici K (2017) Neuropathological staging of brain pathology in sporadic Parkinson’s disease: separating the wheat from the chaff. J Parkinsons Dis 7:S71–S85CrossRefPubMedPubMedCentral Braak H, Del Tredici K (2017) Neuropathological staging of brain pathology in sporadic Parkinson’s disease: separating the wheat from the chaff. J Parkinsons Dis 7:S71–S85CrossRefPubMedPubMedCentral
Zurück zum Zitat Braak H, Bohl JR, Muller CM, Rub U, de Vos RA, Del Tredici K (2006) Stanley Fahn Lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson’s disease reconsidered. Mov Disord 21:2042–2051CrossRefPubMed Braak H, Bohl JR, Muller CM, Rub U, de Vos RA, Del Tredici K (2006) Stanley Fahn Lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson’s disease reconsidered. Mov Disord 21:2042–2051CrossRefPubMed
Zurück zum Zitat Breen DP, Halliday GM, Lang AE (2019) Gut-brain axis and the spread of alpha-synuclein pathology: Vagal highway or dead end? Mov Disord 34:307–316CrossRefPubMed Breen DP, Halliday GM, Lang AE (2019) Gut-brain axis and the spread of alpha-synuclein pathology: Vagal highway or dead end? Mov Disord 34:307–316CrossRefPubMed
Zurück zum Zitat Brettschneider J, Irwin DJ, Boluda S, Byrne MD, Fang L, Lee EB, Robinson JL, Suh E, Van Deerlin VM, Toledo JB, Grossman M, Hurtig H, Dengler R, Petri S, Lee VM, Trojanowski JQ (2017) Progression of alpha-synuclein pathology in multiple system atrophy of the cerebellar type. Neuropathol Appl Neurobiol 43:315–329CrossRefPubMed Brettschneider J, Irwin DJ, Boluda S, Byrne MD, Fang L, Lee EB, Robinson JL, Suh E, Van Deerlin VM, Toledo JB, Grossman M, Hurtig H, Dengler R, Petri S, Lee VM, Trojanowski JQ (2017) Progression of alpha-synuclein pathology in multiple system atrophy of the cerebellar type. Neuropathol Appl Neurobiol 43:315–329CrossRefPubMed
Zurück zum Zitat Brettschneider J, Suh E, Robinson JL, Fang L, Lee EB, Irwin DJ, Grossman M, Van Deerlin VM, Lee VM, Trojanowski JQ (2018) Converging patterns of alpha-synuclein pathology in multiple system atrophy. J Neuropathol Exp Neurol 77:1005–1016CrossRefPubMedPubMedCentral Brettschneider J, Suh E, Robinson JL, Fang L, Lee EB, Irwin DJ, Grossman M, Van Deerlin VM, Lee VM, Trojanowski JQ (2018) Converging patterns of alpha-synuclein pathology in multiple system atrophy. J Neuropathol Exp Neurol 77:1005–1016CrossRefPubMedPubMedCentral
Zurück zum Zitat Bringmann G, God R, Feineis D, Wesemann W, Riederer P, Rausch WD, Reichmann H, Sontag KH (1995) The TaClo concept: 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo), a new toxin for dopaminergic neurons. J Neural Transm Suppl 46:235–244PubMed Bringmann G, God R, Feineis D, Wesemann W, Riederer P, Rausch WD, Reichmann H, Sontag KH (1995) The TaClo concept: 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo), a new toxin for dopaminergic neurons. J Neural Transm Suppl 46:235–244PubMed
Zurück zum Zitat Brockmann K, Srulijes K, Pflederer S, Hauser AK, Schulte C, Maetzler W, Gasser T, Berg D (2015) GBA-associated Parkinson’s disease: reduced survival and more rapid progression in a prospective longitudinal study. Mov Disord 30:407–411CrossRefPubMed Brockmann K, Srulijes K, Pflederer S, Hauser AK, Schulte C, Maetzler W, Gasser T, Berg D (2015) GBA-associated Parkinson’s disease: reduced survival and more rapid progression in a prospective longitudinal study. Mov Disord 30:407–411CrossRefPubMed
Zurück zum Zitat Brooks JA, Houlden H, Melchers A, Islam AJ, Ding J, Li A, Paudel R, Revesz T, Holton JL, Wood N, Lees A, Singleton AB, Scholz SW (2011) Mutational analysis of parkin and PINK1 in multiple system atrophy. Neurobiol Aging 32(548):e545–e547 Brooks JA, Houlden H, Melchers A, Islam AJ, Ding J, Li A, Paudel R, Revesz T, Holton JL, Wood N, Lees A, Singleton AB, Scholz SW (2011) Mutational analysis of parkin and PINK1 in multiple system atrophy. Neurobiol Aging 32(548):e545–e547
Zurück zum Zitat Brück D, Wenning GK, Stefanova N, Fellner L (2016) Glia and alpha-synuclein in neurodegeneration: A complex interaction. Neurobiol Dis 85:262–274CrossRefPubMed Brück D, Wenning GK, Stefanova N, Fellner L (2016) Glia and alpha-synuclein in neurodegeneration: A complex interaction. Neurobiol Dis 85:262–274CrossRefPubMed
Zurück zum Zitat Brudek T, Winge K, Rasmussen NB, Bahl JM, Tanassi J, Agander TK, Hyde TM, Pakkenberg B (2016) Altered alpha-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains. J Neurochem 136:172–185CrossRefPubMed Brudek T, Winge K, Rasmussen NB, Bahl JM, Tanassi J, Agander TK, Hyde TM, Pakkenberg B (2016) Altered alpha-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains. J Neurochem 136:172–185CrossRefPubMed
Zurück zum Zitat Brundin P, Melki R, Kopito R (2010) Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat Rev Mol Cell Biol 11:301–307CrossRefPubMedPubMedCentral Brundin P, Melki R, Kopito R (2010) Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat Rev Mol Cell Biol 11:301–307CrossRefPubMedPubMedCentral
Zurück zum Zitat Bu J, Liu J, Liu K, Wang Z (2019) Diagnostic utility of gut alpha-synuclein in Parkinson’s disease: a systematic review and meta-analysis. Behav Brain Res 364:340–347CrossRefPubMed Bu J, Liu J, Liu K, Wang Z (2019) Diagnostic utility of gut alpha-synuclein in Parkinson’s disease: a systematic review and meta-analysis. Behav Brain Res 364:340–347CrossRefPubMed
Zurück zum Zitat Buchman AS, Nag S, Leurgans SE, Miller J, VanderHorst V, Bennett DA, Schneider JA (2018) Spinal Lewy body pathology in older adults without an antemortem diagnosis of Parkinson’s disease. Brain Pathol 28:560–568CrossRefPubMed Buchman AS, Nag S, Leurgans SE, Miller J, VanderHorst V, Bennett DA, Schneider JA (2018) Spinal Lewy body pathology in older adults without an antemortem diagnosis of Parkinson’s disease. Brain Pathol 28:560–568CrossRefPubMed
Zurück zum Zitat Cairns NJ, Perrin RJ, Franklin EE, Carter D, Vincent B, Xie M, Bateman RJ, Benzinger T, Friedrichsen K, Brooks WS, Halliday GM, McLean C, Ghetti B, Morris JC (2015) Neuropathologic assessment of participants in two multi-center longitudinal observational studies: the Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN). Neuropathology 35:390–400CrossRefPubMedPubMedCentral Cairns NJ, Perrin RJ, Franklin EE, Carter D, Vincent B, Xie M, Bateman RJ, Benzinger T, Friedrichsen K, Brooks WS, Halliday GM, McLean C, Ghetti B, Morris JC (2015) Neuropathologic assessment of participants in two multi-center longitudinal observational studies: the Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN). Neuropathology 35:390–400CrossRefPubMedPubMedCentral
Zurück zum Zitat Calabresi P, Mercuri NB, Di Filippo M (2009) Synaptic plasticity, dopamine and Parkinson’s disease: one step ahead. Brain 132:285–287CrossRefPubMed Calabresi P, Mercuri NB, Di Filippo M (2009) Synaptic plasticity, dopamine and Parkinson’s disease: one step ahead. Brain 132:285–287CrossRefPubMed
Zurück zum Zitat Calafate S, Buist A, Miskiewicz K, Vijayan V, Daneels G, de Strooper B, de Wit J, Verstreken P, Moechars D (2015) Synaptic contacts enhance cell-to-cell tau pathology propagation. Cell Rep 11:1176–1183CrossRefPubMed Calafate S, Buist A, Miskiewicz K, Vijayan V, Daneels G, de Strooper B, de Wit J, Verstreken P, Moechars D (2015) Synaptic contacts enhance cell-to-cell tau pathology propagation. Cell Rep 11:1176–1183CrossRefPubMed
Zurück zum Zitat Callizot N, Combes M, Henriques A, Poindron P (2019) Necrosis, apoptosis, necroptosis, three modes of action of dopaminergic neuron neurotoxins. PLoS One 14:e0215277CrossRefPubMedPubMedCentral Callizot N, Combes M, Henriques A, Poindron P (2019) Necrosis, apoptosis, necroptosis, three modes of action of dopaminergic neuron neurotoxins. PLoS One 14:e0215277CrossRefPubMedPubMedCentral
Zurück zum Zitat Calo L, Wegrzynowicz M, Santivanez-Perez J, Grazia Spillantini M (2016) Synaptic failure and alpha-synuclein. Mov Disord 31:169–177CrossRefPubMed Calo L, Wegrzynowicz M, Santivanez-Perez J, Grazia Spillantini M (2016) Synaptic failure and alpha-synuclein. Mov Disord 31:169–177CrossRefPubMed
Zurück zum Zitat Caminiti SP, Sala A, Iaccarino L, Beretta L, Pilotto A, Gianolli L, Iannaccone S, Magnani G, Padovani A, Ferini-Strambi L, Perani D (2019) Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria. Alzheimers Res Ther 11:20CrossRefPubMedPubMedCentral Caminiti SP, Sala A, Iaccarino L, Beretta L, Pilotto A, Gianolli L, Iannaccone S, Magnani G, Padovani A, Ferini-Strambi L, Perani D (2019) Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria. Alzheimers Res Ther 11:20CrossRefPubMedPubMedCentral
Zurück zum Zitat Campbell BC, McLean CA, Culvenor JG, Gai WP, Blumbergs PC, Jakala P, Beyreuther K, Masters CL, Li QX (2001) The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson’s disease. J Neurochem 76:87–96CrossRefPubMed Campbell BC, McLean CA, Culvenor JG, Gai WP, Blumbergs PC, Jakala P, Beyreuther K, Masters CL, Li QX (2001) The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson’s disease. J Neurochem 76:87–96CrossRefPubMed
Zurück zum Zitat Candelise N, Schmitz M, Llorens F, Villar-Pique A, Cramm M, Thom T, da Silva Correia SM, Gomes Eriton, da Cunha J, Mobius W, Outeiro TF, Alvarez VG, Banchelli M, D’Andrea C, de Angelis M, Zafar S, Rabano A, Matteini P, Zerr I (2019) Seeding variability of different alpha synuclein strains in synucleinopathies. Ann Neurol 85:691–703CrossRefPubMed Candelise N, Schmitz M, Llorens F, Villar-Pique A, Cramm M, Thom T, da Silva Correia SM, Gomes Eriton, da Cunha J, Mobius W, Outeiro TF, Alvarez VG, Banchelli M, D’Andrea C, de Angelis M, Zafar S, Rabano A, Matteini P, Zerr I (2019) Seeding variability of different alpha synuclein strains in synucleinopathies. Ann Neurol 85:691–703CrossRefPubMed
Zurück zum Zitat Canerina-Amaro A, Pereda D, Diaz M, Rodriguez-Barreto D, Casanas-Sanchez V, Heffer M, Garcia-Esparcia P, Ferrer I, Puertas-Avendano R, Marin R (2019) Differential aggregation and phosphorylation of alpha synuclein in membrane compartments associated with Parkinson disease. Front Neurosci 13:382CrossRefPubMedPubMedCentral Canerina-Amaro A, Pereda D, Diaz M, Rodriguez-Barreto D, Casanas-Sanchez V, Heffer M, Garcia-Esparcia P, Ferrer I, Puertas-Avendano R, Marin R (2019) Differential aggregation and phosphorylation of alpha synuclein in membrane compartments associated with Parkinson disease. Front Neurosci 13:382CrossRefPubMedPubMedCentral
Zurück zum Zitat Cazorla M, Kang UJ, Kellendonk C (2015) Balancing the basal ganglia circuitry: a possible new role for dopamine D2 receptors in health and disease. Mov Disord 30:895–903CrossRefPubMedPubMedCentral Cazorla M, Kang UJ, Kellendonk C (2015) Balancing the basal ganglia circuitry: a possible new role for dopamine D2 receptors in health and disease. Mov Disord 30:895–903CrossRefPubMedPubMedCentral
Zurück zum Zitat Cenci MA, Crossman AR (2018) Animal models of l-dopa-induced dyskinesia in Parkinson’s disease. Mov Disord 33:889–899CrossRefPubMed Cenci MA, Crossman AR (2018) Animal models of l-dopa-induced dyskinesia in Parkinson’s disease. Mov Disord 33:889–899CrossRefPubMed
Zurück zum Zitat Cenci MA, Jorntell H, Petersson P (2018) On the neuronal circuitry mediating l-DOPA-induced dyskinesia. J Neural Transm (Vienna) 125:1157–1169CrossRef Cenci MA, Jorntell H, Petersson P (2018) On the neuronal circuitry mediating l-DOPA-induced dyskinesia. J Neural Transm (Vienna) 125:1157–1169CrossRef
Zurück zum Zitat Cersosimo MG (2018) Propagation of alpha-synuclein pathology from the olfactory bulb: possible role in the pathogenesis of dementia with Lewy bodies. Cell Tissue Res 373:233–243CrossRefPubMed Cersosimo MG (2018) Propagation of alpha-synuclein pathology from the olfactory bulb: possible role in the pathogenesis of dementia with Lewy bodies. Cell Tissue Res 373:233–243CrossRefPubMed
Zurück zum Zitat Cersosimo MG, Benarroch EE (2012a) Autonomic involvement in Parkinson’s disease: pathology, pathophysiology, clinical features and possible peripheral biomarkers. J Neurol Sci 313:57–63CrossRefPubMed Cersosimo MG, Benarroch EE (2012a) Autonomic involvement in Parkinson’s disease: pathology, pathophysiology, clinical features and possible peripheral biomarkers. J Neurol Sci 313:57–63CrossRefPubMed
Zurück zum Zitat Cersosimo MG, Benarroch EE (2012b) Pathological correlates of gastrointestinal dysfunction in Parkinson’s disease. Neurobiol Dis 46:559–564CrossRefPubMed Cersosimo MG, Benarroch EE (2012b) Pathological correlates of gastrointestinal dysfunction in Parkinson’s disease. Neurobiol Dis 46:559–564CrossRefPubMed
Zurück zum Zitat Chang A, Fox SH (2016) Psychosis in parkinson’s disease: epidemiology, pathophysiology, and management. Drugs 76:1093–1118CrossRefPubMed Chang A, Fox SH (2016) Psychosis in parkinson’s disease: epidemiology, pathophysiology, and management. Drugs 76:1093–1118CrossRefPubMed
Zurück zum Zitat Chang D, Nalls MA, Hallgrimsdottir IB, Hunkapiller J, van der Brug M, Cai F, Kerchner GA, Ayalon G, Bingol B, Sheng M, Hinds D, Behrens TW, Singleton AB, Bhangale TR, Graham RR (2017) A meta-analysis of genome-wide association studies identifies 17 new Parkinson’s disease risk loci. Nat Genet 49:1511–1516CrossRefPubMedPubMedCentral Chang D, Nalls MA, Hallgrimsdottir IB, Hunkapiller J, van der Brug M, Cai F, Kerchner GA, Ayalon G, Bingol B, Sheng M, Hinds D, Behrens TW, Singleton AB, Bhangale TR, Graham RR (2017) A meta-analysis of genome-wide association studies identifies 17 new Parkinson’s disease risk loci. Nat Genet 49:1511–1516CrossRefPubMedPubMedCentral
Zurück zum Zitat Chartier S, Duyckaerts C (2018) Is Lewy pathology in the human nervous system chiefly an indicator of neuronal protection or of toxicity? Cell Tissue Res 373:149–160CrossRefPubMed Chartier S, Duyckaerts C (2018) Is Lewy pathology in the human nervous system chiefly an indicator of neuronal protection or of toxicity? Cell Tissue Res 373:149–160CrossRefPubMed
Zurück zum Zitat Chavarria C, Rodriguez-Bottero S, Quijano C, Cassina P, Souza JM (2018) Impact of monomeric, oligomeric and fibrillar alpha-synuclein on astrocyte reactivity and toxicity to neurons. Biochem J 475:3153–3169CrossRefPubMed Chavarria C, Rodriguez-Bottero S, Quijano C, Cassina P, Souza JM (2018) Impact of monomeric, oligomeric and fibrillar alpha-synuclein on astrocyte reactivity and toxicity to neurons. Biochem J 475:3153–3169CrossRefPubMed
Zurück zum Zitat Chelban V, Manole A, Pihlstrom L, Schottlaender L, Efthymiou S, Oconnor E, Meissner WG, Holton JL, Houlden H (2017) Analysis of the prion protein gene in multiple system atrophy. Neurobiol Aging 49:216 e15–216 e18CrossRef Chelban V, Manole A, Pihlstrom L, Schottlaender L, Efthymiou S, Oconnor E, Meissner WG, Holton JL, Houlden H (2017) Analysis of the prion protein gene in multiple system atrophy. Neurobiol Aging 49:216 e15–216 e18CrossRef
Zurück zum Zitat Chen YF, Tseng YL, Lan MY, Lai SL, Su CS, Liu JS, Chang YY (2014) The relationship of leukoaraiosis and the clinical severity of vascular parkinsonism. J Neurol Sci 346:255–259CrossRefPubMed Chen YF, Tseng YL, Lan MY, Lai SL, Su CS, Liu JS, Chang YY (2014) The relationship of leukoaraiosis and the clinical severity of vascular parkinsonism. J Neurol Sci 346:255–259CrossRefPubMed
Zurück zum Zitat Chen C, Turnbull DM, Reeve AK (2019a) Mitochondrial dysfunction in Parkinson’s disease-cause or consequence? Biology (Basel) 8:38 Chen C, Turnbull DM, Reeve AK (2019a) Mitochondrial dysfunction in Parkinson’s disease-cause or consequence? Biology (Basel) 8:38
Zurück zum Zitat Chen Z, Chen JA, Shatunov A, Jones AR, Kravitz SN, Huang AY, Lawrence L, Lowe JK, Lewis CM, Payan CAM, Lieb W, Franke A, Deloukas P, Amouyel P, Tzourio C, Dartigues JF, Ludolph A, Bensimon G, Leigh PN, Bronstein JM, Coppola G, Geschwind DH, Al-Chalabi A (2019b) Genome-wide survey of copy number variants finds MAPT duplications in progressive supranuclear palsy. Mov Disord Chen Z, Chen JA, Shatunov A, Jones AR, Kravitz SN, Huang AY, Lawrence L, Lowe JK, Lewis CM, Payan CAM, Lieb W, Franke A, Deloukas P, Amouyel P, Tzourio C, Dartigues JF, Ludolph A, Bensimon G, Leigh PN, Bronstein JM, Coppola G, Geschwind DH, Al-Chalabi A (2019b) Genome-wide survey of copy number variants finds MAPT duplications in progressive supranuclear palsy. Mov Disord
Zurück zum Zitat Chiu CC, Lu CS, Weng YH, Chen YL, Huang YZ, Chen RS, Cheng YC, Huang YC, Liu YC, Lai SC, Lin KJ, Lin YW, Chen YJ, Chen CL, Yeh TH, Wang HL (2019) PARK14 (D331Y) PLA2G6 causes early-onset degeneration of substantia nigra dopaminergic neurons by inducing mitochondrial dysfunction, er stress, mitophagy impairment and transcriptional dysregulation in a knockin mouse model. Mol Neurobiol 56:3835–3853CrossRefPubMed Chiu CC, Lu CS, Weng YH, Chen YL, Huang YZ, Chen RS, Cheng YC, Huang YC, Liu YC, Lai SC, Lin KJ, Lin YW, Chen YJ, Chen CL, Yeh TH, Wang HL (2019) PARK14 (D331Y) PLA2G6 causes early-onset degeneration of substantia nigra dopaminergic neurons by inducing mitochondrial dysfunction, er stress, mitophagy impairment and transcriptional dysregulation in a knockin mouse model. Mol Neurobiol 56:3835–3853CrossRefPubMed
Zurück zum Zitat Christopher L, Duff-Canning S, Koshimori Y, Segura B, Boileau I, Chen R, Lang AE, Houle S, Rusjan P, Strafella AP (2015) Salience network and parahippocampal dopamine dysfunction in memory-impaired Parkinson disease. Ann Neurol 77:269–280CrossRefPubMed Christopher L, Duff-Canning S, Koshimori Y, Segura B, Boileau I, Chen R, Lang AE, Houle S, Rusjan P, Strafella AP (2015) Salience network and parahippocampal dopamine dysfunction in memory-impaired Parkinson disease. Ann Neurol 77:269–280CrossRefPubMed
Zurück zum Zitat Chu Y, Morfini GA, Langhamer LB, He Y, Brady ST, Kordower JH (2012) Alterations in axonal transport motor proteins in sporadic and experimental Parkinson’s disease. Brain 135:2058–2073CrossRefPubMedPubMedCentral Chu Y, Morfini GA, Langhamer LB, He Y, Brady ST, Kordower JH (2012) Alterations in axonal transport motor proteins in sporadic and experimental Parkinson’s disease. Brain 135:2058–2073CrossRefPubMedPubMedCentral
Zurück zum Zitat Chu HY, Atherton JF, Wokosin D, Surmeier DJ, Bevan MD (2015) Heterosynaptic regulation of external globus pallidus inputs to the subthalamic nucleus by the motor cortex. Neuron 85:364–376CrossRefPubMedPubMedCentral Chu HY, Atherton JF, Wokosin D, Surmeier DJ, Bevan MD (2015) Heterosynaptic regulation of external globus pallidus inputs to the subthalamic nucleus by the motor cortex. Neuron 85:364–376CrossRefPubMedPubMedCentral
Zurück zum Zitat Clavaguera F, Akatsu H, Fraser G, Crowther RA, Frank S, Hench J, Probst A, Winkler DT, Reichwald J, Staufenbiel M, Ghetti B, Goedert M, Tolnay M (2013) Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Proc Natl Acad Sci USA 110:9535–9540CrossRefPubMedPubMedCentral Clavaguera F, Akatsu H, Fraser G, Crowther RA, Frank S, Hench J, Probst A, Winkler DT, Reichwald J, Staufenbiel M, Ghetti B, Goedert M, Tolnay M (2013) Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Proc Natl Acad Sci USA 110:9535–9540CrossRefPubMedPubMedCentral
Zurück zum Zitat Colloby SJ, McParland S, O’Brien JT, Attems J (2012) Neuropathological correlates of dopaminergic imaging in Alzheimer’s disease and Lewy body dementias. Brain 135:2798–2808CrossRefPubMed Colloby SJ, McParland S, O’Brien JT, Attems J (2012) Neuropathological correlates of dopaminergic imaging in Alzheimer’s disease and Lewy body dementias. Brain 135:2798–2808CrossRefPubMed
Zurück zum Zitat Colom-Cadena M, Gelpi E, Charif S, Belbin O, Blesa R, Marti MJ, Clarimon J, Lleo A (2013a) Confluence of alpha-synuclein, tau, and beta-amyloid pathologies in dementia with Lewy bodies. J Neuropathol Exp Neurol 72:1203–1212CrossRefPubMed Colom-Cadena M, Gelpi E, Charif S, Belbin O, Blesa R, Marti MJ, Clarimon J, Lleo A (2013a) Confluence of alpha-synuclein, tau, and beta-amyloid pathologies in dementia with Lewy bodies. J Neuropathol Exp Neurol 72:1203–1212CrossRefPubMed
Zurück zum Zitat Colom-Cadena M, Gelpi E, Marti MJ, Charif S, Dols-Icardo O, Blesa R, Clarimon J, Lleo A (2013b) MAPT H1 haplotype is associated with enhanced alpha-synuclein deposition in dementia with Lewy bodies. Neurobiol Aging 34:936–942CrossRefPubMed Colom-Cadena M, Gelpi E, Marti MJ, Charif S, Dols-Icardo O, Blesa R, Clarimon J, Lleo A (2013b) MAPT H1 haplotype is associated with enhanced alpha-synuclein deposition in dementia with Lewy bodies. Neurobiol Aging 34:936–942CrossRefPubMed
Zurück zum Zitat Colom-Cadena M, Grau-Rivera O, Planellas L, Cerquera C, Morenas E, Helgueta S, Munoz L, Kulisevsky J, Marti MJ, Tolosa E, Clarimon J, Lleo A, Gelpi E (2017a) Regional overlap of pathologies in Lewy body disorders. J Neuropathol Exp Neurol 76:216–224PubMed Colom-Cadena M, Grau-Rivera O, Planellas L, Cerquera C, Morenas E, Helgueta S, Munoz L, Kulisevsky J, Marti MJ, Tolosa E, Clarimon J, Lleo A, Gelpi E (2017a) Regional overlap of pathologies in Lewy body disorders. J Neuropathol Exp Neurol 76:216–224PubMed
Zurück zum Zitat Colom-Cadena M, Pegueroles J, Herrmann AG, Henstridge CM, Munoz L, Querol-Vilaseca M, Martin-Paniello CS, Luque-Cabecerans J, Clarimon J, Belbin O, Nunez-Llaves R, Blesa R, Smith C, McKenzie CA, Frosch MP, Roe A, Fortea J, Andilla J, Loza-Alvarez P, Gelpi E, Hyman BT, Spires-Jones TL, Lleo A (2017b) Synaptic phosphorylated alpha-synuclein in dementia with Lewy bodies. Brain 140:3204–3214CrossRefPubMedPubMedCentral Colom-Cadena M, Pegueroles J, Herrmann AG, Henstridge CM, Munoz L, Querol-Vilaseca M, Martin-Paniello CS, Luque-Cabecerans J, Clarimon J, Belbin O, Nunez-Llaves R, Blesa R, Smith C, McKenzie CA, Frosch MP, Roe A, Fortea J, Andilla J, Loza-Alvarez P, Gelpi E, Hyman BT, Spires-Jones TL, Lleo A (2017b) Synaptic phosphorylated alpha-synuclein in dementia with Lewy bodies. Brain 140:3204–3214CrossRefPubMedPubMedCentral
Zurück zum Zitat Coon EA, Cutsforth-Gregory JK, Benarroch EE (2018) Neuropathology of autonomic dysfunction in synucleinopathies. Mov Disord 33:349–358CrossRefPubMed Coon EA, Cutsforth-Gregory JK, Benarroch EE (2018) Neuropathology of autonomic dysfunction in synucleinopathies. Mov Disord 33:349–358CrossRefPubMed
Zurück zum Zitat Coughlin D, Xie SX, Liang M, Williams A, Peterson C, Weintraub D, McMillan CT, Wolk DA, Akhtar RS, Hurtig HI, Branch Coslett H, Hamilton RH, Siderowf AD, Duda JE, Rascovsky K, Lee EB, Lee VM, Grossman M, Trojanowski JQ, Irwin DJ (2018) Cognitive and pathological influences of tau pathology in Lewy body disorders. Ann Neurol 85:259–271 Coughlin D, Xie SX, Liang M, Williams A, Peterson C, Weintraub D, McMillan CT, Wolk DA, Akhtar RS, Hurtig HI, Branch Coslett H, Hamilton RH, Siderowf AD, Duda JE, Rascovsky K, Lee EB, Lee VM, Grossman M, Trojanowski JQ, Irwin DJ (2018) Cognitive and pathological influences of tau pathology in Lewy body disorders. Ann Neurol 85:259–271
Zurück zum Zitat Cousins O, Yousaf T, Wilson H, Pagano G, Politis M (2019) Molecular imaging of dementia with Lewy bodies. Int Rev Neurobiol 144:59–93CrossRefPubMed Cousins O, Yousaf T, Wilson H, Pagano G, Politis M (2019) Molecular imaging of dementia with Lewy bodies. Int Rev Neurobiol 144:59–93CrossRefPubMed
Zurück zum Zitat Covell DJ, Robinson JL, Akhtar RS, Grossman M, Weintraub D, Bucklin HM, Pitkin RM, Riddle D, Yousef A, Trojanowski JQ, Lee VM (2017) Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson’s disease. Neuropathol Appl Neurobiol 43:604–620CrossRefPubMedPubMedCentral Covell DJ, Robinson JL, Akhtar RS, Grossman M, Weintraub D, Bucklin HM, Pitkin RM, Riddle D, Yousef A, Trojanowski JQ, Lee VM (2017) Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson’s disease. Neuropathol Appl Neurobiol 43:604–620CrossRefPubMedPubMedCentral
Zurück zum Zitat Coyle-Gilchrist IT, Dick KM, Patterson K, Vazquez Rodriquez P, Wehmann E, Wilcox A, Lansdall CJ, Dawson KE, Wiggins J, Mead S, Brayne C, Rowe JB (2016) Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes. Neurology 86:1736–1743CrossRefPubMedPubMedCentral Coyle-Gilchrist IT, Dick KM, Patterson K, Vazquez Rodriquez P, Wehmann E, Wilcox A, Lansdall CJ, Dawson KE, Wiggins J, Mead S, Brayne C, Rowe JB (2016) Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes. Neurology 86:1736–1743CrossRefPubMedPubMedCentral
Zurück zum Zitat Critchley M (1981) Arteriosclerotic pseudoparkinsonism. In: Rose FC, Capildeo R (eds) Research Progress in Parkinson’s disease. Pitman, London Critchley M (1981) Arteriosclerotic pseudoparkinsonism. In: Rose FC, Capildeo R (eds) Research Progress in Parkinson’s disease. Pitman, London
Zurück zum Zitat Cykowski MD, Coon EA, Powell SZ, Jenkins SM, Benarroch EE, Low PA, Schmeichel AM, Parisi JE (2015) Expanding the spectrum of neuronal pathology in multiple system atrophy. Brain 138:2293–2309CrossRefPubMedPubMedCentral Cykowski MD, Coon EA, Powell SZ, Jenkins SM, Benarroch EE, Low PA, Schmeichel AM, Parisi JE (2015) Expanding the spectrum of neuronal pathology in multiple system atrophy. Brain 138:2293–2309CrossRefPubMedPubMedCentral
Zurück zum Zitat Daher JP (2017) Interaction of LRRK2 and alpha-synuclein in Parkinson’s disease. Adv Neurobiol 14:209–226CrossRefPubMed Daher JP (2017) Interaction of LRRK2 and alpha-synuclein in Parkinson’s disease. Adv Neurobiol 14:209–226CrossRefPubMed
Zurück zum Zitat Dale GE, Probst A, Luthert P, Martin J, Anderton BH, Leigh PN (1992) Relationships between Lewy bodies and pale bodies in Parkinson’s disease. Acta Neuropathol (Berl) 83:525–529CrossRef Dale GE, Probst A, Luthert P, Martin J, Anderton BH, Leigh PN (1992) Relationships between Lewy bodies and pale bodies in Parkinson’s disease. Acta Neuropathol (Berl) 83:525–529CrossRef
Zurück zum Zitat Dash D, Pandey S (2019) Movement disorders associated with neuronal antibodies. Acta Neurol Scand 139:106–117CrossRefPubMed Dash D, Pandey S (2019) Movement disorders associated with neuronal antibodies. Acta Neurol Scand 139:106–117CrossRefPubMed
Zurück zum Zitat Davis MY, Johnson CO, Leverenz JB, Weintraub D, Trojanowski JQ, Chen-Plotkin A, Van Deerlin VM, Quinn JF, Chung KA, Peterson-Hiller AL, Rosenthal LS, Dawson TM, Albert MS, Goldman JG, Stebbins GT, Bernard B, Wszolek ZK, Ross OA, Dickson DW, Eidelberg D, Mattis PJ, Niethammer M, Yearout D, Hu SC, Cholerton BA, Smith M, Mata IF, Montine TJ, Edwards KL, Zabetian CP (2016) Association of GBA mutations and the E326K polymorphism with motor and cognitive progression in Parkinson disease. JAMA Neurol 73:1217–1224CrossRefPubMedPubMedCentral Davis MY, Johnson CO, Leverenz JB, Weintraub D, Trojanowski JQ, Chen-Plotkin A, Van Deerlin VM, Quinn JF, Chung KA, Peterson-Hiller AL, Rosenthal LS, Dawson TM, Albert MS, Goldman JG, Stebbins GT, Bernard B, Wszolek ZK, Ross OA, Dickson DW, Eidelberg D, Mattis PJ, Niethammer M, Yearout D, Hu SC, Cholerton BA, Smith M, Mata IF, Montine TJ, Edwards KL, Zabetian CP (2016) Association of GBA mutations and the E326K polymorphism with motor and cognitive progression in Parkinson disease. JAMA Neurol 73:1217–1224CrossRefPubMedPubMedCentral
Zurück zum Zitat Davis AA, Leyns CEG, Holtzman DM (2018) Intercellular spread of protein aggregates in neurodegenerative disease. Annu Rev Cell Dev Biol 34:545–568CrossRefPubMedPubMedCentral Davis AA, Leyns CEG, Holtzman DM (2018) Intercellular spread of protein aggregates in neurodegenerative disease. Annu Rev Cell Dev Biol 34:545–568CrossRefPubMedPubMedCentral
Zurück zum Zitat de Iure A, Napolitano F, Beck G, Quiroga Varela A, Durante V, Sciaccaluga M, Mazzocchetti P, Megaro A, Tantucci M, Cardinale A, Punzo D, Mancini A, Costa C, Ghiglieri V, Tozzi A, Picconi B, Papa SM, Usiello A, Calabresi P (2019) Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior. Mov Disord. https://doi.org/10.1002/mds.27632 CrossRefPubMedPubMedCentral de Iure A, Napolitano F, Beck G, Quiroga Varela A, Durante V, Sciaccaluga M, Mazzocchetti P, Megaro A, Tantucci M, Cardinale A, Punzo D, Mancini A, Costa C, Ghiglieri V, Tozzi A, Picconi B, Papa SM, Usiello A, Calabresi P (2019) Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior. Mov Disord. https://​doi.​org/​10.​1002/​mds.​27632 CrossRefPubMedPubMedCentral
Zurück zum Zitat de la Fuente-Fernandez R, Schulzer M, Kuramoto L, Cragg J, Ramachandiran N, Au WL, Mak E, McKenzie J, McCormick S, Sossi V, Ruth TJ, Lee CS, Calne DB, Stoessl AJ (2011) Age-specific progression of nigrostriatal dysfunction in Parkinson’s disease. Ann Neurol 69:803–810CrossRefPubMed de la Fuente-Fernandez R, Schulzer M, Kuramoto L, Cragg J, Ramachandiran N, Au WL, Mak E, McKenzie J, McCormick S, Sossi V, Ruth TJ, Lee CS, Calne DB, Stoessl AJ (2011) Age-specific progression of nigrostriatal dysfunction in Parkinson’s disease. Ann Neurol 69:803–810CrossRefPubMed
Zurück zum Zitat De Pablo-Fernandez E, Breen DP, Bouloux PM, Barker RA, Foltynie T, Warner TT (2017) Neuroendocrine abnormalities in Parkinson’s disease. J Neurol Neurosurg Psychiatry 88:176–185CrossRefPubMed De Pablo-Fernandez E, Breen DP, Bouloux PM, Barker RA, Foltynie T, Warner TT (2017) Neuroendocrine abnormalities in Parkinson’s disease. J Neurol Neurosurg Psychiatry 88:176–185CrossRefPubMed
Zurück zum Zitat De Pablo-Fernandez E, Cerdan Santacruz D, Warner TT, Holton JL (2018) No evidence of iatrogenic human transmission in autopsy confirmed multiple system atrophy. Mov Disord 33:1183–1184CrossRefPubMed De Pablo-Fernandez E, Cerdan Santacruz D, Warner TT, Holton JL (2018) No evidence of iatrogenic human transmission in autopsy confirmed multiple system atrophy. Mov Disord 33:1183–1184CrossRefPubMed
Zurück zum Zitat De Reuck J, Auger F, Durieux N, Cordonnier C, Maurage CA, Deramecourt V, Pasquier F, Leys D, Bordet R (2018) The impact of cerebral amyloid angiopathy in Lewy body dementia: a neuropathological study with magnetic resonance imaging correlations. J Neurodegener Dis Res 1:101 De Reuck J, Auger F, Durieux N, Cordonnier C, Maurage CA, Deramecourt V, Pasquier F, Leys D, Bordet R (2018) The impact of cerebral amyloid angiopathy in Lewy body dementia: a neuropathological study with magnetic resonance imaging correlations. J Neurodegener Dis Res 1:101
Zurück zum Zitat Dehay B (2014) Evidence piles up for prion-like propagation mechanisms in synucleinopathies. Mov Disord 29:187CrossRefPubMed Dehay B (2014) Evidence piles up for prion-like propagation mechanisms in synucleinopathies. Mov Disord 29:187CrossRefPubMed
Zurück zum Zitat Dehay B, Fernagut PO (2016) Alpha-synuclein-based models of Parkinson’s disease. Rev Neurol (Paris) 172:371–378CrossRef Dehay B, Fernagut PO (2016) Alpha-synuclein-based models of Parkinson’s disease. Rev Neurol (Paris) 172:371–378CrossRef
Zurück zum Zitat Del Rey NL, Quiroga-Varela A, Garbayo E, Carballo-Carbajal I, Fernandez-Santiago R, Monje MHG, Trigo-Damas I, Blanco-Prieto MJ, Blesa J (2018) Advances in Parkinson’s disease: 200 years later. Front Neuroanat 12:113PubMedPubMedCentral Del Rey NL, Quiroga-Varela A, Garbayo E, Carballo-Carbajal I, Fernandez-Santiago R, Monje MHG, Trigo-Damas I, Blanco-Prieto MJ, Blesa J (2018) Advances in Parkinson’s disease: 200 years later. Front Neuroanat 12:113PubMedPubMedCentral
Zurück zum Zitat Del Tredici K, Braak H (2012) Spinal cord lesions in sporadic Parkinson’s disease. Acta Neuropathol 124:643–664CrossRefPubMed Del Tredici K, Braak H (2012) Spinal cord lesions in sporadic Parkinson’s disease. Acta Neuropathol 124:643–664CrossRefPubMed
Zurück zum Zitat Del Tredici K, Braak H (2013) Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson’s disease-related dementia. J Neurol Neurosurg Psychiatry 84:774–783CrossRefPubMed Del Tredici K, Braak H (2013) Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson’s disease-related dementia. J Neurol Neurosurg Psychiatry 84:774–783CrossRefPubMed
Zurück zum Zitat Delacourte A, Robitaille Y, Sergeant N, Buee L, Hof PR, Wattez A, Laroche-Cholette A, Mathieu J, Chagnon P, Gauvreau D (1996) Specific pathological Tau protein variants characterize Pick’s disease. J Neuropathol Exp Neurol 55:159–168CrossRefPubMed Delacourte A, Robitaille Y, Sergeant N, Buee L, Hof PR, Wattez A, Laroche-Cholette A, Mathieu J, Chagnon P, Gauvreau D (1996) Specific pathological Tau protein variants characterize Pick’s disease. J Neuropathol Exp Neurol 55:159–168CrossRefPubMed
Zurück zum Zitat DelleDonne A, Klos KJ, Fujishiro H, Ahmed Z, Parisi JE, Josephs KA, Frigerio R, Burnett M, Wszolek ZK, Uitti RJ, Ahlskog JE, Dickson DW (2008) Incidental Lewy body disease and preclinical Parkinson disease. Arch Neurol 65:1074–1080CrossRefPubMed DelleDonne A, Klos KJ, Fujishiro H, Ahmed Z, Parisi JE, Josephs KA, Frigerio R, Burnett M, Wszolek ZK, Uitti RJ, Ahlskog JE, Dickson DW (2008) Incidental Lewy body disease and preclinical Parkinson disease. Arch Neurol 65:1074–1080CrossRefPubMed
Zurück zum Zitat Deramecourt V, Bombois S, Maurage CA, Ghestem A, Drobecq H, Vanmechelen E, Lebert F, Pasquier F, Delacourte A (2006) Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies. J Neuropathol Exp Neurol 65:278–288CrossRefPubMed Deramecourt V, Bombois S, Maurage CA, Ghestem A, Drobecq H, Vanmechelen E, Lebert F, Pasquier F, Delacourte A (2006) Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies. J Neuropathol Exp Neurol 65:278–288CrossRefPubMed
Zurück zum Zitat Dettmer U, Selkoe D, Bartels T (2016) New insights into cellular alpha-synuclein homeostasis in health and disease. Curr Opin Neurobiol 36:15–22CrossRefPubMed Dettmer U, Selkoe D, Bartels T (2016) New insights into cellular alpha-synuclein homeostasis in health and disease. Curr Opin Neurobiol 36:15–22CrossRefPubMed
Zurück zum Zitat Dhillon JS, Trejo-Lopez JA, Riffe C, Levites Y, Sacino AN, Borchelt DR, Yachnis AY, Giasson BI (2019a) Comparative analyses of the in vivo induction and transmission of alpha-synuclein pathology in transgenic mice by MSA brain lysate and recombinant alpha-synuclein fibrils. Acta Neuropathol Commun 7:80CrossRefPubMedPubMedCentral Dhillon JS, Trejo-Lopez JA, Riffe C, Levites Y, Sacino AN, Borchelt DR, Yachnis AY, Giasson BI (2019a) Comparative analyses of the in vivo induction and transmission of alpha-synuclein pathology in transgenic mice by MSA brain lysate and recombinant alpha-synuclein fibrils. Acta Neuropathol Commun 7:80CrossRefPubMedPubMedCentral
Zurück zum Zitat di Domenico A, Carola G, Calatayud C, Pons-Espinal M, Munoz JP, Richaud-Patin Y, Fernandez-Carasa I, Gut M, Faella A, Parameswaran J, Soriano J, Ferrer I, Tolosa E, Zorzano A, Cuervo AM, Raya A, Consiglio A (2019) Patient-specific IPSC-derived astrocytes contribute to non-cell-autonomous neurodegeneration in Parkinson’s disease. Stem Cell Rep 12:213–229CrossRef di Domenico A, Carola G, Calatayud C, Pons-Espinal M, Munoz JP, Richaud-Patin Y, Fernandez-Carasa I, Gut M, Faella A, Parameswaran J, Soriano J, Ferrer I, Tolosa E, Zorzano A, Cuervo AM, Raya A, Consiglio A (2019) Patient-specific IPSC-derived astrocytes contribute to non-cell-autonomous neurodegeneration in Parkinson’s disease. Stem Cell Rep 12:213–229CrossRef
Zurück zum Zitat Dickson DW (2018) Neuropathology of Parkinson disease. Parkinsonism Relat Disord 46(Suppl 1):S30–S33CrossRefPubMed Dickson DW (2018) Neuropathology of Parkinson disease. Parkinsonism Relat Disord 46(Suppl 1):S30–S33CrossRefPubMed
Zurück zum Zitat Dickson DW, Fujishiro H, Delledonne A, Menke J, Ahmed Z, Klos KJ, Josephs KA, Frigerio R, Burnett M, Parisi JE, Ahlskog JE (2008) Evidence that incidental Lewy body disease is pre-symptomatic Parkinson’s disease. Acta Neuropathol 115:437–444CrossRefPubMed Dickson DW, Fujishiro H, Delledonne A, Menke J, Ahmed Z, Klos KJ, Josephs KA, Frigerio R, Burnett M, Parisi JE, Ahlskog JE (2008) Evidence that incidental Lewy body disease is pre-symptomatic Parkinson’s disease. Acta Neuropathol 115:437–444CrossRefPubMed
Zurück zum Zitat Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, Hardy J, Leverenz JB, Del Tredici K, Wszolek ZK, Litvan I (2009) Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria. Lancet Neurol 8:1150–1157CrossRefPubMed Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, Hardy J, Leverenz JB, Del Tredici K, Wszolek ZK, Litvan I (2009) Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria. Lancet Neurol 8:1150–1157CrossRefPubMed
Zurück zum Zitat Dickson DW, Ahmed Z, Algom AA, Tsuboi Y, Josephs KA (2010a) Neuropathology of variants of progressive supranuclear palsy. Curr Opin Neurol 23:394–400CrossRefPubMed Dickson DW, Ahmed Z, Algom AA, Tsuboi Y, Josephs KA (2010a) Neuropathology of variants of progressive supranuclear palsy. Curr Opin Neurol 23:394–400CrossRefPubMed
Zurück zum Zitat Dickson DW, Uchikado H, Fujishiro H, Tsuboi Y (2010b) Evidence in favor of Braak staging of Parkinson’s disease. Mov Disord 25(Suppl 1):S78–S82CrossRefPubMed Dickson DW, Uchikado H, Fujishiro H, Tsuboi Y (2010b) Evidence in favor of Braak staging of Parkinson’s disease. Mov Disord 25(Suppl 1):S78–S82CrossRefPubMed
Zurück zum Zitat Dickson DW, Hauw JJ, Agid Y, Litvan I (2011a) Progressive supranuclear palsy and corticobasal degeneration. In: Dickson DW, Weller RO (eds) Neurodegeneration: the molecular pathology of dementia and movement disorders, 2nd edn. Blackwell Publishing Ltd., Oxford, pp 135–155CrossRef Dickson DW, Hauw JJ, Agid Y, Litvan I (2011a) Progressive supranuclear palsy and corticobasal degeneration. In: Dickson DW, Weller RO (eds) Neurodegeneration: the molecular pathology of dementia and movement disorders, 2nd edn. Blackwell Publishing Ltd., Oxford, pp 135–155CrossRef
Zurück zum Zitat Dickson DW, Kouri N, Murray ME, Josephs KA (2011b) Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau). J Mol Neurosci 45:384–389CrossRefPubMedPubMedCentral Dickson DW, Kouri N, Murray ME, Josephs KA (2011b) Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau). J Mol Neurosci 45:384–389CrossRefPubMedPubMedCentral
Zurück zum Zitat Dickson DW, Heckman MG, Murray ME, Soto AI, Walton RL, Diehl NN, van Gerpen JA, Uitti RJ, Wszolek ZK, Ertekin-Taner N, Knopman DS, Petersen RC, Graff-Radford NR, Boeve BF, Bu G, Ferman TJ, Ross OA (2018) APOE epsilon4 is associated with severity of Lewy body pathology independent of Alzheimer pathology. Neurology 91:e1182–e1195CrossRefPubMedPubMedCentral Dickson DW, Heckman MG, Murray ME, Soto AI, Walton RL, Diehl NN, van Gerpen JA, Uitti RJ, Wszolek ZK, Ertekin-Taner N, Knopman DS, Petersen RC, Graff-Radford NR, Boeve BF, Bu G, Ferman TJ, Ross OA (2018) APOE epsilon4 is associated with severity of Lewy body pathology independent of Alzheimer pathology. Neurology 91:e1182–e1195CrossRefPubMedPubMedCentral
Zurück zum Zitat Dijkstra AA, Voorn P, Berendse HW, Groenewegen HJ, Rozemuller AJ, van de Berg WD (2014) Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson’s disease. Mov Disord 29:1244–1251CrossRefPubMed Dijkstra AA, Voorn P, Berendse HW, Groenewegen HJ, Rozemuller AJ, van de Berg WD (2014) Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson’s disease. Mov Disord 29:1244–1251CrossRefPubMed
Zurück zum Zitat Dirkx MF, den Ouden HE, Aarts E, Timmer MH, Bloem BR, Toni I, Helmich RC (2017) Dopamine controls Parkinson’s tremor by inhibiting the cerebellar thalamus. Brain 140:721–734PubMed Dirkx MF, den Ouden HE, Aarts E, Timmer MH, Bloem BR, Toni I, Helmich RC (2017) Dopamine controls Parkinson’s tremor by inhibiting the cerebellar thalamus. Brain 140:721–734PubMed
Zurück zum Zitat Djaldetti R, Lorberboym M, Karmon Y, Treves TA, Ziv I, Melamed E (2011) Residual striatal dopaminergic nerve terminals in very long-standing Parkinson’s disease: a single photon emission computed tomography imaging study. Mov Disord 26:327–330CrossRefPubMed Djaldetti R, Lorberboym M, Karmon Y, Treves TA, Ziv I, Melamed E (2011) Residual striatal dopaminergic nerve terminals in very long-standing Parkinson’s disease: a single photon emission computed tomography imaging study. Mov Disord 26:327–330CrossRefPubMed
Zurück zum Zitat Dolgacheva LP, Berezhnov AV, Fedotova EI, Zinchenko VP, Abramov AY (2019) Role of DJ-1 in the mechanism of pathogenesis of Parkinson’s disease. J Bioenerg Biomembr 51:175–188CrossRefPubMedPubMedCentral Dolgacheva LP, Berezhnov AV, Fedotova EI, Zinchenko VP, Abramov AY (2019) Role of DJ-1 in the mechanism of pathogenesis of Parkinson’s disease. J Bioenerg Biomembr 51:175–188CrossRefPubMedPubMedCentral
Zurück zum Zitat Don AS, Hsiao JH, Bleasel JM, Couttas TA, Halliday GM, Kim W (2014) Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy. Acta Neuropathol Commun 2:150CrossRefPubMedPubMedCentral Don AS, Hsiao JH, Bleasel JM, Couttas TA, Halliday GM, Kim W (2014) Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy. Acta Neuropathol Commun 2:150CrossRefPubMedPubMedCentral
Zurück zum Zitat Donaghy PC, McKeith I (2014) The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis. Alzheimers Res Ther 6:46CrossRefPubMedPubMedCentral Donaghy PC, McKeith I (2014) The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis. Alzheimers Res Ther 6:46CrossRefPubMedPubMedCentral
Zurück zum Zitat Donker Kaat L, Boon AJ, Azmani A, Kamphorst W, Breteler MM, Anar B, Heutink P, van Swieten JC (2009) Familial aggregation of parkinsonism in progressive supranuclear palsy. Neurology 73:98–105CrossRefPubMed Donker Kaat L, Boon AJ, Azmani A, Kamphorst W, Breteler MM, Anar B, Heutink P, van Swieten JC (2009) Familial aggregation of parkinsonism in progressive supranuclear palsy. Neurology 73:98–105CrossRefPubMed
Zurück zum Zitat Doppler K, Weis J, Karl K, Ebert S, Ebentheuer J, Trenkwalder C, Klebe S, Volkmann J, Sommer C (2015) Distinctive distribution of phospho-alpha-synuclein in dermal nerves in multiple system atrophy. Mov Disord 30:1688–1692CrossRefPubMed Doppler K, Weis J, Karl K, Ebert S, Ebentheuer J, Trenkwalder C, Klebe S, Volkmann J, Sommer C (2015) Distinctive distribution of phospho-alpha-synuclein in dermal nerves in multiple system atrophy. Mov Disord 30:1688–1692CrossRefPubMed
Zurück zum Zitat Double KL, Reyes S, Werry EL, Halliday GM (2010) Selective cell death in neurodegeneration: why are some neurons spared in vulnerable regions? Prog Neurobiol 92:316–329CrossRefPubMed Double KL, Reyes S, Werry EL, Halliday GM (2010) Selective cell death in neurodegeneration: why are some neurons spared in vulnerable regions? Prog Neurobiol 92:316–329CrossRefPubMed
Zurück zum Zitat Driver-Dunckley ED, Zhang N, Adler CH, Serrano GE, Sue LI, Shill H, Mehta SH, Belden CM, Zamrini E, Davis K, Beach T (2019) Brain Lewy-type synucleinopathy density is associated with a lower prevalence of atherosclerotic cardiovascular disease risk factors in patients with Parkinson’s disease. J Parkinsons Dis (in print) Driver-Dunckley ED, Zhang N, Adler CH, Serrano GE, Sue LI, Shill H, Mehta SH, Belden CM, Zamrini E, Davis K, Beach T (2019) Brain Lewy-type synucleinopathy density is associated with a lower prevalence of atherosclerotic cardiovascular disease risk factors in patients with Parkinson’s disease. J Parkinsons Dis (in print)
Zurück zum Zitat Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, McKeith IG, Olanow CW, Poewe W, Sampaio C, Tolosa E, Emre M (2007) Diagnostic procedures for Parkinson’s disease dementia: recommendations from the movement disorder society task force. Mov Disord 22:2314–2324CrossRefPubMed Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, McKeith IG, Olanow CW, Poewe W, Sampaio C, Tolosa E, Emre M (2007) Diagnostic procedures for Parkinson’s disease dementia: recommendations from the movement disorder society task force. Mov Disord 22:2314–2324CrossRefPubMed
Zurück zum Zitat Duffy MF, Collier TJ, Patterson JR, Kemp CJ, Luk KC, Tansey MG, Paumier KL, Kanaan NM, Fischer DL, Polinski NK, Barth OL, Howe JW, Vaikath NN, Majbour NK, El-Agnaf OMA, Sortwell CE (2018) Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration. J Neuroinflamm 15:129CrossRef Duffy MF, Collier TJ, Patterson JR, Kemp CJ, Luk KC, Tansey MG, Paumier KL, Kanaan NM, Fischer DL, Polinski NK, Barth OL, Howe JW, Vaikath NN, Majbour NK, El-Agnaf OMA, Sortwell CE (2018) Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration. J Neuroinflamm 15:129CrossRef
Zurück zum Zitat Dugger BN, Dickson DW (2010) Cell type specific sequestration of choline acetyltransferase and tyrosine hydroxylase within Lewy bodies. Acta Neuropathol 120:633–639CrossRefPubMedPubMedCentral Dugger BN, Dickson DW (2010) Cell type specific sequestration of choline acetyltransferase and tyrosine hydroxylase within Lewy bodies. Acta Neuropathol 120:633–639CrossRefPubMedPubMedCentral
Zurück zum Zitat Dugger BN, Hoffman BR, Scroggins A, Serrano GE, Adler CH, Shill HA, Belden CM, Sabbagh MN, Caviness JN, Driver Dunckley E, Beach TG (2018) Tau immunoreactivity in peripheral tissues of human aging and select tauopathies. Neurosci Lett 696:132–139CrossRefPubMedPubMedCentral Dugger BN, Hoffman BR, Scroggins A, Serrano GE, Adler CH, Shill HA, Belden CM, Sabbagh MN, Caviness JN, Driver Dunckley E, Beach TG (2018) Tau immunoreactivity in peripheral tissues of human aging and select tauopathies. Neurosci Lett 696:132–139CrossRefPubMedPubMedCentral
Zurück zum Zitat Durcan R, Donaghy P, Osborne C, Taylor JP, Thomas AJ (2019) Imaging in prodromal dementia with Lewy bodies: where do we stand? Int J Geriatr Psychiatry 34:635–646CrossRefPubMed Durcan R, Donaghy P, Osborne C, Taylor JP, Thomas AJ (2019) Imaging in prodromal dementia with Lewy bodies: where do we stand? Int J Geriatr Psychiatry 34:635–646CrossRefPubMed
Zurück zum Zitat Duyckaerts C, Clavaguera F, Potier MC (2019) The prion-like propagation hypothesis in Alzheimer’s and Parkinson’s disease. Curr Opin Neurol 32:266–271CrossRefPubMed Duyckaerts C, Clavaguera F, Potier MC (2019) The prion-like propagation hypothesis in Alzheimer’s and Parkinson’s disease. Curr Opin Neurol 32:266–271CrossRefPubMed
Zurück zum Zitat Dzamko N, Gysbers AM, Bandopadhyay R, Bolliger MF, Uchino A, Zhao Y, Takao M, Wauters S, van de Berg WD, Takahashi-Fujigasaki J, Nichols RJ, Holton JL, Murayama S, Halliday GM (2017) LRRK2 levels and phosphorylation in Parkinson’s disease brain and cases with restricted Lewy bodies. Mov Disord 32:423–432CrossRefPubMed Dzamko N, Gysbers AM, Bandopadhyay R, Bolliger MF, Uchino A, Zhao Y, Takao M, Wauters S, van de Berg WD, Takahashi-Fujigasaki J, Nichols RJ, Holton JL, Murayama S, Halliday GM (2017) LRRK2 levels and phosphorylation in Parkinson’s disease brain and cases with restricted Lewy bodies. Mov Disord 32:423–432CrossRefPubMed
Zurück zum Zitat Ebashi M, Ito Y, Uematsu M, Nakamura A, Hirokawa K, Kamei S, Uchihara T (2019) How to demix Alzheimer-type and PSP-type tau lesions out of their mixture-hybrid approach to dissect comorbidity. Acta Neuropathol Commun 7:71CrossRefPubMedPubMedCentral Ebashi M, Ito Y, Uematsu M, Nakamura A, Hirokawa K, Kamei S, Uchihara T (2019) How to demix Alzheimer-type and PSP-type tau lesions out of their mixture-hybrid approach to dissect comorbidity. Acta Neuropathol Commun 7:71CrossRefPubMedPubMedCentral
Zurück zum Zitat Ekman U, Eriksson J, Forsgren L, Mo SJ, Riklund K, Nyberg L (2012) Functional brain activity and presynaptic dopamine uptake in patients with Parkinson’s disease and mild cognitive impairment: a cross-sectional study. Lancet Neurol 11:679–687CrossRefPubMed Ekman U, Eriksson J, Forsgren L, Mo SJ, Riklund K, Nyberg L (2012) Functional brain activity and presynaptic dopamine uptake in patients with Parkinson’s disease and mild cognitive impairment: a cross-sectional study. Lancet Neurol 11:679–687CrossRefPubMed
Zurück zum Zitat Elder GJ, Mactier K, Colloby SJ, Watson R, Blamire AM, O’Brien JT, Taylor JP (2017) The influence of hippocampal atrophy on the cognitive phenotype of dementia with Lewy bodies. Int J Geriatr Psychiatry 32:1182–1189CrossRefPubMedPubMedCentral Elder GJ, Mactier K, Colloby SJ, Watson R, Blamire AM, O’Brien JT, Taylor JP (2017) The influence of hippocampal atrophy on the cognitive phenotype of dementia with Lewy bodies. Int J Geriatr Psychiatry 32:1182–1189CrossRefPubMedPubMedCentral
Zurück zum Zitat Elias S, Israel Z, Bergman H (2008) Physiology of Parkinson’s disease. In: Hallett M, Poewe W (eds) Therapeutics of Parkinson’s disease and other movement disorders. Wiley-Blackwell, New York, pp 25–36CrossRef Elias S, Israel Z, Bergman H (2008) Physiology of Parkinson’s disease. In: Hallett M, Poewe W (eds) Therapeutics of Parkinson’s disease and other movement disorders. Wiley-Blackwell, New York, pp 25–36CrossRef
Zurück zum Zitat Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22:1689–1707CrossRefPubMed Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22:1689–1707CrossRefPubMed
Zurück zum Zitat Engeln M, De Deurwaerdere P, Li Q, Bezard E, Fernagut PO (2015) Widespread monoaminergic dysregulation of both motor and non-motor circuits in parkinsonism and dyskinesia. Cereb Cortex 25:2783–2792CrossRefPubMed Engeln M, De Deurwaerdere P, Li Q, Bezard E, Fernagut PO (2015) Widespread monoaminergic dysregulation of both motor and non-motor circuits in parkinsonism and dyskinesia. Cereb Cortex 25:2783–2792CrossRefPubMed
Zurück zum Zitat Erro R, Picillo M, Amboni M, Savastano R, Scannapieco S, Cuoco S, Santangelo G, Vitale C, Pellecchia MT, Barone P (2019) Comparing postural instability and gait disorder and akinetic-rigid subtyping of Parkinson disease and their stability over time. Eur J Neurol 1:5. https://doi.org/10.1111/ene.13968 CrossRef Erro R, Picillo M, Amboni M, Savastano R, Scannapieco S, Cuoco S, Santangelo G, Vitale C, Pellecchia MT, Barone P (2019) Comparing postural instability and gait disorder and akinetic-rigid subtyping of Parkinson disease and their stability over time. Eur J Neurol 1:5. https://​doi.​org/​10.​1111/​ene.​13968 CrossRef
Zurück zum Zitat Erskine D, Thomas AJ, Taylor JP, Savage MA, Attems J, McKeith IG, Morris CM, Khundakar AA (2017) Neuronal loss and alpha-synuclein pathology in the superior colliculus and its relationship to visual hallucinations in dementia with Lewy bodies. Am J Geriatr Psychiatry 25:595–604CrossRefPubMed Erskine D, Thomas AJ, Taylor JP, Savage MA, Attems J, McKeith IG, Morris CM, Khundakar AA (2017) Neuronal loss and alpha-synuclein pathology in the superior colliculus and its relationship to visual hallucinations in dementia with Lewy bodies. Am J Geriatr Psychiatry 25:595–604CrossRefPubMed
Zurück zum Zitat Erskine D, Ding J, Thomas AJ, Kaganovich A, Khundakar AA, Hanson PS, Taylor JP, McKeith IG, Attems J, Cookson MR, Morris CM (2018) Molecular changes in the absence of severe pathology in the pulvinar in dementia with Lewy bodies. Mov Disord 33:982–991CrossRefPubMedPubMedCentral Erskine D, Ding J, Thomas AJ, Kaganovich A, Khundakar AA, Hanson PS, Taylor JP, McKeith IG, Attems J, Cookson MR, Morris CM (2018) Molecular changes in the absence of severe pathology in the pulvinar in dementia with Lewy bodies. Mov Disord 33:982–991CrossRefPubMedPubMedCentral
Zurück zum Zitat Espay AJ, LeWitt PA, Kaufmann H (2014) Norepinephrine deficiency in Parkinson’s disease: the case for noradrenergic enhancement. Mov Disord 29:1710–1719CrossRefPubMed Espay AJ, LeWitt PA, Kaufmann H (2014) Norepinephrine deficiency in Parkinson’s disease: the case for noradrenergic enhancement. Mov Disord 29:1710–1719CrossRefPubMed
Zurück zum Zitat Espay AJ, Vizcarra JA, Marsili L, Lang AE, Simon DK, Merola A, Josephs KA, Fasano A, Morgante F, Savica R, Greenamyre JT, Cambi F, Yamasaki TR, Tanner CM, Gan-Or Z, Litvan I, Mata IF, Zabetian CP, Brundin P, Fernandez HH, Standaert DG, Kauffman MA, Schwarzschild MA, Sardi SP, Sherer T, Perry G, Leverenz JB (2019) Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases. Neurology 92:329–337CrossRefPubMedPubMedCentral Espay AJ, Vizcarra JA, Marsili L, Lang AE, Simon DK, Merola A, Josephs KA, Fasano A, Morgante F, Savica R, Greenamyre JT, Cambi F, Yamasaki TR, Tanner CM, Gan-Or Z, Litvan I, Mata IF, Zabetian CP, Brundin P, Fernandez HH, Standaert DG, Kauffman MA, Schwarzschild MA, Sardi SP, Sherer T, Perry G, Leverenz JB (2019) Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases. Neurology 92:329–337CrossRefPubMedPubMedCentral
Zurück zum Zitat Evans T, Kok WL, Cowan K, Hefford M, Anichtchik O (2018) Accumulation of beta-synuclein in cortical neurons is associated with autophagy attenuation in the brains of dementia with Lewy body patients. Brain Res 1681:1–13CrossRefPubMed Evans T, Kok WL, Cowan K, Hefford M, Anichtchik O (2018) Accumulation of beta-synuclein in cortical neurons is associated with autophagy attenuation in the brains of dementia with Lewy body patients. Brain Res 1681:1–13CrossRefPubMed
Zurück zum Zitat Falcon B, Zhang W, Murzin AG, Murshudov G, Garringer HJ, Vidal R, Crowther RA, Ghetti B, Scheres SHW, Goedert M (2018) Structures of filaments from Pick’s disease reveal a novel tau protein fold. Nature 561:137–140CrossRefPubMedPubMedCentral Falcon B, Zhang W, Murzin AG, Murshudov G, Garringer HJ, Vidal R, Crowther RA, Ghetti B, Scheres SHW, Goedert M (2018) Structures of filaments from Pick’s disease reveal a novel tau protein fold. Nature 561:137–140CrossRefPubMedPubMedCentral
Zurück zum Zitat Fathy YY, Jonker AJ, Oudejans E, de Jong FJJ, van Dam AW, Rozemuller AJM, van de Berg WDJ (2019) Differential insular cortex subregional vulnerability to alpha-synuclein pathology in Parkinson’s disease and dementia with Lewy bodies. Neuropathol Appl Neurobiol 45:262–277CrossRefPubMed Fathy YY, Jonker AJ, Oudejans E, de Jong FJJ, van Dam AW, Rozemuller AJM, van de Berg WDJ (2019) Differential insular cortex subregional vulnerability to alpha-synuclein pathology in Parkinson’s disease and dementia with Lewy bodies. Neuropathol Appl Neurobiol 45:262–277CrossRefPubMed
Zurück zum Zitat Federoff M, Price TR, Sailer A, Scholz S, Hernandez D, Nicolas A, Singleton AB, Nalls M, Houlden H (2016) Genome-wide estimate of the heritability of multiple system atrophy. Parkinsonism Relat Disord 22:35–41CrossRefPubMed Federoff M, Price TR, Sailer A, Scholz S, Hernandez D, Nicolas A, Singleton AB, Nalls M, Houlden H (2016) Genome-wide estimate of the heritability of multiple system atrophy. Parkinsonism Relat Disord 22:35–41CrossRefPubMed
Zurück zum Zitat Felice VD, Quigley EM, Sullivan AM, O’Keeffe GW, O’Mahony SM (2016) Microbiota-gut-brain signalling in Parkinson’s disease: Implications for non-motor symptoms. Parkinsonism Relat Disord 27:1–8CrossRefPubMed Felice VD, Quigley EM, Sullivan AM, O’Keeffe GW, O’Mahony SM (2016) Microbiota-gut-brain signalling in Parkinson’s disease: Implications for non-motor symptoms. Parkinsonism Relat Disord 27:1–8CrossRefPubMed
Zurück zum Zitat Fellner L, Jellinger KA, Wenning GK, Stefanova N (2011) Glial dysfunction in the pathogenesis of alpha-synucleinopathies: emerging concepts. Acta Neuropathol 121:675–693CrossRefPubMedPubMedCentral Fellner L, Jellinger KA, Wenning GK, Stefanova N (2011) Glial dysfunction in the pathogenesis of alpha-synucleinopathies: emerging concepts. Acta Neuropathol 121:675–693CrossRefPubMedPubMedCentral
Zurück zum Zitat Fellner L, Buchinger E, Brueck D, Irschick R, Wenning GK, Stefanova N (2018) Limited effects of dysfunctional macroautophagy on the accumulation of extracellularly derived alpha-synuclein in oligodendroglia: implications for MSA pathogenesis. BMC Neurosci 19:32CrossRefPubMedPubMedCentral Fellner L, Buchinger E, Brueck D, Irschick R, Wenning GK, Stefanova N (2018) Limited effects of dysfunctional macroautophagy on the accumulation of extracellularly derived alpha-synuclein in oligodendroglia: implications for MSA pathogenesis. BMC Neurosci 19:32CrossRefPubMedPubMedCentral
Zurück zum Zitat Fereshtehnejad SM, Zeighami Y, Dagher A, Postuma RB (2017) Clinical criteria for subtyping Parkinson’s disease: biomarkers and longitudinal progression. Brain 140:1959–1976CrossRefPubMed Fereshtehnejad SM, Zeighami Y, Dagher A, Postuma RB (2017) Clinical criteria for subtyping Parkinson’s disease: biomarkers and longitudinal progression. Brain 140:1959–1976CrossRefPubMed
Zurück zum Zitat Ferguson MC, Garland EM, Hedges L, Womack-Nunley B, Hamid R, Phillips JA 3rd, Shibao CA, Raj SR, Biaggioni I, Robertson D (2014) SHC2 gene copy number in multiple system atrophy (MSA). Clin Auton Res 24:25–30CrossRefPubMed Ferguson MC, Garland EM, Hedges L, Womack-Nunley B, Hamid R, Phillips JA 3rd, Shibao CA, Raj SR, Biaggioni I, Robertson D (2014) SHC2 gene copy number in multiple system atrophy (MSA). Clin Auton Res 24:25–30CrossRefPubMed
Zurück zum Zitat Ferman TJ, Aoki N, Crook JE, Murray ME, Graff-Radford NR, van Gerpen JA, Uitti RJ, Wszolek ZK, Graff-Radford J, Pedraza O, Kantarci K, Boeve BF, Dickson DW (2018) The limbic and neocortical contribution of alpha-synuclein, tau, and amyloid beta to disease duration in dementia with Lewy bodies. Alzheimers Dement 14:330–339CrossRefPubMed Ferman TJ, Aoki N, Crook JE, Murray ME, Graff-Radford NR, van Gerpen JA, Uitti RJ, Wszolek ZK, Graff-Radford J, Pedraza O, Kantarci K, Boeve BF, Dickson DW (2018) The limbic and neocortical contribution of alpha-synuclein, tau, and amyloid beta to disease duration in dementia with Lewy bodies. Alzheimers Dement 14:330–339CrossRefPubMed
Zurück zum Zitat Ferrari R, Kia DA, Tomkins JE, Hardy J, Wood NW, Lovering RC, Lewis PA, Manzoni C (2018) Stratification of candidate genes for Parkinson’s disease using weighted protein-protein interaction network analysis. BMC Genom 19:452CrossRef Ferrari R, Kia DA, Tomkins JE, Hardy J, Wood NW, Lovering RC, Lewis PA, Manzoni C (2018) Stratification of candidate genes for Parkinson’s disease using weighted protein-protein interaction network analysis. BMC Genom 19:452CrossRef
Zurück zum Zitat Ferrer I (2018) Oligodendrogliopathy in neurodegenerative diseases with abnormal protein aggregates: the forgotten partner. Prog Neurobiol 169:24–54CrossRefPubMed Ferrer I (2018) Oligodendrogliopathy in neurodegenerative diseases with abnormal protein aggregates: the forgotten partner. Prog Neurobiol 169:24–54CrossRefPubMed
Zurück zum Zitat Ferrer I, Lopez-Gonzalez I, Carmona M, Arregui L, Dalfo E, Torrejon-Escribano B, Diehl R, Kovacs GG (2014) Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression. J Neuropathol Exp Neurol 73:81–97CrossRefPubMed Ferrer I, Lopez-Gonzalez I, Carmona M, Arregui L, Dalfo E, Torrejon-Escribano B, Diehl R, Kovacs GG (2014) Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression. J Neuropathol Exp Neurol 73:81–97CrossRefPubMed
Zurück zum Zitat Ferrer I, Aguiló García M, Carmona M, Andrés-Benito P, Torrejón-Escribano B, Garcia-Esparcia P, del Rio JA (2019) Involvement of oligodendrocytes in tau seeding and spreading in tauopathies. Front Aging Neurosci 11:112CrossRefPubMedPubMedCentral Ferrer I, Aguiló García M, Carmona M, Andrés-Benito P, Torrejón-Escribano B, Garcia-Esparcia P, del Rio JA (2019) Involvement of oligodendrocytes in tau seeding and spreading in tauopathies. Front Aging Neurosci 11:112CrossRefPubMedPubMedCentral
Zurück zum Zitat Ffytche DH, Creese B, Politis M, Chaudhuri KR, Weintraub D, Ballard C, Aarsland D (2017) The psychosis spectrum in Parkinson disease. Nat Rev Neurol 13:81–95CrossRefPubMedPubMedCentral Ffytche DH, Creese B, Politis M, Chaudhuri KR, Weintraub D, Ballard C, Aarsland D (2017) The psychosis spectrum in Parkinson disease. Nat Rev Neurol 13:81–95CrossRefPubMedPubMedCentral
Zurück zum Zitat Filippini A, Gennarelli M, Russo I (2019) Alpha-synuclein and glia in Parkinson’s disease: a beneficial or a detrimental duet for the endo-lysosomal system? Cell Mol Neurobiol 39:161–168CrossRefPubMed Filippini A, Gennarelli M, Russo I (2019) Alpha-synuclein and glia in Parkinson’s disease: a beneficial or a detrimental duet for the endo-lysosomal system? Cell Mol Neurobiol 39:161–168CrossRefPubMed
Zurück zum Zitat Fitzgerald E, Murphy S, Martinson HA (2019) Alpha-synuclein pathology and the role of the microbiota in Parkinson’s disease. Front Neurosci 13:369CrossRefPubMedPubMedCentral Fitzgerald E, Murphy S, Martinson HA (2019) Alpha-synuclein pathology and the role of the microbiota in Parkinson’s disease. Front Neurosci 13:369CrossRefPubMedPubMedCentral
Zurück zum Zitat Fling BW, Cohen RG, Mancini M, Nutt JG, Fair DA, Horak FB (2013) Asymmetric pedunculopontine network connectivity in parkinsonian patients with freezing of gait. Brain 136:2405–2418CrossRefPubMedPubMedCentral Fling BW, Cohen RG, Mancini M, Nutt JG, Fair DA, Horak FB (2013) Asymmetric pedunculopontine network connectivity in parkinsonian patients with freezing of gait. Brain 136:2405–2418CrossRefPubMedPubMedCentral
Zurück zum Zitat Foguem C, Manckoundia P (2018) Lewy body disease: clinical and pathological “overlap syndrome” between synucleinopathies (Parkinson disease) and tauopathies (Alzheimer disease). Curr Neurol Neurosci Rep 18:24CrossRefPubMed Foguem C, Manckoundia P (2018) Lewy body disease: clinical and pathological “overlap syndrome” between synucleinopathies (Parkinson disease) and tauopathies (Alzheimer disease). Curr Neurol Neurosci Rep 18:24CrossRefPubMed
Zurück zum Zitat Forno LS (1996) Neuropathology of Parkinson’s disease. J Neuropathol Exp Neurol 55:259–272CrossRefPubMed Forno LS (1996) Neuropathology of Parkinson’s disease. J Neuropathol Exp Neurol 55:259–272CrossRefPubMed
Zurück zum Zitat Forno LS, DeLanney LE, Irwin I, Langston JW (1996) Electron microscopy of Lewy bodies in the amygdala-parahippocampal region. Comparison with inclusion bodies in the MPTP-treated squirrel monkey. Adv Neurol 69:217–228PubMed Forno LS, DeLanney LE, Irwin I, Langston JW (1996) Electron microscopy of Lewy bodies in the amygdala-parahippocampal region. Comparison with inclusion bodies in the MPTP-treated squirrel monkey. Adv Neurol 69:217–228PubMed
Zurück zum Zitat Forrest SL, Kril JJ, Stevens CH, Kwok JB, Hallupp M, Kim WS, Huang Y, McGinley CV, Werka H, Kiernan MC, Gotz J, Spillantini MG, Hodges JR, Ittner LM, Halliday GM (2018) Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies. Brain 141:521–534CrossRefPubMed Forrest SL, Kril JJ, Stevens CH, Kwok JB, Hallupp M, Kim WS, Huang Y, McGinley CV, Werka H, Kiernan MC, Gotz J, Spillantini MG, Hodges JR, Ittner LM, Halliday GM (2018) Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies. Brain 141:521–534CrossRefPubMed
Zurück zum Zitat Forrest SL, Crockford DR, Sizemova A, McCann H, Shepherd CE, McGeachie AB, Affleck AJ, Carew-Jones F, Bartley L, Kwok JB, Kim WS, Jary E, Tan RH, McGinley CV, Piguet O, Hodges JR, Kril JJ, Halliday GM (2019a) Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration. Neurology 92:e2472–e2482CrossRefPubMed Forrest SL, Crockford DR, Sizemova A, McCann H, Shepherd CE, McGeachie AB, Affleck AJ, Carew-Jones F, Bartley L, Kwok JB, Kim WS, Jary E, Tan RH, McGinley CV, Piguet O, Hodges JR, Kril JJ, Halliday GM (2019a) Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration. Neurology 92:e2472–e2482CrossRefPubMed
Zurück zum Zitat Forrest SL, Halliday GM, McCann H, McGeachie AB, McGinley CV, Hodges JR, Piguet O, Kwok JB, Spillantini MG, Kril JJ (2019b) Heritability in frontotemporal tauopathies. Alzheimers Dement (Amst) 11:115–124 Forrest SL, Halliday GM, McCann H, McGeachie AB, McGinley CV, Hodges JR, Piguet O, Kwok JB, Spillantini MG, Kril JJ (2019b) Heritability in frontotemporal tauopathies. Alzheimers Dement (Amst) 11:115–124
Zurück zum Zitat Foti SC, Hargreaves I, Carrington S, Kiely AP, Houlden H, Holton JL (2019) Cerebral mitochondrial electron transport chain dysfunction in multiple system atrophy and Parkinson’s disease. Sci Rep 9:6559CrossRefPubMedPubMedCentral Foti SC, Hargreaves I, Carrington S, Kiely AP, Houlden H, Holton JL (2019) Cerebral mitochondrial electron transport chain dysfunction in multiple system atrophy and Parkinson’s disease. Sci Rep 9:6559CrossRefPubMedPubMedCentral
Zurück zum Zitat Francis PT, Perry EK (2007) Cholinergic and other neurotransmitter mechanisms in Parkinson’s disease, Parkinson’s disease dementia, and dementia with Lewy bodies. Mov Disord 22(Suppl 17):S351–S357CrossRefPubMed Francis PT, Perry EK (2007) Cholinergic and other neurotransmitter mechanisms in Parkinson’s disease, Parkinson’s disease dementia, and dementia with Lewy bodies. Mov Disord 22(Suppl 17):S351–S357CrossRefPubMed
Zurück zum Zitat Franquet E, Salvado-Figueres M, Lorenzo-Bosquet C, Cuberas-Borros G, Rovira A, Castell-Conesa J, Hernandez-Vara J (2012) Nigrostriatal pathway dysfunction in a methanol-induced delayed dystonia-parkinsonism. Mov Disord 27:1220–1221CrossRefPubMed Franquet E, Salvado-Figueres M, Lorenzo-Bosquet C, Cuberas-Borros G, Rovira A, Castell-Conesa J, Hernandez-Vara J (2012) Nigrostriatal pathway dysfunction in a methanol-induced delayed dystonia-parkinsonism. Mov Disord 27:1220–1221CrossRefPubMed
Zurück zum Zitat Freestone PS, Chung KK, Guatteo E, Mercuri NB, Nicholson LF, Lipski J (2009) Acute action of rotenone on nigral dopaminergic neurons—involvement of reactive oxygen species and disruption of Ca homeostasis. Eur J Neurosci 30:1849–1859CrossRefPubMed Freestone PS, Chung KK, Guatteo E, Mercuri NB, Nicholson LF, Lipski J (2009) Acute action of rotenone on nigral dopaminergic neurons—involvement of reactive oxygen species and disruption of Ca homeostasis. Eur J Neurosci 30:1849–1859CrossRefPubMed
Zurück zum Zitat Freundt EC, Maynard N, Clancy EK, Roy S, Bousset L, Sourigues Y, Covert M, Melki R, Kirkegaard K, Brahic M (2012) Neuron-to-neuron transmission of alpha-synuclein fibrils through axonal transport. Ann Neurol 72:517–524CrossRefPubMedPubMedCentral Freundt EC, Maynard N, Clancy EK, Roy S, Bousset L, Sourigues Y, Covert M, Melki R, Kirkegaard K, Brahic M (2012) Neuron-to-neuron transmission of alpha-synuclein fibrils through axonal transport. Ann Neurol 72:517–524CrossRefPubMedPubMedCentral
Zurück zum Zitat Friedman JH (2018) Dementia with Lewy bodies and Parkinson’s disease dementia become the same disease. Parkinsonism Relat Disord 46(Suppl 1):S6–S9CrossRefPubMed Friedman JH (2018) Dementia with Lewy bodies and Parkinson’s disease dementia become the same disease. Parkinsonism Relat Disord 46(Suppl 1):S6–S9CrossRefPubMed
Zurück zum Zitat Frigerio R, Fujishiro H, Ahn TB, Josephs KA, Maraganore DM, Delledonne A, Parisi JE, Klos KJ, Boeve BF, Dickson DW, Ahlskog JE (2011) Incidental Lewy body disease: Do some cases represent a preclinical stage of dementia with Lewy bodies? Neurobiol Aging 32:857–863CrossRefPubMed Frigerio R, Fujishiro H, Ahn TB, Josephs KA, Maraganore DM, Delledonne A, Parisi JE, Klos KJ, Boeve BF, Dickson DW, Ahlskog JE (2011) Incidental Lewy body disease: Do some cases represent a preclinical stage of dementia with Lewy bodies? Neurobiol Aging 32:857–863CrossRefPubMed
Zurück zum Zitat Frisina PG, Haroutunian V, Libow LS (2009) The neuropathological basis for depression in Parkinson’s disease. Parkinsonism Relat Disord 15:144–148CrossRefPubMed Frisina PG, Haroutunian V, Libow LS (2009) The neuropathological basis for depression in Parkinson’s disease. Parkinsonism Relat Disord 15:144–148CrossRefPubMed
Zurück zum Zitat Fujioka S, Ogaki K, Tacik PM, Uitti RJ, Ross OA, Wszolek ZK (2014a) Update on novel familial forms of Parkinson’s disease and multiple system atrophy. Parkinsonism Relat Disord 20(Suppl 1):S29–S34CrossRefPubMedPubMedCentral Fujioka S, Ogaki K, Tacik PM, Uitti RJ, Ross OA, Wszolek ZK (2014a) Update on novel familial forms of Parkinson’s disease and multiple system atrophy. Parkinsonism Relat Disord 20(Suppl 1):S29–S34CrossRefPubMedPubMedCentral
Zurück zum Zitat Fujioka S, Van Gerpen JA, Uitti RJ, Dickson DW, Wszolek ZK (2014b) Familial progressive supranuclear palsy: a literature review. Neurodegener Dis 13:180–182CrossRefPubMed Fujioka S, Van Gerpen JA, Uitti RJ, Dickson DW, Wszolek ZK (2014b) Familial progressive supranuclear palsy: a literature review. Neurodegener Dis 13:180–182CrossRefPubMed
Zurück zum Zitat Fujishiro H, Ferman TJ, Boeve BF, Smith GE, Graff-Radford NR, Uitti RJ, Wszolek ZK, Knopman DS, Petersen RC, Parisi JE, Dickson DW (2008a) Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases. J Neuropathol Exp Neurol 67:649–656CrossRefPubMed Fujishiro H, Ferman TJ, Boeve BF, Smith GE, Graff-Radford NR, Uitti RJ, Wszolek ZK, Knopman DS, Petersen RC, Parisi JE, Dickson DW (2008a) Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases. J Neuropathol Exp Neurol 67:649–656CrossRefPubMed
Zurück zum Zitat Fujishiro H, Tsuboi Y, Lin WL, Uchikado H, Dickson DW (2008b) Co-localization of tau and alpha-synuclein in the olfactory bulb in Alzheimer’s disease with amygdala Lewy bodies. Acta Neuropathol 116:17–24CrossRefPubMedPubMedCentral Fujishiro H, Tsuboi Y, Lin WL, Uchikado H, Dickson DW (2008b) Co-localization of tau and alpha-synuclein in the olfactory bulb in Alzheimer’s disease with amygdala Lewy bodies. Acta Neuropathol 116:17–24CrossRefPubMedPubMedCentral
Zurück zum Zitat Fujishiro H, Iseki E, Higashi S, Kasanuki K, Murayama N, Togo T, Katsuse O, Uchikado H, Aoki N, Kosaka K, Arai H, Sato K (2010) Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia. Neurosci Lett 486:19–23CrossRefPubMed Fujishiro H, Iseki E, Higashi S, Kasanuki K, Murayama N, Togo T, Katsuse O, Uchikado H, Aoki N, Kosaka K, Arai H, Sato K (2010) Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia. Neurosci Lett 486:19–23CrossRefPubMed
Zurück zum Zitat Fujiyama F, Unzai T, Karube F (2019) Thalamostriatal projections and striosome-matrix compartments. Neurochem Int 125:67–73CrossRefPubMed Fujiyama F, Unzai T, Karube F (2019) Thalamostriatal projections and striosome-matrix compartments. Neurochem Int 125:67–73CrossRefPubMed
Zurück zum Zitat Gadad BS, Britton GB, Rao KS (2011) Targeting oligomers in neurodegenerative disorders: lessons from alpha-synuclein, tau, and amyloid-beta peptide. J Alzheimers Dis 24(Suppl 2):223–232CrossRefPubMed Gadad BS, Britton GB, Rao KS (2011) Targeting oligomers in neurodegenerative disorders: lessons from alpha-synuclein, tau, and amyloid-beta peptide. J Alzheimers Dis 24(Suppl 2):223–232CrossRefPubMed
Zurück zum Zitat Gai WP, Pountney DL, Power JH, Li QX, Culvenor JG, McLean CA, Jensen PH, Blumbergs PC (2003) Alpha-synuclein fibrils constitute the central core of oligodendroglial inclusion filaments in multiple system atrophy. Exp Neurol 181:68–78CrossRefPubMed Gai WP, Pountney DL, Power JH, Li QX, Culvenor JG, McLean CA, Jensen PH, Blumbergs PC (2003) Alpha-synuclein fibrils constitute the central core of oligodendroglial inclusion filaments in multiple system atrophy. Exp Neurol 181:68–78CrossRefPubMed
Zurück zum Zitat Galts CPC, Bettio LEB, Jewett DC, Yang CC, Brocardo PS, Rodrigues ALS, Thacker JS, Gil-Mohapel J (2019) Depression in neurodegenerative diseases: common mechanisms and current treatment options. Neurosci Biobehav Rev 102:56–84CrossRefPubMed Galts CPC, Bettio LEB, Jewett DC, Yang CC, Brocardo PS, Rodrigues ALS, Thacker JS, Gil-Mohapel J (2019) Depression in neurodegenerative diseases: common mechanisms and current treatment options. Neurosci Biobehav Rev 102:56–84CrossRefPubMed
Zurück zum Zitat Gallucci M, Dell’Acqua C, Boccaletto F, Fenoglio C, Galimberti D, Di Battista ME (2019) Overlap between frontotemporal dementia and dementia with Lewy bodies: a Treviso Dementia (TREDEM) registry case report. J Alzheimers Dis 69:839–847CrossRefPubMed Gallucci M, Dell’Acqua C, Boccaletto F, Fenoglio C, Galimberti D, Di Battista ME (2019) Overlap between frontotemporal dementia and dementia with Lewy bodies: a Treviso Dementia (TREDEM) registry case report. J Alzheimers Dis 69:839–847CrossRefPubMed
Zurück zum Zitat Gao LL, Zhang JR, Chan P, Wu T (2017) Levodopa effect on basal ganglia motor circuit in Parkinson’s disease. CNS Neurosci Ther 23:76–86CrossRefPubMed Gao LL, Zhang JR, Chan P, Wu T (2017) Levodopa effect on basal ganglia motor circuit in Parkinson’s disease. CNS Neurosci Ther 23:76–86CrossRefPubMed
Zurück zum Zitat Gash DM, Rutland K, Hudson NL, Sullivan PG, Bing G, Cass WA, Pandya JD, Liu M, Choi DY, Hunter RL, Gerhardt GA, Smith CD, Slevin JT, Prince TS (2008) Trichloroethylene: parkinsonism and complex 1 mitochondrial neurotoxicity. Ann Neurol 63:184–192CrossRefPubMed Gash DM, Rutland K, Hudson NL, Sullivan PG, Bing G, Cass WA, Pandya JD, Liu M, Choi DY, Hunter RL, Gerhardt GA, Smith CD, Slevin JT, Prince TS (2008) Trichloroethylene: parkinsonism and complex 1 mitochondrial neurotoxicity. Ann Neurol 63:184–192CrossRefPubMed
Zurück zum Zitat Gegg ME, Schapira AHV (2018) The role of glucocerebrosidase in Parkinson disease pathogenesis. FEBS J 285:3591–3603CrossRefPubMed Gegg ME, Schapira AHV (2018) The role of glucocerebrosidase in Parkinson disease pathogenesis. FEBS J 285:3591–3603CrossRefPubMed
Zurück zum Zitat Geibl FF, Henrich MT, Oertel WH (2019) Mesencephalic and extramesencephalic dopaminergic systems in Parkinson’s disease. J Neural Transm (Vienna) 126:377–396CrossRef Geibl FF, Henrich MT, Oertel WH (2019) Mesencephalic and extramesencephalic dopaminergic systems in Parkinson’s disease. J Neural Transm (Vienna) 126:377–396CrossRef
Zurück zum Zitat Geiger JT, Ding J, Crain B, Pletnikova O, Letson C, Dawson TM, Rosenthal LS, Pantelyat A, Gibbs JR, Albert MS, Hernandez DG, Hillis AE, Stone DJ, Singleton AB, Hardy JA, Troncoso JC, Scholz SW (2016) Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies. Neurobiol Dis 94:55–62CrossRefPubMedPubMedCentral Geiger JT, Ding J, Crain B, Pletnikova O, Letson C, Dawson TM, Rosenthal LS, Pantelyat A, Gibbs JR, Albert MS, Hernandez DG, Hillis AE, Stone DJ, Singleton AB, Hardy JA, Troncoso JC, Scholz SW (2016) Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies. Neurobiol Dis 94:55–62CrossRefPubMedPubMedCentral
Zurück zum Zitat Gelpi E, Colom-Cadena M (2019) Oligomers: a hot topic for neurodegeneration and a note of caution for experimental models. Brain 142:228–230CrossRefPubMed Gelpi E, Colom-Cadena M (2019) Oligomers: a hot topic for neurodegeneration and a note of caution for experimental models. Brain 142:228–230CrossRefPubMed
Zurück zum Zitat Gelpi E, Navarro-Otano J, Tolosa E, Gaig C, Compta Y, Rey MJ, Marti MJ, Hernandez I, Valldeoriola F, Rene R, Ribalta T (2014) Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders. Mov Disord 29:1010–1018CrossRefPubMed Gelpi E, Navarro-Otano J, Tolosa E, Gaig C, Compta Y, Rey MJ, Marti MJ, Hernandez I, Valldeoriola F, Rene R, Ribalta T (2014) Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders. Mov Disord 29:1010–1018CrossRefPubMed
Zurück zum Zitat George G, Valiya Parambath S, Lokappa SB, Varkey J (2019) Construction of Parkinson’s disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes. Gene 697:67–77CrossRefPubMed George G, Valiya Parambath S, Lokappa SB, Varkey J (2019) Construction of Parkinson’s disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes. Gene 697:67–77CrossRefPubMed
Zurück zum Zitat Gerson JE, Farmer KM, Henson N, Castillo-Carranza DL, Carretero Murillo M, Sengupta U, Barrett A, Kayed R (2018) Tau oligomers mediate alpha-synuclein toxicity and can be targeted by immunotherapy. Mol Neurodegener 13:13CrossRefPubMedPubMedCentral Gerson JE, Farmer KM, Henson N, Castillo-Carranza DL, Carretero Murillo M, Sengupta U, Barrett A, Kayed R (2018) Tau oligomers mediate alpha-synuclein toxicity and can be targeted by immunotherapy. Mol Neurodegener 13:13CrossRefPubMedPubMedCentral
Zurück zum Zitat Ghazi Sherbaf F, Same K, Aarabi MH (2018) High angular resolution diffusion imaging correlates of depression in Parkinson’s disease: a connectometry study. Acta Neurol Belg 118:573–579CrossRefPubMed Ghazi Sherbaf F, Same K, Aarabi MH (2018) High angular resolution diffusion imaging correlates of depression in Parkinson’s disease: a connectometry study. Acta Neurol Belg 118:573–579CrossRefPubMed
Zurück zum Zitat Ghetti B, Wszolek ZK, Boeve BF, Spina S, Goedert M (2011) Frontotemporal dementia and parkinsonism linked to chromosome 17. In: Dickson DW, Weller RO (eds) Neurodegeneration: the molecular pathology of dementia and movement disorders, 2nd edn. Blackwell Publishing Ltd., Oxford, pp 110–134CrossRef Ghetti B, Wszolek ZK, Boeve BF, Spina S, Goedert M (2011) Frontotemporal dementia and parkinsonism linked to chromosome 17. In: Dickson DW, Weller RO (eds) Neurodegeneration: the molecular pathology of dementia and movement disorders, 2nd edn. Blackwell Publishing Ltd., Oxford, pp 110–134CrossRef
Zurück zum Zitat Giguere N, Burke Nanni S, Trudeau LE (2018) On cell loss and selective vulnerability of neuronal populations in Parkinson’s disease. Front Neurol 9:455CrossRefPubMedPubMedCentral Giguere N, Burke Nanni S, Trudeau LE (2018) On cell loss and selective vulnerability of neuronal populations in Parkinson’s disease. Front Neurol 9:455CrossRefPubMedPubMedCentral
Zurück zum Zitat Gil MJ, Manzano MS, Cuadrado ML, Fernandez C, Gomez E, Matesanz C, Calero M, Rabano A (2018a) Frontotemporal lobar degeneration: Study of a clinicopathological cohort. J Clin Neurosci 58:172–180CrossRefPubMed Gil MJ, Manzano MS, Cuadrado ML, Fernandez C, Gomez E, Matesanz C, Calero M, Rabano A (2018a) Frontotemporal lobar degeneration: Study of a clinicopathological cohort. J Clin Neurosci 58:172–180CrossRefPubMed
Zurück zum Zitat Gil MJ, Manzano MS, Cuadrado ML, Fernandez C, Gomez E, Matesanz C, Calero M, Rabano A (2018b) Argyrophilic grain pathology in frontotemporal lobar degeneration: demographic, clinical, neuropathological, and genetic features. J Alzheimers Dis 63:1109–1117CrossRefPubMed Gil MJ, Manzano MS, Cuadrado ML, Fernandez C, Gomez E, Matesanz C, Calero M, Rabano A (2018b) Argyrophilic grain pathology in frontotemporal lobar degeneration: demographic, clinical, neuropathological, and genetic features. J Alzheimers Dis 63:1109–1117CrossRefPubMed
Zurück zum Zitat Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Durr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K, Vidailhet M (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670–676CrossRefPubMedPubMedCentral Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Durr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K, Vidailhet M (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670–676CrossRefPubMedPubMedCentral
Zurück zum Zitat Ginsberg MD (1985) Carbon monoxide intoxication: clinical features, neuropathology and mechanisms of injury. J Toxicol Clin Toxicol 23:281–288CrossRefPubMed Ginsberg MD (1985) Carbon monoxide intoxication: clinical features, neuropathology and mechanisms of injury. J Toxicol Clin Toxicol 23:281–288CrossRefPubMed
Zurück zum Zitat Godini R, Fallahi H, Ebrahimie E (2019) A comparative system-level analysis of the neurodegenerative diseases. J Cell Physiol 234:5215–5229CrossRefPubMed Godini R, Fallahi H, Ebrahimie E (2019) A comparative system-level analysis of the neurodegenerative diseases. J Cell Physiol 234:5215–5229CrossRefPubMed
Zurück zum Zitat Goedert M, Eisenberg DS, Crowther RA (2017a) Propagation of tau aggregates and neurodegeneration. Annu Rev Neurosci 40:189–210CrossRefPubMed Goedert M, Eisenberg DS, Crowther RA (2017a) Propagation of tau aggregates and neurodegeneration. Annu Rev Neurosci 40:189–210CrossRefPubMed
Zurück zum Zitat Goedert M, Masuda-Suzukake M, Falcon B (2017c) Like prions: the propagation of aggregated tau and alpha-synuclein in neurodegeneration. Brain 140:266–278CrossRefPubMed Goedert M, Masuda-Suzukake M, Falcon B (2017c) Like prions: the propagation of aggregated tau and alpha-synuclein in neurodegeneration. Brain 140:266–278CrossRefPubMed
Zurück zum Zitat Goetz CG, Emre M, Dubois B (2008) Parkinson’s disease dementia: definitions, guidelines, and research perspectives in diagnosis. Ann Neurol 64(Suppl 2):S81–S92PubMed Goetz CG, Emre M, Dubois B (2008) Parkinson’s disease dementia: definitions, guidelines, and research perspectives in diagnosis. Ann Neurol 64(Suppl 2):S81–S92PubMed
Zurück zum Zitat Gomez-Suaga P, Fdez E, Blanca Ramirez M, Hilfiker S (2012) A link between autophagy and the pathophysiology of LRRK2 in Parkinson’s disease. Parkinsons Dis 2012:324521PubMedPubMedCentral Gomez-Suaga P, Fdez E, Blanca Ramirez M, Hilfiker S (2012) A link between autophagy and the pathophysiology of LRRK2 in Parkinson’s disease. Parkinsons Dis 2012:324521PubMedPubMedCentral
Zurück zum Zitat Gomperts SN (2016) Lewy body dementias: dementia with Lewy bodies and Parkinson disease dementia. Continuum (Minneap Minn) 22:435–463 Gomperts SN (2016) Lewy body dementias: dementia with Lewy bodies and Parkinson disease dementia. Continuum (Minneap Minn) 22:435–463
Zurück zum Zitat Gotz J, Halliday G, Nisbet RM (2019) Molecular pathogenesis of the tauopathies. Annu Rev Pathol 14:239–261CrossRefPubMed Gotz J, Halliday G, Nisbet RM (2019) Molecular pathogenesis of the tauopathies. Annu Rev Pathol 14:239–261CrossRefPubMed
Zurück zum Zitat Grabli D, Auré K, Vidailhet M, Roze E (2011) Movement disorders in neurometabolic diseases. In: Gálvez-Jiménez N, Tuite P (eds) Uncommon causes of movement disorders. Cambridge University Press, Cambridge, pp 245–257CrossRef Grabli D, Auré K, Vidailhet M, Roze E (2011) Movement disorders in neurometabolic diseases. In: Gálvez-Jiménez N, Tuite P (eds) Uncommon causes of movement disorders. Cambridge University Press, Cambridge, pp 245–257CrossRef
Zurück zum Zitat Greffard S, Verny M, Bonnet AM, Seilhean D, Hauw JJ, Duyckaerts C (2010) A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death. Neurobiol Aging 31:99–103CrossRefPubMed Greffard S, Verny M, Bonnet AM, Seilhean D, Hauw JJ, Duyckaerts C (2010) A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death. Neurobiol Aging 31:99–103CrossRefPubMed
Zurück zum Zitat Grigoletto J, Pukass K, Gamliel A, Davidi D, Katz-Brull R, Richter-Landsberg C, Sharon R (2017) Higher levels of myelin phospholipids in brains of neuronal alpha-synuclein transgenic mice precede myelin loss. Acta Neuropathol Commun 5:37CrossRefPubMedPubMedCentral Grigoletto J, Pukass K, Gamliel A, Davidi D, Katz-Brull R, Richter-Landsberg C, Sharon R (2017) Higher levels of myelin phospholipids in brains of neuronal alpha-synuclein transgenic mice precede myelin loss. Acta Neuropathol Commun 5:37CrossRefPubMedPubMedCentral
Zurück zum Zitat Grimm MJ, Respondek G, Stamelou M, Arzberger T, Ferguson L, Gelpi E, Giese A, Grossman M, Irwin DJ, Pantelyat A, Rajput A, Roeber S, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Colosimo C, van Eimeren T, Kassubek J, Levin J, Meissner WG, Nilsson C, Oertel WH, Piot I, Poewe W, Wenning GK, Boxer A, Golbe LI, Josephs KA, Litvan I, Morris HR, Whitwell JL, Compta Y, Corvol JC, Lang AE, Rowe JB, Hoglinger GU (2019) How to apply the Movement Disorder Society criteria for diagnosis of progressive supranuclear palsy. Mov Disord. https://doi.org/10.1002/mds.27666 CrossRefPubMedPubMedCentral Grimm MJ, Respondek G, Stamelou M, Arzberger T, Ferguson L, Gelpi E, Giese A, Grossman M, Irwin DJ, Pantelyat A, Rajput A, Roeber S, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Colosimo C, van Eimeren T, Kassubek J, Levin J, Meissner WG, Nilsson C, Oertel WH, Piot I, Poewe W, Wenning GK, Boxer A, Golbe LI, Josephs KA, Litvan I, Morris HR, Whitwell JL, Compta Y, Corvol JC, Lang AE, Rowe JB, Hoglinger GU (2019) How to apply the Movement Disorder Society criteria for diagnosis of progressive supranuclear palsy. Mov Disord. https://​doi.​org/​10.​1002/​mds.​27666 CrossRefPubMedPubMedCentral
Zurück zum Zitat Grozdanov V, Danzer KM (2018) Release and uptake of pathologic alpha-synuclein. Cell Tissue Res 373:175–182CrossRefPubMed Grozdanov V, Danzer KM (2018) Release and uptake of pathologic alpha-synuclein. Cell Tissue Res 373:175–182CrossRefPubMed
Zurück zum Zitat Grunblatt E, Ruder J, Monoranu CM, Riederer P, Youdim MB, Mandel SA (2018) Differential alterations in metabolism and proteolysis-related proteins in human Parkinson’s disease substantia nigra. Neurotox Res 33:560–568CrossRefPubMed Grunblatt E, Ruder J, Monoranu CM, Riederer P, Youdim MB, Mandel SA (2018) Differential alterations in metabolism and proteolysis-related proteins in human Parkinson’s disease substantia nigra. Neurotox Res 33:560–568CrossRefPubMed
Zurück zum Zitat Guan X, Zhang Y, Wei H, Guo T, Zeng Q, Zhou C, Wang J, Gao T, Xuan M, Gu Q, Xu X, Huang P, Pu J, Zhang B, Liu C, Zhang M (2019) Iron-related nigral degeneration influences functional topology mediated by striatal dysfunction in Parkinson’s disease. Neurobiol Aging 75:83–97CrossRefPubMed Guan X, Zhang Y, Wei H, Guo T, Zeng Q, Zhou C, Wang J, Gao T, Xuan M, Gu Q, Xu X, Huang P, Pu J, Zhang B, Liu C, Zhang M (2019) Iron-related nigral degeneration influences functional topology mediated by striatal dysfunction in Parkinson’s disease. Neurobiol Aging 75:83–97CrossRefPubMed
Zurück zum Zitat Guerreiro R, Ross OA, Kun-Rodrigues C, Hernandez DG, Orme T, Eicher JD, Shepherd CE, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Ansorge O, Clarimon J, Lleo A, Morenas-Rodriguez E, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Serrano GE, Beach TG, Lesage S, Galasko D, Masliah E, Santana I, Pastor P, Diez-Fairen M, Aguilar M, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Escott-Price V, Graff-Radford N, Cairns NJ, Morris JC, Pickering-Brown S, Mann D, Halliday GM, Hardy J, Trojanowski JQ, Dickson DW, Singleton A, Stone DJ, Bras J (2018) Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. Lancet Neurol 17:64–74CrossRefPubMed Guerreiro R, Ross OA, Kun-Rodrigues C, Hernandez DG, Orme T, Eicher JD, Shepherd CE, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Ansorge O, Clarimon J, Lleo A, Morenas-Rodriguez E, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Serrano GE, Beach TG, Lesage S, Galasko D, Masliah E, Santana I, Pastor P, Diez-Fairen M, Aguilar M, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Escott-Price V, Graff-Radford N, Cairns NJ, Morris JC, Pickering-Brown S, Mann D, Halliday GM, Hardy J, Trojanowski JQ, Dickson DW, Singleton A, Stone DJ, Bras J (2018) Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. Lancet Neurol 17:64–74CrossRefPubMed
Zurück zum Zitat Guerrero E, Vasudevaraju P, Hegde ML, Britton GB, Rao KS (2013) Recent advances in alpha-synuclein functions, advanced glycation, and toxicity: implications for Parkinson’s disease. Mol Neurobiol 47:525–536CrossRefPubMed Guerrero E, Vasudevaraju P, Hegde ML, Britton GB, Rao KS (2013) Recent advances in alpha-synuclein functions, advanced glycation, and toxicity: implications for Parkinson’s disease. Mol Neurobiol 47:525–536CrossRefPubMed
Zurück zum Zitat Guiney SJ, Adlard PA, Bush AI, Finkelstein DI, Ayton S (2017) Ferroptosis and cell death mechanisms in Parkinson’s disease. Neurochem Int 104:34–48CrossRefPubMed Guiney SJ, Adlard PA, Bush AI, Finkelstein DI, Ayton S (2017) Ferroptosis and cell death mechanisms in Parkinson’s disease. Neurochem Int 104:34–48CrossRefPubMed
Zurück zum Zitat Gundner AL, Duran-Pacheco G, Zimmermann S, Ruf I, Moors T, Baumann K, Jagasia R, van de Berg WDJ, Kremer T (2019) Path mediation analysis reveals GBA impacts Lewy body disease status by increasing alpha-synuclein levels. Neurobiol Dis 121:205–213CrossRefPubMed Gundner AL, Duran-Pacheco G, Zimmermann S, Ruf I, Moors T, Baumann K, Jagasia R, van de Berg WDJ, Kremer T (2019) Path mediation analysis reveals GBA impacts Lewy body disease status by increasing alpha-synuclein levels. Neurobiol Dis 121:205–213CrossRefPubMed
Zurück zum Zitat Hall JM, Lewis SJG (2019) Neural correlates of cognitive impairment in Parkinson’s disease: a review of structural MRI findings. Int Rev Neurobiol 144:1–28CrossRefPubMed Hall JM, Lewis SJG (2019) Neural correlates of cognitive impairment in Parkinson’s disease: a review of structural MRI findings. Int Rev Neurobiol 144:1–28CrossRefPubMed
Zurück zum Zitat Hall JM, Shine JM, Walton CC, Gilat M, Kamsma YP, Naismith SL, Lewis SJ (2014) Early phenotypic differences between Parkinson’s disease patients with and without freezing of gait. Parkinsonism Relat Disord 20:604–607CrossRefPubMed Hall JM, Shine JM, Walton CC, Gilat M, Kamsma YP, Naismith SL, Lewis SJ (2014) Early phenotypic differences between Parkinson’s disease patients with and without freezing of gait. Parkinsonism Relat Disord 20:604–607CrossRefPubMed
Zurück zum Zitat Halliday GM, McCann H (2010) The progression of pathology in Parkinson’s disease. Ann N Y Acad Sci 1184:188–195CrossRefPubMed Halliday GM, McCann H (2010) The progression of pathology in Parkinson’s disease. Ann N Y Acad Sci 1184:188–195CrossRefPubMed
Zurück zum Zitat Halliday G, Hely M, Reid W, Morris J (2008) The progression of pathology in longitudinally followed patients with Parkinson’s disease. Acta Neuropathol 115:409–415CrossRefPubMed Halliday G, Hely M, Reid W, Morris J (2008) The progression of pathology in longitudinally followed patients with Parkinson’s disease. Acta Neuropathol 115:409–415CrossRefPubMed
Zurück zum Zitat Halliday G, Herrero MT, Murphy K, McCann H, Ros-Bernal F, Barcia C, Mori H, Blesa FJ, Obeso JA (2009) No Lewy pathology in monkeys with over 10 years of severe MPTP parkinsonism. Mov Disord 24:1519–1523CrossRefPubMed Halliday G, Herrero MT, Murphy K, McCann H, Ros-Bernal F, Barcia C, Mori H, Blesa FJ, Obeso JA (2009) No Lewy pathology in monkeys with over 10 years of severe MPTP parkinsonism. Mov Disord 24:1519–1523CrossRefPubMed
Zurück zum Zitat Halliday GM, Song YJ, Harding AJ (2011) Striatal beta-amyloid in dementia with Lewy bodies but not Parkinson’s disease. J Neural Transm 118:713–719CrossRefPubMed Halliday GM, Song YJ, Harding AJ (2011) Striatal beta-amyloid in dementia with Lewy bodies but not Parkinson’s disease. J Neural Transm 118:713–719CrossRefPubMed
Zurück zum Zitat Halliday G, McCann H, Shepherd C (2012) Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson’s disease? Expert Rev Neurother 12:673–686CrossRefPubMed Halliday G, McCann H, Shepherd C (2012) Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson’s disease? Expert Rev Neurother 12:673–686CrossRefPubMed
Zurück zum Zitat Halliday GM, Leverenz JB, Schneider JS, Adler CH (2014) The neurobiological basis of cognitive impairment in Parkinson’s disease. Mov Disord 29:634–650CrossRefPubMedPubMedCentral Halliday GM, Leverenz JB, Schneider JS, Adler CH (2014) The neurobiological basis of cognitive impairment in Parkinson’s disease. Mov Disord 29:634–650CrossRefPubMedPubMedCentral
Zurück zum Zitat Hamed M, Schraml F, Wilson J, Galvin J, Sabbagh MN (2018) Occipital and cingulate hypometabolism are significantly under-reported on 18-fluorodeoxyglucose positron emission tomography scans of patients with Lewy body dementia. J Alzheimers Dis Parkinsonism 8:428CrossRefPubMedPubMedCentral Hamed M, Schraml F, Wilson J, Galvin J, Sabbagh MN (2018) Occipital and cingulate hypometabolism are significantly under-reported on 18-fluorodeoxyglucose positron emission tomography scans of patients with Lewy body dementia. J Alzheimers Dis Parkinsonism 8:428CrossRefPubMedPubMedCentral
Zurück zum Zitat Hansen LA, Daniel SE, Wilcock GK, Love S (1998) Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer’s disease and dementia. J Neurol Neurosurg Psychiatry 64:653–656CrossRefPubMedPubMedCentral Hansen LA, Daniel SE, Wilcock GK, Love S (1998) Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer’s disease and dementia. J Neurol Neurosurg Psychiatry 64:653–656CrossRefPubMedPubMedCentral
Zurück zum Zitat Hara K, Watanabe H, Bagarinao E, Kawabata K, Yoneyama N, Ohdake R, Imai K, Masuda M, Yokoi T, Ogura A, Tsuboi T, Ito M, Atsuta N, Niwa H, Taoka T, Maesawa S, Naganawa S, Katsuno M, Sobue G (2018) Corpus callosal involvement is correlated with cognitive impairment in multiple system atrophy. J Neurol 265:2079–2087CrossRefPubMed Hara K, Watanabe H, Bagarinao E, Kawabata K, Yoneyama N, Ohdake R, Imai K, Masuda M, Yokoi T, Ogura A, Tsuboi T, Ito M, Atsuta N, Niwa H, Taoka T, Maesawa S, Naganawa S, Katsuno M, Sobue G (2018) Corpus callosal involvement is correlated with cognitive impairment in multiple system atrophy. J Neurol 265:2079–2087CrossRefPubMed
Zurück zum Zitat Harding AJ, Stimson E, Henderson JM, Halliday GM (2002) Clinical correlates of selective pathology in the amygdala of patients with Parkinson’s disease. Brain 125:2431–2445CrossRefPubMed Harding AJ, Stimson E, Henderson JM, Halliday GM (2002) Clinical correlates of selective pathology in the amygdala of patients with Parkinson’s disease. Brain 125:2431–2445CrossRefPubMed
Zurück zum Zitat Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y, Beach TG, Buratti E, Baralle F, Morita M, Nakano I, Oda T, Tsuchiya K, Akiyama H (2008) Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol 64:60–70CrossRefPubMedPubMedCentral Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y, Beach TG, Buratti E, Baralle F, Morita M, Nakano I, Oda T, Tsuchiya K, Akiyama H (2008) Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol 64:60–70CrossRefPubMedPubMedCentral
Zurück zum Zitat Hata Y, Ma N, Yoneda M, Morimoto S, Okano H, Murayama S, Kawanishi S, Kuzuhara S, Kokubo Y (2018) Nitrative stress and tau accumulation in amyotrophic lateral sclerosis/parkinsonism-dementia complex (ALS/PDC) in the Kii Peninsula, Japan. Front Neurosci 11:751CrossRefPubMedPubMedCentral Hata Y, Ma N, Yoneda M, Morimoto S, Okano H, Murayama S, Kawanishi S, Kuzuhara S, Kokubo Y (2018) Nitrative stress and tau accumulation in amyotrophic lateral sclerosis/parkinsonism-dementia complex (ALS/PDC) in the Kii Peninsula, Japan. Front Neurosci 11:751CrossRefPubMedPubMedCentral
Zurück zum Zitat Hayakawa H, Nagai M, Kawanami A, Nakata Y, Nihira T, Ogino M, Takada M, Saido T, Takano J, Saegusa M, Mikami T, Hamada J, Nishiyama K, Mochizuki H, Mizuno Y (2013) Loss of DARPP-32 and calbindin in multiple system atrophy. J Neural Transm 120:1689–1698CrossRefPubMed Hayakawa H, Nagai M, Kawanami A, Nakata Y, Nihira T, Ogino M, Takada M, Saido T, Takano J, Saegusa M, Mikami T, Hamada J, Nishiyama K, Mochizuki H, Mizuno Y (2013) Loss of DARPP-32 and calbindin in multiple system atrophy. J Neural Transm 120:1689–1698CrossRefPubMed
Zurück zum Zitat Heckman MG, Schottlaender L, Soto-Ortolaza AI, Diehl NN, Rayaprolu S, Ogaki K, Fujioka S, Murray ME, Cheshire WP, Uitti RJ, Wszolek ZK, Farrer MJ, Sailer A, Singleton AB, Chinnery PF, Keogh MJ, Gentleman SM, Holton JL, Aoife K, Mann DM, Al-Sarraj S, Troakes C, Dickson DW, Houlden H, Ross OA (2014) LRRK2 exonic variants and risk of multiple system atrophy. Neurology 83:2256–2261CrossRefPubMedPubMedCentral Heckman MG, Schottlaender L, Soto-Ortolaza AI, Diehl NN, Rayaprolu S, Ogaki K, Fujioka S, Murray ME, Cheshire WP, Uitti RJ, Wszolek ZK, Farrer MJ, Sailer A, Singleton AB, Chinnery PF, Keogh MJ, Gentleman SM, Holton JL, Aoife K, Mann DM, Al-Sarraj S, Troakes C, Dickson DW, Houlden H, Ross OA (2014) LRRK2 exonic variants and risk of multiple system atrophy. Neurology 83:2256–2261CrossRefPubMedPubMedCentral
Zurück zum Zitat Heitz C, Noblet V, Cretin B, Philippi N, Kremer L, Stackfleth M, Hubele F, Armspach JP, Namer I, Blanc F (2015) Neural correlates of visual hallucinations in dementia with Lewy bodies. Alzheimers Res Ther 7:6CrossRefPubMedPubMedCentral Heitz C, Noblet V, Cretin B, Philippi N, Kremer L, Stackfleth M, Hubele F, Armspach JP, Namer I, Blanc F (2015) Neural correlates of visual hallucinations in dementia with Lewy bodies. Alzheimers Res Ther 7:6CrossRefPubMedPubMedCentral
Zurück zum Zitat Helmich RC (2018) The cerebral basis of Parkinsonian tremor: a network perspective. Mov Disord 33:219–231CrossRefPubMed Helmich RC (2018) The cerebral basis of Parkinsonian tremor: a network perspective. Mov Disord 33:219–231CrossRefPubMed
Zurück zum Zitat Helmich RC, Janssen MJ, Oyen WJ, Bloem BR, Toni I (2011) Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor. Ann Neurol 69:269–281CrossRefPubMed Helmich RC, Janssen MJ, Oyen WJ, Bloem BR, Toni I (2011) Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor. Ann Neurol 69:269–281CrossRefPubMed
Zurück zum Zitat Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov Disord 23:837–844CrossRefPubMed Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov Disord 23:837–844CrossRefPubMed
Zurück zum Zitat Hepp DH, Vergoossen DL, Huisman E, Lemstra AW, Berendse HW, Rozemuller AJ, Foncke EM, van de Berg WD (2016) Distribution and load of amyloid-beta pathology in Parkinson disease and dementia with Lewy bodies. J Neuropathol Exp Neurol 75:936–945CrossRefPubMed Hepp DH, Vergoossen DL, Huisman E, Lemstra AW, Berendse HW, Rozemuller AJ, Foncke EM, van de Berg WD (2016) Distribution and load of amyloid-beta pathology in Parkinson disease and dementia with Lewy bodies. J Neuropathol Exp Neurol 75:936–945CrossRefPubMed
Zurück zum Zitat Heras-Garvin A, Weckbecker D, Ryazanov S, Leonov A, Griesinger C, Giese A, Wenning GK, Stefanova N (2019) Anle138b modulates alpha-synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy. Mov Disord 34:255–263CrossRefPubMed Heras-Garvin A, Weckbecker D, Ryazanov S, Leonov A, Griesinger C, Giese A, Wenning GK, Stefanova N (2019) Anle138b modulates alpha-synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy. Mov Disord 34:255–263CrossRefPubMed
Zurück zum Zitat Hernandez D, Paisan Ruiz C, Crawley A, Malkani R, Werner J, Gwinn-Hardy K, Dickson D, Wavrant Devrieze F, Hardy J, Singleton A (2005) The dardarin G 2019 S mutation is a common cause of Parkinson’s disease but not other neurodegenerative diseases. Neurosci Lett 389:137–139CrossRefPubMed Hernandez D, Paisan Ruiz C, Crawley A, Malkani R, Werner J, Gwinn-Hardy K, Dickson D, Wavrant Devrieze F, Hardy J, Singleton A (2005) The dardarin G 2019 S mutation is a common cause of Parkinson’s disease but not other neurodegenerative diseases. Neurosci Lett 389:137–139CrossRefPubMed
Zurück zum Zitat Herz DM, Haagensen BN, Christensen MS, Madsen KH, Rowe JB, Lokkegaard A, Siebner HR (2015) Abnormal dopaminergic modulation of striato-cortical networks underlies levodopa-induced dyskinesias in humans. Brain 138:1658–1666CrossRefPubMedPubMedCentral Herz DM, Haagensen BN, Christensen MS, Madsen KH, Rowe JB, Lokkegaard A, Siebner HR (2015) Abnormal dopaminergic modulation of striato-cortical networks underlies levodopa-induced dyskinesias in humans. Brain 138:1658–1666CrossRefPubMedPubMedCentral
Zurück zum Zitat Hintzen A, Pelzer EA, Tittgemeyer M (2018) Thalamic interactions of cerebellum and basal ganglia. Brain Struct Funct 223:569–587CrossRefPubMed Hintzen A, Pelzer EA, Tittgemeyer M (2018) Thalamic interactions of cerebellum and basal ganglia. Brain Struct Funct 223:569–587CrossRefPubMed
Zurück zum Zitat Hirsch EC, Jenner P, Przedborski S (2013) Pathogenesis of Parkinson’s disease. Mov Disord 28:24–30CrossRefPubMed Hirsch EC, Jenner P, Przedborski S (2013) Pathogenesis of Parkinson’s disease. Mov Disord 28:24–30CrossRefPubMed
Zurück zum Zitat Hoffmann A, Ettle B, Battis K, Reiprich S, Schlachetzki JCM, Masliah E, Wegner M, Kuhlmann T, Riemenschneider MJ, Winkler J (2019) Oligodendroglial a-synucleinopathy-driven neuroinflammation in multiple system atrophy. Brain Pathol 29:380–396CrossRefPubMedPubMedCentral Hoffmann A, Ettle B, Battis K, Reiprich S, Schlachetzki JCM, Masliah E, Wegner M, Kuhlmann T, Riemenschneider MJ, Winkler J (2019) Oligodendroglial a-synucleinopathy-driven neuroinflammation in multiple system atrophy. Brain Pathol 29:380–396CrossRefPubMedPubMedCentral
Zurück zum Zitat Hoglinger GU (2018) Is it useful to classify progressive supranuclear palsy and corticobasal degeneration as different disorders? No. Mov Disord Clin Pract 5:141–144CrossRefPubMedPubMedCentral Hoglinger GU (2018) Is it useful to classify progressive supranuclear palsy and corticobasal degeneration as different disorders? No. Mov Disord Clin Pract 5:141–144CrossRefPubMedPubMedCentral
Zurück zum Zitat Hoglinger GU, Oertel WH, Hirsch EC (2006) The rotenone model of parkinsonism—the 5 years inspection. J Neural Transm Suppl (70):269–272 Hoglinger GU, Oertel WH, Hirsch EC (2006) The rotenone model of parkinsonism—the 5 years inspection. J Neural Transm Suppl (70):269–272
Zurück zum Zitat Hoglinger GU, Melhem NM, Dickson DW, Sleiman PM, Wang LS, Klei L, Rademakers R, de Silva R, Litvan I, Riley DE, van Swieten JC, Heutink P, Wszolek ZK, Uitti RJ, Vandrovcova J, Hurtig HI, Gross RG, Maetzler W, Goldwurm S, Tolosa E, Borroni B, Pastor P, Cantwell LB, Han MR, Dillman A, van der Brug MP, Gibbs JR, Cookson MR, Hernandez DG, Singleton AB, Farrer MJ, Yu CE, Golbe LI, Revesz T, Hardy J, Lees AJ, Devlin B, Hakonarson H, Muller U, Schellenberg GD (2011) Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet 43:699–705CrossRefPubMedPubMedCentral Hoglinger GU, Melhem NM, Dickson DW, Sleiman PM, Wang LS, Klei L, Rademakers R, de Silva R, Litvan I, Riley DE, van Swieten JC, Heutink P, Wszolek ZK, Uitti RJ, Vandrovcova J, Hurtig HI, Gross RG, Maetzler W, Goldwurm S, Tolosa E, Borroni B, Pastor P, Cantwell LB, Han MR, Dillman A, van der Brug MP, Gibbs JR, Cookson MR, Hernandez DG, Singleton AB, Farrer MJ, Yu CE, Golbe LI, Revesz T, Hardy J, Lees AJ, Devlin B, Hakonarson H, Muller U, Schellenberg GD (2011) Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet 43:699–705CrossRefPubMedPubMedCentral
Zurück zum Zitat Hoglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Muller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I (2018) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32:853–864CrossRef Hoglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Muller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I (2018) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32:853–864CrossRef
Zurück zum Zitat Holmqvist S, Chutna O, Bousset L, Aldrin-Kirk P, Li W, Bjorklund T, Wang ZY, Roybon L, Melki R, Li JY (2014) Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol 128:805–820CrossRefPubMed Holmqvist S, Chutna O, Bousset L, Aldrin-Kirk P, Li W, Bjorklund T, Wang ZY, Roybon L, Melki R, Li JY (2014) Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol 128:805–820CrossRefPubMed
Zurück zum Zitat Holton JL, Lees AL, Revesz T (2011) Multiple system atrophy. In: Dickson DW, Weller RO (eds) Neurodegeneration: the molecular pathology of dementia and movement disorders, 2nd edn. Blackwell Publishing Ltd., Oxford, pp 242–252CrossRef Holton JL, Lees AL, Revesz T (2011) Multiple system atrophy. In: Dickson DW, Weller RO (eds) Neurodegeneration: the molecular pathology of dementia and movement disorders, 2nd edn. Blackwell Publishing Ltd., Oxford, pp 242–252CrossRef
Zurück zum Zitat Homma T, Mochizuki Y, Komori T, Isozaki E (2016) Frequent globular neuronal cytoplasmic inclusions in the medial temporal region as a possible characteristic feature in multiple system atrophy with dementia. Neuropathology 36:421–431CrossRefPubMed Homma T, Mochizuki Y, Komori T, Isozaki E (2016) Frequent globular neuronal cytoplasmic inclusions in the medial temporal region as a possible characteristic feature in multiple system atrophy with dementia. Neuropathology 36:421–431CrossRefPubMed
Zurück zum Zitat Horvath J, Burkhard PR, Bouras C, Kovari E (2013a) Etiologies of parkinsonism in a century-long autopsy-based cohort. Brain Pathol 23:28–33CrossRefPubMed Horvath J, Burkhard PR, Bouras C, Kovari E (2013a) Etiologies of parkinsonism in a century-long autopsy-based cohort. Brain Pathol 23:28–33CrossRefPubMed
Zurück zum Zitat Horvath J, Herrmann FR, Burkhard PR, Bouras C, Kovari E (2013b) Neuropathology of dementia in a large cohort of patients with Parkinson’s disease. Parkinsonism Relat Disord 19:864–868 (discussion 864) CrossRefPubMed Horvath J, Herrmann FR, Burkhard PR, Bouras C, Kovari E (2013b) Neuropathology of dementia in a large cohort of patients with Parkinson’s disease. Parkinsonism Relat Disord 19:864–868 (discussion 864) CrossRefPubMed
Zurück zum Zitat Houlden H, Baker M, Morris HR, MacDonald N, Pickering-Brown S, Adamson J, Lees AJ, Rossor MN, Quinn NP, Kertesz A, Khan MN, Hardy J, Lantos PL, St George-Hyslop P, Munoz DG, Mann D, Lang AE, Bergeron C, Bigio EH, Litvan I, Bhatia KP, Dickson D, Wood NW, Hutton M (2001) Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 56:1702–1706CrossRefPubMed Houlden H, Baker M, Morris HR, MacDonald N, Pickering-Brown S, Adamson J, Lees AJ, Rossor MN, Quinn NP, Kertesz A, Khan MN, Hardy J, Lantos PL, St George-Hyslop P, Munoz DG, Mann D, Lang AE, Bergeron C, Bigio EH, Litvan I, Bhatia KP, Dickson D, Wood NW, Hutton M (2001) Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 56:1702–1706CrossRefPubMed
Zurück zum Zitat Hu D, Sun X, Liao X, Zhang X, Zarabi S, Schimmer A, Hong Y, Ford C, Luo Y, Qi X (2019) Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity. Acta Neuropathol 137:939–960CrossRefPubMedPubMedCentral Hu D, Sun X, Liao X, Zhang X, Zarabi S, Schimmer A, Hong Y, Ford C, Luo Y, Qi X (2019) Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity. Acta Neuropathol 137:939–960CrossRefPubMedPubMedCentral
Zurück zum Zitat Huang M, Wang B, Li X, Fu C, Wang C, Kang X (2019) Alpha-synuclein: a multifunctional player in exocytosis, endocytosis, and vesicle recycling. Front Neurosci 13:28CrossRefPubMedPubMedCentral Huang M, Wang B, Li X, Fu C, Wang C, Kang X (2019) Alpha-synuclein: a multifunctional player in exocytosis, endocytosis, and vesicle recycling. Front Neurosci 13:28CrossRefPubMedPubMedCentral
Zurück zum Zitat Hwang J, Bank AM, Mortazavi F, Oakley DH, Frosch MP, Schmahmann JD (2019) Spinal cord a-synuclein deposition associated with myoclonus in patients with MSA-C. Neurology (accepted paper) Hwang J, Bank AM, Mortazavi F, Oakley DH, Frosch MP, Schmahmann JD (2019) Spinal cord a-synuclein deposition associated with myoclonus in patients with MSA-C. Neurology (accepted paper)
Zurück zum Zitat Iljina M, Garcia GA, Horrocks MH, Tosatto L, Choi ML, Ganzinger KA, Abramov AY, Gandhi S, Wood NW, Cremades N, Dobson CM, Knowles TP, Klenerman D (2016) Kinetic model of the aggregation of alpha-synuclein provides insights into prion-like spreading. Proc Natl Acad Sci USA 113:E1206–E1215CrossRefPubMedPubMedCentral Iljina M, Garcia GA, Horrocks MH, Tosatto L, Choi ML, Ganzinger KA, Abramov AY, Gandhi S, Wood NW, Cremades N, Dobson CM, Knowles TP, Klenerman D (2016) Kinetic model of the aggregation of alpha-synuclein provides insights into prion-like spreading. Proc Natl Acad Sci USA 113:E1206–E1215CrossRefPubMedPubMedCentral
Zurück zum Zitat Inzelberg R, Estrada-Cuzcano A, Laitman Y, De Vriendt E, Friedman E, Jordanova A (2018) Kufor–Rakeb syndrome/PARK9: one novel and one possible recurring Ashkenazi ATP13A2 mutation. J Parkinsons Dis 8:399–403CrossRefPubMed Inzelberg R, Estrada-Cuzcano A, Laitman Y, De Vriendt E, Friedman E, Jordanova A (2018) Kufor–Rakeb syndrome/PARK9: one novel and one possible recurring Ashkenazi ATP13A2 mutation. J Parkinsons Dis 8:399–403CrossRefPubMed
Zurück zum Zitat Iodice V, Lipp A, Ahlskog JE, Sandroni P, Fealey RD, Parisi JE, Matsumoto JY, Benarroch EE, Kimpinski K, Singer W, Gehrking TL, Gehrking JA, Sletten DM, Schmeichel AM, Bower JH, Gilman S, Figueroa J, Low PA (2012) Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests. J Neurol Neurosurg Psychiatry 83:453–459CrossRefPubMed Iodice V, Lipp A, Ahlskog JE, Sandroni P, Fealey RD, Parisi JE, Matsumoto JY, Benarroch EE, Kimpinski K, Singer W, Gehrking TL, Gehrking JA, Sletten DM, Schmeichel AM, Bower JH, Gilman S, Figueroa J, Low PA (2012) Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests. J Neurol Neurosurg Psychiatry 83:453–459CrossRefPubMed
Zurück zum Zitat Irwin DJ, Abrams JY, Schonberger LB, Leschek EW, Mills JL, Lee VM, Trojanowski JQ (2013a) Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone. JAMA Neurol 70:462–468CrossRefPubMedPubMedCentral Irwin DJ, Abrams JY, Schonberger LB, Leschek EW, Mills JL, Lee VM, Trojanowski JQ (2013a) Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone. JAMA Neurol 70:462–468CrossRefPubMedPubMedCentral
Zurück zum Zitat Irwin DJ, Cohen TJ, Grossman M, Arnold SE, McCarty-Wood E, Van Deerlin VM, Lee VM, Trojanowski JQ (2013b) Acetylated tau neuropathology in sporadic and hereditary tauopathies. Am J Pathol 183:344–351CrossRefPubMedPubMedCentral Irwin DJ, Cohen TJ, Grossman M, Arnold SE, McCarty-Wood E, Van Deerlin VM, Lee VM, Trojanowski JQ (2013b) Acetylated tau neuropathology in sporadic and hereditary tauopathies. Am J Pathol 183:344–351CrossRefPubMedPubMedCentral
Zurück zum Zitat Irwin DJ, Lee VM, Trojanowski JQ (2013c) Parkinson’s disease dementia: convergence of alpha-synuclein, tau and amyloid-beta pathologies. Nat Rev Neurosci 14:626–636CrossRefPubMedPubMedCentral Irwin DJ, Lee VM, Trojanowski JQ (2013c) Parkinson’s disease dementia: convergence of alpha-synuclein, tau and amyloid-beta pathologies. Nat Rev Neurosci 14:626–636CrossRefPubMedPubMedCentral
Zurück zum Zitat Irwin DJ, Cairns NJ, Grossman M, McMillan CT, Lee EB, Van Deerlin VM, Lee VM, Trojanowski JQ (2015) Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine. Acta Neuropathol 129:469–491CrossRefPubMed Irwin DJ, Cairns NJ, Grossman M, McMillan CT, Lee EB, Van Deerlin VM, Lee VM, Trojanowski JQ (2015) Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine. Acta Neuropathol 129:469–491CrossRefPubMed
Zurück zum Zitat Irwin DJ, Brettschneider J, McMillan CT, Cooper F, Olm C, Arnold SE, Van Deerlin VM, Seeley WW, Miller BL, Lee EB, Lee VM, Grossman M, Trojanowski JQ (2016) Deep clinical and neuropathological phenotyping of Pick disease. Ann Neurol 79:272–287CrossRefPubMed Irwin DJ, Brettschneider J, McMillan CT, Cooper F, Olm C, Arnold SE, Van Deerlin VM, Seeley WW, Miller BL, Lee EB, Lee VM, Grossman M, Trojanowski JQ (2016) Deep clinical and neuropathological phenotyping of Pick disease. Ann Neurol 79:272–287CrossRefPubMed
Zurück zum Zitat Ishiyama M, Yagishita S, Hasegawa K, Yokoyama T (2006) Ultrastructural study (tEM and sEM) of cortical Lewy bodies (abstract). Neuropathol 26(2):A58 Ishiyama M, Yagishita S, Hasegawa K, Yokoyama T (2006) Ultrastructural study (tEM and sEM) of cortical Lewy bodies (abstract). Neuropathol 26(2):A58
Zurück zum Zitat Ito K, Arai K, Yoshiyama Y, Kashiwado K, Sakakibara Y, Hattori T (2008) Astrocytic tau pathology positively correlates with neurofibrillary tangle density in progressive supranuclear palsy. Acta Neuropathol 115:623–628CrossRefPubMed Ito K, Arai K, Yoshiyama Y, Kashiwado K, Sakakibara Y, Hattori T (2008) Astrocytic tau pathology positively correlates with neurofibrillary tangle density in progressive supranuclear palsy. Acta Neuropathol 115:623–628CrossRefPubMed
Zurück zum Zitat Itoh N, Ishiguro K, Arai H, Kokubo Y, Sasaki R, Narita Y, Kuzuhara S (2003) Biochemical and ultrastructural study of neurofibrillary tangles in amyotrophic lateral sclerosis/parkinsonism-dementia complex in the Kii peninsula of Japan. J Neuropathol Exp Neurol 62:791–798CrossRefPubMed Itoh N, Ishiguro K, Arai H, Kokubo Y, Sasaki R, Narita Y, Kuzuhara S (2003) Biochemical and ultrastructural study of neurofibrillary tangles in amyotrophic lateral sclerosis/parkinsonism-dementia complex in the Kii peninsula of Japan. J Neuropathol Exp Neurol 62:791–798CrossRefPubMed
Zurück zum Zitat Iyer A, Claessens M (2019) Disruptive membrane interactions of alpha-synuclein aggregates. Biochim Biophys Acta Proteins Proteom 1867:468–482CrossRefPubMed Iyer A, Claessens M (2019) Disruptive membrane interactions of alpha-synuclein aggregates. Biochim Biophys Acta Proteins Proteom 1867:468–482CrossRefPubMed
Zurück zum Zitat Jabbari E, Woodside J, Tan MMX, Shoai M, Pittman A, Ferrari R, Mok KY, Zhang D, Reynolds RH, de Silva R, Grimm MJ, Respondek G, Muller U, Al-Sarraj S, Gentleman SM, Lees AJ, Warner TT, Hardy J, Revesz T, Hoglinger GU, Holton JL, Ryten M, Morris HR (2018) Variation at the TRIM11 locus modifies progressive supranuclear palsy phenotype. Ann Neurol 84:485–496CrossRefPubMedPubMedCentral Jabbari E, Woodside J, Tan MMX, Shoai M, Pittman A, Ferrari R, Mok KY, Zhang D, Reynolds RH, de Silva R, Grimm MJ, Respondek G, Muller U, Al-Sarraj S, Gentleman SM, Lees AJ, Warner TT, Hardy J, Revesz T, Hoglinger GU, Holton JL, Ryten M, Morris HR (2018) Variation at the TRIM11 locus modifies progressive supranuclear palsy phenotype. Ann Neurol 84:485–496CrossRefPubMedPubMedCentral
Zurück zum Zitat Janda E, Isidoro C, Carresi C, Mollace V (2012) Defective autophagy in Parkinson’s disease: role of oxidative stress. Mol Neurobiol 46:639–661CrossRefPubMed Janda E, Isidoro C, Carresi C, Mollace V (2012) Defective autophagy in Parkinson’s disease: role of oxidative stress. Mol Neurobiol 46:639–661CrossRefPubMed
Zurück zum Zitat Jellinger KA (2003) Prevalence of vascular lesions in dementia with Lewy bodies. A postmortem study. J Neural Transm (Vienna) 110:771–778 Jellinger KA (2003) Prevalence of vascular lesions in dementia with Lewy bodies. A postmortem study. J Neural Transm (Vienna) 110:771–778
Zurück zum Zitat Jellinger KA (2004) Lewy body-related alpha-synucleinopathy in the aged human brain. J Neural Transm 111:1219–1235CrossRefPubMed Jellinger KA (2004) Lewy body-related alpha-synucleinopathy in the aged human brain. J Neural Transm 111:1219–1235CrossRefPubMed
Zurück zum Zitat Jellinger KA (2006) Pathological substrate of dementia in Parkinson’s disease–its relation to DLB and DLBD. Parkinsonism Relat Disord 12:119–120CrossRefPubMed Jellinger KA (2006) Pathological substrate of dementia in Parkinson’s disease–its relation to DLB and DLBD. Parkinsonism Relat Disord 12:119–120CrossRefPubMed
Zurück zum Zitat Jellinger KA (2008b) Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy. Neurodegener Dis 5:339–346CrossRefPubMed Jellinger KA (2008b) Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy. Neurodegener Dis 5:339–346CrossRefPubMed
Zurück zum Zitat Jellinger KA (2009a) A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders. Biochim Biophys Acta 1792:730–740CrossRefPubMed Jellinger KA (2009a) A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders. Biochim Biophys Acta 1792:730–740CrossRefPubMed
Zurück zum Zitat Jellinger KA (2009b) Significance of brain lesions in Parkinson disease dementia and Lewy body dementia. Front Neurol Neurosci 24:114–125CrossRefPubMed Jellinger KA (2009b) Significance of brain lesions in Parkinson disease dementia and Lewy body dementia. Front Neurol Neurosci 24:114–125CrossRefPubMed
Zurück zum Zitat Jellinger KA (2011) Postencephalitic Parkinsonism. In: Dickson DW, Weller RO (eds) Neurodegeneration: the molecular pathology of dementia and movement disorders, 2nd edn. Blackwell Publishing Ltd., Oxford, pp 179–187CrossRef Jellinger KA (2011) Postencephalitic Parkinsonism. In: Dickson DW, Weller RO (eds) Neurodegeneration: the molecular pathology of dementia and movement disorders, 2nd edn. Blackwell Publishing Ltd., Oxford, pp 179–187CrossRef
Zurück zum Zitat Jellinger KA (2012a) The role of alpha-synuclein in neurodegeneration—an update. Transl Neurosci 3:75–122CrossRef Jellinger KA (2012a) The role of alpha-synuclein in neurodegeneration—an update. Transl Neurosci 3:75–122CrossRef
Zurück zum Zitat Jellinger KA (2012b) Neuropathology of sporadic Parkinson’s disease: evaluation and changes of concepts. Mov Disord 27:8–30CrossRefPubMed Jellinger KA (2012b) Neuropathology of sporadic Parkinson’s disease: evaluation and changes of concepts. Mov Disord 27:8–30CrossRefPubMed
Zurück zum Zitat Jellinger KA (2013a) Synuclein and Parkinson’s disease: an update. In: Martinez A, Gil C (eds) Emerging drugs and targets for Parkinson’s disease. The Royal Society of Chemistry, London, pp 175–214CrossRef Jellinger KA (2013a) Synuclein and Parkinson’s disease: an update. In: Martinez A, Gil C (eds) Emerging drugs and targets for Parkinson’s disease. The Royal Society of Chemistry, London, pp 175–214CrossRef
Zurück zum Zitat Jellinger KA (2013b) Mild cognitive impairment in Parkinson disease: heterogenous mechanisms. J Neural Transm (Vienna) 120:157–167CrossRef Jellinger KA (2013b) Mild cognitive impairment in Parkinson disease: heterogenous mechanisms. J Neural Transm (Vienna) 120:157–167CrossRef
Zurück zum Zitat Jellinger KA (2014) Neuropathology. In: Wenning GK, Fanciulli A (eds) Multiple system atrophy. Springer, Vienna, pp 17–55CrossRef Jellinger KA (2014) Neuropathology. In: Wenning GK, Fanciulli A (eds) Multiple system atrophy. Springer, Vienna, pp 17–55CrossRef
Zurück zum Zitat Jellinger KA (2015) Neuropathobiology of non-motor symptoms in Parkinson disease. J Neural Transm (Vienna) 122:1429–1440CrossRef Jellinger KA (2015) Neuropathobiology of non-motor symptoms in Parkinson disease. J Neural Transm (Vienna) 122:1429–1440CrossRef
Zurück zum Zitat Jellinger KA (2016) Neuropathology of movement disorders, vol 1. In: Winn HR (ed) Youmans Neurological surgery, 7th edn. Elsevier-Saunders, Philadelphia, pp e840–e880 Jellinger KA (2016) Neuropathology of movement disorders, vol 1. In: Winn HR (ed) Youmans Neurological surgery, 7th edn. Elsevier-Saunders, Philadelphia, pp e840–e880
Zurück zum Zitat Jellinger KA (2017a) Neuropathology of movement disorders. In: Falup-Pecurariu C, Ferreira J, Martinez-Martin P, Chaudhuri KR (eds) Movement disorders curricula. Springer, Wien, pp 43–48CrossRef Jellinger KA (2017a) Neuropathology of movement disorders. In: Falup-Pecurariu C, Ferreira J, Martinez-Martin P, Chaudhuri KR (eds) Movement disorders curricula. Springer, Wien, pp 43–48CrossRef
Zurück zum Zitat Jellinger KA (2017b) Neuropathology of nonmotor symptoms of Parkinson’s disease. Int Rev Neurobiol 133:13–62CrossRefPubMed Jellinger KA (2017b) Neuropathology of nonmotor symptoms of Parkinson’s disease. Int Rev Neurobiol 133:13–62CrossRefPubMed
Zurück zum Zitat Jellinger KA (2018b) Dementia with Lewy bodies and Parkinson’s disease-dementia: current concepts and controversies. J Neural Transm (Vienna) 125:615–650CrossRef Jellinger KA (2018b) Dementia with Lewy bodies and Parkinson’s disease-dementia: current concepts and controversies. J Neural Transm (Vienna) 125:615–650CrossRef
Zurück zum Zitat Jellinger KA (2019) Is Braak staging valid for all types of Parkinson’s disease? J Neural Transm (Vienna) 126:423–431CrossRef Jellinger KA (2019) Is Braak staging valid for all types of Parkinson’s disease? J Neural Transm (Vienna) 126:423–431CrossRef
Zurück zum Zitat Jellinger KA, Attems J (2006) Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies? Acta Neuropathol 112:253–260CrossRefPubMed Jellinger KA, Attems J (2006) Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies? Acta Neuropathol 112:253–260CrossRefPubMed
Zurück zum Zitat Jellinger KA, Attems J (2008) Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Acta Neuropathol 115:127–136CrossRef Jellinger KA, Attems J (2008) Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Acta Neuropathol 115:127–136CrossRef
Zurück zum Zitat Jellinger KA, Lantos PL (2010) Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update. Acta Neuropathol 119:657–667CrossRefPubMed Jellinger KA, Lantos PL (2010) Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update. Acta Neuropathol 119:657–667CrossRefPubMed
Zurück zum Zitat Jellinger KA, Wenning GK (2016) Multiple system atrophy: pathogenic mechanisms and biomarkers. J Neural Transm (Vienna) 123:555–572CrossRef Jellinger KA, Wenning GK (2016) Multiple system atrophy: pathogenic mechanisms and biomarkers. J Neural Transm (Vienna) 123:555–572CrossRef
Zurück zum Zitat Jellinger KA, Seppi K, Wenning GK (2005) Grading of neuropathology in multiple system atrophy: proposal for a novel scale. Mov Disord 20(Suppl 12):S29–S36CrossRefPubMed Jellinger KA, Seppi K, Wenning GK (2005) Grading of neuropathology in multiple system atrophy: proposal for a novel scale. Mov Disord 20(Suppl 12):S29–S36CrossRefPubMed
Zurück zum Zitat Jiang P, Dickson DW (2018) Parkinson’s disease: experimental models and reality. Acta Neuropathol 135:13–32CrossRefPubMed Jiang P, Dickson DW (2018) Parkinson’s disease: experimental models and reality. Acta Neuropathol 135:13–32CrossRefPubMed
Zurück zum Zitat Jiang P, Gan M, Yen SH, Moussaud S, McLean PJ, Dickson DW (2016) Proaggregant nuclear factor(s) trigger rapid formation of alpha-synuclein aggregates in apoptotic neurons. Acta Neuropathol 132:77–91CrossRefPubMedPubMedCentral Jiang P, Gan M, Yen SH, Moussaud S, McLean PJ, Dickson DW (2016) Proaggregant nuclear factor(s) trigger rapid formation of alpha-synuclein aggregates in apoptotic neurons. Acta Neuropathol 132:77–91CrossRefPubMedPubMedCentral
Zurück zum Zitat Johnson ME, Stecher B, Labrie V, Brundin L, Brundin P (2019) Triggers, facilitators, and aggravators: redefining Parkinson’s disease pathogenesis. Trends Neurosci 42:4–13CrossRefPubMed Johnson ME, Stecher B, Labrie V, Brundin L, Brundin P (2019) Triggers, facilitators, and aggravators: redefining Parkinson’s disease pathogenesis. Trends Neurosci 42:4–13CrossRefPubMed
Zurück zum Zitat Joki H, Higashiyama Y, Nakae Y, Kugimoto C, Doi H, Kimura K, Kishida H, Ueda N, Nakano T, Takahashi T, Koyano S, Takeuchi H, Tanaka F (2018) White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson’s disease with dementia, and Alzheimer’s disease. J Neurol Sci 385:99–104CrossRefPubMed Joki H, Higashiyama Y, Nakae Y, Kugimoto C, Doi H, Kimura K, Kishida H, Ueda N, Nakano T, Takahashi T, Koyano S, Takeuchi H, Tanaka F (2018) White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson’s disease with dementia, and Alzheimer’s disease. J Neurol Sci 385:99–104CrossRefPubMed
Zurück zum Zitat Josephs KA, Ishizawa T, Tsuboi Y, Cookson N, Dickson DW (2002) A clinicopathological study of vascular progressive supranuclear palsy: a multi-infarct disorder presenting as progressive supranuclear palsy. Arch Neurol 59:1597–1601CrossRefPubMed Josephs KA, Ishizawa T, Tsuboi Y, Cookson N, Dickson DW (2002) A clinicopathological study of vascular progressive supranuclear palsy: a multi-infarct disorder presenting as progressive supranuclear palsy. Arch Neurol 59:1597–1601CrossRefPubMed
Zurück zum Zitat Joutsa J, Gardberg M, Roytta M, Kaasinen V (2014) Diagnostic accuracy of parkinsonism syndromes by general neurologists. Parkinsonism Relat Disord 20:840–844CrossRefPubMed Joutsa J, Gardberg M, Roytta M, Kaasinen V (2014) Diagnostic accuracy of parkinsonism syndromes by general neurologists. Parkinsonism Relat Disord 20:840–844CrossRefPubMed
Zurück zum Zitat Kaindlstorfer C, Jellinger KA, Eschlbock S, Stefanova N, Weiss G, Wenning GK (2018) The relevance of iron in the pathogenesis of multiple system atrophy: a viewpoint. J Alzheimers Dis 61:1253–1273CrossRefPubMedPubMedCentral Kaindlstorfer C, Jellinger KA, Eschlbock S, Stefanova N, Weiss G, Wenning GK (2018) The relevance of iron in the pathogenesis of multiple system atrophy: a viewpoint. J Alzheimers Dis 61:1253–1273CrossRefPubMedPubMedCentral
Zurück zum Zitat Kalaitzakis ME, Pearce RK (2009) The morbid anatomy of dementia in Parkinson’s disease. Acta Neuropathol 118:587–598CrossRefPubMed Kalaitzakis ME, Pearce RK (2009) The morbid anatomy of dementia in Parkinson’s disease. Acta Neuropathol 118:587–598CrossRefPubMed
Zurück zum Zitat Kalaitzakis ME, Christian LM, Moran LB, Graeber MB, Pearce RK, Gentleman SM (2009a) Dementia and visual hallucinations associated with limbic pathology in Parkinson’s disease. Parkinsonism Relat Disord 15:196–204CrossRefPubMed Kalaitzakis ME, Christian LM, Moran LB, Graeber MB, Pearce RK, Gentleman SM (2009a) Dementia and visual hallucinations associated with limbic pathology in Parkinson’s disease. Parkinsonism Relat Disord 15:196–204CrossRefPubMed
Zurück zum Zitat Kalaitzakis ME, Pearce RK, Gentleman SM (2009b) Clinical correlates of pathology in the claustrum in Parkinson’s disease and dementia with Lewy bodies. Neurosci Lett 461:12–15CrossRefPubMed Kalaitzakis ME, Pearce RK, Gentleman SM (2009b) Clinical correlates of pathology in the claustrum in Parkinson’s disease and dementia with Lewy bodies. Neurosci Lett 461:12–15CrossRefPubMed
Zurück zum Zitat Kalaitzakis ME, Walls AJ, Pearce RK, Gentleman SM (2011) Striatal Abeta peptide deposition mirrors dementia and differentiates DLB and PDD from other Parkinsonian syndromes. Neurobiol Dis 41:377–384CrossRefPubMed Kalaitzakis ME, Walls AJ, Pearce RK, Gentleman SM (2011) Striatal Abeta peptide deposition mirrors dementia and differentiates DLB and PDD from other Parkinsonian syndromes. Neurobiol Dis 41:377–384CrossRefPubMed
Zurück zum Zitat Kalia LV, Kalia SK (2015) Alpha-synuclein and Lewy pathology in Parkinson’s disease. Curr Opin Neurol 28:375–381CrossRefPubMed Kalia LV, Kalia SK (2015) Alpha-synuclein and Lewy pathology in Parkinson’s disease. Curr Opin Neurol 28:375–381CrossRefPubMed
Zurück zum Zitat Kam TI, Mao X, Park H, Chou SC, Karuppagounder SS, Umanah GE, Yun SP, Brahmachari S, Panicker N, Chen R, Andrabi SA, Qi C, Poirier GG, Pletnikova O, Troncoso JC, Bekris LM, Leverenz JB, Pantelyat A, Ko HS, Rosenthal LS, Dawson TM, Dawson VL (2018) Poly(ADP-ribose) drives pathologic alpha-synuclein neurodegeneration in Parkinson’s disease. Science. https://doi.org/10.1126/science.aat8407 CrossRefPubMedPubMedCentral Kam TI, Mao X, Park H, Chou SC, Karuppagounder SS, Umanah GE, Yun SP, Brahmachari S, Panicker N, Chen R, Andrabi SA, Qi C, Poirier GG, Pletnikova O, Troncoso JC, Bekris LM, Leverenz JB, Pantelyat A, Ko HS, Rosenthal LS, Dawson TM, Dawson VL (2018) Poly(ADP-ribose) drives pathologic alpha-synuclein neurodegeneration in Parkinson’s disease. Science. https://​doi.​org/​10.​1126/​science.​aat8407 CrossRefPubMedPubMedCentral
Zurück zum Zitat Kamin J, Manwani S, Hughes D (2000) Emergency psychiatry: extrapyramidal side effects in the psychiatric emergency service. Psychiatr Serv 51:287–289CrossRefPubMed Kamin J, Manwani S, Hughes D (2000) Emergency psychiatry: extrapyramidal side effects in the psychiatric emergency service. Psychiatr Serv 51:287–289CrossRefPubMed
Zurück zum Zitat Kanazawa T, Uchihara T, Takahashi A, Nakamura A, Orimo S, Mizusawa H (2008) Three-layered structure shared between Lewy bodies and Lewy neurites—three-dimensional reconstruction of triple-labeled sections. Brain Pathol 18:415–422CrossRefPubMedPubMedCentral Kanazawa T, Uchihara T, Takahashi A, Nakamura A, Orimo S, Mizusawa H (2008) Three-layered structure shared between Lewy bodies and Lewy neurites—three-dimensional reconstruction of triple-labeled sections. Brain Pathol 18:415–422CrossRefPubMedPubMedCentral
Zurück zum Zitat Kanazawa T, Adachi E, Orimo S, Nakamura A, Mizusawa H, Uchihara T (2012) Pale neurites, premature alpha-synuclein aggregates with centripetal extension from axon collaterals. Brain Pathol 22:67–78CrossRefPubMed Kanazawa T, Adachi E, Orimo S, Nakamura A, Mizusawa H, Uchihara T (2012) Pale neurites, premature alpha-synuclein aggregates with centripetal extension from axon collaterals. Brain Pathol 22:67–78CrossRefPubMed
Zurück zum Zitat Kane JPM, Surendranathan A, Bentley A, Barker SAH, Taylor JP, Thomas AJ, Allan LM, McNally RJ, James PW, McKeith IG, Burn DJ, O’Brien JT (2018) Clinical prevalence of Lewy body dementia. Alzheimers Res Ther 10:19CrossRefPubMedPubMedCentral Kane JPM, Surendranathan A, Bentley A, Barker SAH, Taylor JP, Thomas AJ, Allan LM, McNally RJ, James PW, McKeith IG, Burn DJ, O’Brien JT (2018) Clinical prevalence of Lewy body dementia. Alzheimers Res Ther 10:19CrossRefPubMedPubMedCentral
Zurück zum Zitat Kang SW, Jeon S, Yoo HS, Chung SJ, Lee PH, Sohn YH, Yun M, Evans AC, Ye BS (2019) Effects of Lewy body disease and Alzheimer disease on brain atrophy and cognitive dysfunction. Neurology 92:e2015–e2026CrossRefPubMed Kang SW, Jeon S, Yoo HS, Chung SJ, Lee PH, Sohn YH, Yun M, Evans AC, Ye BS (2019) Effects of Lewy body disease and Alzheimer disease on brain atrophy and cognitive dysfunction. Neurology 92:e2015–e2026CrossRefPubMed
Zurück zum Zitat Kempster PA, O’Sullivan SS, Holton JL, Revesz T, Lees AJ (2010) Relationships between age and late progression of Parkinson’s disease: a clinico-pathological study. Brain 133:1755–1762CrossRefPubMed Kempster PA, O’Sullivan SS, Holton JL, Revesz T, Lees AJ (2010) Relationships between age and late progression of Parkinson’s disease: a clinico-pathological study. Brain 133:1755–1762CrossRefPubMed
Zurück zum Zitat Kett LR, Dauer WT (2016) Endolysosomal dysfunction in Parkinson’s disease: recent developments and future challenges. Mov Disord 31:1433–1443CrossRefPubMedPubMedCentral Kett LR, Dauer WT (2016) Endolysosomal dysfunction in Parkinson’s disease: recent developments and future challenges. Mov Disord 31:1433–1443CrossRefPubMedPubMedCentral
Zurück zum Zitat Kiely AP, Asi YT, Kara E, Limousin P, Ling H, Lewis P, Proukakis C, Quinn N, Lees AJ, Hardy J, Revesz T, Houlden H, Holton JL (2013) Alpha-synucleinopathy associated with G51D SNCA mutation: a link between Parkinson’s disease and multiple system atrophy? Acta Neuropathol 125:753–769CrossRefPubMedPubMedCentral Kiely AP, Asi YT, Kara E, Limousin P, Ling H, Lewis P, Proukakis C, Quinn N, Lees AJ, Hardy J, Revesz T, Houlden H, Holton JL (2013) Alpha-synucleinopathy associated with G51D SNCA mutation: a link between Parkinson’s disease and multiple system atrophy? Acta Neuropathol 125:753–769CrossRefPubMedPubMedCentral
Zurück zum Zitat Kiely AP, Ling H, Asi YT, Kara E, Proukakis C, Schapira AH, Morris HR, Roberts HC, Lubbe S, Limousin P, Lewis PA, Lees AJ, Quinn N, Hardy J, Love S, Revesz T, Houlden H, Holton JL (2015) Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation. Mol Neurodegener 10:41CrossRefPubMedPubMedCentral Kiely AP, Ling H, Asi YT, Kara E, Proukakis C, Schapira AH, Morris HR, Roberts HC, Lubbe S, Limousin P, Lewis PA, Lees AJ, Quinn N, Hardy J, Love S, Revesz T, Houlden H, Holton JL (2015) Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation. Mol Neurodegener 10:41CrossRefPubMedPubMedCentral
Zurück zum Zitat Kiely AP, Murray CE, Foti SC, Benson BC, Courtney R, Strand C, Lashley T, Holton JL (2018) Immunohistochemical and molecular investigations show alteration in the inflammatory profile of multiple system atrophy brain. J Neuropathol Exp Neurol 77:598–607CrossRefPubMedPubMedCentral Kiely AP, Murray CE, Foti SC, Benson BC, Courtney R, Strand C, Lashley T, Holton JL (2018) Immunohistochemical and molecular investigations show alteration in the inflammatory profile of multiple system atrophy brain. J Neuropathol Exp Neurol 77:598–607CrossRefPubMedPubMedCentral
Zurück zum Zitat Kiely AP, Miners JS, Courtney R, Strand C, Love S, Holton JL (2019) Exploring the putative role of kallikrein-6, calpain-1 and cathepsin-D in the proteolytic degradation of alpha-synuclein in multiple system atrophy. Neuropathol Appl Neurobiol 45:347–360CrossRefPubMed Kiely AP, Miners JS, Courtney R, Strand C, Love S, Holton JL (2019) Exploring the putative role of kallikrein-6, calpain-1 and cathepsin-D in the proteolytic degradation of alpha-synuclein in multiple system atrophy. Neuropathol Appl Neurobiol 45:347–360CrossRefPubMed
Zurück zum Zitat Kim HJ, Jeon BS (2012) Multiple system atrophy with prolonged survival. Mov Disord 27:1834PubMed Kim HJ, Jeon BS (2012) Multiple system atrophy with prolonged survival. Mov Disord 27:1834PubMed
Zurück zum Zitat Ryu H-S, Oh M, Oh JS, Moon H, Park KW, Lee CS, You S, Kim M-J, Kim Y, J., Kim J, Kim KM, Kim JS, Chung SJ (2019) Distinct clinical features of predominant pre-synaptic and transsynaptic nigrostriatal dysfunction in multiple system atrophy. J Neurol Sci (accepted article) Ryu H-S, Oh M, Oh JS, Moon H, Park KW, Lee CS, You S, Kim M-J, Kim Y, J., Kim J, Kim KM, Kim JS, Chung SJ (2019) Distinct clinical features of predominant pre-synaptic and transsynaptic nigrostriatal dysfunction in multiple system atrophy. J Neurol Sci (accepted article)
Zurück zum Zitat Keber U, Klietz M, Carlsson T, Oertel WH, Weihe E, Schafer MK, Hoglinger GU, Depboylu C (2015) Striatal tyrosine hydroxylase-positive neurons are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice. Neuroscience 298:302–317CrossRefPubMed Keber U, Klietz M, Carlsson T, Oertel WH, Weihe E, Schafer MK, Hoglinger GU, Depboylu C (2015) Striatal tyrosine hydroxylase-positive neurons are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice. Neuroscience 298:302–317CrossRefPubMed
Zurück zum Zitat Kim YD, Kim JS, Lee ES, Yang DW, Lee KS, Kim YI (2009) Progressive “vascular” corticobasal syndrome due to bilateral ischemic hemispheric lesions. Intern Med 48:1699–1702CrossRefPubMed Kim YD, Kim JS, Lee ES, Yang DW, Lee KS, Kim YI (2009) Progressive “vascular” corticobasal syndrome due to bilateral ischemic hemispheric lesions. Intern Med 48:1699–1702CrossRefPubMed
Zurück zum Zitat Kim JS, Yang JJ, Lee DK, Lee JM, Youn J, Cho JW (2015) Cognitive impairment and its structural correlates in the parkinsonian subtype of multiple system atrophy. Neurodegener Dis 15:294–300CrossRefPubMed Kim JS, Yang JJ, Lee DK, Lee JM, Youn J, Cho JW (2015) Cognitive impairment and its structural correlates in the parkinsonian subtype of multiple system atrophy. Neurodegener Dis 15:294–300CrossRefPubMed
Zurück zum Zitat Kim EJ, Brown JA, Deng J, Hwang JL, Spina S, Miller ZA, DeMay MG, Valcour V, Karydas A, Ramos EM, Coppola G, Miller BL, Rosen HJ, Seeley WW, Grinberg LT (2018) Mixed TDP-43 proteinopathy and tauopathy in frontotemporal lobar degeneration: nine case series. J Neurol 265:2960–2971CrossRefPubMedPubMedCentral Kim EJ, Brown JA, Deng J, Hwang JL, Spina S, Miller ZA, DeMay MG, Valcour V, Karydas A, Ramos EM, Coppola G, Miller BL, Rosen HJ, Seeley WW, Grinberg LT (2018) Mixed TDP-43 proteinopathy and tauopathy in frontotemporal lobar degeneration: nine case series. J Neurol 265:2960–2971CrossRefPubMedPubMedCentral
Zurück zum Zitat Kingsbury AE, Bandopadhyay R, Silveira-Moriyama L, Ayling H, Kallis C, Sterlacci W, Maeir H, Poewe W, Lees AJ (2010) Brain stem pathology in Parkinson’s disease: an evaluation of the Braak staging model. Mov Disord 25:2508–2515CrossRefPubMed Kingsbury AE, Bandopadhyay R, Silveira-Moriyama L, Ayling H, Kallis C, Sterlacci W, Maeir H, Poewe W, Lees AJ (2010) Brain stem pathology in Parkinson’s disease: an evaluation of the Braak staging model. Mov Disord 25:2508–2515CrossRefPubMed
Zurück zum Zitat Kishore A, Popa T (2014) Cerebellum in levodopa-induced dyskinesias: the unusual suspect in the motor network. Front Neurol 5:157PubMedPubMedCentral Kishore A, Popa T (2014) Cerebellum in levodopa-induced dyskinesias: the unusual suspect in the motor network. Front Neurol 5:157PubMedPubMedCentral
Zurück zum Zitat Klein C, Lochte T, Delamonte SM, Braenne I, Hicks AA, Zschiedrich-Jansen K, Simon DK, Friedman JH, Lohmann K (2016) PLA2G6 mutations and parkinsonism: long-term follow-up of clinical features and neuropathology. Mov Disord 31:1927–1929CrossRefPubMed Klein C, Lochte T, Delamonte SM, Braenne I, Hicks AA, Zschiedrich-Jansen K, Simon DK, Friedman JH, Lohmann K (2016) PLA2G6 mutations and parkinsonism: long-term follow-up of clinical features and neuropathology. Mov Disord 31:1927–1929CrossRefPubMed
Zurück zum Zitat Klietz M, Keber U, Carlsson T, Chiu WH, Hoglinger GU, Weihe E, Schafer MK, Depboylu C (2016) l-DOPA-induced dyskinesia is associated with a deficient numerical downregulation of striatal tyrosine hydroxylase mRNA-expressing neurons. Neuroscience 331:120–133CrossRefPubMed Klietz M, Keber U, Carlsson T, Chiu WH, Hoglinger GU, Weihe E, Schafer MK, Depboylu C (2016) l-DOPA-induced dyskinesia is associated with a deficient numerical downregulation of striatal tyrosine hydroxylase mRNA-expressing neurons. Neuroscience 331:120–133CrossRefPubMed
Zurück zum Zitat Klingelhoefer L, Reichmann H (2017) Parkinson’s disease as a multisystem disorder. J Neural Transm (Vienna) 124:709–713CrossRef Klingelhoefer L, Reichmann H (2017) Parkinson’s disease as a multisystem disorder. J Neural Transm (Vienna) 124:709–713CrossRef
Zurück zum Zitat Ko WKD, Bezard E (2017) Experimental animal models of Parkinson’s disease: a transition from assessing symptomatology to alpha-synuclein targeted disease modification. Exp Neurol 298:172–179CrossRefPubMed Ko WKD, Bezard E (2017) Experimental animal models of Parkinson’s disease: a transition from assessing symptomatology to alpha-synuclein targeted disease modification. Exp Neurol 298:172–179CrossRefPubMed
Zurück zum Zitat Koga S, Dickson DW (2018) Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy. J Neurol Neurosurg Psychiatry 89:175–184CrossRefPubMed Koga S, Dickson DW (2018) Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy. J Neurol Neurosurg Psychiatry 89:175–184CrossRefPubMed
Zurück zum Zitat Koga S, Dickson DW (2019) “Minimal change” multiple system atrophy with limbic-predominant alpha-synuclein pathology. Acta Neuropathol 137:167–169CrossRefPubMed Koga S, Dickson DW (2019) “Minimal change” multiple system atrophy with limbic-predominant alpha-synuclein pathology. Acta Neuropathol 137:167–169CrossRefPubMed
Zurück zum Zitat Koga S, Aoki N, Uitti RJ, van Gerpen JA, Cheshire WP, Josephs KA, Wszolek ZK, Langston JW, Dickson DW (2015) When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients. Neurology 85:404–412CrossRefPubMedPubMedCentral Koga S, Aoki N, Uitti RJ, van Gerpen JA, Cheshire WP, Josephs KA, Wszolek ZK, Langston JW, Dickson DW (2015) When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients. Neurology 85:404–412CrossRefPubMedPubMedCentral
Zurück zum Zitat Koga S, Parks A, Uitti RJ, van Gerpen JA, Cheshire WP, Wszolek ZK, Dickson DW (2017a) Profile of cognitive impairment and underlying pathology in multiple system atrophy. Mov Disord 32:405–413CrossRefPubMed Koga S, Parks A, Uitti RJ, van Gerpen JA, Cheshire WP, Wszolek ZK, Dickson DW (2017a) Profile of cognitive impairment and underlying pathology in multiple system atrophy. Mov Disord 32:405–413CrossRefPubMed
Zurück zum Zitat Koga S, Roemer SF, Kasanuki K, Dickson DW (2019) Cerebrovascular pathology presenting as corticobasal syndrome: an autopsy case series of “vascular CBS”. Parkinsonism Relat Disord (in press) Koga S, Roemer SF, Kasanuki K, Dickson DW (2019) Cerebrovascular pathology presenting as corticobasal syndrome: an autopsy case series of “vascular CBS”. Parkinsonism Relat Disord (in press)
Zurück zum Zitat Koga S, Sanchez-Contreras M, Josephs KA, Uitti RJ, Graff-Radford N, van Gerpen JA, Cheshire WP, Wszolek ZK, Rademakers R, Dickson DW (2017b) Distribution and characteristics of transactive response DNA binding protein 43 kDa pathology in progressive supranuclear palsy. Mov Disord 32:246–255CrossRefPubMed Koga S, Sanchez-Contreras M, Josephs KA, Uitti RJ, Graff-Radford N, van Gerpen JA, Cheshire WP, Wszolek ZK, Rademakers R, Dickson DW (2017b) Distribution and characteristics of transactive response DNA binding protein 43 kDa pathology in progressive supranuclear palsy. Mov Disord 32:246–255CrossRefPubMed
Zurück zum Zitat Koga S, Kouri N, Walton RL, Ebbert MTW, Josephs KA, Litvan I, Graff-Radford N, Ahlskog JE, Uitti RJ, van Gerpen JA, Boeve BF, Parks A, Ross OA, Dickson DW (2018a) Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype. Acta Neuropathol 136:389–404CrossRefPubMedPubMedCentral Koga S, Kouri N, Walton RL, Ebbert MTW, Josephs KA, Litvan I, Graff-Radford N, Ahlskog JE, Uitti RJ, van Gerpen JA, Boeve BF, Parks A, Ross OA, Dickson DW (2018a) Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype. Acta Neuropathol 136:389–404CrossRefPubMedPubMedCentral
Zurück zum Zitat Koga S, Lin WL, Walton RL, Ross OA, Dickson DW (2018b) TDP-43 pathology in multiple system atrophy: colocalization of TDP-43 and alpha-synuclein in glial cytoplasmic inclusions. Neuropathol Appl Neurobiol 44:707–721CrossRefPubMedPubMedCentral Koga S, Lin WL, Walton RL, Ross OA, Dickson DW (2018b) TDP-43 pathology in multiple system atrophy: colocalization of TDP-43 and alpha-synuclein in glial cytoplasmic inclusions. Neuropathol Appl Neurobiol 44:707–721CrossRefPubMedPubMedCentral
Zurück zum Zitat Kokubo Y, Taniguchi A, Hasegawa M, Hayakawa Y, Morimoto S, Yoneda M, Hirokawa Y, Shiraishi T, Saito Y, Murayama S, Kuzuhara S (2012) Alpha-synuclein pathology in the amyotrophic lateral sclerosis/parkinsonism dementia complex in the Kii Peninsula, Japan. J Neuropathol Exp Neurol 71:625–630CrossRefPubMed Kokubo Y, Taniguchi A, Hasegawa M, Hayakawa Y, Morimoto S, Yoneda M, Hirokawa Y, Shiraishi T, Saito Y, Murayama S, Kuzuhara S (2012) Alpha-synuclein pathology in the amyotrophic lateral sclerosis/parkinsonism dementia complex in the Kii Peninsula, Japan. J Neuropathol Exp Neurol 71:625–630CrossRefPubMed
Zurück zum Zitat Köllensperger M, Geser F, Seppi K, Stampfer-Kountchev M, Sawires M, Scherfler C, Boesch S, Mueller J, Koukouni V, Quinn N, Pellecchia MT, Barone P, Schimke N, Dodel R, Oertel W, Dupont E, Ostergaard K, Daniels C, Deuschl G, Gurevich T, Giladi N, Coelho M, Sampaio C, Nilsson C, Widner H, Sorbo FD, Albanese A, Cardozo A, Tolosa E, Abele M, Klockgether T, Kamm C, Gasser T, Djaldetti R, Colosimo C, Meco G, Schrag A, Poewe W, Wenning GK (2008) Red flags for multiple system atrophy. Mov Disord 23:1093–1099CrossRefPubMed Köllensperger M, Geser F, Seppi K, Stampfer-Kountchev M, Sawires M, Scherfler C, Boesch S, Mueller J, Koukouni V, Quinn N, Pellecchia MT, Barone P, Schimke N, Dodel R, Oertel W, Dupont E, Ostergaard K, Daniels C, Deuschl G, Gurevich T, Giladi N, Coelho M, Sampaio C, Nilsson C, Widner H, Sorbo FD, Albanese A, Cardozo A, Tolosa E, Abele M, Klockgether T, Kamm C, Gasser T, Djaldetti R, Colosimo C, Meco G, Schrag A, Poewe W, Wenning GK (2008) Red flags for multiple system atrophy. Mov Disord 23:1093–1099CrossRefPubMed
Zurück zum Zitat Konno T, Ross OA, Teive HAG, Slawek J, Dickson DW, Wszolek ZK (2017) DCTN1-related neurodegeneration: Perry syndrome and beyond. Parkinsonism Relat Disord 41:14–24CrossRefPubMedPubMedCentral Konno T, Ross OA, Teive HAG, Slawek J, Dickson DW, Wszolek ZK (2017) DCTN1-related neurodegeneration: Perry syndrome and beyond. Parkinsonism Relat Disord 41:14–24CrossRefPubMedPubMedCentral
Zurück zum Zitat Kordower JH, Olanow CW, Dodiya HB, Chu Y, Beach TG, Adler CH, Halliday GM, Bartus RT (2013) Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease. Brain 136:2419–2431CrossRefPubMedPubMedCentral Kordower JH, Olanow CW, Dodiya HB, Chu Y, Beach TG, Adler CH, Halliday GM, Bartus RT (2013) Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease. Brain 136:2419–2431CrossRefPubMedPubMedCentral
Zurück zum Zitat Kosaka K, Tsuchiya K, Yoshimura M (1988) Lewy body disease with and without dementia: a clinicopathological study of 35 cases. Clin Neuropathol 7:299–305PubMed Kosaka K, Tsuchiya K, Yoshimura M (1988) Lewy body disease with and without dementia: a clinicopathological study of 35 cases. Clin Neuropathol 7:299–305PubMed
Zurück zum Zitat Kotzbauer PT, Giasson BI, Kravitz AV, Golbe LI, Mark MH, Trojanowski JQ, Lee VM (2004) Fibrillization of alpha-synuclein and tau in familial Parkinson’s disease caused by the A53T alpha-synuclein mutation. Exp Neurol 187:279–288CrossRefPubMed Kotzbauer PT, Giasson BI, Kravitz AV, Golbe LI, Mark MH, Trojanowski JQ, Lee VM (2004) Fibrillization of alpha-synuclein and tau in familial Parkinson’s disease caused by the A53T alpha-synuclein mutation. Exp Neurol 187:279–288CrossRefPubMed
Zurück zum Zitat Kouri N, Oshima K, Takahashi M, Murray ME, Ahmed Z, Parisi JE, Yen SH, Dickson DW (2013) Corticobasal degeneration with olivopontocerebellar atrophy and TDP-43 pathology: an unusual clinicopathologic variant of CBD. Acta Neuropathol 125:741–752CrossRefPubMedPubMedCentral Kouri N, Oshima K, Takahashi M, Murray ME, Ahmed Z, Parisi JE, Yen SH, Dickson DW (2013) Corticobasal degeneration with olivopontocerebellar atrophy and TDP-43 pathology: an unusual clinicopathologic variant of CBD. Acta Neuropathol 125:741–752CrossRefPubMedPubMedCentral
Zurück zum Zitat Kouri N, Carlomagno Y, Baker M, Liesinger AM, Caselli RJ, Wszolek ZK, Petrucelli L, Boeve BF, Parisi JE, Josephs KA, Uitti RJ, Ross OA, Graff-Radford NR, DeTure MA, Dickson DW, Rademakers R (2014) Novel mutation in MAPT exon 13 (p. N410H) causes corticobasal degeneration. Acta Neuropathol 127:271–282CrossRefPubMedPubMedCentral Kouri N, Carlomagno Y, Baker M, Liesinger AM, Caselli RJ, Wszolek ZK, Petrucelli L, Boeve BF, Parisi JE, Josephs KA, Uitti RJ, Ross OA, Graff-Radford NR, DeTure MA, Dickson DW, Rademakers R (2014) Novel mutation in MAPT exon 13 (p. N410H) causes corticobasal degeneration. Acta Neuropathol 127:271–282CrossRefPubMedPubMedCentral
Zurück zum Zitat Kouri N, Ross OA, Dombroski B, Younkin CS, Serie DJ, Soto-Ortolaza A, Baker M, Finch NC, Yoon H, Kim J, Fujioka S, McLean CA, Ghetti B, Spina S, Cantwell LB, Farlow MR, Grafman J, Huey ED, Ryung Han M, Beecher S, Geller ET, Kretzschmar HA, Roeber S, Gearing M, Juncos JL, Vonsattel JP, Van Deerlin VM, Grossman M, Hurtig HI, Gross RG, Arnold SE, Trojanowski JQ, Lee VM, Wenning GK, White CL, Hoglinger GU, Muller U, Devlin B, Golbe LI, Crook J, Parisi JE, Boeve BF, Josephs KA, Wszolek ZK, Uitti RJ, Graff-Radford NR, Litvan I, Younkin SG, Wang LS, Ertekin-Taner N, Rademakers R, Hakonarsen H, Schellenberg GD, Dickson DW (2015) Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy. Nat Commun 6:7247CrossRefPubMed Kouri N, Ross OA, Dombroski B, Younkin CS, Serie DJ, Soto-Ortolaza A, Baker M, Finch NC, Yoon H, Kim J, Fujioka S, McLean CA, Ghetti B, Spina S, Cantwell LB, Farlow MR, Grafman J, Huey ED, Ryung Han M, Beecher S, Geller ET, Kretzschmar HA, Roeber S, Gearing M, Juncos JL, Vonsattel JP, Van Deerlin VM, Grossman M, Hurtig HI, Gross RG, Arnold SE, Trojanowski JQ, Lee VM, Wenning GK, White CL, Hoglinger GU, Muller U, Devlin B, Golbe LI, Crook J, Parisi JE, Boeve BF, Josephs KA, Wszolek ZK, Uitti RJ, Graff-Radford NR, Litvan I, Younkin SG, Wang LS, Ertekin-Taner N, Rademakers R, Hakonarsen H, Schellenberg GD, Dickson DW (2015) Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy. Nat Commun 6:7247CrossRefPubMed
Zurück zum Zitat Kovacs GG, Rozemuller AJ, van Swieten JC, Gelpi E, Majtenyi K, Al-Sarraj S, Troakes C, Bodi I, King A, Hortobagyi T, Esiri MM, Ansorge O, Giaccone G, Ferrer I, Arzberger T, Bogdanovic N, Nilsson T, Leisser I, Alafuzoff I, Ironside JW, Kretzschmar H, Budka H (2013) Neuropathology of the hippocampus in FTLD-Tau with Pick bodies: a study of the BrainNet Europe Consortium. Neuropathol Appl Neurobiol 39:166–178CrossRefPubMed Kovacs GG, Rozemuller AJ, van Swieten JC, Gelpi E, Majtenyi K, Al-Sarraj S, Troakes C, Bodi I, King A, Hortobagyi T, Esiri MM, Ansorge O, Giaccone G, Ferrer I, Arzberger T, Bogdanovic N, Nilsson T, Leisser I, Alafuzoff I, Ironside JW, Kretzschmar H, Budka H (2013) Neuropathology of the hippocampus in FTLD-Tau with Pick bodies: a study of the BrainNet Europe Consortium. Neuropathol Appl Neurobiol 39:166–178CrossRefPubMed
Zurück zum Zitat Kovacs GG, Robinson JL, Xie SX, Lee EB, Grossman M, Wolk DA, Irwin DJ, Weintraub D, Kim CF, Schuck T, Yousef A, Wagner ST, Suh E, Van Deerlin VM, Lee VM, Trojanowski JQ (2017) Evaluating the patterns of aging-related tau astrogliopathy unravels novel insights into brain aging and neurodegenerative diseases. J Neuropathol Exp Neurol 76:270–288CrossRefPubMedPubMedCentral Kovacs GG, Robinson JL, Xie SX, Lee EB, Grossman M, Wolk DA, Irwin DJ, Weintraub D, Kim CF, Schuck T, Yousef A, Wagner ST, Suh E, Van Deerlin VM, Lee VM, Trojanowski JQ (2017) Evaluating the patterns of aging-related tau astrogliopathy unravels novel insights into brain aging and neurodegenerative diseases. J Neuropathol Exp Neurol 76:270–288CrossRefPubMedPubMedCentral
Zurück zum Zitat Kreisler A, Mastain B, Tison F, Fenelon G, Destee A (2007) Multi-infarct disorder presenting as corticobasal degeneration (DCB): vascular pseudo-corticobasal degeneration? Rev Neurol (Paris) 163:1191–1199CrossRef Kreisler A, Mastain B, Tison F, Fenelon G, Destee A (2007) Multi-infarct disorder presenting as corticobasal degeneration (DCB): vascular pseudo-corticobasal degeneration? Rev Neurol (Paris) 163:1191–1199CrossRef
Zurück zum Zitat Krejciova Z, Carlson GA, Giles K, Prusiner SB (2019) Replication of multiple system atrophy prions in primary astrocyte cultures from transgenic mice expressing human alpha-synuclein. Acta Neuropathol Commun 7:81CrossRefPubMedPubMedCentral Krejciova Z, Carlson GA, Giles K, Prusiner SB (2019) Replication of multiple system atrophy prions in primary astrocyte cultures from transgenic mice expressing human alpha-synuclein. Acta Neuropathol Commun 7:81CrossRefPubMedPubMedCentral
Zurück zum Zitat Krismer F, Wenning GK (2017) Multiple system atrophy: insights into a rare and debilitating movement disorder. Nat Rev Neurol 13:232–243CrossRefPubMed Krismer F, Wenning GK (2017) Multiple system atrophy: insights into a rare and debilitating movement disorder. Nat Rev Neurol 13:232–243CrossRefPubMed
Zurück zum Zitat Kübler D, Wachter T, Cabanel N, Su Z, Turkheimer FE, Dodel R, Brooks DJ, Oertel WH, Gerhard A (2019) Widespread microglial activation in multiple system atrophy. Mov Disord 34:564–568PubMedPubMedCentral Kübler D, Wachter T, Cabanel N, Su Z, Turkheimer FE, Dodel R, Brooks DJ, Oertel WH, Gerhard A (2019) Widespread microglial activation in multiple system atrophy. Mov Disord 34:564–568PubMedPubMedCentral
Zurück zum Zitat Kujawska M, Jodynis-Liebert J (2018) What is the evidence that Parkinson’s disease is a prion disorder, which originates in the gut? Int J Mol Sci 19:3573CrossRefPubMedCentral Kujawska M, Jodynis-Liebert J (2018) What is the evidence that Parkinson’s disease is a prion disorder, which originates in the gut? Int J Mol Sci 19:3573CrossRefPubMedCentral
Zurück zum Zitat Kun-Rodrigues C, Orme T, Carmona S, Hernandez DG, Ross OA, Eicher JD, Shepherd C, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Dawson T, Rosenthal L, Ansorge O, Clarimon J, Lleo A, Morenas-Rodriguez E, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Serrano GE, Beach TG, Lesage S, Galasko D, Masliah E, Santana I, Pastor P, Diez-Fairen M, Aguilar M, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Escott-Price V, Graff-Radford N, Cairns NJ, Morris JC, Pickering-Brown S, Mann D, Halliday GM, Hardy J, Trojanowski JQ, Dickson DW, Singleton A, Stone DJ, Guerreiro R, Bras J (2019) A comprehensive screening of copy number variability in dementia with Lewy bodies. Neurobiol Aging 75:223e1–223e10CrossRef Kun-Rodrigues C, Orme T, Carmona S, Hernandez DG, Ross OA, Eicher JD, Shepherd C, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Dawson T, Rosenthal L, Ansorge O, Clarimon J, Lleo A, Morenas-Rodriguez E, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Serrano GE, Beach TG, Lesage S, Galasko D, Masliah E, Santana I, Pastor P, Diez-Fairen M, Aguilar M, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Escott-Price V, Graff-Radford N, Cairns NJ, Morris JC, Pickering-Brown S, Mann D, Halliday GM, Hardy J, Trojanowski JQ, Dickson DW, Singleton A, Stone DJ, Guerreiro R, Bras J (2019) A comprehensive screening of copy number variability in dementia with Lewy bodies. Neurobiol Aging 75:223e1–223e10CrossRef
Zurück zum Zitat Kuusisto E, Parkkinen L, Alafuzoff I (2003) Morphogenesis of Lewy bodies: dissimilar incorporation of alpha-synuclein, ubiquitin, and p62. J Neuropathol Exp Neurol 62:1241–1253CrossRefPubMed Kuusisto E, Parkkinen L, Alafuzoff I (2003) Morphogenesis of Lewy bodies: dissimilar incorporation of alpha-synuclein, ubiquitin, and p62. J Neuropathol Exp Neurol 62:1241–1253CrossRefPubMed
Zurück zum Zitat Kuzumaki N, Suda Y, Iwasawa C, Narita M, Sone T, Watanabe M, Maekawa A, Matsumoto T, Akamatsu W, Igarashi K, Tamura H, Takeshima H, Tawfik VL, Ushijima T, Hattori N, Okano H (2019) Cell-specific overexpression of COMT in dopaminergic neurons of Parkinson’s disease. Brain 142:1675–1689CrossRefPubMed Kuzumaki N, Suda Y, Iwasawa C, Narita M, Sone T, Watanabe M, Maekawa A, Matsumoto T, Akamatsu W, Igarashi K, Tamura H, Takeshima H, Tawfik VL, Ushijima T, Hattori N, Okano H (2019) Cell-specific overexpression of COMT in dopaminergic neurons of Parkinson’s disease. Brain 142:1675–1689CrossRefPubMed
Zurück zum Zitat La Vitola P, Beeg M, Balducci C, Santamaria G, Restelli E, Colombo L, Caldinelli L, Pollegioni L, Gobbi M, Chiesa R, Forloni G (2019) Cellular prion protein neither binds to alpha-synuclein oligomers nor mediates their detrimental effects. Brain 142:249–254CrossRefPubMed La Vitola P, Beeg M, Balducci C, Santamaria G, Restelli E, Colombo L, Caldinelli L, Pollegioni L, Gobbi M, Chiesa R, Forloni G (2019) Cellular prion protein neither binds to alpha-synuclein oligomers nor mediates their detrimental effects. Brain 142:249–254CrossRefPubMed
Zurück zum Zitat Lam B, Khan A, Keith J, Rogaeva E, Bilbao J, St George-Hyslop P, Ghani M, Freedman M, Stuss DT, Chow T, Black SE, Masellis M (2018) Characterizing familial corticobasal syndrome due to Alzheimer’s disease pathology and PSEN1 mutations. Alzheimers Dement 13:520–530CrossRef Lam B, Khan A, Keith J, Rogaeva E, Bilbao J, St George-Hyslop P, Ghani M, Freedman M, Stuss DT, Chow T, Black SE, Masellis M (2018) Characterizing familial corticobasal syndrome due to Alzheimer’s disease pathology and PSEN1 mutations. Alzheimers Dement 13:520–530CrossRef
Zurück zum Zitat Lane EL (2019) l-DOPA for Parkinson’s disease-a bittersweet pill. Eur J Neurosci 49:384–398CrossRefPubMed Lane EL (2019) l-DOPA for Parkinson’s disease-a bittersweet pill. Eur J Neurosci 49:384–398CrossRefPubMed
Zurück zum Zitat Lang AE (2011) A critical appraisal of the premotor symptoms of Parkinson’s disease: potential usefulness in early diagnosis and design of neuroprotective trials. Mov Disord 26:775–783CrossRefPubMed Lang AE (2011) A critical appraisal of the premotor symptoms of Parkinson’s disease: potential usefulness in early diagnosis and design of neuroprotective trials. Mov Disord 26:775–783CrossRefPubMed
Zurück zum Zitat Langston JW, Forno LS, Tetrud J, Reeves AG, Kaplan JA, Karluk D (1999) Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann Neurol 46:598–605CrossRefPubMed Langston JW, Forno LS, Tetrud J, Reeves AG, Kaplan JA, Karluk D (1999) Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann Neurol 46:598–605CrossRefPubMed
Zurück zum Zitat Laurens B, Vergnet S, Lopez MC, Foubert-Samier A, Tison F, Fernagut PO, Meissner WG (2017) Multiple system atrophy—state of the art. Curr Neurol Neurosci Rep 17:41CrossRefPubMed Laurens B, Vergnet S, Lopez MC, Foubert-Samier A, Tison F, Fernagut PO, Meissner WG (2017) Multiple system atrophy—state of the art. Curr Neurol Neurosci Rep 17:41CrossRefPubMed
Zurück zum Zitat Lautenschlager J, Stephens AD, Fusco G, Strohl F, Curry N, Zacharopoulou M, Michel CH, Laine R, Nespovitaya N, Fantham M, Pinotsi D, Zago W, Fraser P, Tandon A, St George-Hyslop P, Rees E, Phillips JJ, De Simone A, Kaminski CF, Schierle GSK (2018) C-terminal calcium binding of alpha-synuclein modulates synaptic vesicle interaction. Nat Commun 9:712CrossRefPubMedPubMedCentral Lautenschlager J, Stephens AD, Fusco G, Strohl F, Curry N, Zacharopoulou M, Michel CH, Laine R, Nespovitaya N, Fantham M, Pinotsi D, Zago W, Fraser P, Tandon A, St George-Hyslop P, Rees E, Phillips JJ, De Simone A, Kaminski CF, Schierle GSK (2018) C-terminal calcium binding of alpha-synuclein modulates synaptic vesicle interaction. Nat Commun 9:712CrossRefPubMedPubMedCentral
Zurück zum Zitat Lawton M, Baig F, Rolinski M, Ruffman C, Nithi K, May MT, Ben-Shlomo Y, Hu MT (2015) Parkinson’s disease subtypes in the Oxford Parkinson Disease Centre (OPDC) discovery cohort. J Parkinsons Dis 5:269–279CrossRefPubMedPubMedCentral Lawton M, Baig F, Rolinski M, Ruffman C, Nithi K, May MT, Ben-Shlomo Y, Hu MT (2015) Parkinson’s disease subtypes in the Oxford Parkinson Disease Centre (OPDC) discovery cohort. J Parkinsons Dis 5:269–279CrossRefPubMedPubMedCentral
Zurück zum Zitat Lawton M, Ben-Shlomo Y, May MT, Baig F, Barber TR, Klein JC, Swallow DMA, Malek N, Grosset KA, Bajaj N, Barker RA, Williams N, Burn DJ, Foltynie T, Morris HR, Wood NW, Grosset DG, Hu MTM (2018) Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression. J Neurol Neurosurg Psychiatry 89:1279–1287CrossRefPubMed Lawton M, Ben-Shlomo Y, May MT, Baig F, Barber TR, Klein JC, Swallow DMA, Malek N, Grosset KA, Bajaj N, Barker RA, Williams N, Burn DJ, Foltynie T, Morris HR, Wood NW, Grosset DG, Hu MTM (2018) Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression. J Neurol Neurosurg Psychiatry 89:1279–1287CrossRefPubMed
Zurück zum Zitat Lee MJ, Shin JH, Seoung JK, Lee JH, Yoon U, Oh JH, Jung DS, Kim EJ (2015) Cognitive impairments associated with morphological changes in cortical and subcortical structures in multiple system atrophy of the cerebellar type. Eur J Neurol 23:92–100CrossRefPubMed Lee MJ, Shin JH, Seoung JK, Lee JH, Yoon U, Oh JH, Jung DS, Kim EJ (2015) Cognitive impairments associated with morphological changes in cortical and subcortical structures in multiple system atrophy of the cerebellar type. Eur J Neurol 23:92–100CrossRefPubMed
Zurück zum Zitat Lehtonen S, Sonninen TM, Wojciechowski S, Goldsteins G, Koistinaho J (2019) Dysfunction of cellular proteostasis in Parkinson’s disease. Front Neurosci 13:457CrossRefPubMedPubMedCentral Lehtonen S, Sonninen TM, Wojciechowski S, Goldsteins G, Koistinaho J (2019) Dysfunction of cellular proteostasis in Parkinson’s disease. Front Neurosci 13:457CrossRefPubMedPubMedCentral
Zurück zum Zitat Lema Tomé CM, Tyson T, Rey NL, Grathwohl S, Britschgi M, Brundin P (2013) Inflammation and alpha-synuclein’s prion-like behavior in Parkinson’s disease—is there a link? Mol Neurobiol 47:561–574CrossRefPubMed Lema Tomé CM, Tyson T, Rey NL, Grathwohl S, Britschgi M, Brundin P (2013) Inflammation and alpha-synuclein’s prion-like behavior in Parkinson’s disease—is there a link? Mol Neurobiol 47:561–574CrossRefPubMed
Zurück zum Zitat Lenka A, Ingalhalikar M, Shah A, Saini J, Arumugham SS, Hegde S, George L, Reddy V, Reddy YCJ, Yadav R, Pal PK (2018) Hippocampal subfield atrophy in patients with Parkinson’s disease and psychosis. J Neural Transm (Vienna) 125:1361–1372CrossRef Lenka A, Ingalhalikar M, Shah A, Saini J, Arumugham SS, Hegde S, George L, Reddy V, Reddy YCJ, Yadav R, Pal PK (2018) Hippocampal subfield atrophy in patients with Parkinson’s disease and psychosis. J Neural Transm (Vienna) 125:1361–1372CrossRef
Zurück zum Zitat Leverenz JB, Umar I, Wang Q, Montine TJ, McMillan PJ, Tsuang DW, Jin J, Pan C, Shin J, Zhu D, Zhang J (2007) Proteomic identification of novel proteins in cortical lewy bodies. Brain Pathol 17:139–145CrossRefPubMedPubMedCentral Leverenz JB, Umar I, Wang Q, Montine TJ, McMillan PJ, Tsuang DW, Jin J, Pan C, Shin J, Zhu D, Zhang J (2007) Proteomic identification of novel proteins in cortical lewy bodies. Brain Pathol 17:139–145CrossRefPubMedPubMedCentral
Zurück zum Zitat Leverenz JB, Hamilton R, Tsuang DW, Schantz A, Vavrek D, Larson EB, Kukull WA, Lopez O, Galasko D, Masliah E, Kaye J, Woltjer R, Clark C, Trojanowski JQ, Montine TJ (2008) Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient. Brain Pathol 18:220–224CrossRefPubMedPubMedCentral Leverenz JB, Hamilton R, Tsuang DW, Schantz A, Vavrek D, Larson EB, Kukull WA, Lopez O, Galasko D, Masliah E, Kaye J, Woltjer R, Clark C, Trojanowski JQ, Montine TJ (2008) Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient. Brain Pathol 18:220–224CrossRefPubMedPubMedCentral
Zurück zum Zitat Li A, Paudel R, Johnson R, Courtney R, Lees AJ, Holton JL, Hardy J, Revesz T, Houlden H (2013) Pantothenate kinase-associated neurodegeneration is not a synucleinopathy. Neuropathol Appl Neurobiol 39:121–131CrossRefPubMed Li A, Paudel R, Johnson R, Courtney R, Lees AJ, Holton JL, Hardy J, Revesz T, Houlden H (2013) Pantothenate kinase-associated neurodegeneration is not a synucleinopathy. Neuropathol Appl Neurobiol 39:121–131CrossRefPubMed
Zurück zum Zitat Li M, Ma Q, Zhao X, Wang C, Wu H, Li J, Yang W (2018) Dilemma of multiple system atrophy and spinocerebellar ataxias. J Neurol 265:2764–2772CrossRefPubMed Li M, Ma Q, Zhao X, Wang C, Wu H, Li J, Yang W (2018) Dilemma of multiple system atrophy and spinocerebellar ataxias. J Neurol 265:2764–2772CrossRefPubMed
Zurück zum Zitat Li X, Koudstaal W, Fletcher L, Costa M, van Winsen M, Siregar B, Inganas H, Kim J, Keogh E, Macedo J, Holland T, Perry S, Bard F, Hoozemans JJ, Goudsmit J, Apetri A, Pascual G (2019) Naturally occurring antibodies isolated from PD patients inhibit synuclein seeding in vitro and recognize Lewy pathology. Acta Neuropathol 137:825–836CrossRefPubMedPubMedCentral Li X, Koudstaal W, Fletcher L, Costa M, van Winsen M, Siregar B, Inganas H, Kim J, Keogh E, Macedo J, Holland T, Perry S, Bard F, Hoozemans JJ, Goudsmit J, Apetri A, Pascual G (2019) Naturally occurring antibodies isolated from PD patients inhibit synuclein seeding in vitro and recognize Lewy pathology. Acta Neuropathol 137:825–836CrossRefPubMedPubMedCentral
Zurück zum Zitat Licker V, Turck N, Kovari E, Burkhardt K, Cote M, Surini-Demiri M, Lobrinus JA, Sanchez JC, Burkhard PR (2014) Proteomic analysis of human substantia nigra identifies novel candidates involved in Parkinson’s disease pathogenesis. Proteomics 14:784–794CrossRefPubMed Licker V, Turck N, Kovari E, Burkhardt K, Cote M, Surini-Demiri M, Lobrinus JA, Sanchez JC, Burkhard PR (2014) Proteomic analysis of human substantia nigra identifies novel candidates involved in Parkinson’s disease pathogenesis. Proteomics 14:784–794CrossRefPubMed
Zurück zum Zitat Lima VA, do Nascimento LA, Eliezer D, Follmer C (2019) Role of Parkinson’s disease-linked mutations and n-terminal acetylation on the oligomerization of alpha-synuclein induced by 3,4-dihydroxyphenylacetaldehyde. ACS Chem Neurosci 10:690–703CrossRefPubMed Lima VA, do Nascimento LA, Eliezer D, Follmer C (2019) Role of Parkinson’s disease-linked mutations and n-terminal acetylation on the oligomerization of alpha-synuclein induced by 3,4-dihydroxyphenylacetaldehyde. ACS Chem Neurosci 10:690–703CrossRefPubMed
Zurück zum Zitat Limphaibool N, Iwanowski P, Holstad MJV, Perkowska K (2018) Parkinsonism in inherited metabolic disorders: key considerations and major features. Front Neurol 9:857CrossRefPubMedPubMedCentral Limphaibool N, Iwanowski P, Holstad MJV, Perkowska K (2018) Parkinsonism in inherited metabolic disorders: key considerations and major features. Front Neurol 9:857CrossRefPubMedPubMedCentral
Zurück zum Zitat Lin CH, Tan EK, Yang CC, Yi Z, Wu RM (2015) COQ2 gene variants associate with cerebellar subtype of multiple system atrophy in Chinese. Mov Disord 30:436–437CrossRefPubMed Lin CH, Tan EK, Yang CC, Yi Z, Wu RM (2015) COQ2 gene variants associate with cerebellar subtype of multiple system atrophy in Chinese. Mov Disord 30:436–437CrossRefPubMed
Zurück zum Zitat Lin G, Wang L, Marcogliese PC, Bellen HJ (2019) Sphingolipids in the pathogenesis of Parkinson’s disease and parkinsonism. Trends Endocrinol Metab 30:106–117CrossRefPubMed Lin G, Wang L, Marcogliese PC, Bellen HJ (2019) Sphingolipids in the pathogenesis of Parkinson’s disease and parkinsonism. Trends Endocrinol Metab 30:106–117CrossRefPubMed
Zurück zum Zitat Ling H, Holton JL, Lees AJ, Revesz T (2013) TDP-43 pathology is present in most post-encephalitic parkinsonism brains (Scientific correspondence). Neuropathol Appl Neurobiol 40:654–657CrossRef Ling H, Holton JL, Lees AJ, Revesz T (2013) TDP-43 pathology is present in most post-encephalitic parkinsonism brains (Scientific correspondence). Neuropathol Appl Neurobiol 40:654–657CrossRef
Zurück zum Zitat Ling H, de Silva R, Massey LA, Courtney R, Hondhamuni G, Bajaj N, Lowe J, Holton JL, Lees A, Revesz T (2014) Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant. Neuropathol Appl Neurobiol 40:149–163CrossRefPubMedPubMedCentral Ling H, de Silva R, Massey LA, Courtney R, Hondhamuni G, Bajaj N, Lowe J, Holton JL, Lees A, Revesz T (2014) Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant. Neuropathol Appl Neurobiol 40:149–163CrossRefPubMedPubMedCentral
Zurück zum Zitat Ling H, Asi YT, Petrovic IN, Ahmed Z, Prashanth LK, Hazrati LN, Nishizawa M, Ozawa T, Lang A, Lees AJ, Revesz T, Holton JL (2015) Minimal change multiple system atrophy: an aggressive variant? Mov Disord 30:960–967CrossRefPubMed Ling H, Asi YT, Petrovic IN, Ahmed Z, Prashanth LK, Hazrati LN, Nishizawa M, Ozawa T, Lang A, Lees AJ, Revesz T, Holton JL (2015) Minimal change multiple system atrophy: an aggressive variant? Mov Disord 30:960–967CrossRefPubMed
Zurück zum Zitat Ling H, Kovacs GG, Vonsattel JP, Davey K, Mok KY, Hardy J, Morris HR, Warner TT, Holton JL, Revesz T (2016) Astrogliopathy predominates the earliest stage of corticobasal degeneration pathology. Brain 139:3237–3252CrossRefPubMed Ling H, Kovacs GG, Vonsattel JP, Davey K, Mok KY, Hardy J, Morris HR, Warner TT, Holton JL, Revesz T (2016) Astrogliopathy predominates the earliest stage of corticobasal degeneration pathology. Brain 139:3237–3252CrossRefPubMed
Zurück zum Zitat Lionnet A, Leclair-Visonneau L, Neunlist M, Murayama S, Takao M, Adler CH, Derkinderen P, Beach TG (2018) Does Parkinson’s disease start in the gut? Acta Neuropathol 135:1–12CrossRefPubMed Lionnet A, Leclair-Visonneau L, Neunlist M, Murayama S, Takao M, Adler CH, Derkinderen P, Beach TG (2018) Does Parkinson’s disease start in the gut? Acta Neuropathol 135:1–12CrossRefPubMed
Zurück zum Zitat Liu M, Choi DY, Hunter RL, Pandya JD, Cass WA, Sullivan PG, Kim HC, Gash DM, Bing G (2010) Trichloroethylene induces dopaminergic neurodegeneration in Fisher 344 rats. J Neurochem 112:773–783CrossRefPubMed Liu M, Choi DY, Hunter RL, Pandya JD, Cass WA, Sullivan PG, Kim HC, Gash DM, Bing G (2010) Trichloroethylene induces dopaminergic neurodegeneration in Fisher 344 rats. J Neurochem 112:773–783CrossRefPubMed
Zurück zum Zitat Liu AKL, Lim EJ, Ahmed I, Chang RC, Pearce RKB, Gentleman SM (2018) Review: revisiting the human cholinergic nucleus of the diagonal band of Broca. Neuropathol Appl Neurobiol 44:647–662CrossRefPubMedPubMedCentral Liu AKL, Lim EJ, Ahmed I, Chang RC, Pearce RKB, Gentleman SM (2018) Review: revisiting the human cholinergic nucleus of the diagonal band of Broca. Neuropathol Appl Neurobiol 44:647–662CrossRefPubMedPubMedCentral
Zurück zum Zitat Liu AKL, Chau TW, Lim EJ, Ahmed I, Chang RC, Kalaitzakis ME, Graeber MB, Gentleman SM, Pearce RKB (2019a) Hippocampal CA2 Lewy pathology is associated with cholinergic degeneration in Parkinson’s disease with cognitive decline. Acta Neuropathol Commun 7:61CrossRefPubMedPubMedCentral Liu AKL, Chau TW, Lim EJ, Ahmed I, Chang RC, Kalaitzakis ME, Graeber MB, Gentleman SM, Pearce RKB (2019a) Hippocampal CA2 Lewy pathology is associated with cholinergic degeneration in Parkinson’s disease with cognitive decline. Acta Neuropathol Commun 7:61CrossRefPubMedPubMedCentral
Zurück zum Zitat Liu X, Hebron M, Shi W, Lonskaya I, Moussa CE (2019b) Ubiquitin specific protease-13 independently regulates parkin ubiquitination and alpha-synuclein clearance in alpha-synucleinopathies. Hum Mol Genet 28:548–560CrossRefPubMed Liu X, Hebron M, Shi W, Lonskaya I, Moussa CE (2019b) Ubiquitin specific protease-13 independently regulates parkin ubiquitination and alpha-synuclein clearance in alpha-synucleinopathies. Hum Mol Genet 28:548–560CrossRefPubMed
Zurück zum Zitat Longhena F, Faustini G, Missale C, Pizzi M, Spano P, Bellucci A (2017) The contribution of alpha-synuclein spreading to Parkinson’s disease synaptopathy. Neural Plast 2017:5012129CrossRefPubMedPubMedCentral Longhena F, Faustini G, Missale C, Pizzi M, Spano P, Bellucci A (2017) The contribution of alpha-synuclein spreading to Parkinson’s disease synaptopathy. Neural Plast 2017:5012129CrossRefPubMedPubMedCentral
Zurück zum Zitat Longhena F, Faustini G, Varanita T, Zaltieri M, Porrini V, Tessari I, Poliani PL, Missale C, Borroni B, Padovani A, Bubacco L, Pizzi M, Spano P, Bellucci A (2018) Synapsin III is a key component of alpha-synuclein fibrils in Lewy bodies of PD brains. Brain Pathol 28:875–888CrossRefPubMedPubMedCentral Longhena F, Faustini G, Varanita T, Zaltieri M, Porrini V, Tessari I, Poliani PL, Missale C, Borroni B, Padovani A, Bubacco L, Pizzi M, Spano P, Bellucci A (2018) Synapsin III is a key component of alpha-synuclein fibrils in Lewy bodies of PD brains. Brain Pathol 28:875–888CrossRefPubMedPubMedCentral
Zurück zum Zitat Lopez KLR, Simpson JE, Watson LC, Mortiboys H, Hautbergue GM, Bandmann O, Highley JR (2019) TIGAR inclusion pathology is specific for Lewy body diseases. Brain Res 1706:218–223CrossRefPubMed Lopez KLR, Simpson JE, Watson LC, Mortiboys H, Hautbergue GM, Bandmann O, Highley JR (2019) TIGAR inclusion pathology is specific for Lewy body diseases. Brain Res 1706:218–223CrossRefPubMed
Zurück zum Zitat Lu X, Kim-Han JS, Harmon S, Sakiyama-Elbert SE, O’Malley KL (2014) The Parkinsonian mimetic, 6-OHDA, impairs axonal transport in dopaminergic axons. Mol Neurodegener 9:17CrossRefPubMedPubMedCentral Lu X, Kim-Han JS, Harmon S, Sakiyama-Elbert SE, O’Malley KL (2014) The Parkinsonian mimetic, 6-OHDA, impairs axonal transport in dopaminergic axons. Mol Neurodegener 9:17CrossRefPubMedPubMedCentral
Zurück zum Zitat Lubbe S, Morris HR (2014) Recent advances in Parkinson’s disease genetics. J Neurol 261:259–266CrossRefPubMed Lubbe S, Morris HR (2014) Recent advances in Parkinson’s disease genetics. J Neurol 261:259–266CrossRefPubMed
Zurück zum Zitat Ludtmann MHR, Angelova PR, Horrocks MH, Choi ML, Rodrigues M, Baev AY, Berezhnov AV, Yao Z, Little D, Banushi B, Al-Menhali AS, Ranasinghe RT, Whiten DR, Yapom R, Dolt KS, Devine MJ, Gissen P, Kunath T, Jaganjac M, Pavlov EV, Klenerman D, Abramov AY, Gandhi S (2018) Alpha-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson’s disease. Nat Commun 9:2293CrossRefPubMedPubMedCentral Ludtmann MHR, Angelova PR, Horrocks MH, Choi ML, Rodrigues M, Baev AY, Berezhnov AV, Yao Z, Little D, Banushi B, Al-Menhali AS, Ranasinghe RT, Whiten DR, Yapom R, Dolt KS, Devine MJ, Gissen P, Kunath T, Jaganjac M, Pavlov EV, Klenerman D, Abramov AY, Gandhi S (2018) Alpha-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson’s disease. Nat Commun 9:2293CrossRefPubMedPubMedCentral
Zurück zum Zitat Lue L-F, Walker DG, Adler CH, Shill H, Tran H, Akiyama H, Sue LI, Caviness J, Sabbagh MN, Beach TG (2012) Biochemical increase in phosphorylated a-synuclein precedes histopathology of Lewy-type synucleinopathies. Brain Pathol 22:745–756CrossRefPubMedPubMedCentral Lue L-F, Walker DG, Adler CH, Shill H, Tran H, Akiyama H, Sue LI, Caviness J, Sabbagh MN, Beach TG (2012) Biochemical increase in phosphorylated a-synuclein precedes histopathology of Lewy-type synucleinopathies. Brain Pathol 22:745–756CrossRefPubMedPubMedCentral
Zurück zum Zitat Lunati A, Lesage S, Brice A (2018) The genetic landscape of Parkinson’s disease. Rev Neurol (Paris) 174:628–643CrossRef Lunati A, Lesage S, Brice A (2018) The genetic landscape of Parkinson’s disease. Rev Neurol (Paris) 174:628–643CrossRef
Zurück zum Zitat Ma LY, Liu GL, Wang DX, Zhang MM, Kou WY, Feng T (2019) Alpha-synuclein in peripheral tissues in Parkinson’s disease. ACS Chem Neurosci 10:812–823CrossRefPubMed Ma LY, Liu GL, Wang DX, Zhang MM, Kou WY, Feng T (2019) Alpha-synuclein in peripheral tissues in Parkinson’s disease. ACS Chem Neurosci 10:812–823CrossRefPubMed
Zurück zum Zitat Maeda S, Sato Y, Takashima A (2018) Frontotemporal dementia with parkinsonism linked to chromosome-17 mutations enhance tau oligomer formation. Neurobiol Aging 69:26–32CrossRefPubMed Maeda S, Sato Y, Takashima A (2018) Frontotemporal dementia with parkinsonism linked to chromosome-17 mutations enhance tau oligomer formation. Neurobiol Aging 69:26–32CrossRefPubMed
Zurück zum Zitat Maffeo E, Montuschi A, Stura G, Giordana MT (2014) Chronic acquired hepatocerebral degeneration, pallidal T1 MRI hyperintensity and manganese in a series of cirrhotic patients. Neurol Sci 35:523–530CrossRefPubMed Maffeo E, Montuschi A, Stura G, Giordana MT (2014) Chronic acquired hepatocerebral degeneration, pallidal T1 MRI hyperintensity and manganese in a series of cirrhotic patients. Neurol Sci 35:523–530CrossRefPubMed
Zurück zum Zitat Maillet A, Krack P, Lhommee E, Metereau E, Klinger H, Favre E, Le Bars D, Schmitt E, Bichon A, Pelissier P, Fraix V, Castrioto A, Sgambato-Faure V, Broussolle E, Tremblay L, Thobois S (2016) The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson’s disease. Brain 139:2486–2502CrossRefPubMed Maillet A, Krack P, Lhommee E, Metereau E, Klinger H, Favre E, Le Bars D, Schmitt E, Bichon A, Pelissier P, Fraix V, Castrioto A, Sgambato-Faure V, Broussolle E, Tremblay L, Thobois S (2016) The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson’s disease. Brain 139:2486–2502CrossRefPubMed
Zurück zum Zitat Maiti P, Manna J, Dunbar GL (2017) Current understanding of the molecular mechanisms in Parkinson’s disease: targets for potential treatments. Transl Neurodegener 6:28CrossRefPubMedPubMedCentral Maiti P, Manna J, Dunbar GL (2017) Current understanding of the molecular mechanisms in Parkinson’s disease: targets for potential treatments. Transl Neurodegener 6:28CrossRefPubMedPubMedCentral
Zurück zum Zitat Mak E, Donaghy PC, McKiernan E, Firbank MJ, Lloyd J, Petrides GS, Thomas AJ, O’Brien JT (2019) Beta amyloid deposition maps onto hippocampal and subiculum atrophy in dementia with Lewy bodies. Neurobiol Aging 73:74–81CrossRefPubMed Mak E, Donaghy PC, McKiernan E, Firbank MJ, Lloyd J, Petrides GS, Thomas AJ, O’Brien JT (2019) Beta amyloid deposition maps onto hippocampal and subiculum atrophy in dementia with Lewy bodies. Neurobiol Aging 73:74–81CrossRefPubMed
Zurück zum Zitat Malandrini A, Rubegni A, Battisti C, Berti G, Federico A (2013) Electron-dense lamellated inclusions in 2 siblings with Kufor-Rakeb syndrome. Mov Disord 28:1751–1752CrossRefPubMed Malandrini A, Rubegni A, Battisti C, Berti G, Federico A (2013) Electron-dense lamellated inclusions in 2 siblings with Kufor-Rakeb syndrome. Mov Disord 28:1751–1752CrossRefPubMed
Zurück zum Zitat Mandel RJ, Marmion DJ, Kirik D, Chu Y, Heindel C, McCown T, Gray SJ, Kordower JH (2017) Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates. Acta Neuropathol Commun 5:47CrossRefPubMedPubMedCentral Mandel RJ, Marmion DJ, Kirik D, Chu Y, Heindel C, McCown T, Gray SJ, Kordower JH (2017) Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates. Acta Neuropathol Commun 5:47CrossRefPubMedPubMedCentral
Zurück zum Zitat Maor G, Rapaport D, Horowitz M (2019) The effect of mutant GBA1 on accumulation and aggregation of alpha-synuclein. Hum Mol Genet 28:1768–1781CrossRefPubMed Maor G, Rapaport D, Horowitz M (2019) The effect of mutant GBA1 on accumulation and aggregation of alpha-synuclein. Hum Mol Genet 28:1768–1781CrossRefPubMed
Zurück zum Zitat Marder K (2010) Cognitive impairment and dementia in Parkinson’s disease. Mov Disord 25(Suppl 1):S110–S116CrossRefPubMed Marder K (2010) Cognitive impairment and dementia in Parkinson’s disease. Mov Disord 25(Suppl 1):S110–S116CrossRefPubMed
Zurück zum Zitat Markesbery WR, Jicha GA, Liu H, Schmitt FA (2009) Lewy body pathology in normal elderly subjects. J Neuropathol Exp Neurol 68:816–822CrossRefPubMed Markesbery WR, Jicha GA, Liu H, Schmitt FA (2009) Lewy body pathology in normal elderly subjects. J Neuropathol Exp Neurol 68:816–822CrossRefPubMed
Zurück zum Zitat Markopoulou K, Dickson DW, McComb RD, Wszolek ZK, Katechalidou L, Avery L, Stansbury MS, Chase BA (2008) Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson’s disease. Variability in familial Parkinson’s disease. Acta Neuropathol 116:25–35CrossRefPubMedPubMedCentral Markopoulou K, Dickson DW, McComb RD, Wszolek ZK, Katechalidou L, Avery L, Stansbury MS, Chase BA (2008) Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson’s disease. Variability in familial Parkinson’s disease. Acta Neuropathol 116:25–35CrossRefPubMedPubMedCentral
Zurück zum Zitat Marras C, Alcalay RN, Caspell-Garcia C, Coffey C, Chan P, Duda JE, Facheris MF, Fernandez-Santiago R, Ruiz-Martinez J, Mestre T, Saunders-Pullman R, Pont-Sunyer C, Tolosa E, Waro B (2016) Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson’s disease. Mov Disord 31:1192–1202CrossRefPubMed Marras C, Alcalay RN, Caspell-Garcia C, Coffey C, Chan P, Duda JE, Facheris MF, Fernandez-Santiago R, Ruiz-Martinez J, Mestre T, Saunders-Pullman R, Pont-Sunyer C, Tolosa E, Waro B (2016) Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson’s disease. Mov Disord 31:1192–1202CrossRefPubMed
Zurück zum Zitat Marras C, Lang A, van de Warrenburg BP, Sue CM, Tabrizi SJ, Bertram L, Mercimek-Mahmutoglu S, Ebrahimi-Fakhari D, Warner TT, Durr A, Assmann B, Lohmann K, Kostic V, Klein C (2017) Nomenclature of genetic movement disorders: recommendations of the International Parkinson and Movement Disorder Society task force. Mov Disord 32:724–725CrossRefPubMed Marras C, Lang A, van de Warrenburg BP, Sue CM, Tabrizi SJ, Bertram L, Mercimek-Mahmutoglu S, Ebrahimi-Fakhari D, Warner TT, Durr A, Assmann B, Lohmann K, Kostic V, Klein C (2017) Nomenclature of genetic movement disorders: recommendations of the International Parkinson and Movement Disorder Society task force. Mov Disord 32:724–725CrossRefPubMed
Zurück zum Zitat Marras C, Beck JC, Bower JH, Roberts E, Ritz B, Ross GW, Abbott RD, Savica R, Van Den Eeden SK, Willis AW, Tanner CM (2018) Prevalence of Parkinson’s disease across North America. NPJ Parkinsons Dis 4:21CrossRefPubMedPubMedCentral Marras C, Beck JC, Bower JH, Roberts E, Ritz B, Ross GW, Abbott RD, Savica R, Van Den Eeden SK, Willis AW, Tanner CM (2018) Prevalence of Parkinson’s disease across North America. NPJ Parkinsons Dis 4:21CrossRefPubMedPubMedCentral
Zurück zum Zitat Masaracchia C, Hnida M, Gerhardt E, Lopes da Fonseca T, Villar-Pique A, Branco T, Stahlberg MA, Dean C, Fernandez CO, Milosevic I, Outeiro TF (2018) Membrane binding, internalization, and sorting of alpha-synuclein in the cell. Acta Neuropathol Commun 6:79CrossRefPubMedPubMedCentral Masaracchia C, Hnida M, Gerhardt E, Lopes da Fonseca T, Villar-Pique A, Branco T, Stahlberg MA, Dean C, Fernandez CO, Milosevic I, Outeiro TF (2018) Membrane binding, internalization, and sorting of alpha-synuclein in the cell. Acta Neuropathol Commun 6:79CrossRefPubMedPubMedCentral
Zurück zum Zitat Masui K, Nakata Y, Fujii N, Iwaki T (2012) Extensive distribution of glial cytoplasmic inclusions in an autopsied case of multiple system atrophy with a prolonged 18-year clinical course. Neuropathology 32:69–76CrossRefPubMed Masui K, Nakata Y, Fujii N, Iwaki T (2012) Extensive distribution of glial cytoplasmic inclusions in an autopsied case of multiple system atrophy with a prolonged 18-year clinical course. Neuropathology 32:69–76CrossRefPubMed
Zurück zum Zitat Matsuo A, Akiguchi I, Lee GC, McGeer EG, McGeer PL, Kimura J (1998) Myelin degeneration in multiple system atrophy detected by unique antibodies. Am J Pathol 153:735–744CrossRefPubMedPubMedCentral Matsuo A, Akiguchi I, Lee GC, McGeer EG, McGeer PL, Kimura J (1998) Myelin degeneration in multiple system atrophy detected by unique antibodies. Am J Pathol 153:735–744CrossRefPubMedPubMedCentral
Zurück zum Zitat Matsusue E, Fujii S, Kanasaki Y, Sugihara S, Miyata H, Ohama E, Ogawa T (2008) Putaminal lesion in multiple system atrophy: postmortem MR-pathological correlations. Neuroradiology 50:559–567CrossRefPubMed Matsusue E, Fujii S, Kanasaki Y, Sugihara S, Miyata H, Ohama E, Ogawa T (2008) Putaminal lesion in multiple system atrophy: postmortem MR-pathological correlations. Neuroradiology 50:559–567CrossRefPubMed
Zurück zum Zitat McAleese KE, Walker L, Erskine D, Thomas AJ, McKeith IG, Attems J (2017) TDP-43 pathology in Alzheimer’s disease, dementia with Lewy bodies and ageing. Brain Pathol 27:472–479CrossRefPubMed McAleese KE, Walker L, Erskine D, Thomas AJ, McKeith IG, Attems J (2017) TDP-43 pathology in Alzheimer’s disease, dementia with Lewy bodies and ageing. Brain Pathol 27:472–479CrossRefPubMed
Zurück zum Zitat McCormack A, Chegeni N, Chegini F, Colella A, Power J, Keating D, Chataway T (2016) Purification of alpha-synuclein containing inclusions from human post mortem brain tissue. J Neurosci Methods 266:141–150CrossRefPubMed McCormack A, Chegeni N, Chegini F, Colella A, Power J, Keating D, Chataway T (2016) Purification of alpha-synuclein containing inclusions from human post mortem brain tissue. J Neurosci Methods 266:141–150CrossRefPubMed
Zurück zum Zitat McCormack A, Keating DJ, Chegeni N, Colella A, Wang JJ, Chataway T (2019) Abundance of synaptic vesicle-related proteins in alpha-synuclein-containing protein inclusions suggests a targeted formation mechanism. Neurotox Res 35:883–897CrossRefPubMed McCormack A, Keating DJ, Chegeni N, Colella A, Wang JJ, Chataway T (2019) Abundance of synaptic vesicle-related proteins in alpha-synuclein-containing protein inclusions suggests a targeted formation mechanism. Neurotox Res 35:883–897CrossRefPubMed
Zurück zum Zitat McGregor MM, Nelson AB (2019) Circuit mechanisms of Parkinson’s disease. Neuron 101:1042–1056CrossRefPubMed McGregor MM, Nelson AB (2019) Circuit mechanisms of Parkinson’s disease. Neuron 101:1042–1056CrossRefPubMed
Zurück zum Zitat McKee AC, Abdolmohammadi B, Stein TD (2018) The neuropathology of chronic traumatic encephalopathy. Handb Clin Neurol 158:297–307CrossRefPubMed McKee AC, Abdolmohammadi B, Stein TD (2018) The neuropathology of chronic traumatic encephalopathy. Handb Clin Neurol 158:297–307CrossRefPubMed
Zurück zum Zitat McKeith I (2007) Dementia with Lewy bodies and Parkinson’s disease with dementia: where two worlds collide. Pract Neurol 7:374–382CrossRefPubMed McKeith I (2007) Dementia with Lewy bodies and Parkinson’s disease with dementia: where two worlds collide. Pract Neurol 7:374–382CrossRefPubMed
Zurück zum Zitat McKeith IG, Dickson DW, Lowe J, Emre M, O’Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863–1872CrossRefPubMed McKeith IG, Dickson DW, Lowe J, Emre M, O’Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863–1872CrossRefPubMed
Zurück zum Zitat McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O’Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K (2017) Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 89:88–100CrossRefPubMedPubMedCentral McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O’Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K (2017) Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 89:88–100CrossRefPubMedPubMedCentral
Zurück zum Zitat Mehanna R, Jankovic J (2013) Movement disorders in cerebrovascular disease. Lancet Neurol 12:597–608CrossRefPubMed Mehanna R, Jankovic J (2013) Movement disorders in cerebrovascular disease. Lancet Neurol 12:597–608CrossRefPubMed
Zurück zum Zitat Melzer TR, Stark MR, Keenan RJ, Myall DJ, MacAskill MR, Pitcher TL, Livingston L, Grenfell S, Horne KL, Young BN, Pascoe MJ, Almuqbel MM, Wang J, Marsh SH, Miller DH, Dalrymple-Alford JC, Anderson TJ (2019) Beta amyloid deposition is not associated with cognitive impairment in Parkinson’s disease. Front Neurol 10:391CrossRefPubMedPubMedCentral Melzer TR, Stark MR, Keenan RJ, Myall DJ, MacAskill MR, Pitcher TL, Livingston L, Grenfell S, Horne KL, Young BN, Pascoe MJ, Almuqbel MM, Wang J, Marsh SH, Miller DH, Dalrymple-Alford JC, Anderson TJ (2019) Beta amyloid deposition is not associated with cognitive impairment in Parkinson’s disease. Front Neurol 10:391CrossRefPubMedPubMedCentral
Zurück zum Zitat Mendoza-Santiesteban CE, Palma JA, Martinez J, Norcliffe-Kaufmann L, Hedges TR 3rd, Kaufmann H (2015) Progressive retinal structure abnormalities in multiple system atrophy. Mov Disord 30:1944–1953CrossRefPubMedPubMedCentral Mendoza-Santiesteban CE, Palma JA, Martinez J, Norcliffe-Kaufmann L, Hedges TR 3rd, Kaufmann H (2015) Progressive retinal structure abnormalities in multiple system atrophy. Mov Disord 30:1944–1953CrossRefPubMedPubMedCentral
Zurück zum Zitat Mensikova K, Tuckova L, Kolarikova K, Bartonikova T, Vodicka R, Ehrmann J, Vrtel R, Prochazka M, Kanovsky P, Kovacs GG (2019) Atypical parkinsonism of progressive supranuclear palsy-parkinsonism (PSP-P) phenotype with rare variants in FBXO7 and VPS35 genes associated with Lewy body pathology. Acta Neuropathol 137:171–173CrossRefPubMed Mensikova K, Tuckova L, Kolarikova K, Bartonikova T, Vodicka R, Ehrmann J, Vrtel R, Prochazka M, Kanovsky P, Kovacs GG (2019) Atypical parkinsonism of progressive supranuclear palsy-parkinsonism (PSP-P) phenotype with rare variants in FBXO7 and VPS35 genes associated with Lewy body pathology. Acta Neuropathol 137:171–173CrossRefPubMed
Zurück zum Zitat Meredith GE, Rademacher DJ (2011) MPTP mouse models of Parkinson’s disease: an update. J Parkinsons Dis 1:19–33PubMedPubMedCentral Meredith GE, Rademacher DJ (2011) MPTP mouse models of Parkinson’s disease: an update. J Parkinsons Dis 1:19–33PubMedPubMedCentral
Zurück zum Zitat Michel PP, Hirsch EC, Hunot S (2016) Understanding dopaminergic cell death pathways in Parkinson disease. Neuron 90:675–691CrossRefPubMed Michel PP, Hirsch EC, Hunot S (2016) Understanding dopaminergic cell death pathways in Parkinson disease. Neuron 90:675–691CrossRefPubMed
Zurück zum Zitat Mietelska-Porowska A, Wasik U, Goras M, Filipek A, Niewiadomska G (2014) Tau protein modifications and interactions: their role in function and dysfunction. Int J Mol Sci 15:4671–4713CrossRefPubMedPubMedCentral Mietelska-Porowska A, Wasik U, Goras M, Filipek A, Niewiadomska G (2014) Tau protein modifications and interactions: their role in function and dysfunction. Int J Mol Sci 15:4671–4713CrossRefPubMedPubMedCentral
Zurück zum Zitat Mikasa M, Kanai K, Li Y, Yoshino H, Mogushi K, Hayashida A, Ikeda A, Kawajiri S, Okuma Y, Kashihara K, Sato T, Kondo H, Funayama M, Nishioka K, Hattori N (2018) COQ2 variants in Parkinson’s disease and multiple system atrophy. J Neural Transm (Vienna) 125:937–944CrossRef Mikasa M, Kanai K, Li Y, Yoshino H, Mogushi K, Hayashida A, Ikeda A, Kawajiri S, Okuma Y, Kashihara K, Sato T, Kondo H, Funayama M, Nishioka K, Hattori N (2018) COQ2 variants in Parkinson’s disease and multiple system atrophy. J Neural Transm (Vienna) 125:937–944CrossRef
Zurück zum Zitat Miklossy J, Steele JC, Yu S, McCall S, Sandberg G, McGeer EG, McGeer PL (2008) Enduring involvement of tau, beta-amyloid, alpha-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam (ALS/PDC). Acta Neuropathol 116:625–637CrossRefPubMed Miklossy J, Steele JC, Yu S, McCall S, Sandberg G, McGeer EG, McGeer PL (2008) Enduring involvement of tau, beta-amyloid, alpha-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam (ALS/PDC). Acta Neuropathol 116:625–637CrossRefPubMed
Zurück zum Zitat Milosevic L, Gramer R, Kim TH, Algarni M, Fasano A, Kalia SK, Hodaie M, Lozano AM, Popovic MR, Hutchison WD (2019) Modulation of inhibitory plasticity in basal ganglia output nuclei of patients with Parkinson’s disease. Neurobiol Dis 124:46–56CrossRefPubMed Milosevic L, Gramer R, Kim TH, Algarni M, Fasano A, Kalia SK, Hodaie M, Lozano AM, Popovic MR, Hutchison WD (2019) Modulation of inhibitory plasticity in basal ganglia output nuclei of patients with Parkinson’s disease. Neurobiol Dis 124:46–56CrossRefPubMed
Zurück zum Zitat Mimuro M, Yoshida M, Kuzuhara S, Kokubo Y (2018) Amyotrophic lateral sclerosis and parkinsonism-dementia complex of the Hohara focus of the Kii Peninsula: a multiple proteinopathy? Neuropathology 38:98–107CrossRefPubMed Mimuro M, Yoshida M, Kuzuhara S, Kokubo Y (2018) Amyotrophic lateral sclerosis and parkinsonism-dementia complex of the Hohara focus of the Kii Peninsula: a multiple proteinopathy? Neuropathology 38:98–107CrossRefPubMed
Zurück zum Zitat Mishima T, Koga S, Lin WL, Kasanuki K, Castanedes-Casey M, Wszolek ZK, Oh SJ, Tsuboi Y, Dickson DW (2017) Perry syndrome: a distinctive type of TDP-43 proteinopathy. J Neuropathol Exp Neurol 76:676–682CrossRefPubMedPubMedCentral Mishima T, Koga S, Lin WL, Kasanuki K, Castanedes-Casey M, Wszolek ZK, Oh SJ, Tsuboi Y, Dickson DW (2017) Perry syndrome: a distinctive type of TDP-43 proteinopathy. J Neuropathol Exp Neurol 76:676–682CrossRefPubMedPubMedCentral
Zurück zum Zitat Mishima T, Fujioka S, Tomiyama H, Yabe I, Kurisaki R, Fujii N, Neshige R, Ross OA, Farrer MJ, Dickson DW, Wszolek ZK, Hattori N, Tsuboi Y (2018) Establishing diagnostic criteria for Perry syndrome. J Neurol Neurosurg Psychiatry 89:482–487CrossRefPubMed Mishima T, Fujioka S, Tomiyama H, Yabe I, Kurisaki R, Fujii N, Neshige R, Ross OA, Farrer MJ, Dickson DW, Wszolek ZK, Hattori N, Tsuboi Y (2018) Establishing diagnostic criteria for Perry syndrome. J Neurol Neurosurg Psychiatry 89:482–487CrossRefPubMed
Zurück zum Zitat Mitsui J, Matsukawa T, Sasaki H, Yabe I, Matsushima M, Durr A, Brice A, Takashima H, Kikuchi A, Aoki M, Ishiura H, Yasuda T, Date H, Ahsan B, Iwata A, Goto J, Ichikawa Y, Nakahara Y, Momose Y, Takahashi Y, Hara K, Kakita A, Yamada M, Takahashi H, Onodera O, Nishizawa M, Watanabe H, Ito M, Sobue G, Ishikawa K, Mizusawa H, Kanai K, Hattori T, Kuwabara S, Arai K, Koyano S, Kuroiwa Y, Hasegawa K, Yuasa T, Yasui K, Nakashima K, Ito H, Izumi Y, Kaji R, Kato T, Kusunoki S, Osaki Y, Horiuchi M, Kondo T, Murayama S, Hattori N, Yamamoto M, Murata M, Satake W, Toda T, Filla A, Klockgether T, Wullner U, Nicholson G, Gilman S, Tanner CM, Kukull WA, Stern MB, Lee VM, Trojanowski JQ, Masliah E, Low PA, Sandroni P, Ozelius LJ, Foroud T, Tsuji S (2015) Variants associated with Gaucher disease in multiple system atrophy. Ann Clin Transl Neurol 2:417–426CrossRefPubMedPubMedCentral Mitsui J, Matsukawa T, Sasaki H, Yabe I, Matsushima M, Durr A, Brice A, Takashima H, Kikuchi A, Aoki M, Ishiura H, Yasuda T, Date H, Ahsan B, Iwata A, Goto J, Ichikawa Y, Nakahara Y, Momose Y, Takahashi Y, Hara K, Kakita A, Yamada M, Takahashi H, Onodera O, Nishizawa M, Watanabe H, Ito M, Sobue G, Ishikawa K, Mizusawa H, Kanai K, Hattori T, Kuwabara S, Arai K, Koyano S, Kuroiwa Y, Hasegawa K, Yuasa T, Yasui K, Nakashima K, Ito H, Izumi Y, Kaji R, Kato T, Kusunoki S, Osaki Y, Horiuchi M, Kondo T, Murayama S, Hattori N, Yamamoto M, Murata M, Satake W, Toda T, Filla A, Klockgether T, Wullner U, Nicholson G, Gilman S, Tanner CM, Kukull WA, Stern MB, Lee VM, Trojanowski JQ, Masliah E, Low PA, Sandroni P, Ozelius LJ, Foroud T, Tsuji S (2015) Variants associated with Gaucher disease in multiple system atrophy. Ann Clin Transl Neurol 2:417–426CrossRefPubMedPubMedCentral
Zurück zum Zitat Miyaji Y, Koyama K, Kurokawa T, Mitomi M, Suzuki Y, Kuroiwa Y (2013) Vascular corticobasal syndrome caused by unilateral internal carotid artery occlusion. J Stroke Cerebrovasc Dis 22:1193–1195CrossRefPubMed Miyaji Y, Koyama K, Kurokawa T, Mitomi M, Suzuki Y, Kuroiwa Y (2013) Vascular corticobasal syndrome caused by unilateral internal carotid artery occlusion. J Stroke Cerebrovasc Dis 22:1193–1195CrossRefPubMed
Zurück zum Zitat Molano J, Boeve B, Ferman T, Smith G, Parisi J, Dickson D, Knopman D, Graff-Radford N, Geda Y, Lucas J, Kantarci K, Shiung M, Jack C, Silber M, Pankratz VS, Petersen R (2010) Mild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological study. Brain 133:540–556CrossRefPubMed Molano J, Boeve B, Ferman T, Smith G, Parisi J, Dickson D, Knopman D, Graff-Radford N, Geda Y, Lucas J, Kantarci K, Shiung M, Jack C, Silber M, Pankratz VS, Petersen R (2010) Mild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological study. Brain 133:540–556CrossRefPubMed
Zurück zum Zitat Monzio Compagnoni G, Kleiner G, Samarani M, Aureli M, Faustini G, Bellucci A, Ronchi D, Bordoni A, Garbellini M, Salani S, Fortunato F, Frattini E, Abati E, Bergamini C, Fato R, Tabano S, Miozzo M, Serratto G, Passafaro M, Deleidi M, Silipigni R, Nizzardo M, Bresolin N, Comi GP, Corti S, Quinzii CM, Di Fonzo A (2018) Mitochondrial dysregulation and impaired autophagy in iPSC-derived dopaminergic neurons of multiple system atrophy. Stem Cell Rep 11:1185–1198CrossRef Monzio Compagnoni G, Kleiner G, Samarani M, Aureli M, Faustini G, Bellucci A, Ronchi D, Bordoni A, Garbellini M, Salani S, Fortunato F, Frattini E, Abati E, Bergamini C, Fato R, Tabano S, Miozzo M, Serratto G, Passafaro M, Deleidi M, Silipigni R, Nizzardo M, Bresolin N, Comi GP, Corti S, Quinzii CM, Di Fonzo A (2018) Mitochondrial dysregulation and impaired autophagy in iPSC-derived dopaminergic neurons of multiple system atrophy. Stem Cell Rep 11:1185–1198CrossRef
Zurück zum Zitat Mor DE, Tsika E, Mazzulli JR, Gould NS, Kim H, Daniels MJ, Doshi S, Gupta P, Grossman JL, Tan VX, Kalb RG, Caldwell KA, Caldwell GA, Wolfe JH, Ischiropoulos H (2017) Dopamine induces soluble alpha-synuclein oligomers and nigrostriatal degeneration. Nat Neurosci 20:1560–1568CrossRefPubMedPubMedCentral Mor DE, Tsika E, Mazzulli JR, Gould NS, Kim H, Daniels MJ, Doshi S, Gupta P, Grossman JL, Tan VX, Kalb RG, Caldwell KA, Caldwell GA, Wolfe JH, Ischiropoulos H (2017) Dopamine induces soluble alpha-synuclein oligomers and nigrostriatal degeneration. Nat Neurosci 20:1560–1568CrossRefPubMedPubMedCentral
Zurück zum Zitat Mor DE, Daniels MJ, Ischiropoulos H (2019) The usual suspects, dopamine and alpha-synuclein, conspire to cause neurodegeneration. Mov Disord 34:167–179CrossRefPubMedPubMedCentral Mor DE, Daniels MJ, Ischiropoulos H (2019) The usual suspects, dopamine and alpha-synuclein, conspire to cause neurodegeneration. Mov Disord 34:167–179CrossRefPubMedPubMedCentral
Zurück zum Zitat Morbelli S, Chincarini A, Brendel M, Rominger A, Bruffaerts R, Vandenberghe R, Kramberger MG, Trost M, Garibotto V, Nicastro N, Frisoni GB, Lemstra AW, van der Zande J, Pilotto A, Padovani A, Garcia-Ptacek S, Savitcheva I, Ochoa-Figueroa MA, Davidsson A, Camacho V, Peira E, Arnaldi D, Bauckneht M, Pardini M, Sambuceti G, Aarsland D, Nobili F (2019) Metabolic patterns across core features in dementia with Lewy bodies. Ann Neurol 85:715–725CrossRefPubMed Morbelli S, Chincarini A, Brendel M, Rominger A, Bruffaerts R, Vandenberghe R, Kramberger MG, Trost M, Garibotto V, Nicastro N, Frisoni GB, Lemstra AW, van der Zande J, Pilotto A, Padovani A, Garcia-Ptacek S, Savitcheva I, Ochoa-Figueroa MA, Davidsson A, Camacho V, Peira E, Arnaldi D, Bauckneht M, Pardini M, Sambuceti G, Aarsland D, Nobili F (2019) Metabolic patterns across core features in dementia with Lewy bodies. Ann Neurol 85:715–725CrossRefPubMed
Zurück zum Zitat Mori F, Inenaga C, Yoshimoto M, Umezu H, Tanaka R, Takahashi H, Wakabayashi K (2002) Alpha-synuclein immunoreactivity in normal and neoplastic Schwann cells. Acta Neuropathol 103:145–151CrossRefPubMed Mori F, Inenaga C, Yoshimoto M, Umezu H, Tanaka R, Takahashi H, Wakabayashi K (2002) Alpha-synuclein immunoreactivity in normal and neoplastic Schwann cells. Acta Neuropathol 103:145–151CrossRefPubMed
Zurück zum Zitat Mori F, Nishie M, Kakita A, Yoshimoto M, Takahashi H, Wakabayashi K (2006) Relationship among alpha-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra. J Neuropathol Exp Neurol 65:808–815CrossRefPubMed Mori F, Nishie M, Kakita A, Yoshimoto M, Takahashi H, Wakabayashi K (2006) Relationship among alpha-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra. J Neuropathol Exp Neurol 65:808–815CrossRefPubMed
Zurück zum Zitat Mori F, Okada KI, Nomura T, Kobayashi Y (2016) The pedunculopontine tegmental nucleus as a motor and cognitive interface between the cerebellum and basal ganglia. Front Neuroanat 10:109CrossRefPubMedPubMedCentral Mori F, Okada KI, Nomura T, Kobayashi Y (2016) The pedunculopontine tegmental nucleus as a motor and cognitive interface between the cerebellum and basal ganglia. Front Neuroanat 10:109CrossRefPubMedPubMedCentral
Zurück zum Zitat Morimoto S, Hatsuta H, Kokubo Y, Nakano Y, Hasegawa M, Yoneda M, Hirokawa Y, Kuzuhara S, Shiraishi T, Murayama S (2018) Unusual tau pathology of the cerebellum in patients with amyotrophic lateral sclerosis/parkinsonism-dementia complex from the Kii Peninsula, Japan. Brain Pathol 28:287–291CrossRefPubMedPubMedCentral Morimoto S, Hatsuta H, Kokubo Y, Nakano Y, Hasegawa M, Yoneda M, Hirokawa Y, Kuzuhara S, Shiraishi T, Murayama S (2018) Unusual tau pathology of the cerebellum in patients with amyotrophic lateral sclerosis/parkinsonism-dementia complex from the Kii Peninsula, Japan. Brain Pathol 28:287–291CrossRefPubMedPubMedCentral
Zurück zum Zitat Morita K, Kawaguchi Y (2019) A dual role hypothesis of the cortico-basal-ganglia pathways: opponency and temporal difference through dopamine and adenosine. Front Neural Circuits 12:111CrossRefPubMedPubMedCentral Morita K, Kawaguchi Y (2019) A dual role hypothesis of the cortico-basal-ganglia pathways: opponency and temporal difference through dopamine and adenosine. Front Neural Circuits 12:111CrossRefPubMedPubMedCentral
Zurück zum Zitat Mosharov EV, Borgkvist A, Sulzer D (2015) Presynaptic effects of levodopa and their possible role in dyskinesia. Mov Disord 30:45–53CrossRefPubMed Mosharov EV, Borgkvist A, Sulzer D (2015) Presynaptic effects of levodopa and their possible role in dyskinesia. Mov Disord 30:45–53CrossRefPubMed
Zurück zum Zitat Moskvina V, Harold D, Russo G, Vedernikov A, Sharma M, Saad M, Holmans P, Bras JM, Bettella F, Keller MF, Nicolaou N, Simon-Sanchez J, Gibbs JR, Schulte C, Durr A, Guerreiro R, Hernandez D, Brice A, Stefansson H, Majamaa K, Gasser T, Heutink P, Wood N, Martinez M, Singleton AB, Nalls MA, Hardy J, Owen MJ, O’Donovan MC, Williams J, Morris HR, Williams NM (2013) Analysis of genome-wide association studies of Alzheimer disease and of Parkinson disease to determine if these 2 diseases share a common genetic risk. JAMA Neurol 70:1268–1276PubMedPubMedCentral Moskvina V, Harold D, Russo G, Vedernikov A, Sharma M, Saad M, Holmans P, Bras JM, Bettella F, Keller MF, Nicolaou N, Simon-Sanchez J, Gibbs JR, Schulte C, Durr A, Guerreiro R, Hernandez D, Brice A, Stefansson H, Majamaa K, Gasser T, Heutink P, Wood N, Martinez M, Singleton AB, Nalls MA, Hardy J, Owen MJ, O’Donovan MC, Williams J, Morris HR, Williams NM (2013) Analysis of genome-wide association studies of Alzheimer disease and of Parkinson disease to determine if these 2 diseases share a common genetic risk. JAMA Neurol 70:1268–1276PubMedPubMedCentral
Zurück zum Zitat MSA-Research-Collaboration, Collaboration M-SAR (2013) Mutations in COQ2 in familial and sporadic multiple-system atrophy. N Engl J Med 369:233–244CrossRef MSA-Research-Collaboration, Collaboration M-SAR (2013) Mutations in COQ2 in familial and sporadic multiple-system atrophy. N Engl J Med 369:233–244CrossRef
Zurück zum Zitat Mudher A, Colin M, Dujardin S, Medina M, Dewachter I, Alavi Naini SM, Mandelkow EM, Mandelkow E, Buee L, Goedert M, Brion JP (2017) What is the evidence that tau pathology spreads through prion-like propagation? Acta Neuropathol Commun 5:99CrossRefPubMedPubMedCentral Mudher A, Colin M, Dujardin S, Medina M, Dewachter I, Alavi Naini SM, Mandelkow EM, Mandelkow E, Buee L, Goedert M, Brion JP (2017) What is the evidence that tau pathology spreads through prion-like propagation? Acta Neuropathol Commun 5:99CrossRefPubMedPubMedCentral
Zurück zum Zitat Muller SK, Bender A, Laub C, Hogen T, Schlaudraff F, Liss B, Klopstock T, Elstner M (2013) Lewy body pathology is associated with mitochondrial DNA damage in Parkinson’s disease. Neurobiol Aging 34:2231–2233CrossRefPubMed Muller SK, Bender A, Laub C, Hogen T, Schlaudraff F, Liss B, Klopstock T, Elstner M (2013) Lewy body pathology is associated with mitochondrial DNA damage in Parkinson’s disease. Neurobiol Aging 34:2231–2233CrossRefPubMed
Zurück zum Zitat Mullin S, Hughes D, Mehta A, Schapira AHV (2019) Neurological effects of glucocerebrosidase gene mutations. Eur J Neurol 26:e329–e388CrossRef Mullin S, Hughes D, Mehta A, Schapira AHV (2019) Neurological effects of glucocerebrosidase gene mutations. Eur J Neurol 26:e329–e388CrossRef
Zurück zum Zitat Munch G, Luth HJ, Wong A, Arendt T, Hirsch E, Ravid R, Riederer P (2000) Crosslinking of alpha-synuclein by advanced glycation endproducts—an early pathophysiological step in Lewy body formation? J Chem Neuroanat 20:253–257CrossRefPubMed Munch G, Luth HJ, Wong A, Arendt T, Hirsch E, Ravid R, Riederer P (2000) Crosslinking of alpha-synuclein by advanced glycation endproducts—an early pathophysiological step in Lewy body formation? J Chem Neuroanat 20:253–257CrossRefPubMed
Zurück zum Zitat Munoz DG, Morris HR, Rossor M (2011) Pick’s disease. In: Dickson DW, Weller RO (eds) Neurodegeneration: the molecular pathology of dementia and movement disorders, 2nd edn. Blackwell Publishing Ltd., Oxford, pp 156–164CrossRef Munoz DG, Morris HR, Rossor M (2011) Pick’s disease. In: Dickson DW, Weller RO (eds) Neurodegeneration: the molecular pathology of dementia and movement disorders, 2nd edn. Blackwell Publishing Ltd., Oxford, pp 156–164CrossRef
Zurück zum Zitat Murray ME, Kouri N, Lin WL, Jack CR Jr, Dickson DW, Vemuri P (2014) Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias. Alzheimers Res Ther 6:1CrossRefPubMedPubMedCentral Murray ME, Kouri N, Lin WL, Jack CR Jr, Dickson DW, Vemuri P (2014) Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias. Alzheimers Res Ther 6:1CrossRefPubMedPubMedCentral
Zurück zum Zitat Naasan G, Shany-Ur T, Sidhu M, Barton C, Ketelle R, Shdo SM, Kramer JH, Miller BL, Seeley WW (2019) Corticobasal syndrome with visual hallucinations and probable REM-sleep behavior disorder: an autopsied case report of a patient with CBD and LBD pathology. Neurocase 25:26–33CrossRefPubMedPubMedCentral Naasan G, Shany-Ur T, Sidhu M, Barton C, Ketelle R, Shdo SM, Kramer JH, Miller BL, Seeley WW (2019) Corticobasal syndrome with visual hallucinations and probable REM-sleep behavior disorder: an autopsied case report of a patient with CBD and LBD pathology. Neurocase 25:26–33CrossRefPubMedPubMedCentral
Zurück zum Zitat Nakamoto FK, Okamoto S, Mitsui J, Sone T, Ishikawa M, Yamamoto Y, Kanegae Y, Nakatake Y, Imaizumi K, Ishiura H, Tsuji S, Okano H (2018) The pathogenesis linked to coenzyme Q10 insufficiency in iPSC-derived neurons from patients with multiple-system atrophy. Sci Rep 8:14215CrossRefPubMedPubMedCentral Nakamoto FK, Okamoto S, Mitsui J, Sone T, Ishikawa M, Yamamoto Y, Kanegae Y, Nakatake Y, Imaizumi K, Ishiura H, Tsuji S, Okano H (2018) The pathogenesis linked to coenzyme Q10 insufficiency in iPSC-derived neurons from patients with multiple-system atrophy. Sci Rep 8:14215CrossRefPubMedPubMedCentral
Zurück zum Zitat Nakamura K, Mori F, Kon T, Tanji K, Miki Y, Tomiyama M, Kurotaki H, Toyoshima Y, Kakita A, Takahashi H, Yamada M, Wakabayashi K (2015) Filamentous aggregations of phosphorylated alpha-synuclein in Schwann cells (Schwann cell cytoplasmic inclusions) in multiple system atrophy. Acta Neuropathol Commun 3:29CrossRefPubMedPubMedCentral Nakamura K, Mori F, Kon T, Tanji K, Miki Y, Tomiyama M, Kurotaki H, Toyoshima Y, Kakita A, Takahashi H, Yamada M, Wakabayashi K (2015) Filamentous aggregations of phosphorylated alpha-synuclein in Schwann cells (Schwann cell cytoplasmic inclusions) in multiple system atrophy. Acta Neuropathol Commun 3:29CrossRefPubMedPubMedCentral
Zurück zum Zitat Nakata Y, Yasuda T, Fukaya M, Yamamori S, Itakura M, Nihira T, Hayakawa H, Kawanami A, Kataoka M, Nagai M, Sakagami H, Takahashi M, Mizuno Y, Mochizuki H (2012) Accumulation of alpha-synuclein triggered by presynaptic dysfunction. J Neurosci 32:17186–17196CrossRefPubMedPubMedCentral Nakata Y, Yasuda T, Fukaya M, Yamamori S, Itakura M, Nihira T, Hayakawa H, Kawanami A, Kataoka M, Nagai M, Sakagami H, Takahashi M, Mizuno Y, Mochizuki H (2012) Accumulation of alpha-synuclein triggered by presynaptic dysfunction. J Neurosci 32:17186–17196CrossRefPubMedPubMedCentral
Zurück zum Zitat Narasimhan S, Guo JL, Changolkar L, Stieber A, McBride JD, Silva LV, He Z, Zhang B, Gathagan RJ, Trojanowski JQ, Lee VMY (2017) Pathological tau strains from human brains recapitulate the diversity of tauopathies in nontransgenic mouse brain. J Neurosci 37:11406–11423CrossRefPubMedPubMedCentral Narasimhan S, Guo JL, Changolkar L, Stieber A, McBride JD, Silva LV, He Z, Zhang B, Gathagan RJ, Trojanowski JQ, Lee VMY (2017) Pathological tau strains from human brains recapitulate the diversity of tauopathies in nontransgenic mouse brain. J Neurosci 37:11406–11423CrossRefPubMedPubMedCentral
Zurück zum Zitat Ndayisaba A, Jellinger K, Berger T, Wenning GK (2019) TNFalpha inhibitors as targets for protective therapies in MSA: a viewpoint. J Neuroinflamm 16:80CrossRef Ndayisaba A, Jellinger K, Berger T, Wenning GK (2019) TNFalpha inhibitors as targets for protective therapies in MSA: a viewpoint. J Neuroinflamm 16:80CrossRef
Zurück zum Zitat Nejad-Davarani S, Koeppe RA, Albin RL, Frey KA, Muller M, Bohnen NI (2019) Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with [(18)F]-FEOBV. Mol Psychiatry 24:322–327CrossRefPubMed Nejad-Davarani S, Koeppe RA, Albin RL, Frey KA, Muller M, Bohnen NI (2019) Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with [(18)F]-FEOBV. Mol Psychiatry 24:322–327CrossRefPubMed
Zurück zum Zitat Nervi A, Reitz C, Tang MX, Santana V, Piriz A, Reyes D, Lantigua R, Medrano M, Jimenez-Velazquez IZ, Lee JH, Mayeux R (2011) Familial aggregation of dementia with Lewy bodies. Arch Neurol 68:90–93CrossRefPubMedPubMedCentral Nervi A, Reitz C, Tang MX, Santana V, Piriz A, Reyes D, Lantigua R, Medrano M, Jimenez-Velazquez IZ, Lee JH, Mayeux R (2011) Familial aggregation of dementia with Lewy bodies. Arch Neurol 68:90–93CrossRefPubMedPubMedCentral
Zurück zum Zitat Neumann M, Mackenzie IRA (2019) Review: neuropathology of non-tau frontotemporal lobar degeneration. Neuropathol Appl Neurobiol 45:19–40CrossRefPubMed Neumann M, Mackenzie IRA (2019) Review: neuropathology of non-tau frontotemporal lobar degeneration. Neuropathol Appl Neurobiol 45:19–40CrossRefPubMed
Zurück zum Zitat Neumann WJ, Schroll H, de Almeida Marcelino AL, Horn A, Ewert S, Irmen F, Krause P, Schneider GH, Hamker F, Kuhn AA (2018) Functional segregation of basal ganglia pathways in Parkinson’s disease. Brain 141:2655–2669PubMed Neumann WJ, Schroll H, de Almeida Marcelino AL, Horn A, Ewert S, Irmen F, Krause P, Schneider GH, Hamker F, Kuhn AA (2018) Functional segregation of basal ganglia pathways in Parkinson’s disease. Brain 141:2655–2669PubMed
Zurück zum Zitat Nguyen M, Wong YC, Ysselstein D, Severino A, Krainc D (2019) Synaptic, mitochondrial, and lysosomal dysfunction in Parkinson’s disease. Trends Neurosci 42:140–149CrossRefPubMed Nguyen M, Wong YC, Ysselstein D, Severino A, Krainc D (2019) Synaptic, mitochondrial, and lysosomal dysfunction in Parkinson’s disease. Trends Neurosci 42:140–149CrossRefPubMed
Zurück zum Zitat Ni Z, Pinto AD, Lang AE, Chen R (2010) Involvement of the cerebellothalamocortical pathway in Parkinson disease. Ann Neurol 68:816–824CrossRefPubMed Ni Z, Pinto AD, Lang AE, Chen R (2010) Involvement of the cerebellothalamocortical pathway in Parkinson disease. Ann Neurol 68:816–824CrossRefPubMed
Zurück zum Zitat Nishida N, Yoshida K, Hata Y, Arai Y, Kinoshita K (2015) Pathological features of preclinical or early clinical stages of corticobasal degeneration: a comparison with advanced cases. Neuropathol Appl Neurobiol 41:893–905CrossRefPubMed Nishida N, Yoshida K, Hata Y, Arai Y, Kinoshita K (2015) Pathological features of preclinical or early clinical stages of corticobasal degeneration: a comparison with advanced cases. Neuropathol Appl Neurobiol 41:893–905CrossRefPubMed
Zurück zum Zitat Niu H, Shen L, Li T, Ren C, Ding S, Wang L, Zhang Z, Liu X, Zhang Q, Geng D, Wu X, Li H (2018) Alpha-synuclein overexpression in the olfactory bulb initiates prodromal symptoms and pathology of Parkinson’s disease. Transl Neurodegener 7:25CrossRefPubMedPubMedCentral Niu H, Shen L, Li T, Ren C, Ding S, Wang L, Zhang Z, Liu X, Zhang Q, Geng D, Wu X, Li H (2018) Alpha-synuclein overexpression in the olfactory bulb initiates prodromal symptoms and pathology of Parkinson’s disease. Transl Neurodegener 7:25CrossRefPubMedPubMedCentral
Zurück zum Zitat Nouraei N, Mason DM, Miner KM, Carcella MA, Bhatia TN, Dumm BK, Soni D, Johnson DA, Luk KC, Leak RK (2018) Critical appraisal of pathology transmission in the alpha-synuclein fibril model of Lewy body disorders. Exp Neurol 299:172–196CrossRefPubMed Nouraei N, Mason DM, Miner KM, Carcella MA, Bhatia TN, Dumm BK, Soni D, Johnson DA, Luk KC, Leak RK (2018) Critical appraisal of pathology transmission in the alpha-synuclein fibril model of Lewy body disorders. Exp Neurol 299:172–196CrossRefPubMed
Zurück zum Zitat Nykjaer C, Brudek T, Salvesen L, Pakkenberg B (2017) Changes in the cell population in brain white matter in multiple system atrophy. Mov Disord 32:1074–1082CrossRefPubMed Nykjaer C, Brudek T, Salvesen L, Pakkenberg B (2017) Changes in the cell population in brain white matter in multiple system atrophy. Mov Disord 32:1074–1082CrossRefPubMed
Zurück zum Zitat Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW, Klein C, Bonifati V, Jankovic J, Lozano AM, Deuschl G, Bergman H, Tolosa E, Rodriguez-Violante M, Fahn S, Postuma RB, Berg D, Marek K, Standaert DG, Surmeier DJ, Olanow CW, Kordower JH, Calabresi P, Schapira AHV, Stoessl AJ (2017) Past, present, and future of Parkinson’s disease: a special essay on the 200th Anniversary of the Shaking Palsy. Mov Disord 32:1264–1310CrossRefPubMedPubMedCentral Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW, Klein C, Bonifati V, Jankovic J, Lozano AM, Deuschl G, Bergman H, Tolosa E, Rodriguez-Violante M, Fahn S, Postuma RB, Berg D, Marek K, Standaert DG, Surmeier DJ, Olanow CW, Kordower JH, Calabresi P, Schapira AHV, Stoessl AJ (2017) Past, present, and future of Parkinson’s disease: a special essay on the 200th Anniversary of the Shaking Palsy. Mov Disord 32:1264–1310CrossRefPubMedPubMedCentral
Zurück zum Zitat Odagiri S, Tanji K, Mori F, Kakita A, Takahashi H, Wakabayashi K (2012) Autophagic adapter protein NBR1 is localized in Lewy bodies and glial cytoplasmic inclusions and is involved in aggregate formation in alpha-synucleinopathy. Acta Neuropathol 124:173–186CrossRefPubMed Odagiri S, Tanji K, Mori F, Kakita A, Takahashi H, Wakabayashi K (2012) Autophagic adapter protein NBR1 is localized in Lewy bodies and glial cytoplasmic inclusions and is involved in aggregate formation in alpha-synucleinopathy. Acta Neuropathol 124:173–186CrossRefPubMed
Zurück zum Zitat Ogaki K, Martens YA, Heckman MG, Koga S, Labbe C, Lorenzo-Betancor O, Wernick AI, Walton RL, Soto AI, Vargas ER, Nielsen HM, Fujioka S, Kanekiyo T, Uitti RJ, van Gerpen JA, Cheshire WP, Wszolek ZK, Low PA, Singer W, Dickson DW, Bu G, Ross OA (2018) Multiple system atrophy and apolipoprotein E. Mov Disord 33:647–650CrossRefPubMedPubMedCentral Ogaki K, Martens YA, Heckman MG, Koga S, Labbe C, Lorenzo-Betancor O, Wernick AI, Walton RL, Soto AI, Vargas ER, Nielsen HM, Fujioka S, Kanekiyo T, Uitti RJ, van Gerpen JA, Cheshire WP, Wszolek ZK, Low PA, Singer W, Dickson DW, Bu G, Ross OA (2018) Multiple system atrophy and apolipoprotein E. Mov Disord 33:647–650CrossRefPubMedPubMedCentral
Zurück zum Zitat Oinas M, Paetau A, Myllykangas L, Notkola IL, Kalimo H, Polvikoski T (2010) Alpha-synuclein pathology in the spinal cord autonomic nuclei associates with alpha-synuclein pathology in the brain: a population-based Vantaa 85+ study. Acta Neuropathol 119:715–722CrossRefPubMed Oinas M, Paetau A, Myllykangas L, Notkola IL, Kalimo H, Polvikoski T (2010) Alpha-synuclein pathology in the spinal cord autonomic nuclei associates with alpha-synuclein pathology in the brain: a population-based Vantaa 85+ study. Acta Neuropathol 119:715–722CrossRefPubMed
Zurück zum Zitat O’Keeffe GW, Sullivan AM (2018) Evidence for dopaminergic axonal degeneration as an early pathological process in Parkinson’s disease. Parkinsonism Relat Disord 56:9–15CrossRefPubMed O’Keeffe GW, Sullivan AM (2018) Evidence for dopaminergic axonal degeneration as an early pathological process in Parkinson’s disease. Parkinsonism Relat Disord 56:9–15CrossRefPubMed
Zurück zum Zitat Olah J, Bertrand P, Ovadi J (2017) Role of the microtubule-associated TPPP/p25 in Parkinson’s and related diseases and its therapeutic potential. Expert Rev Proteom 14:301–309CrossRef Olah J, Bertrand P, Ovadi J (2017) Role of the microtubule-associated TPPP/p25 in Parkinson’s and related diseases and its therapeutic potential. Expert Rev Proteom 14:301–309CrossRef
Zurück zum Zitat Olanow CW, Savolainen M, Chu Y, Halliday GM, Kordower JH (2019) Temporal evolution of microglia and alpha-synuclein accumulation following foetal grafting in Parkinson’s disease. Brain 142:1690–1700CrossRefPubMed Olanow CW, Savolainen M, Chu Y, Halliday GM, Kordower JH (2019) Temporal evolution of microglia and alpha-synuclein accumulation following foetal grafting in Parkinson’s disease. Brain 142:1690–1700CrossRefPubMed
Zurück zum Zitat Oppedal K, Ferreira D, Cavallin L, Lemstra AW, Ten Kate M, Padovani A, Rektorova I, Bonanni L, Wahlund LO, Engedal K, Nobili F, Kramberger M, Taylor JP, Hort J, Snaedal J, Blanc F, Walker Z, Antonini A, Westman E, Aarsland D (2019) A signature pattern of cortical atrophy in dementia with Lewy bodies: a study on 333 patients from the European DLB consortium. Alzheimers Dement 15:400–409CrossRefPubMed Oppedal K, Ferreira D, Cavallin L, Lemstra AW, Ten Kate M, Padovani A, Rektorova I, Bonanni L, Wahlund LO, Engedal K, Nobili F, Kramberger M, Taylor JP, Hort J, Snaedal J, Blanc F, Walker Z, Antonini A, Westman E, Aarsland D (2019) A signature pattern of cortical atrophy in dementia with Lewy bodies: a study on 333 patients from the European DLB consortium. Alzheimers Dement 15:400–409CrossRefPubMed
Zurück zum Zitat O’Regan G, deSouza RM, Balestrino R, Schapira AH (2017) Glucocerebrosidase mutations in Parkinson disease. J Parkinsons Dis 7:411–422CrossRefPubMed O’Regan G, deSouza RM, Balestrino R, Schapira AH (2017) Glucocerebrosidase mutations in Parkinson disease. J Parkinsons Dis 7:411–422CrossRefPubMed
Zurück zum Zitat Orimo S, Uchihara T, Nakamura A, Mori F, Kakita A, Wakabayashi K, Takahashi H (2008) Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson’s disease. Brain 131:642–650CrossRefPubMed Orimo S, Uchihara T, Nakamura A, Mori F, Kakita A, Wakabayashi K, Takahashi H (2008) Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson’s disease. Brain 131:642–650CrossRefPubMed
Zurück zum Zitat Orme T, Guerreiro R, Bras J (2018) The genetics of dementia with Lewy bodies: current understanding and future directions. Curr Neurol Neurosci Rep 18:67CrossRefPubMedPubMedCentral Orme T, Guerreiro R, Bras J (2018) The genetics of dementia with Lewy bodies: current understanding and future directions. Curr Neurol Neurosci Rep 18:67CrossRefPubMedPubMedCentral
Zurück zum Zitat Ortega-de San Luis C, Sanchez-Garcia MA, Nieto-Gonzalez JL, Garcia-Junco-Clemente P, Montero-Sanchez A, Fernandez-Chacon R, Pascual A (2018) Substantia nigra dopaminergic neurons and striatal interneurons are engaged in three parallel but interdependent postnatal neurotrophic circuits. Aging Cell 17:e12821CrossRefPubMedPubMedCentral Ortega-de San Luis C, Sanchez-Garcia MA, Nieto-Gonzalez JL, Garcia-Junco-Clemente P, Montero-Sanchez A, Fernandez-Chacon R, Pascual A (2018) Substantia nigra dopaminergic neurons and striatal interneurons are engaged in three parallel but interdependent postnatal neurotrophic circuits. Aging Cell 17:e12821CrossRefPubMedPubMedCentral
Zurück zum Zitat Ortuno-Lizaran I, Esquiva G, Beach TG, Serrano GE, Adler CH, Lax P, Cuenca N (2018) Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson’s disease. Acta Neuropathol Commun 6:90CrossRefPubMedPubMedCentral Ortuno-Lizaran I, Esquiva G, Beach TG, Serrano GE, Adler CH, Lax P, Cuenca N (2018) Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson’s disease. Acta Neuropathol Commun 6:90CrossRefPubMedPubMedCentral
Zurück zum Zitat Osaki Y, Ben-Shlomo Y, Lees AJ, Wenning GK, Quinn NP (2009) A validation exercise on the new consensus criteria for multiple system atrophy. Mov Disord 24:2272–2276CrossRefPubMed Osaki Y, Ben-Shlomo Y, Lees AJ, Wenning GK, Quinn NP (2009) A validation exercise on the new consensus criteria for multiple system atrophy. Mov Disord 24:2272–2276CrossRefPubMed
Zurück zum Zitat Ou R, Wei Q, Hou Y, Yuan X, Song W, Cao B, Liu H, Zhang L, Chen Y, Shang H (2018) Vascular risk factors and depression in Parkinson’s disease. Eur J Neurol 25:637–643CrossRefPubMed Ou R, Wei Q, Hou Y, Yuan X, Song W, Cao B, Liu H, Zhang L, Chen Y, Shang H (2018) Vascular risk factors and depression in Parkinson’s disease. Eur J Neurol 25:637–643CrossRefPubMed
Zurück zum Zitat Ouchi H, Toyoshima Y, Tada M, Oyake M, Aida I, Tomita I, Satoh A, Tsujihata M, Takahashi H, Nishizawa M, Shimohata T (2014) Pathology and sensitivity of current clinical criteria in corticobasal syndrome. Mov Disord 29:238–244CrossRefPubMed Ouchi H, Toyoshima Y, Tada M, Oyake M, Aida I, Tomita I, Satoh A, Tsujihata M, Takahashi H, Nishizawa M, Shimohata T (2014) Pathology and sensitivity of current clinical criteria in corticobasal syndrome. Mov Disord 29:238–244CrossRefPubMed
Zurück zum Zitat Outeiro TF, Koss DJ, Erskine D, Walker L, Kurzawa-Akanbi M, Burn D, Donaghy P, Morris C, Taylor JP, Thomas A, Attems J, McKeith I (2019b) Dementia with Lewy bodies: an update and outlook. Mol Neurodegener 14:5CrossRefPubMedPubMedCentral Outeiro TF, Koss DJ, Erskine D, Walker L, Kurzawa-Akanbi M, Burn D, Donaghy P, Morris C, Taylor JP, Thomas A, Attems J, McKeith I (2019b) Dementia with Lewy bodies: an update and outlook. Mol Neurodegener 14:5CrossRefPubMedPubMedCentral
Zurück zum Zitat Overk C, Rockenstein E, Valera E, Stefanova N, Wenning G, Masliah E (2018) Multiple system atrophy: experimental models and reality. Acta Neuropathol 135:33–47CrossRefPubMed Overk C, Rockenstein E, Valera E, Stefanova N, Wenning G, Masliah E (2018) Multiple system atrophy: experimental models and reality. Acta Neuropathol 135:33–47CrossRefPubMed
Zurück zum Zitat Oyanagi K, Hashimoto T, Yamazaki M (2011) Parkinsonism-dementia complex of Guam. In: Dickson DW, Weller RO (eds) Neurodegeneration: the molecular pathology of dementia and movement disorders, 2nd edn. Blackwell Publishing Ltd., Oxford, pp 171–178CrossRef Oyanagi K, Hashimoto T, Yamazaki M (2011) Parkinsonism-dementia complex of Guam. In: Dickson DW, Weller RO (eds) Neurodegeneration: the molecular pathology of dementia and movement disorders, 2nd edn. Blackwell Publishing Ltd., Oxford, pp 171–178CrossRef
Zurück zum Zitat Ozawa T (2007) Morphological substrate of autonomic failure and neurohormonal dysfunction in multiple system atrophy: impact on determining phenotype spectrum. Acta Neuropathol (Berl) 114:201–211CrossRef Ozawa T (2007) Morphological substrate of autonomic failure and neurohormonal dysfunction in multiple system atrophy: impact on determining phenotype spectrum. Acta Neuropathol (Berl) 114:201–211CrossRef
Zurück zum Zitat Ozawa T, Onodera O (2017) Multiple system atrophy: clinicopathological characteristics in Japanese patients. Proc Jpn Acad Ser B Phys Biol Sci 93:251–258CrossRefPubMedPubMedCentral Ozawa T, Onodera O (2017) Multiple system atrophy: clinicopathological characteristics in Japanese patients. Proc Jpn Acad Ser B Phys Biol Sci 93:251–258CrossRefPubMedPubMedCentral
Zurück zum Zitat Pagano G, Niccolini F, Politis M (2018) The serotonergic system in Parkinson’s patients with dyskinesia: evidence from imaging studies. J Neural Transm (Vienna) 125:1217–1223CrossRef Pagano G, Niccolini F, Politis M (2018) The serotonergic system in Parkinson’s patients with dyskinesia: evidence from imaging studies. J Neural Transm (Vienna) 125:1217–1223CrossRef
Zurück zum Zitat Paisan-Ruiz C, Guevara R, Federoff M, Hanagasi H, Sina F, Elahi E, Schneider SA, Schwingenschuh P, Bajaj N, Emre M, Singleton AB, Hardy J, Bhatia KP, Brandner S, Lees AJ, Houlden H (2010) Early-onset l-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations. Mov Disord 25:1791–1800CrossRefPubMedPubMedCentral Paisan-Ruiz C, Guevara R, Federoff M, Hanagasi H, Sina F, Elahi E, Schneider SA, Schwingenschuh P, Bajaj N, Emre M, Singleton AB, Hardy J, Bhatia KP, Brandner S, Lees AJ, Houlden H (2010) Early-onset l-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations. Mov Disord 25:1791–1800CrossRefPubMedPubMedCentral
Zurück zum Zitat Pan T, Kondo S, Le W, Jankovic J (2008) The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson’s disease. Brain 131:1969–1978CrossRefPubMed Pan T, Kondo S, Le W, Jankovic J (2008) The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson’s disease. Brain 131:1969–1978CrossRefPubMed
Zurück zum Zitat Pan PY, Zhu Y, Shen Y, Yue Z (2019) Crosstalk between presynaptic trafficking and autophagy in Parkinson’s disease. Neurobiol Dis 122:64–71CrossRefPubMed Pan PY, Zhu Y, Shen Y, Yue Z (2019) Crosstalk between presynaptic trafficking and autophagy in Parkinson’s disease. Neurobiol Dis 122:64–71CrossRefPubMed
Zurück zum Zitat Pan-Montojo F, Anichtchik O, Dening Y, Knels L, Pursche S, Jung R, Jackson S, Gille G, Spillantini MG, Reichmann H, Funk RH (2010) Progression of Parkinson’s disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS One 5:e8762CrossRefPubMedPubMedCentral Pan-Montojo F, Anichtchik O, Dening Y, Knels L, Pursche S, Jung R, Jackson S, Gille G, Spillantini MG, Reichmann H, Funk RH (2010) Progression of Parkinson’s disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS One 5:e8762CrossRefPubMedPubMedCentral
Zurück zum Zitat Paolicelli RC, Bergamini G, Rajendran L (2019) Cell-to-cell communication by extracellular vesicles: focus on microglia. Neuroscience 405:148–157CrossRefPubMed Paolicelli RC, Bergamini G, Rajendran L (2019) Cell-to-cell communication by extracellular vesicles: focus on microglia. Neuroscience 405:148–157CrossRefPubMed
Zurück zum Zitat Park JS, Blair NF, Sue CM (2015) The role of ATP13A2 in Parkinson’s disease: clinical phenotypes and molecular mechanisms. Mov Disord 30:770–779CrossRefPubMed Park JS, Blair NF, Sue CM (2015) The role of ATP13A2 in Parkinson’s disease: clinical phenotypes and molecular mechanisms. Mov Disord 30:770–779CrossRefPubMed
Zurück zum Zitat Parkkinen L, Hartikainen P, Alafuzoff I (2007) Abundant glial alpha-synuclein pathology in a case without overt clinical symptoms. Clin Neuropathol 26:276–283CrossRefPubMed Parkkinen L, Hartikainen P, Alafuzoff I (2007) Abundant glial alpha-synuclein pathology in a case without overt clinical symptoms. Clin Neuropathol 26:276–283CrossRefPubMed
Zurück zum Zitat Parkkinen L, Pirttila T, Alafuzoff I (2008) Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance. Acta Neuropathol 115:399–407CrossRefPubMedPubMedCentral Parkkinen L, Pirttila T, Alafuzoff I (2008) Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance. Acta Neuropathol 115:399–407CrossRefPubMedPubMedCentral
Zurück zum Zitat Parkkinen L, O’Sullivan SS, Collins C, Petrie A, Holton JL, Revesz T, Lees AJ (2011) Disentangling the relationship between Lewy bodies and nigral neuronal loss in Parkinson’s disease. J Parkinsons Dis 1:277–286PubMedPubMedCentral Parkkinen L, O’Sullivan SS, Collins C, Petrie A, Holton JL, Revesz T, Lees AJ (2011) Disentangling the relationship between Lewy bodies and nigral neuronal loss in Parkinson’s disease. J Parkinsons Dis 1:277–286PubMedPubMedCentral
Zurück zum Zitat Pasquini J, Ceravolo R, Qamhawi Z, Lee JY, Deuschl G, Brooks DJ, Bonuccelli U, Pavese N (2018) Progression of tremor in early stages of Parkinson’s disease: a clinical and neuroimaging study. Brain 141:811–821CrossRefPubMed Pasquini J, Ceravolo R, Qamhawi Z, Lee JY, Deuschl G, Brooks DJ, Bonuccelli U, Pavese N (2018) Progression of tremor in early stages of Parkinson’s disease: a clinical and neuroimaging study. Brain 141:811–821CrossRefPubMed
Zurück zum Zitat Paulus W, Jellinger K (1991) The neuropathologic basis of different clinical subgroups of Parkinson’s disease. J Neuropathol Exp Neurol 50:743–755CrossRefPubMed Paulus W, Jellinger K (1991) The neuropathologic basis of different clinical subgroups of Parkinson’s disease. J Neuropathol Exp Neurol 50:743–755CrossRefPubMed
Zurück zum Zitat Pedersen KM, Marner L, Pakkenberg H, Pakkenberg B (2005) No global loss of neocortical neurons in parkinson’s disease: a quantitative stereological study. Mov Disord 20:164–171CrossRefPubMed Pedersen KM, Marner L, Pakkenberg H, Pakkenberg B (2005) No global loss of neocortical neurons in parkinson’s disease: a quantitative stereological study. Mov Disord 20:164–171CrossRefPubMed
Zurück zum Zitat Peelaerts W, Bousset L, Baekelandt V, Melki R (2018) a-Synuclein strains and seeding in Parkinson’s disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences. Cell Tissue Res 373:195–212CrossRefPubMed Peelaerts W, Bousset L, Baekelandt V, Melki R (2018) a-Synuclein strains and seeding in Parkinson’s disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences. Cell Tissue Res 373:195–212CrossRefPubMed
Zurück zum Zitat Pelzer EA, Melzer C, Timmermann L, von Cramon DY, Tittgemeyer M (2017) Basal ganglia and cerebellar interconnectivity within the human thalamus. Brain Struct Funct 222:381–392CrossRefPubMed Pelzer EA, Melzer C, Timmermann L, von Cramon DY, Tittgemeyer M (2017) Basal ganglia and cerebellar interconnectivity within the human thalamus. Brain Struct Funct 222:381–392CrossRefPubMed
Zurück zum Zitat Peng C, Gathagan RJ, Covell DJ, Medellin C, Stieber A, Robinson JL, Zhang B, Pitkin RM, Olufemi MF, Luk KC, Trojanowski JQ, Lee VM (2018a) Cellular milieu imparts distinct pathological alpha-synuclein strains in alpha-synucleinopathies. Nature 557:558–563CrossRefPubMedPubMedCentral Peng C, Gathagan RJ, Covell DJ, Medellin C, Stieber A, Robinson JL, Zhang B, Pitkin RM, Olufemi MF, Luk KC, Trojanowski JQ, Lee VM (2018a) Cellular milieu imparts distinct pathological alpha-synuclein strains in alpha-synucleinopathies. Nature 557:558–563CrossRefPubMedPubMedCentral
Zurück zum Zitat Peng C, Gathagan RJ, Lee VM (2018b) Distinct alpha-synuclein strains and implications for heterogeneity among alpha-synucleinopathies. Neurobiol Dis 109:209–218CrossRefPubMed Peng C, Gathagan RJ, Lee VM (2018b) Distinct alpha-synuclein strains and implications for heterogeneity among alpha-synucleinopathies. Neurobiol Dis 109:209–218CrossRefPubMed
Zurück zum Zitat Perez XA, Zhang D, Bordia T, Quik M (2017) Striatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice. Mov Disord 32:538–548CrossRefPubMedPubMedCentral Perez XA, Zhang D, Bordia T, Quik M (2017) Striatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice. Mov Disord 32:538–548CrossRefPubMedPubMedCentral
Zurück zum Zitat Perez XA, Bordia T, Quik M (2018) The striatal cholinergic system in l-dopa-induced dyskinesias. J Neural Transm (Vienna) 125:1251–1262CrossRef Perez XA, Bordia T, Quik M (2018) The striatal cholinergic system in l-dopa-induced dyskinesias. J Neural Transm (Vienna) 125:1251–1262CrossRef
Zurück zum Zitat Perez-Pardo P, Kliest T, Dodiya HB, Broersen LM, Garssen J, Keshavarzian A, Kraneveld AD (2017) The gut-brain axis in Parkinson’s disease: possibilities for food-based therapies. Eur J Pharmacol 817:86–95CrossRefPubMed Perez-Pardo P, Kliest T, Dodiya HB, Broersen LM, Garssen J, Keshavarzian A, Kraneveld AD (2017) The gut-brain axis in Parkinson’s disease: possibilities for food-based therapies. Eur J Pharmacol 817:86–95CrossRefPubMed
Zurück zum Zitat Perl DP, Olanow CW (2007) The neuropathology of manganese-induced parkinsonism. J Neuropathol Exp Neurol 66:675–682CrossRefPubMed Perl DP, Olanow CW (2007) The neuropathology of manganese-induced parkinsonism. J Neuropathol Exp Neurol 66:675–682CrossRefPubMed
Zurück zum Zitat Pessoa Rocha N, Reis HJ, Vanden Berghe P, Cirillo C (2014) Depression and cognitive impairment in Parkinson’s disease: a role for inflammation and immunomodulation? Neuroimmunomodulation 21:88–94CrossRefPubMed Pessoa Rocha N, Reis HJ, Vanden Berghe P, Cirillo C (2014) Depression and cognitive impairment in Parkinson’s disease: a role for inflammation and immunomodulation? Neuroimmunomodulation 21:88–94CrossRefPubMed
Zurück zum Zitat Petersen RC, Parisi JE, Dickson DW, Johnson KA, Knopman DS, Boeve BF, Jicha GA, Ivnik RJ, Smith GE, Tangalos EG, Braak H, Kokmen E (2006) Neuropathologic features of amnestic mild cognitive impairment. Arch Neurol 63:665–672CrossRefPubMed Petersen RC, Parisi JE, Dickson DW, Johnson KA, Knopman DS, Boeve BF, Jicha GA, Ivnik RJ, Smith GE, Tangalos EG, Braak H, Kokmen E (2006) Neuropathologic features of amnestic mild cognitive impairment. Arch Neurol 63:665–672CrossRefPubMed
Zurück zum Zitat Petrovic IN, Ling H, Asi Y, Ahmed Z, Kukkle PL, Hazrati LN, Lang AE, Revesz T, Holton JL, Lees AJ (2012) Multiple system atrophy-parkinsonism with slow progression and prolonged survival: a diagnostic catch. Mov Disord 27:1186–1190CrossRefPubMed Petrovic IN, Ling H, Asi Y, Ahmed Z, Kukkle PL, Hazrati LN, Lang AE, Revesz T, Holton JL, Lees AJ (2012) Multiple system atrophy-parkinsonism with slow progression and prolonged survival: a diagnostic catch. Mov Disord 27:1186–1190CrossRefPubMed
Zurück zum Zitat Picconi B, Paille V, Ghiglieri V, Bagetta V, Barone I, Lindgren HS, Bernardi G, Angela Cenci M, Calabresi P (2008) l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation. Neurobiol Dis 29:327–335CrossRefPubMed Picconi B, Paille V, Ghiglieri V, Bagetta V, Barone I, Lindgren HS, Bernardi G, Angela Cenci M, Calabresi P (2008) l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation. Neurobiol Dis 29:327–335CrossRefPubMed
Zurück zum Zitat Picillo M, Lizarraga KJ, Friesen EL, Chau H, Zhang M, Sato C, Rooke G, Munhoz RP, Rogaeva E, Fraser PE, Kalia SK, Kalia LV (2018) Parkinsonism due to A53E alpha-synuclein gene mutation: clinical, genetic, epigenetic, and biochemical features. Mov Disord 33:1950–1955CrossRefPubMed Picillo M, Lizarraga KJ, Friesen EL, Chau H, Zhang M, Sato C, Rooke G, Munhoz RP, Rogaeva E, Fraser PE, Kalia SK, Kalia LV (2018) Parkinsonism due to A53E alpha-synuclein gene mutation: clinical, genetic, epigenetic, and biochemical features. Mov Disord 33:1950–1955CrossRefPubMed
Zurück zum Zitat Pietracupa S, Martin-Bastida A, Piccini P (2017) Iron metabolism and its detection through MRI in parkinsonian disorders: a systematic review. Neurol Sci 38:2095–2101CrossRefPubMed Pietracupa S, Martin-Bastida A, Piccini P (2017) Iron metabolism and its detection through MRI in parkinsonian disorders: a systematic review. Neurol Sci 38:2095–2101CrossRefPubMed
Zurück zum Zitat Pihlstrom L, Blauwendraat C, Cappelletti C, Berge-Seidl V, Langmyhr M, Henriksen SP, van de Berg WDJ, Gibbs JR, Cookson MR, Singleton AB, Nalls MA, Toft M (2018) A comprehensive analysis of SNCA-related genetic risk in sporadic Parkinson disease. Ann Neurol 84:117–129CrossRefPubMedPubMedCentral Pihlstrom L, Blauwendraat C, Cappelletti C, Berge-Seidl V, Langmyhr M, Henriksen SP, van de Berg WDJ, Gibbs JR, Cookson MR, Singleton AB, Nalls MA, Toft M (2018) A comprehensive analysis of SNCA-related genetic risk in sporadic Parkinson disease. Ann Neurol 84:117–129CrossRefPubMedPubMedCentral
Zurück zum Zitat Pinho R, Paiva I, Jercic KG, Fonseca-Ornelas L, Gerhardt E, Fahlbusch C, Garcia-Esparcia P, Kerimoglu C, Pavlou MAS, Villar-Pique A, Szego E, Lopes da Fonseca T, Odoardi F, Soeroes S, Rego AC, Fischle W, Schwamborn JC, Meyer T, Kugler S, Ferrer I, Attems J, Fischer A, Becker S, Zweckstetter M, Borovecki F, Outeiro TF (2019) Nuclear localization and phosphorylation modulate pathological effects of alpha-synuclein. Hum Mol Genet 28:31–50CrossRefPubMed Pinho R, Paiva I, Jercic KG, Fonseca-Ornelas L, Gerhardt E, Fahlbusch C, Garcia-Esparcia P, Kerimoglu C, Pavlou MAS, Villar-Pique A, Szego E, Lopes da Fonseca T, Odoardi F, Soeroes S, Rego AC, Fischle W, Schwamborn JC, Meyer T, Kugler S, Ferrer I, Attems J, Fischer A, Becker S, Zweckstetter M, Borovecki F, Outeiro TF (2019) Nuclear localization and phosphorylation modulate pathological effects of alpha-synuclein. Hum Mol Genet 28:31–50CrossRefPubMed
Zurück zum Zitat Poletti M, Frosini D, Pagni C, Baldacci F, Nicoletti V, Tognoni G, Lucetti C, Del Dotto P, Ceravolo R, Bonuccelli U (2012) Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 83:601–606CrossRefPubMed Poletti M, Frosini D, Pagni C, Baldacci F, Nicoletti V, Tognoni G, Lucetti C, Del Dotto P, Ceravolo R, Bonuccelli U (2012) Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 83:601–606CrossRefPubMed
Zurück zum Zitat Polinski NK, Volpicelli-Daley LA, Sortwell CE, Luk KC, Cremades N, Gottler LM, Froula J, Duffy MF, Lee VMY, Martinez TN, Dave KD (2018) Best practices for generating and using alpha-synuclein pre-formed fibrils to model Parkinson’s disease in rodents. J Parkinsons Dis 8:303–322CrossRefPubMedPubMedCentral Polinski NK, Volpicelli-Daley LA, Sortwell CE, Luk KC, Cremades N, Gottler LM, Froula J, Duffy MF, Lee VMY, Martinez TN, Dave KD (2018) Best practices for generating and using alpha-synuclein pre-formed fibrils to model Parkinson’s disease in rodents. J Parkinsons Dis 8:303–322CrossRefPubMedPubMedCentral
Zurück zum Zitat Politis M, Wu K, Loane C, Kiferle L, Molloy S, Brooks DJ, Piccini P (2010) Staging of serotonergic dysfunction in Parkinson’s disease: an in vivo 11C-DASB PET study. Neurobiol Dis 40:216–221CrossRefPubMed Politis M, Wu K, Loane C, Kiferle L, Molloy S, Brooks DJ, Piccini P (2010) Staging of serotonergic dysfunction in Parkinson’s disease: an in vivo 11C-DASB PET study. Neurobiol Dis 40:216–221CrossRefPubMed
Zurück zum Zitat Politis M, Wu K, Loane C, Brooks DJ, Kiferle L, Turkheimer FE, Bain P, Molloy S, Piccini P (2014) Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson’s disease patients. J Clin Investig 124:1340–1349CrossRefPubMedPubMedCentral Politis M, Wu K, Loane C, Brooks DJ, Kiferle L, Turkheimer FE, Bain P, Molloy S, Piccini P (2014) Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson’s disease patients. J Clin Investig 124:1340–1349CrossRefPubMedPubMedCentral
Zurück zum Zitat Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science 276:2045–2047CrossRefPubMed Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science 276:2045–2047CrossRefPubMed
Zurück zum Zitat Pont-Sunyer C, Tolosa E, Caspell-Garcia C, Coffey C, Alcalay RN, Chan P, Duda JE, Facheris M, Fernandez-Santiago R, Marek K, Lomena F, Marras C, Mondragon E, Saunders-Pullman R, Waro B (2017) The prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: clinical and imaging Studies. Mov Disord 32:726–738CrossRefPubMed Pont-Sunyer C, Tolosa E, Caspell-Garcia C, Coffey C, Alcalay RN, Chan P, Duda JE, Facheris M, Fernandez-Santiago R, Marek K, Lomena F, Marras C, Mondragon E, Saunders-Pullman R, Waro B (2017) The prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: clinical and imaging Studies. Mov Disord 32:726–738CrossRefPubMed
Zurück zum Zitat Poplawska-Domaszewicz K, Florczak-Wyspianska J, Kozubski W, Michalak S (2018) Paraneoplastic movement disorders. Rev Neurosci 29:745–755CrossRefPubMed Poplawska-Domaszewicz K, Florczak-Wyspianska J, Kozubski W, Michalak S (2018) Paraneoplastic movement disorders. Rev Neurosci 29:745–755CrossRefPubMed
Zurück zum Zitat Post MR, Lieberman OJ, Mosharov EV (2018) Can interactions between alpha-synuclein, dopamine and calcium explain selective neurodegeneration in Parkinson’s disease? Front Neurosci 12:161CrossRefPubMedPubMedCentral Post MR, Lieberman OJ, Mosharov EV (2018) Can interactions between alpha-synuclein, dopamine and calcium explain selective neurodegeneration in Parkinson’s disease? Front Neurosci 12:161CrossRefPubMedPubMedCentral
Zurück zum Zitat Power JH, Barnes OL, Chegini F (2017) Lewy bodies and the mechanisms of neuronal cell death in Parkinson’s disease and dementia with Lewy bodies. Brain Pathol 27:3–12CrossRefPubMed Power JH, Barnes OL, Chegini F (2017) Lewy bodies and the mechanisms of neuronal cell death in Parkinson’s disease and dementia with Lewy bodies. Brain Pathol 27:3–12CrossRefPubMed
Zurück zum Zitat Prasad V, Wasser Y, Hans F, Goswami A, Katona I, Outeiro TF, Kahle PJ, Schulz JB, Voigt A (2019) Monitoring alpha-synuclein multimerization in vivo. FASEB J 33:2116–2131CrossRefPubMed Prasad V, Wasser Y, Hans F, Goswami A, Katona I, Outeiro TF, Kahle PJ, Schulz JB, Voigt A (2019) Monitoring alpha-synuclein multimerization in vivo. FASEB J 33:2116–2131CrossRefPubMed
Zurück zum Zitat Prots I, Grosch J, Brazdis RM, Simmnacher K, Veber V, Havlicek S, Hannappel C, Krach F, Krumbiegel M, Schutz O, Reis A, Wrasidlo W, Galasko DR, Groemer TW, Masliah E, Schlotzer-Schrehardt U, Xiang W, Winkler J, Winner B (2018) Alpha-synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies. Proc Natl Acad Sci USA 115:7813–7818CrossRefPubMedPubMedCentral Prots I, Grosch J, Brazdis RM, Simmnacher K, Veber V, Havlicek S, Hannappel C, Krach F, Krumbiegel M, Schutz O, Reis A, Wrasidlo W, Galasko DR, Groemer TW, Masliah E, Schlotzer-Schrehardt U, Xiang W, Winkler J, Winner B (2018) Alpha-synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies. Proc Natl Acad Sci USA 115:7813–7818CrossRefPubMedPubMedCentral
Zurück zum Zitat Puska G, Lutz MI, Molnar K, Regelsberger G, Ricken G, Pirker W, Laszlo L, Kovacs GG (2018) Lysosomal response in relation to alpha-synuclein pathology differs between Parkinson’s disease and multiple system atrophy. Neurobiol Dis 114:140–152CrossRefPubMed Puska G, Lutz MI, Molnar K, Regelsberger G, Ricken G, Pirker W, Laszlo L, Kovacs GG (2018) Lysosomal response in relation to alpha-synuclein pathology differs between Parkinson’s disease and multiple system atrophy. Neurobiol Dis 114:140–152CrossRefPubMed
Zurück zum Zitat Qamhawi Z, Towey D, Shah B, Pagano G, Seibyl J, Marek K, Borghammer P, Brooks DJ, Pavese N (2015) Clinical correlates of raphe serotonergic dysfunction in early Parkinson’s disease. Brain 138:2964–2973CrossRefPubMed Qamhawi Z, Towey D, Shah B, Pagano G, Seibyl J, Marek K, Borghammer P, Brooks DJ, Pavese N (2015) Clinical correlates of raphe serotonergic dysfunction in early Parkinson’s disease. Brain 138:2964–2973CrossRefPubMed
Zurück zum Zitat Quadri M, Mandemakers W, Grochowska MM, Masius R, Geut H, Fabrizio E, Breedveld GJ, Kuipers D, Minneboo M, Vergouw LJM, Carreras Mascaro A, Yonova-Doing E, Simons E, Zhao T, Di Fonzo AB, Chang HC, Parchi P, Melis M, Correia Guedes L, Criscuolo C, Thomas A, Brouwer RWW, Heijsman D, Ingrassia AMT, Calandra Buonaura G, Rood JP, Capellari S, Rozemuller AJ, Sarchioto M, Fen Chien H, Vanacore N, Olgiati S, Wu-Chou YH, Yeh TH, Boon AJW, Hoogers SE, Ghazvini M, Ijpma AS, van Ijcken WFJ, Onofrj M, Barone P, Nicholl DJ, Puschmann A, De Mari M, Kievit AJ, Barbosa E, De Michele G, Majoor-Krakauer D, van Swieten JC, de Jong FJ, Ferreira JJ, Cossu G, Lu CS, Meco G, Cortelli P, van de Berg WDJ, Bonifati V (2018) LRP10 genetic variants in familial Parkinson’s disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study. Lancet Neurol 17:597–608CrossRefPubMed Quadri M, Mandemakers W, Grochowska MM, Masius R, Geut H, Fabrizio E, Breedveld GJ, Kuipers D, Minneboo M, Vergouw LJM, Carreras Mascaro A, Yonova-Doing E, Simons E, Zhao T, Di Fonzo AB, Chang HC, Parchi P, Melis M, Correia Guedes L, Criscuolo C, Thomas A, Brouwer RWW, Heijsman D, Ingrassia AMT, Calandra Buonaura G, Rood JP, Capellari S, Rozemuller AJ, Sarchioto M, Fen Chien H, Vanacore N, Olgiati S, Wu-Chou YH, Yeh TH, Boon AJW, Hoogers SE, Ghazvini M, Ijpma AS, van Ijcken WFJ, Onofrj M, Barone P, Nicholl DJ, Puschmann A, De Mari M, Kievit AJ, Barbosa E, De Michele G, Majoor-Krakauer D, van Swieten JC, de Jong FJ, Ferreira JJ, Cossu G, Lu CS, Meco G, Cortelli P, van de Berg WDJ, Bonifati V (2018) LRP10 genetic variants in familial Parkinson’s disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study. Lancet Neurol 17:597–608CrossRefPubMed
Zurück zum Zitat Quinn JG, Coulson DT, Brockbank S, Beyer N, Ravid R, Hellemans J, Irvine GB, Johnston JA (2012) Alpha-synuclein mRNA and soluble alpha-synuclein protein levels in post-mortem brain from patients with Parkinson’s disease, dementia with Lewy bodies, and Alzheimer’s disease. Brain Res 1459:71–80CrossRefPubMed Quinn JG, Coulson DT, Brockbank S, Beyer N, Ravid R, Hellemans J, Irvine GB, Johnston JA (2012) Alpha-synuclein mRNA and soluble alpha-synuclein protein levels in post-mortem brain from patients with Parkinson’s disease, dementia with Lewy bodies, and Alzheimer’s disease. Brain Res 1459:71–80CrossRefPubMed
Zurück zum Zitat Racette BA, Criswell SR, Lundin JI, Hobson A, Seixas N, Kotzbauer PT, Evanoff BA, Perlmutter JS, Zhang J, Sheppard L, Checkoway H (2012) Increased risk of parkinsonism associated with welding exposure. Neurotoxicology 33:1356–1361CrossRefPubMed Racette BA, Criswell SR, Lundin JI, Hobson A, Seixas N, Kotzbauer PT, Evanoff BA, Perlmutter JS, Zhang J, Sheppard L, Checkoway H (2012) Increased risk of parkinsonism associated with welding exposure. Neurotoxicology 33:1356–1361CrossRefPubMed
Zurück zum Zitat Rajput AH, Sitte HH, Rajput A, Fenton ME, Pifl C, Hornykiewicz O (2008) Globus pallidus dopamine and Parkinson motor subtypes: clinical and brain biochemical correlation. Neurology 70:1403–1410CrossRefPubMed Rajput AH, Sitte HH, Rajput A, Fenton ME, Pifl C, Hornykiewicz O (2008) Globus pallidus dopamine and Parkinson motor subtypes: clinical and brain biochemical correlation. Neurology 70:1403–1410CrossRefPubMed
Zurück zum Zitat Ray NJ, Bradburn S, Murgatroyd C, Toseeb U, Mir P, Kountouriotis GK, Teipel SJ, Grothe MJ (2018) In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson’s disease. Brain 141:165–176CrossRefPubMed Ray NJ, Bradburn S, Murgatroyd C, Toseeb U, Mir P, Kountouriotis GK, Teipel SJ, Grothe MJ (2018) In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson’s disease. Brain 141:165–176CrossRefPubMed
Zurück zum Zitat Rebeiz JJ, Kolodny EH, Richardson EP Jr (1968) Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 18:20–33CrossRefPubMed Rebeiz JJ, Kolodny EH, Richardson EP Jr (1968) Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 18:20–33CrossRefPubMed
Zurück zum Zitat Reed X, Bandres-Ciga S, Blauwendraat C, Cookson MR (2019) The role of monogenic genes in idiopathic Parkinson’s disease. Neurobiol Dis 124:230–239CrossRefPubMed Reed X, Bandres-Ciga S, Blauwendraat C, Cookson MR (2019) The role of monogenic genes in idiopathic Parkinson’s disease. Neurobiol Dis 124:230–239CrossRefPubMed
Zurück zum Zitat Reetz K, Gaser C, Klein C, Hagenah J, Buchel C, Gottschalk S, Pramstaller PP, Siebner HR, Binkofski F (2009) Structural findings in the basal ganglia in genetically determined and idiopathic Parkinson’s disease. Mov Disord 24:99–103CrossRefPubMed Reetz K, Gaser C, Klein C, Hagenah J, Buchel C, Gottschalk S, Pramstaller PP, Siebner HR, Binkofski F (2009) Structural findings in the basal ganglia in genetically determined and idiopathic Parkinson’s disease. Mov Disord 24:99–103CrossRefPubMed
Zurück zum Zitat Refolo V, Bez F, Polissidis A, Kuzdas-Wood D, Sturm E, Kamaratou M, Poewe W, Stefanis L, Angela Cenci M, Romero-Ramos M, Wenning GK, Stefanova N (2018) Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies. Acta Neuropathol Commun 6:2CrossRefPubMedPubMedCentral Refolo V, Bez F, Polissidis A, Kuzdas-Wood D, Sturm E, Kamaratou M, Poewe W, Stefanis L, Angela Cenci M, Romero-Ramos M, Wenning GK, Stefanova N (2018) Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies. Acta Neuropathol Commun 6:2CrossRefPubMedPubMedCentral
Zurück zum Zitat Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF (2008) A systematic review of prevalence studies of depression in Parkinson’s disease. Mov Disord 23:183–189 (quiz 313) CrossRefPubMed Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF (2008) A systematic review of prevalence studies of depression in Parkinson’s disease. Mov Disord 23:183–189 (quiz 313) CrossRefPubMed
Zurück zum Zitat Rektor I, Bohnen NI, Korczyn AD, Gryb V, Kumar H, Kramberger MG, de Leeuw FE, Pirtosek Z, Rektorova I, Schlesinger I, Slawek J, Valkovic P, Vesely B (2018) An updated diagnostic approach to subtype definition of vascular parkinsonism—recommendations from an expert working group. Parkinsonism Relat Disord 49:9–16CrossRefPubMed Rektor I, Bohnen NI, Korczyn AD, Gryb V, Kumar H, Kramberger MG, de Leeuw FE, Pirtosek Z, Rektorova I, Schlesinger I, Slawek J, Valkovic P, Vesely B (2018) An updated diagnostic approach to subtype definition of vascular parkinsonism—recommendations from an expert working group. Parkinsonism Relat Disord 49:9–16CrossRefPubMed
Zurück zum Zitat Ren S, Zhang H, Zheng W, Liu M, Gao F, Wang Z, Chen Z (2019) Altered functional connectivity of cerebello-cortical circuit in multiple system atrophy (cerebellar-type). Front Neurosci 12:996CrossRefPubMedPubMedCentral Ren S, Zhang H, Zheng W, Liu M, Gao F, Wang Z, Chen Z (2019) Altered functional connectivity of cerebello-cortical circuit in multiple system atrophy (cerebellar-type). Front Neurosci 12:996CrossRefPubMedPubMedCentral
Zurück zum Zitat Respondek G, Kurz C, Arzberger T, Compta Y, Englund E, Ferguson LW, Gelpi E, Giese A, Irwin DJ, Meissner WG, Nilsson C, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Josephs KA, Lang AE, Mollenhauer B, Muller U, Whitwell JL, Antonini A, Bhatia KP, Bordelon Y, Corvol JC, Colosimo C, Dodel R, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris H, Nestor P, Oertel WH, Rabinovici GD, Rowe JB, van Eimeren T, Wenning GK, Boxer A, Golbe LI, Litvan I, Stamelou M, Hoglinger GU (2017) Which ante mortem clinical features predict progressive supranuclear palsy pathology? Mov Disord 32:995–1005CrossRefPubMedPubMedCentral Respondek G, Kurz C, Arzberger T, Compta Y, Englund E, Ferguson LW, Gelpi E, Giese A, Irwin DJ, Meissner WG, Nilsson C, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Josephs KA, Lang AE, Mollenhauer B, Muller U, Whitwell JL, Antonini A, Bhatia KP, Bordelon Y, Corvol JC, Colosimo C, Dodel R, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris H, Nestor P, Oertel WH, Rabinovici GD, Rowe JB, van Eimeren T, Wenning GK, Boxer A, Golbe LI, Litvan I, Stamelou M, Hoglinger GU (2017) Which ante mortem clinical features predict progressive supranuclear palsy pathology? Mov Disord 32:995–1005CrossRefPubMedPubMedCentral
Zurück zum Zitat Rey NL, Wesson DW, Brundin P (2018) The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases. Neurobiol Dis 109:226–248CrossRefPubMed Rey NL, Wesson DW, Brundin P (2018) The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases. Neurobiol Dis 109:226–248CrossRefPubMed
Zurück zum Zitat Reyes JF, Rey NL, Bousset L, Melki R, Brundin P, Angot E (2014) Alpha-synuclein transfers from neurons to oligodendrocytes. Glia 62:387–398CrossRefPubMed Reyes JF, Rey NL, Bousset L, Melki R, Brundin P, Angot E (2014) Alpha-synuclein transfers from neurons to oligodendrocytes. Glia 62:387–398CrossRefPubMed
Zurück zum Zitat Reynolds RH, Botia J, Nalls MA, Hardy J, Gagliano Taliun SA, Ryten M (2019) Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability. NPJ Parkinsons Dis 5:6CrossRefPubMedPubMedCentral Reynolds RH, Botia J, Nalls MA, Hardy J, Gagliano Taliun SA, Ryten M (2019) Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability. NPJ Parkinsons Dis 5:6CrossRefPubMedPubMedCentral
Zurück zum Zitat Rietdijk CD, Perez-Pardo P, Garssen J, van Wezel RJ, Kraneveld AD (2017) Exploring Braak’s hypothesis of Parkinson’s disease. Front Neurol 8:37CrossRefPubMedPubMedCentral Rietdijk CD, Perez-Pardo P, Garssen J, van Wezel RJ, Kraneveld AD (2017) Exploring Braak’s hypothesis of Parkinson’s disease. Front Neurol 8:37CrossRefPubMedPubMedCentral
Zurück zum Zitat Rizzo G, Copetti M, Arcuti S, Martino D, Fontana A, Logroscino G (2016) Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis. Neurology 86:566–576CrossRefPubMed Rizzo G, Copetti M, Arcuti S, Martino D, Fontana A, Logroscino G (2016) Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis. Neurology 86:566–576CrossRefPubMed
Zurück zum Zitat Rizzo G, Arcuti S, Copetti M, Alessandria M, Savica R, Fontana A, Liguori R, Logroscino G (2018) Accuracy of clinical diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 89:358–366CrossRefPubMed Rizzo G, Arcuti S, Copetti M, Alessandria M, Savica R, Fontana A, Liguori R, Logroscino G (2018) Accuracy of clinical diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 89:358–366CrossRefPubMed
Zurück zum Zitat Robakis D, Cortes E, Clark LN, Vonsattel JP, Virmani T, Alcalay RN, Crary JF, Levy OA (2016) The effect of MAPT haplotype on neocortical Lewy body pathology in Parkinson disease. J Neural Transm (Vienna) 123:583–588CrossRef Robakis D, Cortes E, Clark LN, Vonsattel JP, Virmani T, Alcalay RN, Crary JF, Levy OA (2016) The effect of MAPT haplotype on neocortical Lewy body pathology in Parkinson disease. J Neural Transm (Vienna) 123:583–588CrossRef
Zurück zum Zitat Robinson JL, Lee EB, Xie SX, Rennert L, Suh E, Bredenberg C, Caswell C, Van Deerlin VM, Yan N, Yousef A, Hurtig HI, Siderowf A, Grossman M, McMillan CT, Miller B, Duda JE, Irwin DJ, Wolk D, Elman L, McCluskey L, Chen-Plotkin A, Weintraub D, Arnold SE, Brettschneider J, Lee VM, Trojanowski JQ (2018) Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Brain 141:2181–2193CrossRefPubMedPubMedCentral Robinson JL, Lee EB, Xie SX, Rennert L, Suh E, Bredenberg C, Caswell C, Van Deerlin VM, Yan N, Yousef A, Hurtig HI, Siderowf A, Grossman M, McMillan CT, Miller B, Duda JE, Irwin DJ, Wolk D, Elman L, McCluskey L, Chen-Plotkin A, Weintraub D, Arnold SE, Brettschneider J, Lee VM, Trojanowski JQ (2018) Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Brain 141:2181–2193CrossRefPubMedPubMedCentral
Zurück zum Zitat Rocha Cabrero F, Morrison EH (2019) Lewy Bodies, 2019/02/07 edn. StatPearls Publishing, Treasure Island Rocha Cabrero F, Morrison EH (2019) Lewy Bodies, 2019/02/07 edn. StatPearls Publishing, Treasure Island
Zurück zum Zitat Rocha EM, De Miranda B, Sanders LH (2018) Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease. Neurobiol Dis 109:249–257CrossRefPubMed Rocha EM, De Miranda B, Sanders LH (2018) Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease. Neurobiol Dis 109:249–257CrossRefPubMed
Zurück zum Zitat Rockenstein E, Nuber S, Overk CR, Ubhi K, Mante M, Patrick C, Adame A, Trejo-Morales M, Gerez J, Picotti P, Jensen PH, Campioni S, Riek R, Winkler J, Gage HH, Winner B, Masliah E (2014) Accumulation of oligomer-prone a-synuclein exacerbates synaptic and neuronal degeneration in vivo. Brain 137:1496–1513CrossRefPubMedPubMedCentral Rockenstein E, Nuber S, Overk CR, Ubhi K, Mante M, Patrick C, Adame A, Trejo-Morales M, Gerez J, Picotti P, Jensen PH, Campioni S, Riek R, Winkler J, Gage HH, Winner B, Masliah E (2014) Accumulation of oligomer-prone a-synuclein exacerbates synaptic and neuronal degeneration in vivo. Brain 137:1496–1513CrossRefPubMedPubMedCentral
Zurück zum Zitat Rohan Z, Rahimi J, Weis S, Kapas I, Auff E, Mitrovic N, Liberski PP, Sikorska B, Matej R, Kovacs GG (2015) Screening for alpha-synuclein immunoreactive neuronal inclusions in the hippocampus allows identification of atypical MSA (FTLD-synuclein). Acta Neuropathol 130:299–301CrossRefPubMed Rohan Z, Rahimi J, Weis S, Kapas I, Auff E, Mitrovic N, Liberski PP, Sikorska B, Matej R, Kovacs GG (2015) Screening for alpha-synuclein immunoreactive neuronal inclusions in the hippocampus allows identification of atypical MSA (FTLD-synuclein). Acta Neuropathol 130:299–301CrossRefPubMed
Zurück zum Zitat Rohan Z, Milenkovic I, Lutz MI, Matej R, Kovacs GG (2016) Shared and distinct patterns of oligodendroglial response in alpha-synucleinopathies and tauopathies. J Neuropathol Exp Neurol 75:1100–1109CrossRefPubMed Rohan Z, Milenkovic I, Lutz MI, Matej R, Kovacs GG (2016) Shared and distinct patterns of oligodendroglial response in alpha-synucleinopathies and tauopathies. J Neuropathol Exp Neurol 75:1100–1109CrossRefPubMed
Zurück zum Zitat Rohani M, Lang AE, Sina F, Elahi E, Fasano A, Hardy J, Bras J, Alavi A (2017) Action myoclonus and seizure in Kufor–Rakeb syndrome. Mov Disord Clin Pract 5:195–199CrossRefPubMedPubMedCentral Rohani M, Lang AE, Sina F, Elahi E, Fasano A, Hardy J, Bras J, Alavi A (2017) Action myoclonus and seizure in Kufor–Rakeb syndrome. Mov Disord Clin Pract 5:195–199CrossRefPubMedPubMedCentral
Zurück zum Zitat Ronchi D, Di Biase E, Franco G, Melzi V, Del Sorbo F, Elia A, Barzaghi C, Garavaglia B, Bergamini C, Fato R, Mora G, Del Bo R, Fortunato F, Borellini L, Trezzi I, Compagnoni GM, Monfrini E, Frattini E, Bonato S, Cogiamanian F, Ardolino G, Priori A, Bresolin N, Corti S, Comi GP, Di Fonzo A (2016) Mutational analysis of COQ2 in patients with MSA in Italy. Neurobiol Aging 45:213e1–213e2CrossRef Ronchi D, Di Biase E, Franco G, Melzi V, Del Sorbo F, Elia A, Barzaghi C, Garavaglia B, Bergamini C, Fato R, Mora G, Del Bo R, Fortunato F, Borellini L, Trezzi I, Compagnoni GM, Monfrini E, Frattini E, Bonato S, Cogiamanian F, Ardolino G, Priori A, Bresolin N, Corti S, Comi GP, Di Fonzo A (2016) Mutational analysis of COQ2 in patients with MSA in Italy. Neurobiol Aging 45:213e1–213e2CrossRef
Zurück zum Zitat Rongve A, Aarsland D (2013) Dementia in Parkinson’s disease and dementia with Lewy bodies. In: Dening T, Thomas A (eds) Oxford textbook of old age psychiatry 2e. Oxford University Press, Oxford, pp 469–478 Rongve A, Aarsland D (2013) Dementia in Parkinson’s disease and dementia with Lewy bodies. In: Dening T, Thomas A (eds) Oxford textbook of old age psychiatry 2e. Oxford University Press, Oxford, pp 469–478
Zurück zum Zitat Rosborough K, Patel N, Kalia LV (2017) Alpha-synuclein and parkinsonism: updates and future perspectives. Curr Neurol Neurosci Rep 17:31CrossRefPubMed Rosborough K, Patel N, Kalia LV (2017) Alpha-synuclein and parkinsonism: updates and future perspectives. Curr Neurol Neurosci Rep 17:31CrossRefPubMed
Zurück zum Zitat Rosqvist K, Horne M, Hagell P, Iwarsson S, Nilsson MH, Odin P (2018) Levodopa effect and motor function in late stage Parkinson’s disease. J Parkinsons Dis 8:59–70CrossRefPubMed Rosqvist K, Horne M, Hagell P, Iwarsson S, Nilsson MH, Odin P (2018) Levodopa effect and motor function in late stage Parkinson’s disease. J Parkinsons Dis 8:59–70CrossRefPubMed
Zurück zum Zitat Rudakou U, Ouled Amar Bencheikh B, Ruskey JA, Krohn L, Laurent SB, Spiegelman D, Liong C, Fahn S, Waters C, Monchi O, Fon EA, Dauvilliers Y, Alcalay RN, Dupre N, Gan-Or Z (2019) Common and rare GCH1 variants are associated with Parkinson’s disease. Neurobiol Aging 73:231CrossRefPubMed Rudakou U, Ouled Amar Bencheikh B, Ruskey JA, Krohn L, Laurent SB, Spiegelman D, Liong C, Fahn S, Waters C, Monchi O, Fon EA, Dauvilliers Y, Alcalay RN, Dupre N, Gan-Or Z (2019) Common and rare GCH1 variants are associated with Parkinson’s disease. Neurobiol Aging 73:231CrossRefPubMed
Zurück zum Zitat Rudow G, O’Brien R, Savonenko AV, Resnick SM, Zonderman AB, Pletnikova O, Marsh L, Dawson TM, Crain BJ, West MJ, Troncoso JC (2008) Morphometry of the human substantia nigra in ageing and Parkinson’s disease. Acta Neuropathol 115:461–470CrossRefPubMedPubMedCentral Rudow G, O’Brien R, Savonenko AV, Resnick SM, Zonderman AB, Pletnikova O, Marsh L, Dawson TM, Crain BJ, West MJ, Troncoso JC (2008) Morphometry of the human substantia nigra in ageing and Parkinson’s disease. Acta Neuropathol 115:461–470CrossRefPubMedPubMedCentral
Zurück zum Zitat Ruf VC, Nubling GS, Willikens S, Shi S, Schmidt F, Levin J, Botzel K, Kamp F, Giese A (2019) Different effects of alpha-synuclein mutants on lipid binding and aggregation detected by single molecule fluorescence spectroscopy and tht fluorescence-based measurements. ACS Chem Neurosci 10:1649–1659CrossRefPubMed Ruf VC, Nubling GS, Willikens S, Shi S, Schmidt F, Levin J, Botzel K, Kamp F, Giese A (2019) Different effects of alpha-synuclein mutants on lipid binding and aggregation detected by single molecule fluorescence spectroscopy and tht fluorescence-based measurements. ACS Chem Neurosci 10:1649–1659CrossRefPubMed
Zurück zum Zitat Ruffmann C, Zini M, Goldwurm S, Bramerio M, Spinello S, Rusconi D, Gambacorta M, Tagliavini F, Pezzoli G, Giaccone G (2012) Lewy body pathology and typical Parkinson disease in a patient with a heterozygous (R275 W) mutation in the Parkin gene (PARK2). Acta Neuropathol 123:901–903CrossRefPubMed Ruffmann C, Zini M, Goldwurm S, Bramerio M, Spinello S, Rusconi D, Gambacorta M, Tagliavini F, Pezzoli G, Giaccone G (2012) Lewy body pathology and typical Parkinson disease in a patient with a heterozygous (R275 W) mutation in the Parkin gene (PARK2). Acta Neuropathol 123:901–903CrossRefPubMed
Zurück zum Zitat Ruffmann C, Calboli FC, Bravi I, Gveric D, Curry LK, de Smith A, Pavlou S, Buxton JL, Blakemore AI, Takousis P, Molloy S, Piccini P, Dexter DT, Roncaroli F, Gentleman SM, Middleton LT (2016) Cortical Lewy bodies and Abeta burden are associated with prevalence and timing of dementia in Lewy body diseases. Neuropathol Appl Neurobiol 42:436–450CrossRefPubMed Ruffmann C, Calboli FC, Bravi I, Gveric D, Curry LK, de Smith A, Pavlou S, Buxton JL, Blakemore AI, Takousis P, Molloy S, Piccini P, Dexter DT, Roncaroli F, Gentleman SM, Middleton LT (2016) Cortical Lewy bodies and Abeta burden are associated with prevalence and timing of dementia in Lewy body diseases. Neuropathol Appl Neurobiol 42:436–450CrossRefPubMed
Zurück zum Zitat Rumpf JJ, Albers J, Fricke C, Mueller W, Classen J (2018) Structural abnormality of substantia nigra induced by methamphetamine abuse. Mov Disord 32:1784–1788CrossRef Rumpf JJ, Albers J, Fricke C, Mueller W, Classen J (2018) Structural abnormality of substantia nigra induced by methamphetamine abuse. Mov Disord 32:1784–1788CrossRef
Zurück zum Zitat Russ C, Lovestone S, Baker M, Pickering-Brown SM, Andersen PM, Furlong R, Mann D, Powell JF (2001) The extended haplotype of the microtubule associated protein tau gene is not associated with Pick’s disease. Neurosci Lett 299:156–158CrossRefPubMed Russ C, Lovestone S, Baker M, Pickering-Brown SM, Andersen PM, Furlong R, Mann D, Powell JF (2001) The extended haplotype of the microtubule associated protein tau gene is not associated with Pick’s disease. Neurosci Lett 299:156–158CrossRefPubMed
Zurück zum Zitat Sailer A, Scholz SW, Nalls MA, Schulte C, Federoff M, Price TR, Lees A, Ross OA, Dickson DW, Mok K, Mencacci NE, Schottlaender L, Chelban V, Ling H, O’Sullivan SS, Wood NW, Traynor BJ, Ferrucci L, Federoff HJ, Mhyre TR, Morris HR, Deuschl G, Quinn N, Widner H, Albanese A, Infante J, Bhatia KP, Poewe W, Oertel W, Hoglinger GU, Wullner U, Goldwurm S, Pellecchia MT, Ferreira J, Tolosa E, Bloem BR, Rascol O, Meissner WG, Hardy JA, Revesz T, Holton JL, Gasser T, Wenning GK, Singleton AB, Houlden H (2016) A genome-wide association study in multiple system atrophy. Neurology 87:1591–1598CrossRefPubMedPubMedCentral Sailer A, Scholz SW, Nalls MA, Schulte C, Federoff M, Price TR, Lees A, Ross OA, Dickson DW, Mok K, Mencacci NE, Schottlaender L, Chelban V, Ling H, O’Sullivan SS, Wood NW, Traynor BJ, Ferrucci L, Federoff HJ, Mhyre TR, Morris HR, Deuschl G, Quinn N, Widner H, Albanese A, Infante J, Bhatia KP, Poewe W, Oertel W, Hoglinger GU, Wullner U, Goldwurm S, Pellecchia MT, Ferreira J, Tolosa E, Bloem BR, Rascol O, Meissner WG, Hardy JA, Revesz T, Holton JL, Gasser T, Wenning GK, Singleton AB, Houlden H (2016) A genome-wide association study in multiple system atrophy. Neurology 87:1591–1598CrossRefPubMedPubMedCentral
Zurück zum Zitat Sakamoto R, Tsuchiya K, Yoshida R, Itoh Y, Furuta N, Kosuga A, Sugai Y, Mimura M (2009) Progressive supranuclear palsy combined with Alzheimer’s disease: a clinicopathological study of two autopsy cases. Neuropathology 29:219–229CrossRefPubMed Sakamoto R, Tsuchiya K, Yoshida R, Itoh Y, Furuta N, Kosuga A, Sugai Y, Mimura M (2009) Progressive supranuclear palsy combined with Alzheimer’s disease: a clinicopathological study of two autopsy cases. Neuropathology 29:219–229CrossRefPubMed
Zurück zum Zitat Salvesen L, Ullerup BH, Sunay FB, Brudek T, Lokkegaard A, Agander TK, Winge K, Pakkenberg B (2015) Changes in total cell numbers of the basal ganglia in patients with multiple system atrophy—a stereological study. Neurobiol Dis 74:104–113CrossRefPubMed Salvesen L, Ullerup BH, Sunay FB, Brudek T, Lokkegaard A, Agander TK, Winge K, Pakkenberg B (2015) Changes in total cell numbers of the basal ganglia in patients with multiple system atrophy—a stereological study. Neurobiol Dis 74:104–113CrossRefPubMed
Zurück zum Zitat Sampedro F, Marin-Lahoz J, Martinez-Horta S, Pagonabarraga J, Kulisevsky J (2019) Dopaminergic degeneration induces early posterior cortical thinning in Parkinson’s disease. Neurobiol Dis 124:29–35CrossRefPubMed Sampedro F, Marin-Lahoz J, Martinez-Horta S, Pagonabarraga J, Kulisevsky J (2019) Dopaminergic degeneration induces early posterior cortical thinning in Parkinson’s disease. Neurobiol Dis 124:29–35CrossRefPubMed
Zurück zum Zitat Samudra N, Patel N, Womack KB, Khemani P, Chitnis S (2016) Psychosis in Parkinson disease: a review of etiology, phenomenology, and management. Drugs Aging 33:855–863CrossRefPubMedPubMedCentral Samudra N, Patel N, Womack KB, Khemani P, Chitnis S (2016) Psychosis in Parkinson disease: a review of etiology, phenomenology, and management. Drugs Aging 33:855–863CrossRefPubMedPubMedCentral
Zurück zum Zitat Santiago RM, Vital MABF, Sato MDO, Adam GP (2016) Depression in Parkinson’s disease is associated with a serotoninergic system change secondary to neuroinflammation. Int J Neurol Neurother 3:061CrossRef Santiago RM, Vital MABF, Sato MDO, Adam GP (2016) Depression in Parkinson’s disease is associated with a serotoninergic system change secondary to neuroinflammation. Int J Neurol Neurother 3:061CrossRef
Zurück zum Zitat Sassone J, Valtorta F, Ciammola A (2019) Early dyskinesias in Parkinson’s disease patients with parkin mutation: a primary corticostriatal synaptopathy? Front Neurosci 13:273CrossRefPubMedPubMedCentral Sassone J, Valtorta F, Ciammola A (2019) Early dyskinesias in Parkinson’s disease patients with parkin mutation: a primary corticostriatal synaptopathy? Front Neurosci 13:273CrossRefPubMedPubMedCentral
Zurück zum Zitat Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA (2013a) Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism. JAMA Neurol 70:859–866CrossRefPubMedPubMedCentral Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA (2013a) Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism. JAMA Neurol 70:859–866CrossRefPubMedPubMedCentral
Zurück zum Zitat Savica R, Grossardt BR, Bower JH, Boeve BF, Ahlskog JE, Rocca WA (2013b) Incidence of dementia with Lewy bodies and Parkinson disease dementia. JAMA Neurol 70:1396–1402CrossRefPubMedPubMedCentral Savica R, Grossardt BR, Bower JH, Boeve BF, Ahlskog JE, Rocca WA (2013b) Incidence of dementia with Lewy bodies and Parkinson disease dementia. JAMA Neurol 70:1396–1402CrossRefPubMedPubMedCentral
Zurück zum Zitat Savica R, Beach TG, Hentz JG, Sabbagh MN, Serrano GE, Sue LI, Dugger BN, Shill HA, Driver-Dunckley E, Caviness JN, Mehta SH, Jacobson SA, Belden CM, Davis KJ, Zamrini E, Shprecher DR, Adler CH (2019) Lewy body pathology in Alzheimer’s disease: a clinicopathological prospective study. Acta Neurol Scand 139:76–81CrossRefPubMed Savica R, Beach TG, Hentz JG, Sabbagh MN, Serrano GE, Sue LI, Dugger BN, Shill HA, Driver-Dunckley E, Caviness JN, Mehta SH, Jacobson SA, Belden CM, Davis KJ, Zamrini E, Shprecher DR, Adler CH (2019) Lewy body pathology in Alzheimer’s disease: a clinicopathological prospective study. Acta Neurol Scand 139:76–81CrossRefPubMed
Zurück zum Zitat Schapira AHV, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci 18:435–450CrossRefPubMed Schapira AHV, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci 18:435–450CrossRefPubMed
Zurück zum Zitat Schneider SA, Alcalay RN (2017) Neuropathology of genetic synucleinopathies with parkinsonism: review of the literature. Mov Disord 32:1504–1523CrossRefPubMedPubMedCentral Schneider SA, Alcalay RN (2017) Neuropathology of genetic synucleinopathies with parkinsonism: review of the literature. Mov Disord 32:1504–1523CrossRefPubMedPubMedCentral
Zurück zum Zitat Schofield EC, Hodges JR, Macdonald V, Cordato NJ, Kril JJ, Halliday GM (2011) Cortical atrophy differentiates Richardson’s syndrome from the parkinsonian form of progressive supranuclear palsy. Mov Disord 26:256–263CrossRefPubMed Schofield EC, Hodges JR, Macdonald V, Cordato NJ, Kril JJ, Halliday GM (2011) Cortical atrophy differentiates Richardson’s syndrome from the parkinsonian form of progressive supranuclear palsy. Mov Disord 26:256–263CrossRefPubMed
Zurück zum Zitat Scholz SW, Houlden H, Schulte C, Sharma M, Li A, Berg D, Melchers A, Paudel R, Gibbs JR, Simon-Sanchez J, Paisan-Ruiz C, Bras J, Ding J, Chen H, Traynor BJ, Arepalli S, Zonozi RR, Revesz T, Holton J, Wood N, Lees A, Oertel W, Wullner U, Goldwurm S, Pellecchia MT, Illig T, Riess O, Fernandez HH, Rodriguez RL, Okun MS, Poewe W, Wenning GK, Hardy JA, Singleton AB, Del Sorbo F, Schneider S, Bhatia KP, Gasser T (2009) SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol 65:610–614CrossRefPubMedPubMedCentral Scholz SW, Houlden H, Schulte C, Sharma M, Li A, Berg D, Melchers A, Paudel R, Gibbs JR, Simon-Sanchez J, Paisan-Ruiz C, Bras J, Ding J, Chen H, Traynor BJ, Arepalli S, Zonozi RR, Revesz T, Holton J, Wood N, Lees A, Oertel W, Wullner U, Goldwurm S, Pellecchia MT, Illig T, Riess O, Fernandez HH, Rodriguez RL, Okun MS, Poewe W, Wenning GK, Hardy JA, Singleton AB, Del Sorbo F, Schneider S, Bhatia KP, Gasser T (2009) SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol 65:610–614CrossRefPubMedPubMedCentral
Zurück zum Zitat Schottlaender LV, Bettencourt C, Kiely AP, Chalasani A, Neergheen V, Holton JL, Hargreaves I, Houlden H (2016) Coenzyme Q10 levels are decreased in the cerebellum of multiple-system atrophy patients. PLoS One 11:e0149557CrossRefPubMedPubMedCentral Schottlaender LV, Bettencourt C, Kiely AP, Chalasani A, Neergheen V, Holton JL, Hargreaves I, Houlden H (2016) Coenzyme Q10 levels are decreased in the cerebellum of multiple-system atrophy patients. PLoS One 11:e0149557CrossRefPubMedPubMedCentral
Zurück zum Zitat Schulte C, Gasser T (2011) Genetic basis of Parkinson’s disease: inheritance, penetrance, and expression. Appl Clin Genet 4:67–80PubMedPubMedCentral Schulte C, Gasser T (2011) Genetic basis of Parkinson’s disease: inheritance, penetrance, and expression. Appl Clin Genet 4:67–80PubMedPubMedCentral
Zurück zum Zitat Schulz J, Pagano G, Fernandez Bonfante JA, Wilson H, Politis M (2018) Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson’s disease. Brain 141:1501–1516CrossRefPubMedPubMedCentral Schulz J, Pagano G, Fernandez Bonfante JA, Wilson H, Politis M (2018) Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson’s disease. Brain 141:1501–1516CrossRefPubMedPubMedCentral
Zurück zum Zitat Schulz J, Takousis P, Wohlers I, Itua IOG, Dobricic V, Rucker G, Binder H, Middleton L, Ioannidis JPA, Perneczky R, Bertram L, Lill CM (2019) Meta-analyses identify differentially expressed microRNAs in Parkinson’s disease. Ann Neurol 85:835–851CrossRefPubMed Schulz J, Takousis P, Wohlers I, Itua IOG, Dobricic V, Rucker G, Binder H, Middleton L, Ioannidis JPA, Perneczky R, Bertram L, Lill CM (2019) Meta-analyses identify differentially expressed microRNAs in Parkinson’s disease. Ann Neurol 85:835–851CrossRefPubMed
Zurück zum Zitat Schulz-Schaeffer WJ (2010) The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia. Acta Neuropathol 120:131–143CrossRefPubMedPubMedCentral Schulz-Schaeffer WJ (2010) The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia. Acta Neuropathol 120:131–143CrossRefPubMedPubMedCentral
Zurück zum Zitat Schulz-Schaeffer WJ (2015) Is cell death primary or secondary in the pathophysiology of idiopathic Parkinson’s disease? Biomolecules 5:1467–1479CrossRefPubMedPubMedCentral Schulz-Schaeffer WJ (2015) Is cell death primary or secondary in the pathophysiology of idiopathic Parkinson’s disease? Biomolecules 5:1467–1479CrossRefPubMedPubMedCentral
Zurück zum Zitat Schumacher J, Peraza LR, Firbank M, Thomas AJ, Kaiser M, Gallagher P, O’Brien JT, Blamire AM, Taylor JP (2019) Dysfunctional brain dynamics and their origin in Lewy body dementia. Brain 142:1767–1782CrossRefPubMedPubMedCentral Schumacher J, Peraza LR, Firbank M, Thomas AJ, Kaiser M, Gallagher P, O’Brien JT, Blamire AM, Taylor JP (2019) Dysfunctional brain dynamics and their origin in Lewy body dementia. Brain 142:1767–1782CrossRefPubMedPubMedCentral
Zurück zum Zitat Scudamore O, Ciossek T (2018) Increased oxidative stress exacerbates alpha-synuclein aggregation in vivo. J Neuropathol Exp Neurol 77:443–453CrossRefPubMed Scudamore O, Ciossek T (2018) Increased oxidative stress exacerbates alpha-synuclein aggregation in vivo. J Neuropathol Exp Neurol 77:443–453CrossRefPubMed
Zurück zum Zitat Seidel K, Schols L, Nuber S, Petrasch-Parwez E, Gierga K, Wszolek Z, Dickson D, Gai WP, Bornemann A, Riess O, Rami A, Den Dunnen WF, Deller T, Rub U, Kruger R (2010) First appraisal of brain pathology owing to A30P mutant alpha-synuclein. Ann Neurol 67:684–689CrossRefPubMed Seidel K, Schols L, Nuber S, Petrasch-Parwez E, Gierga K, Wszolek Z, Dickson D, Gai WP, Bornemann A, Riess O, Rami A, Den Dunnen WF, Deller T, Rub U, Kruger R (2010) First appraisal of brain pathology owing to A30P mutant alpha-synuclein. Ann Neurol 67:684–689CrossRefPubMed
Zurück zum Zitat Seidel K, Mahlke J, Sonny S, Krüger R, Heinsen H, Auburger G, Bouzrou M, Grinberg LT, Wicht H, Korf H-W, den Dunnen W, Rüb U (2015) The brainstem pathologies of Parkinson’s disease and dementia with Lewy bodies. Brain Pathol 25:121–135CrossRefPubMed Seidel K, Mahlke J, Sonny S, Krüger R, Heinsen H, Auburger G, Bouzrou M, Grinberg LT, Wicht H, Korf H-W, den Dunnen W, Rüb U (2015) The brainstem pathologies of Parkinson’s disease and dementia with Lewy bodies. Brain Pathol 25:121–135CrossRefPubMed
Zurück zum Zitat Sekiya H, Kowa H, Koga H, Takata M, Satake W, Futamura N, Funakawa I, Jinnai K, Takahashi M, Kondo T, Ueno Y, Kanagawa M, Kobayashi K, Toda T (2019) Wide distribution of alpha-synuclein oligomers in multiple system atrophy brain detected by proximity ligation. Acta Neuropathol 137:455–466CrossRefPubMed Sekiya H, Kowa H, Koga H, Takata M, Satake W, Futamura N, Funakawa I, Jinnai K, Takahashi M, Kondo T, Ueno Y, Kanagawa M, Kobayashi K, Toda T (2019) Wide distribution of alpha-synuclein oligomers in multiple system atrophy brain detected by proximity ligation. Acta Neuropathol 137:455–466CrossRefPubMed
Zurück zum Zitat Selikhova M, Williams DR, Kempster PA, Holton JL, Revesz T, Lees AJ (2009) A clinico-pathological study of subtypes in Parkinson’s disease. Brain 132:2947–2957CrossRefPubMed Selikhova M, Williams DR, Kempster PA, Holton JL, Revesz T, Lees AJ (2009) A clinico-pathological study of subtypes in Parkinson’s disease. Brain 132:2947–2957CrossRefPubMed
Zurück zum Zitat Sestini S, Alongi P, Berti V, Calcagni ML, Cecchin D, Chiaravalloti A, Chincarini A, Cistaro A, Guerra UP, Pappatà S, Tiraboschi P, Nobili F (2019) The role of molecular imaging in the frame of the revised dementia with Lewy body criteria. Clin Transl Imaging 7:83–98CrossRef Sestini S, Alongi P, Berti V, Calcagni ML, Cecchin D, Chiaravalloti A, Chincarini A, Cistaro A, Guerra UP, Pappatà S, Tiraboschi P, Nobili F (2019) The role of molecular imaging in the frame of the revised dementia with Lewy body criteria. Clin Transl Imaging 7:83–98CrossRef
Zurück zum Zitat Seto-Salvia N, Pagonabarraga J, Houlden H, Pascual-Sedano B, Dols-Icardo O, Tucci A, Paisan-Ruiz C, Campolongo A, Anton-Aguirre S, Martin I, Munoz L, Bufill E, Vilageliu L, Grinberg D, Cozar M, Blesa R, Lleo A, Hardy J, Kulisevsky J, Clarimon J (2012) Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson’s disease course. Mov Disord 27:393–399CrossRefPubMed Seto-Salvia N, Pagonabarraga J, Houlden H, Pascual-Sedano B, Dols-Icardo O, Tucci A, Paisan-Ruiz C, Campolongo A, Anton-Aguirre S, Martin I, Munoz L, Bufill E, Vilageliu L, Grinberg D, Cozar M, Blesa R, Lleo A, Hardy J, Kulisevsky J, Clarimon J (2012) Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson’s disease course. Mov Disord 27:393–399CrossRefPubMed
Zurück zum Zitat Shah A, Prasad S, Rastogi B, Dash S, Saini J, Pal PK, Ingalhalikar M (2019) Altered structural connectivity of the motor subnetwork in multiple system atrophy with cerebellar features. Eur Radiol 29:2783–2791CrossRefPubMed Shah A, Prasad S, Rastogi B, Dash S, Saini J, Pal PK, Ingalhalikar M (2019) Altered structural connectivity of the motor subnetwork in multiple system atrophy with cerebellar features. Eur Radiol 29:2783–2791CrossRefPubMed
Zurück zum Zitat Shahmoradian SH, Lewis AJ, Genoud C, Graff-Meyer A, Hench J, Moors T, Schweighauser G, Wang J, Goldie KN, Suetterlin R, Castano-Diez D, Perez-Navarro P, Huisman E, Ipsen S, Ingrassia A, de Gier Y, Rozemuller AJM, Da Paepe A, Erny J, Staempfli A, Hoernschemeyer J, Grosserueschkamp F, Niedieker D, El-Mashtoly SF, Quadri M, van Ijcken WFJ, Bonifati V, Gerwert K, Bohrmann B, Frank S, Britschgi M, Stahlberg H, van de Berg W, Lauer ME (2018) Lewy pathology in Parkinson’s disease consists of a crowded organellar, membranous medley (This article is a preprint and has not been peer-reviewed). bioRxiv. https://doi.org/10.1101/137976 CrossRef Shahmoradian SH, Lewis AJ, Genoud C, Graff-Meyer A, Hench J, Moors T, Schweighauser G, Wang J, Goldie KN, Suetterlin R, Castano-Diez D, Perez-Navarro P, Huisman E, Ipsen S, Ingrassia A, de Gier Y, Rozemuller AJM, Da Paepe A, Erny J, Staempfli A, Hoernschemeyer J, Grosserueschkamp F, Niedieker D, El-Mashtoly SF, Quadri M, van Ijcken WFJ, Bonifati V, Gerwert K, Bohrmann B, Frank S, Britschgi M, Stahlberg H, van de Berg W, Lauer ME (2018) Lewy pathology in Parkinson’s disease consists of a crowded organellar, membranous medley (This article is a preprint and has not been peer-reviewed). bioRxiv. https://​doi.​org/​10.​1101/​137976 CrossRef
Zurück zum Zitat Sharma M, Wenning G, Krüger R (2014) Mutant COQ2 in multiple-system atrophy. N Engl J Med 371:80–83CrossRefPubMed Sharma M, Wenning G, Krüger R (2014) Mutant COQ2 in multiple-system atrophy. N Engl J Med 371:80–83CrossRefPubMed
Zurück zum Zitat Sharp ME, Marder KS, Cote L, Clark LN, Nichols WC, Vonsattel JP, Alcalay RN (2014) Parkinson’s disease with Lewy bodies associated with a heterozygous PARKIN dosage mutation. Mov Disord 29:566–568CrossRefPubMed Sharp ME, Marder KS, Cote L, Clark LN, Nichols WC, Vonsattel JP, Alcalay RN (2014) Parkinson’s disease with Lewy bodies associated with a heterozygous PARKIN dosage mutation. Mov Disord 29:566–568CrossRefPubMed
Zurück zum Zitat Shimohata T, Aiba I, Nishizawa M (2015) Criteria for the diagnosis of corticobasal degeneration. Brain Nerve 67:513–523PubMed Shimohata T, Aiba I, Nishizawa M (2015) Criteria for the diagnosis of corticobasal degeneration. Brain Nerve 67:513–523PubMed
Zurück zum Zitat Shimozawa A, Ono M, Takahara D, Tarutani A, Imura S, Masuda-Suzukake M, Higuchi M, Yanai K, Hisanaga SI, Hasegawa M (2017) Propagation of pathological alpha-synuclein in marmoset brain. Acta Neuropathol Commun 5:12CrossRefPubMedPubMedCentral Shimozawa A, Ono M, Takahara D, Tarutani A, Imura S, Masuda-Suzukake M, Higuchi M, Yanai K, Hisanaga SI, Hasegawa M (2017) Propagation of pathological alpha-synuclein in marmoset brain. Acta Neuropathol Commun 5:12CrossRefPubMedPubMedCentral
Zurück zum Zitat Shine JM, Matar E, Ward PB, Frank MJ, Moustafa AA, Pearson M, Naismith SL, Lewis SJ (2013) Freezing of gait in Parkinson’s disease is associated with functional decoupling between the cognitive control network and the basal ganglia. Brain 136:3671–3681CrossRefPubMed Shine JM, Matar E, Ward PB, Frank MJ, Moustafa AA, Pearson M, Naismith SL, Lewis SJ (2013) Freezing of gait in Parkinson’s disease is associated with functional decoupling between the cognitive control network and the basal ganglia. Brain 136:3671–3681CrossRefPubMed
Zurück zum Zitat Shinotoh H, Shimada H, Kokubo Y, Tagai K, Niwa F, Kitamura S, Endo H, Ono M, Kimura Y, Hirano S, Mimuro M, Ichise M, Sahara N, Zhang MR, Suhara T, Higuchi M (2019) Tau imaging detects distinctive distribution of tau pathology in ALS/PDC on the Kii Peninsula. Neurology 92:e136–e147CrossRefPubMedPubMedCentral Shinotoh H, Shimada H, Kokubo Y, Tagai K, Niwa F, Kitamura S, Endo H, Ono M, Kimura Y, Hirano S, Mimuro M, Ichise M, Sahara N, Zhang MR, Suhara T, Higuchi M (2019) Tau imaging detects distinctive distribution of tau pathology in ALS/PDC on the Kii Peninsula. Neurology 92:e136–e147CrossRefPubMedPubMedCentral
Zurück zum Zitat Shuaib UA, Rajput AH, Robinson CA, Rajput A (2016) Neuroleptic-induced parkinsonism: clinicopathological study. Mov Disord 31:360–365CrossRefPubMed Shuaib UA, Rajput AH, Robinson CA, Rajput A (2016) Neuroleptic-induced parkinsonism: clinicopathological study. Mov Disord 31:360–365CrossRefPubMed
Zurück zum Zitat Sian-Hulsmann J, Mandel S, Youdim MB, Riederer P (2011) The relevance of iron in the pathogenesis of Parkinson’s disease. J Neurochem 118:939–957CrossRefPubMed Sian-Hulsmann J, Mandel S, Youdim MB, Riederer P (2011) The relevance of iron in the pathogenesis of Parkinson’s disease. J Neurochem 118:939–957CrossRefPubMed
Zurück zum Zitat Sian-Hulsmann J, Monoranu C, Strobel S, Riederer P (2015) Lewy bodies: a spectator or salient killer? CNS Neurol Disord Drug Targets 14:947–955CrossRefPubMed Sian-Hulsmann J, Monoranu C, Strobel S, Riederer P (2015) Lewy bodies: a spectator or salient killer? CNS Neurol Disord Drug Targets 14:947–955CrossRefPubMed
Zurück zum Zitat Siepel FJ, Bronnick KS, Booij J, Ravina BM, Lebedev AV, Pereira JB, Gruner R, Aarsland D (2014) Cognitive executive impairment and dopaminergic deficits in de novo Parkinson’s disease. Mov Disord 29:1802–1808CrossRefPubMed Siepel FJ, Bronnick KS, Booij J, Ravina BM, Lebedev AV, Pereira JB, Gruner R, Aarsland D (2014) Cognitive executive impairment and dopaminergic deficits in de novo Parkinson’s disease. Mov Disord 29:1802–1808CrossRefPubMed
Zurück zum Zitat Simonyan K, Cho H, Hamzehei Sichani A, Rubien-Thomas E, Hallett M (2017) The direct basal ganglia pathway is hyperfunctional in focal dystonia. Brain 140:3179–3190CrossRefPubMedPubMedCentral Simonyan K, Cho H, Hamzehei Sichani A, Rubien-Thomas E, Hallett M (2017) The direct basal ganglia pathway is hyperfunctional in focal dystonia. Brain 140:3179–3190CrossRefPubMedPubMedCentral
Zurück zum Zitat Sklerov M, Kang UJ, Liong C, Clark L, Marder K, Pauciulo M, Nichols WC, Chung WK, Honig LS, Cortes E, Vonsattel JP, Alcalay RN (2017) Frequency of GBA variants in autopsy-proven multiple system atrophy. Mov Disord Clin Pract 4:574–581CrossRefPubMedPubMedCentral Sklerov M, Kang UJ, Liong C, Clark L, Marder K, Pauciulo M, Nichols WC, Chung WK, Honig LS, Cortes E, Vonsattel JP, Alcalay RN (2017) Frequency of GBA variants in autopsy-proven multiple system atrophy. Mov Disord Clin Pract 4:574–581CrossRefPubMedPubMedCentral
Zurück zum Zitat Skogseth RE, Hortobagyi T, Soennesyn H, Chwiszczuk L, Ffytche D, Rongve A, Ballard C, Aarsland D (2017) Accuracy of clinical diagnosis of dementia with Lewy bodies versus neuropathology. J Alzheimers Dis 59:1139–1152CrossRefPubMed Skogseth RE, Hortobagyi T, Soennesyn H, Chwiszczuk L, Ffytche D, Rongve A, Ballard C, Aarsland D (2017) Accuracy of clinical diagnosis of dementia with Lewy bodies versus neuropathology. J Alzheimers Dis 59:1139–1152CrossRefPubMed
Zurück zum Zitat Smith C, Malek N, Grosset KA, Cullen B, Gentleman SM, Grosset DG (2019) The neuropathology of dementia in patients with Parkinson’s disease: a systematic review of autopsy studies. J Neurol Neurosurg Psychiatry (in press) Smith C, Malek N, Grosset KA, Cullen B, Gentleman SM, Grosset DG (2019) The neuropathology of dementia in patients with Parkinson’s disease: a systematic review of autopsy studies. J Neurol Neurosurg Psychiatry (in press)
Zurück zum Zitat Snijders AH, Takakusaki K, Debu B, Lozano AM, Krishna V, Fasano A, Aziz TZ, Papa SM, Factor SA, Hallett M (2016) Physiology of freezing of gait. Ann Neurol 80:644–659CrossRefPubMed Snijders AH, Takakusaki K, Debu B, Lozano AM, Krishna V, Fasano A, Aziz TZ, Papa SM, Factor SA, Hallett M (2016) Physiology of freezing of gait. Ann Neurol 80:644–659CrossRefPubMed
Zurück zum Zitat Spay C, Meyer G, Welter ML, Lau B, Boulinguez P, Ballanger B (2018) Functional imaging correlates of akinesia in Parkinson’s disease: still open issues. Neuroimage Clin 21:101644CrossRefPubMedPubMedCentral Spay C, Meyer G, Welter ML, Lau B, Boulinguez P, Ballanger B (2018) Functional imaging correlates of akinesia in Parkinson’s disease: still open issues. Neuroimage Clin 21:101644CrossRefPubMedPubMedCentral
Zurück zum Zitat Spillantini MG, Goedert M (2013) Tau pathology and neurodegeneration. Lancet Neurol 12:609–622CrossRefPubMed Spillantini MG, Goedert M (2013) Tau pathology and neurodegeneration. Lancet Neurol 12:609–622CrossRefPubMed
Zurück zum Zitat Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 95:6469–6473CrossRefPubMedPubMedCentral Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 95:6469–6473CrossRefPubMedPubMedCentral
Zurück zum Zitat Srulijes K, Hauser AK, Guella I, Asselta R, Brockmann K, Schulte C, Solda G, Cilia R, Maetzler W, Schols L, Wenning GK, Poewe W, Barone P, Wullner U, Oertel W, Berg D, Goldwurm S, Gasser T (2013) No association of GBA mutations and multiple system atrophy. Eur J Neurol 20:e61–e62CrossRefPubMed Srulijes K, Hauser AK, Guella I, Asselta R, Brockmann K, Schulte C, Solda G, Cilia R, Maetzler W, Schols L, Wenning GK, Poewe W, Barone P, Wullner U, Oertel W, Berg D, Goldwurm S, Gasser T (2013) No association of GBA mutations and multiple system atrophy. Eur J Neurol 20:e61–e62CrossRefPubMed
Zurück zum Zitat Stankovic I, Quinn N, Vignatelli L, Antonini A, Berg D, Coon E, Cortelli P, Fanciulli A, Ferreira JJ, Freeman R, Halliday G, Hoglinger GU, Iodice V, Kaufmann H, Klockgether T, Kostic V, Krismer F, Lang A, Levin J, Low P, Mathias C, Meissner WG, Kaufmann LN, Palma JA, Panicker JN, Pellecchia MT, Sakakibara R, Schmahmann J, Scholz SW, Singer W, Stamelou M, Tolosa E, Tsuji S, Seppi K, Poewe W, Wenning GK (2019) A critique of the second consensus criteria for multiple system atrophy. Mov Disord. https://doi.org/10.1002/mds.27701 CrossRefPubMedPubMedCentral Stankovic I, Quinn N, Vignatelli L, Antonini A, Berg D, Coon E, Cortelli P, Fanciulli A, Ferreira JJ, Freeman R, Halliday G, Hoglinger GU, Iodice V, Kaufmann H, Klockgether T, Kostic V, Krismer F, Lang A, Levin J, Low P, Mathias C, Meissner WG, Kaufmann LN, Palma JA, Panicker JN, Pellecchia MT, Sakakibara R, Schmahmann J, Scholz SW, Singer W, Stamelou M, Tolosa E, Tsuji S, Seppi K, Poewe W, Wenning GK (2019) A critique of the second consensus criteria for multiple system atrophy. Mov Disord. https://​doi.​org/​10.​1002/​mds.​27701 CrossRefPubMedPubMedCentral
Zurück zum Zitat Steele JC, McGeer PL (2008) The ALS/PDC syndrome of Guam and the cycad hypothesis. Neurology 70:1984–1990CrossRefPubMed Steele JC, McGeer PL (2008) The ALS/PDC syndrome of Guam and the cycad hypothesis. Neurology 70:1984–1990CrossRefPubMed
Zurück zum Zitat Stefanova N (2014) Animal models. In: Wenning GK, Fanciulli A (eds) Multiple system atrophy. Springer, Vienna, pp 83–96CrossRef Stefanova N (2014) Animal models. In: Wenning GK, Fanciulli A (eds) Multiple system atrophy. Springer, Vienna, pp 83–96CrossRef
Zurück zum Zitat Stejskalova Z, Rohan Z, Rusina R, Tesar A, Kukal J, Kovacs GG, Bartos A, Matej R (2019) Pyramidal system involvement in progressive supranuclear palsy—a clinicopathological correlation. BMC Neurol 19:42CrossRefPubMedPubMedCentral Stejskalova Z, Rohan Z, Rusina R, Tesar A, Kukal J, Kovacs GG, Bartos A, Matej R (2019) Pyramidal system involvement in progressive supranuclear palsy—a clinicopathological correlation. BMC Neurol 19:42CrossRefPubMedPubMedCentral
Zurück zum Zitat Strang KH, Croft CL, Sorrentino ZA, Chakrabarty P, Golde TE, Giasson BI (2018) Distinct differences in prion-like seeding and aggregation between tau protein variants provide mechanistic insights into tauopathies. J Biol Chem 293:2408–2421CrossRefPubMed Strang KH, Croft CL, Sorrentino ZA, Chakrabarty P, Golde TE, Giasson BI (2018) Distinct differences in prion-like seeding and aggregation between tau protein variants provide mechanistic insights into tauopathies. J Biol Chem 293:2408–2421CrossRefPubMed
Zurück zum Zitat Su Y, Deng MF, Xiong W, Xie AJ, Guo J, Liang ZH, Hu B, Chen JG, Zhu X, Man HY, Lu Y, Liu D, Tang B, Zhu LQ (2019) MicroRNA-26a/death-associated protein kinase 1 signaling induces synucleinopathy and dopaminergic neuron degeneration in Parkinson’s disease. Biol Psychiatry 85:769–781CrossRefPubMed Su Y, Deng MF, Xiong W, Xie AJ, Guo J, Liang ZH, Hu B, Chen JG, Zhu X, Man HY, Lu Y, Liu D, Tang B, Zhu LQ (2019) MicroRNA-26a/death-associated protein kinase 1 signaling induces synucleinopathy and dopaminergic neuron degeneration in Parkinson’s disease. Biol Psychiatry 85:769–781CrossRefPubMed
Zurück zum Zitat Sulzer D, Surmeier DJ (2013) Neuronal vulnerability, pathogenesis, and Parkinson’s disease. Mov Disord 28:41–50CrossRefPubMed Sulzer D, Surmeier DJ (2013) Neuronal vulnerability, pathogenesis, and Parkinson’s disease. Mov Disord 28:41–50CrossRefPubMed
Zurück zum Zitat Sumikura H, Takao M, Hatsuta H, Ito S, Nakano Y, Uchino A, Nogami A, Saito Y, Mochizuki H, Murayama S (2015) Distribution of alpha-synuclein in the spinal cord and dorsal root ganglia in an autopsy cohort of elderly persons. Acta Neuropathol Commun 3:57CrossRefPubMedPubMedCentral Sumikura H, Takao M, Hatsuta H, Ito S, Nakano Y, Uchino A, Nogami A, Saito Y, Mochizuki H, Murayama S (2015) Distribution of alpha-synuclein in the spinal cord and dorsal root ganglia in an autopsy cohort of elderly persons. Acta Neuropathol Commun 3:57CrossRefPubMedPubMedCentral
Zurück zum Zitat Sun QY, Guo JF, Han WW, Zuo X, Wang L, Yao LY, Pan Q, Xia K, Yan XX, Tang BS (2013) Genetic association study of glucocerebrosidase gene L444P mutation in essential tremor and multiple system atrophy in mainland China. J Clin Neurosci 20:217–219CrossRefPubMed Sun QY, Guo JF, Han WW, Zuo X, Wang L, Yao LY, Pan Q, Xia K, Yan XX, Tang BS (2013) Genetic association study of glucocerebrosidase gene L444P mutation in essential tremor and multiple system atrophy in mainland China. J Clin Neurosci 20:217–219CrossRefPubMed
Zurück zum Zitat Sun Z, Xiang X, Tang B, Chen Z, Peng H, Xia K, Jiang H (2015) SNP rs11931074 of the SNCA gene may not be associated with multiple system atrophy in Chinese population. Int J Neurosci 125:612–615CrossRefPubMed Sun Z, Xiang X, Tang B, Chen Z, Peng H, Xia K, Jiang H (2015) SNP rs11931074 of the SNCA gene may not be associated with multiple system atrophy in Chinese population. Int J Neurosci 125:612–615CrossRefPubMed
Zurück zum Zitat Sun Z, Ohta Y, Yamashita T, Sato K, Takemoto M, Hishikawa N, Abe K (2016) New susceptible variant of COQ2 gene in Japanese patients with sporadic multiple system atrophy. Neurol Genet 2:e54CrossRefPubMedPubMedCentral Sun Z, Ohta Y, Yamashita T, Sato K, Takemoto M, Hishikawa N, Abe K (2016) New susceptible variant of COQ2 gene in Japanese patients with sporadic multiple system atrophy. Neurol Genet 2:e54CrossRefPubMedPubMedCentral
Zurück zum Zitat Sun Y, Pham AN, Hare DJ, Waite TD (2018) Kinetic modeling of pH-dependent oxidation of dopamine by iron and its relevance to Parkinson’s disease. Front Neurosci 12:859CrossRefPubMedPubMedCentral Sun Y, Pham AN, Hare DJ, Waite TD (2018) Kinetic modeling of pH-dependent oxidation of dopamine by iron and its relevance to Parkinson’s disease. Front Neurosci 12:859CrossRefPubMedPubMedCentral
Zurück zum Zitat Sun R, Yang S, Zheng B, Liu J, Ma X (2019) Apolipoprotein E polymorphisms and Parkinson disease with or without dementia: a meta-analysis including 6453 participants. J Geriatr Psychiatry Neurol 32:3–15CrossRefPubMed Sun R, Yang S, Zheng B, Liu J, Ma X (2019) Apolipoprotein E polymorphisms and Parkinson disease with or without dementia: a meta-analysis including 6453 participants. J Geriatr Psychiatry Neurol 32:3–15CrossRefPubMed
Zurück zum Zitat Suryanarayana SM, Hellgren Kotaleski J, Grillner S, Gurney KN (2019) Roles for globus pallidus externa revealed in a computational model of action selection in the basal ganglia. Neural Netw 109:113–136CrossRefPubMed Suryanarayana SM, Hellgren Kotaleski J, Grillner S, Gurney KN (2019) Roles for globus pallidus externa revealed in a computational model of action selection in the basal ganglia. Neural Netw 109:113–136CrossRefPubMed
Zurück zum Zitat Svensson E, Horvath-Puho E, Thomsen RW, Djurhuus JC, Pedersen L, Borghammer P, Sorensen HT (2015) Vagotomy and subsequent risk of Parkinson’s disease. Ann Neurol 78:522–529CrossRefPubMed Svensson E, Horvath-Puho E, Thomsen RW, Djurhuus JC, Pedersen L, Borghammer P, Sorensen HT (2015) Vagotomy and subsequent risk of Parkinson’s disease. Ann Neurol 78:522–529CrossRefPubMed
Zurück zum Zitat Swirski M, Miners JS, de Silva R, Lashley T, Ling H, Holton J, Revesz T, Love S (2014) Evaluating the relationship between amyloid-ß and a-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson’s disease. Alzheimers Res Ther 6:77CrossRefPubMedPubMedCentral Swirski M, Miners JS, de Silva R, Lashley T, Ling H, Holton J, Revesz T, Love S (2014) Evaluating the relationship between amyloid-ß and a-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson’s disease. Alzheimers Res Ther 6:77CrossRefPubMedPubMedCentral
Zurück zum Zitat Taba P (2017) Toxic-induced parkinsonism. In: Falup-Pecurariu C, Ferreira J, Martinez-Martin P, Chaudhuri KR (eds) Movement disorders curricula. Springer, Wien, pp 225–232CrossRef Taba P (2017) Toxic-induced parkinsonism. In: Falup-Pecurariu C, Ferreira J, Martinez-Martin P, Chaudhuri KR (eds) Movement disorders curricula. Springer, Wien, pp 225–232CrossRef
Zurück zum Zitat Tacik P, Fiesel FC, Fujioka S, Ross OA, Pretelt F, Castaneda Cardona C, Kidd A, Hlavac M, Raizis A, Okun MS, Traynor S, Strongosky AJ, Springer W, Wszolek ZK (2014) Three families with Perry syndrome from distinct parts of the world. Parkinsonism Relat Disord 20:884–888CrossRefPubMedPubMedCentral Tacik P, Fiesel FC, Fujioka S, Ross OA, Pretelt F, Castaneda Cardona C, Kidd A, Hlavac M, Raizis A, Okun MS, Traynor S, Strongosky AJ, Springer W, Wszolek ZK (2014) Three families with Perry syndrome from distinct parts of the world. Parkinsonism Relat Disord 20:884–888CrossRefPubMedPubMedCentral
Zurück zum Zitat Taghdiri F, Sato C, Ghani M, Moreno D, Rogaeva E, Tartaglia MC (2016) Novel GRN mutations in patients with corticobasal syndrome. Sci Rep 6:22913CrossRefPubMedPubMedCentral Taghdiri F, Sato C, Ghani M, Moreno D, Rogaeva E, Tartaglia MC (2016) Novel GRN mutations in patients with corticobasal syndrome. Sci Rep 6:22913CrossRefPubMedPubMedCentral
Zurück zum Zitat Taguchi K, Watanabe Y, Tsujimura A, Tanaka M (2019) Expression of alpha-synuclein is regulated in a neuronal cell type-dependent manner. Anat Sci Int 94:11–22CrossRefPubMed Taguchi K, Watanabe Y, Tsujimura A, Tanaka M (2019) Expression of alpha-synuclein is regulated in a neuronal cell type-dependent manner. Anat Sci Int 94:11–22CrossRefPubMed
Zurück zum Zitat Taipa R, Pereira C, Reis I, Alonso I, Bastos-Lima A, Melo-Pires M, Magalhaes M (2016) DJ-1 linked parkinsonism (PARK7) is associated with Lewy body pathology. Brain 139:1680–1687CrossRefPubMed Taipa R, Pereira C, Reis I, Alonso I, Bastos-Lima A, Melo-Pires M, Magalhaes M (2016) DJ-1 linked parkinsonism (PARK7) is associated with Lewy body pathology. Brain 139:1680–1687CrossRefPubMed
Zurück zum Zitat Takanashi M, Funayama M, Matsuura E, Yoshino H, Li Y, Tsuyama S, Takashima H, Nishioka K, Hattori N (2018) Isolated nigral degeneration without pathological protein aggregation in autopsied brains with LRRK2 p.R1441H homozygous and heterozygous mutations. Acta Neuropathol Commun 6:105CrossRefPubMedPubMedCentral Takanashi M, Funayama M, Matsuura E, Yoshino H, Li Y, Tsuyama S, Takashima H, Nishioka K, Hattori N (2018) Isolated nigral degeneration without pathological protein aggregation in autopsied brains with LRRK2 p.R1441H homozygous and heterozygous mutations. Acta Neuropathol Commun 6:105CrossRefPubMedPubMedCentral
Zurück zum Zitat Tamguney G, Korczyn AD (2018) A critical review of the prion hypothesis of human synucleinopathies. Cell Tissue Res 373:213–220CrossRefPubMed Tamguney G, Korczyn AD (2018) A critical review of the prion hypothesis of human synucleinopathies. Cell Tissue Res 373:213–220CrossRefPubMed
Zurück zum Zitat Tanaka G, Yamanaka T, Furukawa Y, Kajimura N, Mitsuoka K, Nukina N (2019) Sequence- and seed-structure-dependent polymorphic fibrils of alpha-synuclein. Biochim Biophys Acta Mol Basis Dis 1865:1410–1420CrossRefPubMed Tanaka G, Yamanaka T, Furukawa Y, Kajimura N, Mitsuoka K, Nukina N (2019) Sequence- and seed-structure-dependent polymorphic fibrils of alpha-synuclein. Biochim Biophys Acta Mol Basis Dis 1865:1410–1420CrossRefPubMed
Zurück zum Zitat Taniguchi-Watanabe S, Arai T, Kametani F, Nonaka T, Masuda-Suzukake M, Tarutani A, Murayama S, Saito Y, Arima K, Yoshida M, Akiyama H, Robinson A, Mann DMA, Iwatsubo T, Hasegawa M (2016) Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau. Acta Neuropathol 131:267–280CrossRefPubMed Taniguchi-Watanabe S, Arai T, Kametani F, Nonaka T, Masuda-Suzukake M, Tarutani A, Murayama S, Saito Y, Arima K, Yoshida M, Akiyama H, Robinson A, Mann DMA, Iwatsubo T, Hasegawa M (2016) Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau. Acta Neuropathol 131:267–280CrossRefPubMed
Zurück zum Zitat Tardivel M, Begard S, Bousset L, Dujardin S, Coens A, Melki R, Buee L, Colin M (2016) Tunneling nanotube (TNT)-mediated neuron-to neuron transfer of pathological tau protein assemblies. Acta Neuropathol Commun 4:117CrossRefPubMedPubMedCentral Tardivel M, Begard S, Bousset L, Dujardin S, Coens A, Melki R, Buee L, Colin M (2016) Tunneling nanotube (TNT)-mediated neuron-to neuron transfer of pathological tau protein assemblies. Acta Neuropathol Commun 4:117CrossRefPubMedPubMedCentral
Zurück zum Zitat Tatsumi S, Mimuro M, Iwasaki Y, Takahashi R, Kakita A, Takahashi H, Yoshida M (2014a) Argyrophilic grains are reliable disease-specific features of corticobasal degeneration. J Neuropathol Exp Neurol 73:30–38CrossRefPubMed Tatsumi S, Mimuro M, Iwasaki Y, Takahashi R, Kakita A, Takahashi H, Yoshida M (2014a) Argyrophilic grains are reliable disease-specific features of corticobasal degeneration. J Neuropathol Exp Neurol 73:30–38CrossRefPubMed
Zurück zum Zitat Tatsumi S, Uchihara T, Aiba I, Iwasaki Y, Mimuro M, Takahashi R, Yoshida M (2014b) Ultrastructural differences in pretangles between Alzheimer disease and corticobasal degeneration revealed by comparative light and electron microscopy. Acta Neuropathol Commun 2:161CrossRefPubMedPubMedCentral Tatsumi S, Uchihara T, Aiba I, Iwasaki Y, Mimuro M, Takahashi R, Yoshida M (2014b) Ultrastructural differences in pretangles between Alzheimer disease and corticobasal degeneration revealed by comparative light and electron microscopy. Acta Neuropathol Commun 2:161CrossRefPubMedPubMedCentral
Zurück zum Zitat Tecuapetla F, Jin X, Lima SQ, Costa RM (2016) Complementary contributions of striatal projection pathways to action initiation and execution. Cell 166:703–715CrossRefPubMed Tecuapetla F, Jin X, Lima SQ, Costa RM (2016) Complementary contributions of striatal projection pathways to action initiation and execution. Cell 166:703–715CrossRefPubMed
Zurück zum Zitat Tercjak A, Bergareche A, Caballero C, Tunon T, Linazasoro G (2014) Lewy bodies under atomic force microscope. Ultrastruct Pathol 38:1–5CrossRefPubMed Tercjak A, Bergareche A, Caballero C, Tunon T, Linazasoro G (2014) Lewy bodies under atomic force microscope. Ultrastruct Pathol 38:1–5CrossRefPubMed
Zurück zum Zitat Thakur P, Breger LS, Lundblad M, Wan OW, Mattsson B, Luk KC, Lee VMY, Trojanowski JQ, Bjorklund A (2017) Modeling Parkinson’s disease pathology by combination of fibril seeds and alpha-synuclein overexpression in the rat brain. Proc Natl Acad Sci USA 114:E8284–E8293CrossRefPubMedPubMedCentral Thakur P, Breger LS, Lundblad M, Wan OW, Mattsson B, Luk KC, Lee VMY, Trojanowski JQ, Bjorklund A (2017) Modeling Parkinson’s disease pathology by combination of fibril seeds and alpha-synuclein overexpression in the rat brain. Proc Natl Acad Sci USA 114:E8284–E8293CrossRefPubMedPubMedCentral
Zurück zum Zitat Thal DR, von Arnim CA, Griffin WS, Mrak RE, Walker L, Attems J, Arzberger T (2015) Frontotemporal lobar degeneration FTLD-tau: preclinical lesions, vascular, and Alzheimer-related co-pathologies. J Neural Transm (Vienna) 122:1007–1018CrossRef Thal DR, von Arnim CA, Griffin WS, Mrak RE, Walker L, Attems J, Arzberger T (2015) Frontotemporal lobar degeneration FTLD-tau: preclinical lesions, vascular, and Alzheimer-related co-pathologies. J Neural Transm (Vienna) 122:1007–1018CrossRef
Zurück zum Zitat Thobois S, Prange S, Sgambato-Faure V, Tremblay L, Broussolle E (2017) Imaging the etiology of apathy, anxiety, and depression in Parkinson’s disease: implication for treatment. Curr Neurol Neurosci Rep 17:76CrossRefPubMed Thobois S, Prange S, Sgambato-Faure V, Tremblay L, Broussolle E (2017) Imaging the etiology of apathy, anxiety, and depression in Parkinson’s disease: implication for treatment. Curr Neurol Neurosci Rep 17:76CrossRefPubMed
Zurück zum Zitat Thomas AJ, Mahin-Babaei F, Saidi M, Lett D, Taylor JP, Walker L, Attems J (2018) Improving the identification of dementia with Lewy bodies in the context of an Alzheimer’s-type dementia. Alzheimers Res Ther 10:27CrossRefPubMedPubMedCentral Thomas AJ, Mahin-Babaei F, Saidi M, Lett D, Taylor JP, Walker L, Attems J (2018) Improving the identification of dementia with Lewy bodies in the context of an Alzheimer’s-type dementia. Alzheimers Res Ther 10:27CrossRefPubMedPubMedCentral
Zurück zum Zitat Thomas AJ, Donaghy P, Roberts G, Colloby SJ, Barnett NA, Petrides G, Lloyd J, Olsen K, Taylor JP, McKeith I, O’Brien JT (2019) Diagnostic accuracy of dopaminergic imaging in prodromal dementia with Lewy bodies. Psychol Med 49:396–402CrossRefPubMed Thomas AJ, Donaghy P, Roberts G, Colloby SJ, Barnett NA, Petrides G, Lloyd J, Olsen K, Taylor JP, McKeith I, O’Brien JT (2019) Diagnostic accuracy of dopaminergic imaging in prodromal dementia with Lewy bodies. Psychol Med 49:396–402CrossRefPubMed
Zurück zum Zitat Tiraboschi P, Attems J, Thomas A, Brown A, Jaros E, Lett DJ, Ossola M, Perry RH, Ramsay L, Walker L, McKeith IG (2015) Clinicians’ ability to diagnose dementia with Lewy bodies is not affected by beta-amyloid load. Neurology 84:496–499CrossRefPubMedPubMedCentral Tiraboschi P, Attems J, Thomas A, Brown A, Jaros E, Lett DJ, Ossola M, Perry RH, Ramsay L, Walker L, McKeith IG (2015) Clinicians’ ability to diagnose dementia with Lewy bodies is not affected by beta-amyloid load. Neurology 84:496–499CrossRefPubMedPubMedCentral
Zurück zum Zitat Titova N, Qamar MA, Chaudhuri KR (2017) The nonmotor features of Parkinson’s disease. Int Rev Neurobiol 132:33–54CrossRefPubMed Titova N, Qamar MA, Chaudhuri KR (2017) The nonmotor features of Parkinson’s disease. Int Rev Neurobiol 132:33–54CrossRefPubMed
Zurück zum Zitat Togo T, Cookson N, Dickson DW (2002) Argyrophilic grain disease: neuropathology, frequency in a dementia brain bank and lack of relationship with apolipoprotein E. Brain Pathol 12:45–52CrossRefPubMed Togo T, Cookson N, Dickson DW (2002) Argyrophilic grain disease: neuropathology, frequency in a dementia brain bank and lack of relationship with apolipoprotein E. Brain Pathol 12:45–52CrossRefPubMed
Zurück zum Zitat Tomiyama M (2017) Symptoms and pathophysiology of dyskinesias. Brain Nerve 69:1409–1416PubMed Tomiyama M (2017) Symptoms and pathophysiology of dyskinesias. Brain Nerve 69:1409–1416PubMed
Zurück zum Zitat Tomiyama H, Hatano T, Hattori N (2007) Clinical molecular genetics for PARK8 (LRRK2). Brain Nerve 59:839–850PubMed Tomiyama H, Hatano T, Hattori N (2007) Clinical molecular genetics for PARK8 (LRRK2). Brain Nerve 59:839–850PubMed
Zurück zum Zitat Tong J, Wong H, Guttman M, Ang LC, Forno LS, Shimadzu M, Rajput AH, Muenter MD, Kish SJ, Hornykiewicz O, Furukawa Y (2010) Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson’s disease and progressive supranuclear palsy: a comparative investigation. Brain 133:172–188CrossRefPubMed Tong J, Wong H, Guttman M, Ang LC, Forno LS, Shimadzu M, Rajput AH, Muenter MD, Kish SJ, Hornykiewicz O, Furukawa Y (2010) Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson’s disease and progressive supranuclear palsy: a comparative investigation. Brain 133:172–188CrossRefPubMed
Zurück zum Zitat Tran TN, Vo TNN, Frei K, Truong DD (2018) Levodopa-induced dyskinesia: clinical features, incidence, and risk factors. J Neural Transm (Vienna) 125:1109–1117CrossRef Tran TN, Vo TNN, Frei K, Truong DD (2018) Levodopa-induced dyskinesia: clinical features, incidence, and risk factors. J Neural Transm (Vienna) 125:1109–1117CrossRef
Zurück zum Zitat Trinh J, Zeldenrust FMJ, Huang J, Kasten M, Schaake S, Petkovic S, Madoev H, Grunewald A, Almuammar S, Konig IR, Lill CM, Lohmann K, Klein C, Marras C (2018) Genotype-phenotype relations for the Parkinson’s disease genes SNCA, LRRK2, VPS35: MDSGene systematic review. Mov Disord 33:1857–1870CrossRefPubMed Trinh J, Zeldenrust FMJ, Huang J, Kasten M, Schaake S, Petkovic S, Madoev H, Grunewald A, Almuammar S, Konig IR, Lill CM, Lohmann K, Klein C, Marras C (2018) Genotype-phenotype relations for the Parkinson’s disease genes SNCA, LRRK2, VPS35: MDSGene systematic review. Mov Disord 33:1857–1870CrossRefPubMed
Zurück zum Zitat Trojanowski JQ, Revesz T (2007) Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy. Neuropathol Appl Neurobiol 33:615–620CrossRefPubMed Trojanowski JQ, Revesz T (2007) Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy. Neuropathol Appl Neurobiol 33:615–620CrossRefPubMed
Zurück zum Zitat Tsang AH, Chung KK (2009) Oxidative and nitrosative stress in Parkinson’s disease. Biochim Biophys Acta 1792:643–650CrossRefPubMed Tsang AH, Chung KK (2009) Oxidative and nitrosative stress in Parkinson’s disease. Biochim Biophys Acta 1792:643–650CrossRefPubMed
Zurück zum Zitat Tzoulis C, Schwarzlmuller T, Biermann M, Haugarvoll K, Bindoff LA (2016) Mitochondrial DNA homeostasis is essential for nigrostriatal integrity. Mitochondrion 28:33–37CrossRefPubMed Tzoulis C, Schwarzlmuller T, Biermann M, Haugarvoll K, Bindoff LA (2016) Mitochondrial DNA homeostasis is essential for nigrostriatal integrity. Mitochondrion 28:33–37CrossRefPubMed
Zurück zum Zitat Ubhi K, Rockenstein E, Mante M, Inglis C, Adame A, Patrick C, Whitney K, Masliah E (2010) Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors. J Neurosci 30:6236–6246CrossRefPubMedPubMedCentral Ubhi K, Rockenstein E, Mante M, Inglis C, Adame A, Patrick C, Whitney K, Masliah E (2010) Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors. J Neurosci 30:6236–6246CrossRefPubMedPubMedCentral
Zurück zum Zitat Uchihara T (2014) Pretangles and neurofibrillary changes: Similarities and differences between AD and CBD based on molecular and morphological evolution. Neuropathology 34:571–577CrossRefPubMed Uchihara T (2014) Pretangles and neurofibrillary changes: Similarities and differences between AD and CBD based on molecular and morphological evolution. Neuropathology 34:571–577CrossRefPubMed
Zurück zum Zitat Uchikado H, DelleDonne A, Ahmed Z, Dickson DW (2006a) Lewy bodies in progressive supranuclear palsy represent an independent disease process. J Neuropathol Exp Neurol 65:387–395CrossRefPubMed Uchikado H, DelleDonne A, Ahmed Z, Dickson DW (2006a) Lewy bodies in progressive supranuclear palsy represent an independent disease process. J Neuropathol Exp Neurol 65:387–395CrossRefPubMed
Zurück zum Zitat Uchikado H, Lin WL, DeLucia MW, Dickson DW (2006b) Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol 65:685–697CrossRefPubMed Uchikado H, Lin WL, DeLucia MW, Dickson DW (2006b) Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol 65:685–697CrossRefPubMed
Zurück zum Zitat Uemura N, Yagi H, Uemura MT, Hatanaka Y, Yamakado H, Takahashi R (2018) Inoculation of alpha-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve. Mol Neurodegener 13:21CrossRefPubMedPubMedCentral Uemura N, Yagi H, Uemura MT, Hatanaka Y, Yamakado H, Takahashi R (2018) Inoculation of alpha-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve. Mol Neurodegener 13:21CrossRefPubMedPubMedCentral
Zurück zum Zitat Uitti RJ, Rajput AH, Ashenhurst EM, Rozdilsky B (1985) Cyanide-induced parkinsonism: a clinicopathologic report. Neurology 35:921–925CrossRefPubMed Uitti RJ, Rajput AH, Ashenhurst EM, Rozdilsky B (1985) Cyanide-induced parkinsonism: a clinicopathologic report. Neurology 35:921–925CrossRefPubMed
Zurück zum Zitat Vaikath NN, Erskine D, Morris CM, Majbour NK, Vekrellis K, Li JY, El-Agnaf OMA (2018) Heterogeneity in alpha-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer’s disease. Neuropathol Appl Neurobiol. https://doi.org/10.1111/nan.12531 CrossRefPubMed Vaikath NN, Erskine D, Morris CM, Majbour NK, Vekrellis K, Li JY, El-Agnaf OMA (2018) Heterogeneity in alpha-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer’s disease. Neuropathol Appl Neurobiol. https://​doi.​org/​10.​1111/​nan.​12531 CrossRefPubMed
Zurück zum Zitat Valdinocci D, Radford RAW, Goulding M, Hayashi J, Chung RS, Pountney DL (2018) Extracellular Interactions of alpha-synuclein in multiple system atrophy. Int J Mol Sci 19:4129CrossRefPubMedCentral Valdinocci D, Radford RAW, Goulding M, Hayashi J, Chung RS, Pountney DL (2018) Extracellular Interactions of alpha-synuclein in multiple system atrophy. Int J Mol Sci 19:4129CrossRefPubMedCentral
Zurück zum Zitat Valera E, Spencer B, Mott J, Trejo M, Adame A, Mante M, Rockenstein E, Troncoso JC, Beach TG, Masliah E, Desplats P (2017) MicroRNA-101 modulates autophagy and oligodendroglial alpha-synuclein accumulation in multiple system atrophy. Front Mol Neurosci 10:329CrossRefPubMedPubMedCentral Valera E, Spencer B, Mott J, Trejo M, Adame A, Mante M, Rockenstein E, Troncoso JC, Beach TG, Masliah E, Desplats P (2017) MicroRNA-101 modulates autophagy and oligodendroglial alpha-synuclein accumulation in multiple system atrophy. Front Mol Neurosci 10:329CrossRefPubMedPubMedCentral
Zurück zum Zitat van de Berg WD, Hepp DH, Dijkstra AA, Rozemuller JA, Berendse HW, Foncke E (2012) Patterns of alpha-synuclein pathology in incidental cases and clinical subtypes of Parkinson’s disease. Parkinsonism Relat Disord 18(Suppl 1):S28–S30CrossRefPubMed van de Berg WD, Hepp DH, Dijkstra AA, Rozemuller JA, Berendse HW, Foncke E (2012) Patterns of alpha-synuclein pathology in incidental cases and clinical subtypes of Parkinson’s disease. Parkinsonism Relat Disord 18(Suppl 1):S28–S30CrossRefPubMed
Zurück zum Zitat Van Do B, Gouel F, Jonneaux A, Timmerman K, Gele P, Petrault M, Bastide M, Laloux C, Moreau C, Bordet R, Devos D, Devedjian JC (2016) Ferroptosis, a newly characterized form of cell death in Parkinson’s disease that is regulated by PKC. Neurobiol Dis 94:169–178CrossRef Van Do B, Gouel F, Jonneaux A, Timmerman K, Gele P, Petrault M, Bastide M, Laloux C, Moreau C, Bordet R, Devos D, Devedjian JC (2016) Ferroptosis, a newly characterized form of cell death in Parkinson’s disease that is regulated by PKC. Neurobiol Dis 94:169–178CrossRef
Zurück zum Zitat Vasili E, Dominguez-Meijide A, Outeiro TF (2019) Spreading of alpha-synuclein and tau: a systematic comparison of the mechanisms involved. Front Mol Neurosci 12:107CrossRefPubMedPubMedCentral Vasili E, Dominguez-Meijide A, Outeiro TF (2019) Spreading of alpha-synuclein and tau: a systematic comparison of the mechanisms involved. Front Mol Neurosci 12:107CrossRefPubMedPubMedCentral
Zurück zum Zitat Vergouw LJM, van Steenoven I, van de Berg WDJ, Teunissen CE, van Swieten JC, Bonifati V, Lemstra AW, de Jong FJ (2017) An update on the genetics of dementia with Lewy bodies. Parkinsonism Relat Disord 43:1–8CrossRefPubMed Vergouw LJM, van Steenoven I, van de Berg WDJ, Teunissen CE, van Swieten JC, Bonifati V, Lemstra AW, de Jong FJ (2017) An update on the genetics of dementia with Lewy bodies. Parkinsonism Relat Disord 43:1–8CrossRefPubMed
Zurück zum Zitat Verheijen BM, Oyanagi K, van Leeuwen FW (2018) Dysfunction of protein quality control in parkinsonism–dementia complex of Guam. Front Neurol 9:173CrossRefPubMedPubMedCentral Verheijen BM, Oyanagi K, van Leeuwen FW (2018) Dysfunction of protein quality control in parkinsonism–dementia complex of Guam. Front Neurol 9:173CrossRefPubMedPubMedCentral
Zurück zum Zitat Vermeiren Y, De Deyn PP (2017) Targeting the norepinephrinergic system in Parkinson’s disease and related disorders: the locus coeruleus story. Neurochem Int 102:22–32CrossRefPubMed Vermeiren Y, De Deyn PP (2017) Targeting the norepinephrinergic system in Parkinson’s disease and related disorders: the locus coeruleus story. Neurochem Int 102:22–32CrossRefPubMed
Zurück zum Zitat Verstraeten A, Theuns J, Van Broeckhoven C (2015) Progress in unraveling the genetic etiology of Parkinson disease in a genomic era. Trends Genet 31:140–149CrossRefPubMed Verstraeten A, Theuns J, Van Broeckhoven C (2015) Progress in unraveling the genetic etiology of Parkinson disease in a genomic era. Trends Genet 31:140–149CrossRefPubMed
Zurück zum Zitat Veys L, Vandenabeele M, Ortuno-Lizaran I, Baekelandt V, Cuenca N, Moons L, De Groef L (2019) Retinal alpha-synuclein deposits in Parkinson’s disease patients and animal models. Acta Neuropathol 137:379–395CrossRefPubMed Veys L, Vandenabeele M, Ortuno-Lizaran I, Baekelandt V, Cuenca N, Moons L, De Groef L (2019) Retinal alpha-synuclein deposits in Parkinson’s disease patients and animal models. Acta Neuropathol 137:379–395CrossRefPubMed
Zurück zum Zitat Vilensky JA (ed) (2011) Encephalitis lethargica: during and after the epidemic. Oxford University Press, Oxford Vilensky JA (ed) (2011) Encephalitis lethargica: during and after the epidemic. Oxford University Press, Oxford
Zurück zum Zitat Virmani T, Moskowitz CB, Vonsattel JP, Fahn S (2015) Clinicopathological characteristics of freezing of gait in autopsy-confirmed Parkinson’s disease. Mov Disord 30:1874–1884CrossRefPubMed Virmani T, Moskowitz CB, Vonsattel JP, Fahn S (2015) Clinicopathological characteristics of freezing of gait in autopsy-confirmed Parkinson’s disease. Mov Disord 30:1874–1884CrossRefPubMed
Zurück zum Zitat Volpicelli-Daley LA (2017) Effects of alpha-synuclein on axonal transport. Neurobiol Dis 105:321–327CrossRefPubMed Volpicelli-Daley LA (2017) Effects of alpha-synuclein on axonal transport. Neurobiol Dis 105:321–327CrossRefPubMed
Zurück zum Zitat Volta M, Milnerwood AJ, Farrer MJ (2015) Insights from late-onset familial parkinsonism on the pathogenesis of idiopathic Parkinson’s disease. Lancet Neurol 14:1054–1064CrossRefPubMed Volta M, Milnerwood AJ, Farrer MJ (2015) Insights from late-onset familial parkinsonism on the pathogenesis of idiopathic Parkinson’s disease. Lancet Neurol 14:1054–1064CrossRefPubMed
Zurück zum Zitat Voon V, Napier TC, Frank MJ, Sgambato-Faure V, Grace AA, Rodriguez-Oroz M, Obeso J, Bezard E, Fernagut PO (2017) Impulse control disorders and levodopa-induced dyskinesias in Parkinson’s disease: an update. Lancet Neurol 16:238–250CrossRefPubMed Voon V, Napier TC, Frank MJ, Sgambato-Faure V, Grace AA, Rodriguez-Oroz M, Obeso J, Bezard E, Fernagut PO (2017) Impulse control disorders and levodopa-induced dyskinesias in Parkinson’s disease: an update. Lancet Neurol 16:238–250CrossRefPubMed
Zurück zum Zitat Voronkov DN, Salkov VN, Anufriev PL, Khudoerkov RM (2018) Lewy bodies in Parkinson’s disease: histological, immunohistochemical, and interferometric examinations. Arkhiv Patologii 80:9–13CrossRefPubMed Voronkov DN, Salkov VN, Anufriev PL, Khudoerkov RM (2018) Lewy bodies in Parkinson’s disease: histological, immunohistochemical, and interferometric examinations. Arkhiv Patologii 80:9–13CrossRefPubMed
Zurück zum Zitat Voutsinas GE, Stavrou EF, Karousos G, Dasoula A, Papachatzopoulou A, Syrrou M, Verkerk AJ, van der Spek P, Patrinos GP, Stoger R, Athanassiadou A (2010) Allelic imbalance of expression and epigenetic regulation within the alpha-synuclein wild-type and p.Ala53Thr alleles in Parkinson disease. Hum Mutat 31:685–691CrossRefPubMed Voutsinas GE, Stavrou EF, Karousos G, Dasoula A, Papachatzopoulou A, Syrrou M, Verkerk AJ, van der Spek P, Patrinos GP, Stoger R, Athanassiadou A (2010) Allelic imbalance of expression and epigenetic regulation within the alpha-synuclein wild-type and p.Ala53Thr alleles in Parkinson disease. Hum Mutat 31:685–691CrossRefPubMed
Zurück zum Zitat Vriend C, Raijmakers P, Veltman DJ, van Dijk KD, van der Werf YD, Foncke EM, Smit JH, Berendse HW, van den Heuvel OA (2014) Depressive symptoms in Parkinson’s disease are related to reduced [123I]FP-CIT binding in the caudate nucleus. J Neurol Neurosurg Psychiatry 85:159–164CrossRefPubMed Vriend C, Raijmakers P, Veltman DJ, van Dijk KD, van der Werf YD, Foncke EM, Smit JH, Berendse HW, van den Heuvel OA (2014) Depressive symptoms in Parkinson’s disease are related to reduced [123I]FP-CIT binding in the caudate nucleus. J Neurol Neurosurg Psychiatry 85:159–164CrossRefPubMed
Zurück zum Zitat Wakabayashi K, Miki Y (2018) Multi-organ distribution of alpha-synuclein pathology in dementia with Lewy bodies. Brain Nerve 70:489–500PubMed Wakabayashi K, Miki Y (2018) Multi-organ distribution of alpha-synuclein pathology in dementia with Lewy bodies. Brain Nerve 70:489–500PubMed
Zurück zum Zitat Wakabayashi K, Mori F, Nishie M, Oyama Y, Kurihara A, Yoshimoto M, Kuroda N (2005) An autopsy case of early (“minimal change”) olivopontocerebellar atrophy (multiple system atrophy-cerebellar). Acta Neuropathol 110:185–190CrossRefPubMed Wakabayashi K, Mori F, Nishie M, Oyama Y, Kurihara A, Yoshimoto M, Kuroda N (2005) An autopsy case of early (“minimal change”) olivopontocerebellar atrophy (multiple system atrophy-cerebellar). Acta Neuropathol 110:185–190CrossRefPubMed
Zurück zum Zitat Wakabayashi K, Mori F, Tanji K, Orimo S, Takahashi H (2010) Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain. Acta Neuropathol 120:1–12CrossRefPubMed Wakabayashi K, Mori F, Tanji K, Orimo S, Takahashi H (2010) Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain. Acta Neuropathol 120:1–12CrossRefPubMed
Zurück zum Zitat Wakabayashi K, Tanji K, Odagiri S, Miki Y, Mori F, Takahashi H (2013) The Lewy body in Parkinson’s disease and related neurodegenerative disorders. Mol Neurobiol 47:495–508CrossRefPubMed Wakabayashi K, Tanji K, Odagiri S, Miki Y, Mori F, Takahashi H (2013) The Lewy body in Parkinson’s disease and related neurodegenerative disorders. Mol Neurobiol 47:495–508CrossRefPubMed
Zurück zum Zitat Walker DG, Lue LF, Adler CH, Shill HA, Caviness JN, Sabbagh MN, Akiyama H, Serrano GE, Sue LI, Beach TG (2013) Changes in properties of serine 129 phosphorylated alpha-synuclein with progression of Lewy-type histopathology in human brains. Exp Neurol 240:190–204CrossRefPubMed Walker DG, Lue LF, Adler CH, Shill HA, Caviness JN, Sabbagh MN, Akiyama H, Serrano GE, Sue LI, Beach TG (2013) Changes in properties of serine 129 phosphorylated alpha-synuclein with progression of Lewy-type histopathology in human brains. Exp Neurol 240:190–204CrossRefPubMed
Zurück zum Zitat Walker L, McAleese KE, Thomas AJ, Johnson M, Martin-Ruiz C, Parker C, Colloby SJ, Jellinger K, Attems J (2015) Neuropathologically mixed Alzheimer’s and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes. Acta Neuropathol 129:729–748CrossRefPubMed Walker L, McAleese KE, Thomas AJ, Johnson M, Martin-Ruiz C, Parker C, Colloby SJ, Jellinger K, Attems J (2015) Neuropathologically mixed Alzheimer’s and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes. Acta Neuropathol 129:729–748CrossRefPubMed
Zurück zum Zitat Wang Y, Balaji V, Kaniyappan S, Kruger L, Irsen S, Tepper K, Chandupatla R, Maetzler W, Schneider A, Mandelkow E, Mandelkow EM (2017) The release and trans-synaptic transmission of Tau via exosomes. Mol Neurodegener 12:5CrossRefPubMedPubMedCentral Wang Y, Balaji V, Kaniyappan S, Kruger L, Irsen S, Tepper K, Chandupatla R, Maetzler W, Schneider A, Mandelkow E, Mandelkow EM (2017) The release and trans-synaptic transmission of Tau via exosomes. Mol Neurodegener 12:5CrossRefPubMedPubMedCentral
Zurück zum Zitat Wang B, Underwood R, Kamath A, Britain C, McFerrin MB, McLean PJ, Volpicelli-Daley LA, Whitaker RH, Placzek WJ, Becker K, Ma J, Yacoubian TA (2018) 14-3-3 proteins reduce cell-to-cell transfer and propagation of pathogenic alpha-synuclein. J Neurosci 38:8211–8232CrossRefPubMedPubMedCentral Wang B, Underwood R, Kamath A, Britain C, McFerrin MB, McLean PJ, Volpicelli-Daley LA, Whitaker RH, Placzek WJ, Becker K, Ma J, Yacoubian TA (2018) 14-3-3 proteins reduce cell-to-cell transfer and propagation of pathogenic alpha-synuclein. J Neurosci 38:8211–8232CrossRefPubMedPubMedCentral
Zurück zum Zitat Wang X, Becker K, Levine N, Zhang M, Lieberman AP, Moore DJ, Ma J (2019) Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration. Acta Neuropathol Commun 7:41CrossRefPubMedPubMedCentral Wang X, Becker K, Levine N, Zhang M, Lieberman AP, Moore DJ, Ma J (2019) Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration. Acta Neuropathol Commun 7:41CrossRefPubMedPubMedCentral
Zurück zum Zitat Waring SC, Esteban-Santillan C, Reed DM, Craig UK, Labarthe DR, Petersen RC, Kurland LT (2004) Incidence of amyotrophic lateral sclerosis and of the parkinsonism-dementia complex of Guam, 1950-1989. Neuroepidemiology 23:192–200CrossRefPubMed Waring SC, Esteban-Santillan C, Reed DM, Craig UK, Labarthe DR, Petersen RC, Kurland LT (2004) Incidence of amyotrophic lateral sclerosis and of the parkinsonism-dementia complex of Guam, 1950-1989. Neuroepidemiology 23:192–200CrossRefPubMed
Zurück zum Zitat Watanabe H, Riku Y, Nakamura T, Hara K, Ito M, Hirayama M, Yoshida M, Katsuno M, Sobue G (2016) Expanding concept of clinical conditions and symptoms in multiple system atrophy. Rinsho Shinkeigaku 56:457–464CrossRefPubMed Watanabe H, Riku Y, Nakamura T, Hara K, Ito M, Hirayama M, Yoshida M, Katsuno M, Sobue G (2016) Expanding concept of clinical conditions and symptoms in multiple system atrophy. Rinsho Shinkeigaku 56:457–464CrossRefPubMed
Zurück zum Zitat Wei L, Hu X, Yuan Y, Liu W, Chen H (2018) Abnormal ventral tegmental area-anterior cingulate cortex connectivity in Parkinson’s disease with depression. Behav Brain Res 347:132–139CrossRefPubMed Wei L, Hu X, Yuan Y, Liu W, Chen H (2018) Abnormal ventral tegmental area-anterior cingulate cortex connectivity in Parkinson’s disease with depression. Behav Brain Res 347:132–139CrossRefPubMed
Zurück zum Zitat Weismiller HA, Murphy R, Wei G, Ma B, Nussinov R, Margittai M (2018) Structural disorder in four-repeat Tau fibrils reveals a new mechanism for barriers to cross-seeding of Tau isoforms. J Biol Chem 293:17336–17348CrossRefPubMedPubMedCentral Weismiller HA, Murphy R, Wei G, Ma B, Nussinov R, Margittai M (2018) Structural disorder in four-repeat Tau fibrils reveals a new mechanism for barriers to cross-seeding of Tau isoforms. J Biol Chem 293:17336–17348CrossRefPubMedPubMedCentral
Zurück zum Zitat Wenning GK, Quinn N, Magalhaes M, Mathias C, Daniel SE (1994) “Minimal change” multiple system atrophy. Mov Disord 9:161–166CrossRefPubMed Wenning GK, Quinn N, Magalhaes M, Mathias C, Daniel SE (1994) “Minimal change” multiple system atrophy. Mov Disord 9:161–166CrossRefPubMed
Zurück zum Zitat Wenning GK, Jellinger K, Litvan I (1997) Supranuclear gaze palsy and eyelid apraxia in postencephalitic parkinsonism. J Neural Transm 104:845–865CrossRefPubMed Wenning GK, Jellinger K, Litvan I (1997) Supranuclear gaze palsy and eyelid apraxia in postencephalitic parkinsonism. J Neural Transm 104:845–865CrossRefPubMed
Zurück zum Zitat Wenning GK, Litvan I, Tolosa E (2011) Milestones in atypical and secondary parkinsonisms. Mov Disord 26:1083–1095CrossRefPubMed Wenning GK, Litvan I, Tolosa E (2011) Milestones in atypical and secondary parkinsonisms. Mov Disord 26:1083–1095CrossRefPubMed
Zurück zum Zitat Wenning GK, Geser F, Krismer F, Seppi K, Duerr S, Boesch S, Kollensperger M, Goebel G, Pfeiffer KP, Barone P, Pellecchia MT, Quinn NP, Koukouni V, Fowler CJ, Schrag A, Mathias CJ, Giladi N, Gurevich T, Dupont E, Ostergaard K, Nilsson CF, Widner H, Oertel W, Eggert KM, Albanese A, del Sorbo F, Tolosa E, Cardozo A, Deuschl G, Hellriegel H, Klockgether T, Dodel R, Sampaio C, Coelho M, Djaldetti R, Melamed E, Gasser T, Kamm C, Meco G, Colosimo C, Rascol O, Meissner WG, Tison F, Poewe W (2013) The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol 12:264–274CrossRefPubMedPubMedCentral Wenning GK, Geser F, Krismer F, Seppi K, Duerr S, Boesch S, Kollensperger M, Goebel G, Pfeiffer KP, Barone P, Pellecchia MT, Quinn NP, Koukouni V, Fowler CJ, Schrag A, Mathias CJ, Giladi N, Gurevich T, Dupont E, Ostergaard K, Nilsson CF, Widner H, Oertel W, Eggert KM, Albanese A, del Sorbo F, Tolosa E, Cardozo A, Deuschl G, Hellriegel H, Klockgether T, Dodel R, Sampaio C, Coelho M, Djaldetti R, Melamed E, Gasser T, Kamm C, Meco G, Colosimo C, Rascol O, Meissner WG, Tison F, Poewe W (2013) The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol 12:264–274CrossRefPubMedPubMedCentral
Zurück zum Zitat Wenning G, Trojanowski JQ, Kaufmann H, Wisniewski T, Rocca WA, Low PA (2018) Is multiple system atrophy an infectious disease? Ann Neurol 83:10–12CrossRefPubMedPubMedCentral Wenning G, Trojanowski JQ, Kaufmann H, Wisniewski T, Rocca WA, Low PA (2018) Is multiple system atrophy an infectious disease? Ann Neurol 83:10–12CrossRefPubMedPubMedCentral
Zurück zum Zitat Wichmann T, Bergman H, DeLong MR (2018) Basal ganglia, movement disorders and deep brain stimulation: advances made through non-human primate research. J Neural Transm (Vienna) 125:419–430CrossRef Wichmann T, Bergman H, DeLong MR (2018) Basal ganglia, movement disorders and deep brain stimulation: advances made through non-human primate research. J Neural Transm (Vienna) 125:419–430CrossRef
Zurück zum Zitat Wider C, Dickson DW, Stoessl AJ, Tsuboi Y, Chapon F, Gutmann L, Lechevalier B, Calne DB, Personett DA, Hulihan M, Kachergus J, Rademakers R, Baker MC, Grantier LL, Sujith OK, Brown L, Calne S, Farrer MJ, Wszolek ZK (2009) Pallidonigral TDP-43 pathology in Perry syndrome. Parkinsonism Relat Disord 15:281–286CrossRefPubMed Wider C, Dickson DW, Stoessl AJ, Tsuboi Y, Chapon F, Gutmann L, Lechevalier B, Calne DB, Personett DA, Hulihan M, Kachergus J, Rademakers R, Baker MC, Grantier LL, Sujith OK, Brown L, Calne S, Farrer MJ, Wszolek ZK (2009) Pallidonigral TDP-43 pathology in Perry syndrome. Parkinsonism Relat Disord 15:281–286CrossRefPubMed
Zurück zum Zitat Wilkaniec A, Lenkiewicz AM, Czapski GA, Jesko HM, Hilgier W, Brodzik R, Gassowska-Dobrowolska M, Culmsee C, Adamczyk A (2019) Extracellular alpha-synuclein oligomers induce parkin s-nitrosylation: relevance to sporadic Parkinson’s disease etiopathology. Mol Neurobiol 56:125–140CrossRefPubMed Wilkaniec A, Lenkiewicz AM, Czapski GA, Jesko HM, Hilgier W, Brodzik R, Gassowska-Dobrowolska M, Culmsee C, Adamczyk A (2019) Extracellular alpha-synuclein oligomers induce parkin s-nitrosylation: relevance to sporadic Parkinson’s disease etiopathology. Mol Neurobiol 56:125–140CrossRefPubMed
Zurück zum Zitat Williams DR, Holton JL, Strand K, de Silva R, Lees AJ, Revesz T (2007) Differences in tau load are associated with different clinical phenotypes in progressive supranuclear palsy observations (abstr.). Neuropathol Appl Neurobiol 33:248–275CrossRef Williams DR, Holton JL, Strand K, de Silva R, Lees AJ, Revesz T (2007) Differences in tau load are associated with different clinical phenotypes in progressive supranuclear palsy observations (abstr.). Neuropathol Appl Neurobiol 33:248–275CrossRef
Zurück zum Zitat Williams-Gray CH, Foltynie T, Lewis SJ, Barker RA (2006) Cognitive deficits and psychosis in Parkinson’s disease: a review of pathophysiology and therapeutic options. CNS Drugs 20:477–505CrossRefPubMed Williams-Gray CH, Foltynie T, Lewis SJ, Barker RA (2006) Cognitive deficits and psychosis in Parkinson’s disease: a review of pathophysiology and therapeutic options. CNS Drugs 20:477–505CrossRefPubMed
Zurück zum Zitat Wilson H, Niccolini F, Pellicano C, Politis M (2019) Cortical thinning across Parkinson’s disease stages and clinical correlates. J Neurol Sci 398:31–38CrossRefPubMed Wilson H, Niccolini F, Pellicano C, Politis M (2019) Cortical thinning across Parkinson’s disease stages and clinical correlates. J Neurol Sci 398:31–38CrossRefPubMed
Zurück zum Zitat Woerman AL, Kazmi SA, Patel S, Freyman Y, Oehler A, Aoyagi A, Mordes DA, Halliday GM, Middleton LT, Gentleman SM, Olson SH, Prusiner SB (2018) MSA prions exhibit remarkable stability and resistance to inactivation. Acta Neuropathol 135:49–63CrossRefPubMed Woerman AL, Kazmi SA, Patel S, Freyman Y, Oehler A, Aoyagi A, Mordes DA, Halliday GM, Middleton LT, Gentleman SM, Olson SH, Prusiner SB (2018) MSA prions exhibit remarkable stability and resistance to inactivation. Acta Neuropathol 135:49–63CrossRefPubMed
Zurück zum Zitat Woerman AL, Oehler A, Kazmi SA, Lee J, Halliday GM, Middleton LT, Gentleman SM, Mordes DA, Spina S, Grinberg LT, Olson SH, Prusiner SB (2019) Multiple system atrophy prions retain strain specificity after serial propagation in two different Tg(SNCA*A53T) mouse lines. Acta Neuropathol 137:437–454CrossRefPubMedPubMedCentral Woerman AL, Oehler A, Kazmi SA, Lee J, Halliday GM, Middleton LT, Gentleman SM, Mordes DA, Spina S, Grinberg LT, Olson SH, Prusiner SB (2019) Multiple system atrophy prions retain strain specificity after serial propagation in two different Tg(SNCA*A53T) mouse lines. Acta Neuropathol 137:437–454CrossRefPubMedPubMedCentral
Zurück zum Zitat Wszolek ZK, Slowinski J, Golan M, Dickson DW (2005) Frontotemporal dementia and parkinsonism linked to chromosome 17. Folia Neuropathol 43:258–270PubMed Wszolek ZK, Slowinski J, Golan M, Dickson DW (2005) Frontotemporal dementia and parkinsonism linked to chromosome 17. Folia Neuropathol 43:258–270PubMed
Zurück zum Zitat Xia Y, Zhang G, Han C, Ma K, Guo X, Wan F, Kou L, Yin S, Liu L, Huang J, Xiong N, Wang T (2019) Microglia as modulators of exosomal alpha-synuclein transmission. Cell Death Dis 10:174CrossRefPubMedPubMedCentral Xia Y, Zhang G, Han C, Ma K, Guo X, Wan F, Kou L, Yin S, Liu L, Huang J, Xiong N, Wang T (2019) Microglia as modulators of exosomal alpha-synuclein transmission. Cell Death Dis 10:174CrossRefPubMedPubMedCentral
Zurück zum Zitat Yabe I, Soma H, Takei A, Fujiki N, Yanagihara T, Sasaki H (2006) MSA-C is the predominant clinical phenotype of MSA in Japan: analysis of 142 patients with probable MSA. J Neurol Sci 249:115–121CrossRefPubMed Yabe I, Soma H, Takei A, Fujiki N, Yanagihara T, Sasaki H (2006) MSA-C is the predominant clinical phenotype of MSA in Japan: analysis of 142 patients with probable MSA. J Neurol Sci 249:115–121CrossRefPubMed
Zurück zum Zitat Yamasaki TR, Holmes BB, Furman JL, Dhavale DD, Su BW, Song ES, Cairns NJ, Kotzbauer PT, Diamond MI (2019) Parkinson’s disease and multiple system atrophy have distinct alpha-synuclein seed characteristics. J Biol Chem 294:1045–1058CrossRefPubMed Yamasaki TR, Holmes BB, Furman JL, Dhavale DD, Su BW, Song ES, Cairns NJ, Kotzbauer PT, Diamond MI (2019) Parkinson’s disease and multiple system atrophy have distinct alpha-synuclein seed characteristics. J Biol Chem 294:1045–1058CrossRefPubMed
Zurück zum Zitat Yamashita S, Sakashita N, Yamashita T, Tawara N, Tasaki M, Kawakami K, Komohara Y, Fujiwara Y, Kamikawa M, Nakagawa T, Hirano T, Maeda Y, Hasegawa M, Takeya M, Ando Y (2014) Concomitant accumulation of alpha-synuclein and TDP-43 in a patient with corticobasal degeneration. J Neurol 261:2209–2217CrossRefPubMed Yamashita S, Sakashita N, Yamashita T, Tawara N, Tasaki M, Kawakami K, Komohara Y, Fujiwara Y, Kamikawa M, Nakagawa T, Hirano T, Maeda Y, Hasegawa M, Takeya M, Ando Y (2014) Concomitant accumulation of alpha-synuclein and TDP-43 in a patient with corticobasal degeneration. J Neurol 261:2209–2217CrossRefPubMed
Zurück zum Zitat Yamazaki M, Hasegawa M, Mori O, Murayama S, Tsuchiya K, Ikeda K, Chen KM, Katayama Y, Oyanagi K (2005) Tau-positive fine granules in the cerebral white matter: a novel finding among the tauopathies exclusive to parkinsonism-dementia complex of Guam. J Neuropathol Exp Neurol 64:839–846CrossRefPubMed Yamazaki M, Hasegawa M, Mori O, Murayama S, Tsuchiya K, Ikeda K, Chen KM, Katayama Y, Oyanagi K (2005) Tau-positive fine granules in the cerebral white matter: a novel finding among the tauopathies exclusive to parkinsonism-dementia complex of Guam. J Neuropathol Exp Neurol 64:839–846CrossRefPubMed
Zurück zum Zitat Yang HS, Yu L, White CC, Chibnik LB, Chhatwal JP, Sperling RA, Bennett DA, Schneider JA, De Jager PL (2018) Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE epsilon4 haplotype status: a community-based cohort study. Lancet Neurol 17:773–781CrossRefPubMedPubMedCentral Yang HS, Yu L, White CC, Chibnik LB, Chhatwal JP, Sperling RA, Bennett DA, Schneider JA, De Jager PL (2018) Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE epsilon4 haplotype status: a community-based cohort study. Lancet Neurol 17:773–781CrossRefPubMedPubMedCentral
Zurück zum Zitat Yasuda T, Nakata Y, Mochizuki H (2013) Alpha-synuclein and neuronal cell death. Mol Neurobiol 47:466–483CrossRefPubMed Yasuda T, Nakata Y, Mochizuki H (2013) Alpha-synuclein and neuronal cell death. Mol Neurobiol 47:466–483CrossRefPubMed
Zurück zum Zitat Yokota O, Tsuchiya K, Terada S, Ishizu H, Uchikado H, Ikeda M, Oyanagi K, Nakano I, Murayama S, Kuroda S, Akiyama H (2008) Basophilic inclusion body disease and neuronal intermediate filament inclusion disease: a comparative clinicopathological study. Acta Neuropathol 115:561–575CrossRefPubMed Yokota O, Tsuchiya K, Terada S, Ishizu H, Uchikado H, Ikeda M, Oyanagi K, Nakano I, Murayama S, Kuroda S, Akiyama H (2008) Basophilic inclusion body disease and neuronal intermediate filament inclusion disease: a comparative clinicopathological study. Acta Neuropathol 115:561–575CrossRefPubMed
Zurück zum Zitat Yokoyama Y, Toyoshima Y, Shiga A, Tada M, Kitamura H, Hasegawa K, Onodera O, Ikeuchi T, Someya T, Nishizawa M, Kakita A, Takahashi H (2016) Pathological and clinical spectrum of progressive supranuclear palsy: with special reference to astrocytic tau pathology. Brain Pathol 26:155–166CrossRefPubMed Yokoyama Y, Toyoshima Y, Shiga A, Tada M, Kitamura H, Hasegawa K, Onodera O, Ikeuchi T, Someya T, Nishizawa M, Kakita A, Takahashi H (2016) Pathological and clinical spectrum of progressive supranuclear palsy: with special reference to astrocytic tau pathology. Brain Pathol 26:155–166CrossRefPubMed
Zurück zum Zitat Yokoyama JS, Karch CM, Fan CC, Bonham LW, Kouri N, Ross OA, Rademakers R, Kim J, Wang Y, Hoglinger GU, Muller U, Ferrari R, Hardy J, Momeni P, Sugrue LP, Hess CP, James Barkovich A, Boxer AL, Seeley WW, Rabinovici GD, Rosen HJ, Miller BL, Schmansky NJ, Fischl B, Hyman BT, Dickson DW, Schellenberg GD, Andreassen OA, Dale AM, Desikan RS (2017) Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia. Acta Neuropathol 133:825–837CrossRefPubMedPubMedCentral Yokoyama JS, Karch CM, Fan CC, Bonham LW, Kouri N, Ross OA, Rademakers R, Kim J, Wang Y, Hoglinger GU, Muller U, Ferrari R, Hardy J, Momeni P, Sugrue LP, Hess CP, James Barkovich A, Boxer AL, Seeley WW, Rabinovici GD, Rosen HJ, Miller BL, Schmansky NJ, Fischl B, Hyman BT, Dickson DW, Schellenberg GD, Andreassen OA, Dale AM, Desikan RS (2017) Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia. Acta Neuropathol 133:825–837CrossRefPubMedPubMedCentral
Zurück zum Zitat Yoshida M (2014) Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration. Neuropathology 34:555–570CrossRefPubMed Yoshida M (2014) Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration. Neuropathology 34:555–570CrossRefPubMed
Zurück zum Zitat Yoshida K, Hata Y, Kinoshita K, Takashima S, Tanaka K, Nishida N (2017) Incipient progressive supranuclear palsy is more common than expected and may comprise clinicopathological subtypes: a forensic autopsy series. Acta Neuropathol 133:809–823CrossRefPubMed Yoshida K, Hata Y, Kinoshita K, Takashima S, Tanaka K, Nishida N (2017) Incipient progressive supranuclear palsy is more common than expected and may comprise clinicopathological subtypes: a forensic autopsy series. Acta Neuropathol 133:809–823CrossRefPubMed
Zurück zum Zitat Yoshino H, Nishioka K, Li Y, Oji Y, Oyama G, Hatano T, Machida Y, Shimo Y, Hayashida A, Ikeda A, Mogushi K, Shibagaki Y, Hosaka A, Iwanaga H, Fujitake J, Ohi T, Miyazaki D, Sekijima Y, Oki M, Kusaka H, Fujimoto KI, Ugawa Y, Funayama M, Hattori N (2018) GCH1 mutations in dopa-responsive dystonia and Parkinson’s disease. J Neurol 265:1860–1870CrossRefPubMed Yoshino H, Nishioka K, Li Y, Oji Y, Oyama G, Hatano T, Machida Y, Shimo Y, Hayashida A, Ikeda A, Mogushi K, Shibagaki Y, Hosaka A, Iwanaga H, Fujitake J, Ohi T, Miyazaki D, Sekijima Y, Oki M, Kusaka H, Fujimoto KI, Ugawa Y, Funayama M, Hattori N (2018) GCH1 mutations in dopa-responsive dystonia and Parkinson’s disease. J Neurol 265:1860–1870CrossRefPubMed
Zurück zum Zitat Young CB, Sonne J (2018) Neuroanatomy, Basal Ganglia. StatPearls Publishing, Treasure Island Young CB, Sonne J (2018) Neuroanatomy, Basal Ganglia. StatPearls Publishing, Treasure Island
Zurück zum Zitat Yousaf T, Dervenoulas G, Valkimadi PE, Politis M (2019) Neuroimaging in Lewy body dementia. J Neurol 266:1–26CrossRefPubMed Yousaf T, Dervenoulas G, Valkimadi PE, Politis M (2019) Neuroimaging in Lewy body dementia. J Neurol 266:1–26CrossRefPubMed
Zurück zum Zitat Yuan X, Chen Y, Cao B, Zhao B, Wei Q, Guo X, Yang Y, Yuan L, Shang H (2015) An association analysis of the R1628P and G2385R polymorphisms of the LRRK2 gene in multiple system atrophy in a Chinese population. Parkinsonism Relat Disord 21:147–149CrossRefPubMed Yuan X, Chen Y, Cao B, Zhao B, Wei Q, Guo X, Yang Y, Yuan L, Shang H (2015) An association analysis of the R1628P and G2385R polymorphisms of the LRRK2 gene in multiple system atrophy in a Chinese population. Parkinsonism Relat Disord 21:147–149CrossRefPubMed
Zurück zum Zitat Zaccai J, Brayne C, McKeith I, Matthews F, Ince PG (2008) Patterns and stages of alpha-synucleinopathy: relevance in a population-based cohort. Neurology 70:1042–1048CrossRefPubMed Zaccai J, Brayne C, McKeith I, Matthews F, Ince PG (2008) Patterns and stages of alpha-synucleinopathy: relevance in a population-based cohort. Neurology 70:1042–1048CrossRefPubMed
Zurück zum Zitat Zaltieri M, Grigoletto J, Longhena F, Navarria L, Favero G, Castrezzati S, Colivicchi MA, Della Corte L, Rezzani R, Pizzi M, Benfenati F, Spillantini MG, Missale C, Spano P, Bellucci A (2015a) Alpha-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons. J Cell Sci 128:2231–2243CrossRefPubMed Zaltieri M, Grigoletto J, Longhena F, Navarria L, Favero G, Castrezzati S, Colivicchi MA, Della Corte L, Rezzani R, Pizzi M, Benfenati F, Spillantini MG, Missale C, Spano P, Bellucci A (2015a) Alpha-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons. J Cell Sci 128:2231–2243CrossRefPubMed
Zurück zum Zitat Zaltieri M, Longhena F, Pizzi M, Missale C, Spano P, Bellucci A (2015b) Mitochondrial dysfunction and alpha-synuclein synaptic pathology in Parkinson’s disease: who’s on first? Parkinsons Dis 2015:108029PubMedPubMedCentral Zaltieri M, Longhena F, Pizzi M, Missale C, Spano P, Bellucci A (2015b) Mitochondrial dysfunction and alpha-synuclein synaptic pathology in Parkinson’s disease: who’s on first? Parkinsons Dis 2015:108029PubMedPubMedCentral
Zurück zum Zitat Zange L, Noack C, Hahn K, Stenzel W, Lipp A (2015) Phosphorylated alpha-synuclein in skin nerve fibres differentiates Parkinson’s disease from multiple system atrophy. Brain 138:2310–2321CrossRefPubMed Zange L, Noack C, Hahn K, Stenzel W, Lipp A (2015) Phosphorylated alpha-synuclein in skin nerve fibres differentiates Parkinson’s disease from multiple system atrophy. Brain 138:2310–2321CrossRefPubMed
Zurück zum Zitat Zeng XS, Geng WS, Jia JJ, Chen L, Zhang PP (2018) Cellular and molecular basis of neurodegeneration in Parkinson disease. Front Aging Neurosci 10:109CrossRefPubMedPubMedCentral Zeng XS, Geng WS, Jia JJ, Chen L, Zhang PP (2018) Cellular and molecular basis of neurodegeneration in Parkinson disease. Front Aging Neurosci 10:109CrossRefPubMedPubMedCentral
Zurück zum Zitat Zhai S, Shen W, Graves SM, Surmeier DJ (2019) Dopaminergic modulation of striatal function and Parkinson’s disease. J Neural Transm (Vienna) 126:411–422CrossRef Zhai S, Shen W, Graves SM, Surmeier DJ (2019) Dopaminergic modulation of striatal function and Parkinson’s disease. J Neural Transm (Vienna) 126:411–422CrossRef
Zurück zum Zitat Zhang Y, Larcher KM, Misic B, Dagher A (2017) Anatomical and functional organization of the human substantia nigra and its connections. Elife 6:e26653CrossRefPubMedPubMedCentral Zhang Y, Larcher KM, Misic B, Dagher A (2017) Anatomical and functional organization of the human substantia nigra and its connections. Elife 6:e26653CrossRefPubMedPubMedCentral
Zurück zum Zitat Zhang G, Xia Y, Wan F, Ma K, Guo X, Kou L, Yin S, Han C, Liu L, Huang J, Xiong N, Wang T (2018a) New perspectives on roles of alpha-synuclein in Parkinson’s disease. Front Aging Neurosci 10:370CrossRefPubMedPubMedCentral Zhang G, Xia Y, Wan F, Ma K, Guo X, Kou L, Yin S, Han C, Liu L, Huang J, Xiong N, Wang T (2018a) New perspectives on roles of alpha-synuclein in Parkinson’s disease. Front Aging Neurosci 10:370CrossRefPubMedPubMedCentral
Zurück zum Zitat Zhao Q, Yang X, Tian S, An R, Zheng J, Xu Y (2016) Association of the COQ2 V393A variant with risk of multiple system atrophy in East Asians: a case-control study and meta-analysis of the literature. Neurol Sci 37:423–430CrossRefPubMed Zhao Q, Yang X, Tian S, An R, Zheng J, Xu Y (2016) Association of the COQ2 V393A variant with risk of multiple system atrophy in East Asians: a case-control study and meta-analysis of the literature. Neurol Sci 37:423–430CrossRefPubMed
Zurück zum Zitat Zhou ZD, Selvaratnam T, Lee JCT, Chao YX, Tan EK (2019) Molecular targets for modulating the protein translation vital to proteostasis and neuron degeneration in Parkinson’s disease. Transl Neurodegener 8:6CrossRefPubMedPubMedCentral Zhou ZD, Selvaratnam T, Lee JCT, Chao YX, Tan EK (2019) Molecular targets for modulating the protein translation vital to proteostasis and neuron degeneration in Parkinson’s disease. Transl Neurodegener 8:6CrossRefPubMedPubMedCentral
Zurück zum Zitat Zhu Y, Song X, Xu M, Hu X, Li E, Liu J, Yuan Y, Gao JH, Liu W (2016) Impaired interhemispheric synchrony in Parkinson’s disease with depression. Sci Rep 6:27477CrossRefPubMedPubMedCentral Zhu Y, Song X, Xu M, Hu X, Li E, Liu J, Yuan Y, Gao JH, Liu W (2016) Impaired interhemispheric synchrony in Parkinson’s disease with depression. Sci Rep 6:27477CrossRefPubMedPubMedCentral
Zurück zum Zitat Zhukareva V, Shah K, Uryu K, Braak H, Del Tredici K, Sundarraj S, Clark C, Trojanowski JQ, Lee VM (2002) Biochemical analysis of tau proteins in argyrophilic grain disease, Alzheimer’s disease, and Pick’s disease : a comparative study. Am J Pathol 161:1135–1141CrossRefPubMedPubMedCentral Zhukareva V, Shah K, Uryu K, Braak H, Del Tredici K, Sundarraj S, Clark C, Trojanowski JQ, Lee VM (2002) Biochemical analysis of tau proteins in argyrophilic grain disease, Alzheimer’s disease, and Pick’s disease : a comparative study. Am J Pathol 161:1135–1141CrossRefPubMedPubMedCentral
Zurück zum Zitat Zijlmans JC, Daniel SE, Hughes AJ, Revesz T, Lees AJ (2004) Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord 19:630–640CrossRefPubMed Zijlmans JC, Daniel SE, Hughes AJ, Revesz T, Lees AJ (2004) Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord 19:630–640CrossRefPubMed
Zurück zum Zitat Zondler L, Kostka M, Garidel P, Heinzelmann U, Hengerer B, Mayer B, Weishaupt JH, Gillardon F, Danzer KM (2017) Proteasome impairment by alpha-synuclein. PLoS One 12:e0184040CrossRefPubMedPubMedCentral Zondler L, Kostka M, Garidel P, Heinzelmann U, Hengerer B, Mayer B, Weishaupt JH, Gillardon F, Danzer KM (2017) Proteasome impairment by alpha-synuclein. PLoS One 12:e0184040CrossRefPubMedPubMedCentral
Zurück zum Zitat Ztaou S, Amalric M (2019) Contribution of cholinergic interneurons to striatal pathophysiology in Parkinson’s disease. Neurochem Int 126:1–10CrossRefPubMed Ztaou S, Amalric M (2019) Contribution of cholinergic interneurons to striatal pathophysiology in Parkinson’s disease. Neurochem Int 126:1–10CrossRefPubMed
Zurück zum Zitat Zucca FA, Segura-Aguilar J, Ferrari E, Munoz P, Paris I, Sulzer D, Sarna T, Casella L, Zecca L (2017) Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson’s disease. Prog Neurobiol 155:96–119CrossRefPubMed Zucca FA, Segura-Aguilar J, Ferrari E, Munoz P, Paris I, Sulzer D, Sarna T, Casella L, Zecca L (2017) Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson’s disease. Prog Neurobiol 155:96–119CrossRefPubMed
Zurück zum Zitat Zunke F, Moise AC, Belur NR, Gelyana E, Stojkovska I, Dzaferbegovic H, Toker NJ, Jeon S, Fredriksen K, Mazzulli JR (2018) Reversible conformational conversion of alpha-synuclein into toxic assemblies by glucosylceramide. Neuron 97(92–107):e110 Zunke F, Moise AC, Belur NR, Gelyana E, Stojkovska I, Dzaferbegovic H, Toker NJ, Jeon S, Fredriksen K, Mazzulli JR (2018) Reversible conformational conversion of alpha-synuclein into toxic assemblies by glucosylceramide. Neuron 97(92–107):e110
Metadaten
Titel
Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update—I. Hypokinetic-rigid movement disorders
verfasst von
Kurt A. Jellinger
Publikationsdatum
18.06.2019
Verlag
Springer Vienna
Erschienen in
Journal of Neural Transmission / Ausgabe 8/2019
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-019-02028-6

Weitere Artikel der Ausgabe 8/2019

Journal of Neural Transmission 8/2019 Zur Ausgabe

Neurology and Preclinical Neurological Studies - Original Article

Do complexing proteins provide mechanical protection for botulinum neurotoxins?

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.